data_2e70_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2e70 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 3.9 m120 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.758 0.313 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -72.87 -52.97 12.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.922 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 38.9 tp -65.45 -12.73 55.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 706' ' ' ILE . . . . . 0.527 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -65.78 108.22 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.195 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 122.95 -17.67 8.08 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.493 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -77.81 155.27 31.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.875 0.369 . . . . 0.0 110.868 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 64.6 m -85.6 112.33 20.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 33.7 m -112.84 145.7 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 22.0 ttp85 -119.71 112.23 19.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . 0.438 HG23 ' N ' ' A' ' 713' ' ' SER . 20.9 mt -57.81 138.13 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.148 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 713' ' ' SER . . . . . 0.438 ' N ' HG23 ' A' ' 712' ' ' ILE . 12.4 t -114.43 -28.39 7.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -113.99 177.13 4.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 75.42 179.56 44.59 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.456 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 716' ' ' PRO . . . . . 0.513 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.4 Cg_endo -69.86 -4.7 14.63 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.682 2.255 . . . . 0.0 112.315 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.513 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 56.1 m-85 -109.47 29.74 7.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.923 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -64.84 124.41 21.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.922 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 89.14 19.59 49.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.501 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 720' ' ' TYR . . . . . 0.451 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 18.4 m-85 -108.47 143.07 37.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.861 0.362 . . . . 0.0 110.921 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 27.9 mm -98.13 153.85 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.129 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -173.43 158.54 28.0 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.508 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 40.8 t -101.67 125.26 55.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.388 . . . . 0.0 111.136 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 27.0 t -61.47 111.12 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -90.46 -37.18 14.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.938 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -142.12 148.8 38.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.826 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -114.71 118.62 34.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.161 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.84 167.9 9.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.145 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -65.35 -42.7 92.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 73.6 m -125.25 19.36 8.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.853 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.05 173.19 16.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.182 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 732' ' ' ALA . . . . . 0.451 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -150.86 118.2 6.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.088 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 733' ' ' ARG . . . . . 0.421 ' HD3' ' CB ' ' A' ' 744' ' ' SER . 25.2 mmt180 -75.98 101.53 5.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 734' ' ' VAL . . . . . 0.46 HG11 ' N ' ' A' ' 735' ' ' GLU . 82.2 t -108.21 141.62 23.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 735' ' ' GLU . . . . . 0.46 ' N ' HG11 ' A' ' 734' ' ' VAL . 21.6 tt0 -102.95 104.2 14.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.86 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 736' ' ' LEU . . . . . 0.451 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 47.8 mt -51.79 159.3 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -91.1 -43.77 9.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.838 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 57.0 m -73.05 -69.15 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 43.0 p -65.7 -7.47 15.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.151 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 29.6 p 40.28 47.28 2.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -125.01 148.85 48.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 23.2 m -94.32 104.94 16.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.153 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 6.9 pt -115.12 146.9 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 744' ' ' SER . . . . . 0.421 ' CB ' ' HD3' ' A' ' 733' ' ' ARG . 2.5 t -94.87 132.13 40.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 40.2 t -142.73 147.35 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.1 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . 0.455 ' HB3' ' CG ' ' A' ' 749' ' ' ARG . 10.7 t0 -46.78 127.73 10.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.868 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -48.86 -37.01 18.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -74.72 -44.13 51.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.944 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 749' ' ' ARG . . . . . 0.455 ' CG ' ' HB3' ' A' ' 746' ' ' ASP . 84.0 mtt180 -55.11 -14.45 1.61 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.451 ' CD1' ' HB3' ' A' ' 732' ' ' ALA . 28.3 mt -92.84 129.21 38.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 22.2 m -101.6 95.66 6.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 2.8 p -43.46 118.82 1.45 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.162 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 11.2 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.178 179.893 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 10.4 p30 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.783 0.325 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.56 -61.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 21.4 tp -61.6 -15.59 40.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.967 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 706' ' ' ILE . . . . . 0.531 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -63.67 105.41 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.189 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 119.64 -12.09 11.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.493 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -75.68 160.89 29.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.927 0.394 . . . . 0.0 110.881 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 87.2 m -94.67 106.5 18.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 29.4 m -111.03 155.44 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.13 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -125.19 113.57 17.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . 0.469 HG12 ' CD2' ' A' ' 750' ' ' LEU . 64.3 mt -63.24 104.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.085 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 3.2 m -104.07 28.25 6.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.877 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -161.14 142.07 11.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 97.04 -166.08 23.26 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.525 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 716' ' ' PRO . . . . . 0.562 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.6 Cg_endo -69.75 -27.94 25.93 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.679 2.253 . . . . 0.0 112.342 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.562 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 53.7 m-85 -96.88 44.38 1.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.964 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -71.97 136.0 46.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.897 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 73.6 40.07 47.62 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.474 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 720' ' ' TYR . . . . . 0.458 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 17.7 m-85 -127.09 140.57 52.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.346 . . . . 0.0 110.966 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 36.2 mm -96.53 153.62 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.145 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -170.24 164.21 37.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.437 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 53.2 t -108.68 123.05 64.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 111.08 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 724' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 707' ' ' GLY . 46.7 t -65.17 111.68 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -93.09 -30.01 15.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -143.84 144.41 31.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.841 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 727' ' ' ALA . . . . . 0.443 ' CB ' HD11 ' A' ' 706' ' ' ILE . . . -108.61 114.89 29.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.07 157.24 17.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.099 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 729' ' ' GLU . . . . . 0.47 ' O ' ' NE ' ' A' ' 747' ' ' ARG . 27.6 tt0 -44.23 -73.8 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 43.5 m -103.35 20.78 17.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.74 173.26 16.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 732' ' ' ALA . . . . . 0.423 ' HB1' ' CD1' ' A' ' 750' ' ' LEU . . . -152.72 122.81 7.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.083 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 34.8 mmm-85 -75.0 96.62 3.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.888 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 734' ' ' VAL . . . . . 0.417 HG11 ' N ' ' A' ' 735' ' ' GLU . 73.7 t -100.76 145.7 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.145 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 735' ' ' GLU . . . . . 0.417 ' N ' HG11 ' A' ' 734' ' ' VAL . 10.0 tt0 -106.95 101.86 11.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.929 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 736' ' ' LEU . . . . . 0.458 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 53.5 mt -49.71 158.4 0.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -87.69 -48.62 7.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 68.5 m -61.67 -74.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 81.5 p -58.59 -28.9 66.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.135 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.8 m 61.81 49.3 4.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -137.57 152.07 49.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 18.9 m -84.98 137.69 32.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 13.1 pt -143.39 142.93 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.155 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 94.6 p -86.68 112.16 21.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.834 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.417 ' CG1' HD21 ' A' ' 750' ' ' LEU . 72.6 t -127.07 148.06 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.16 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -54.94 131.98 45.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 747' ' ' ARG . . . . . 0.47 ' NE ' ' O ' ' A' ' 729' ' ' GLU . 48.8 mtm180 -52.73 -28.82 23.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.875 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -77.55 -44.65 27.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.94 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -58.29 -14.41 7.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.469 ' CD2' HG12 ' A' ' 712' ' ' ILE . 14.4 mt -99.07 128.25 45.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.907 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 29.0 m -113.51 102.94 10.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.085 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 18.4 p -45.17 119.42 2.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.151 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 85.0 t . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.16 179.89 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 7.8 p30 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.804 0.335 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -78.88 -66.31 0.88 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . 0.432 HD12 ' CG ' ' A' ' 708' ' ' GLN . 27.2 tp -59.62 -14.1 12.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.914 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 706' ' ' ILE . . . . . 0.529 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -62.83 104.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.128 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 125.21 -16.03 7.22 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.472 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 708' ' ' GLN . . . . . 0.432 ' CG ' HD12 ' A' ' 705' ' ' LEU . 48.7 mm-40 -77.32 158.78 29.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.0 110.875 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 62.3 m -90.71 110.23 21.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 29.4 m -112.54 144.98 19.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.097 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 711' ' ' ARG . . . . . 0.462 ' CZ ' ' HA2' ' A' ' 719' ' ' GLY . 29.1 ttt85 -116.99 110.89 18.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.837 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 51.2 mt -59.62 114.3 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 42.4 p -108.4 18.05 21.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -147.98 137.44 22.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 99.99 -173.67 25.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.525 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 716' ' ' PRO . . . . . 0.566 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.4 Cg_endo -69.7 -16.75 37.96 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.764 2.309 . . . . 0.0 112.315 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.566 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 35.2 m-85 -98.2 23.22 8.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -58.36 135.61 57.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.855 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 719' ' ' GLY . . . . . 0.462 ' HA2' ' CZ ' ' A' ' 711' ' ' ARG . . . 79.15 28.62 53.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.475 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -116.6 142.68 46.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.905 0.384 . . . . 0.0 110.917 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 12.5 mm -101.94 148.96 6.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.132 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -167.26 160.67 34.4 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.487 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 54.8 t -101.56 123.19 54.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.899 0.38 . . . . 0.0 111.156 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 59.2 t -60.43 105.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.187 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -83.56 -37.4 23.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -143.11 148.96 37.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 727' ' ' ALA . . . . . 0.416 ' CB ' HD11 ' A' ' 706' ' ' ILE . . . -115.4 116.43 28.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -100.68 168.2 9.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.111 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -64.54 -45.72 85.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 72.6 m -122.97 19.4 10.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -159.87 173.32 16.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 732' ' ' ALA . . . . . 0.469 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -151.64 121.2 6.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.138 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -79.73 97.16 6.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 66.5 t -101.3 147.81 7.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -107.25 100.6 10.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 67.0 mt -50.76 159.43 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -95.6 -31.19 13.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 3.6 t -76.1 -62.43 1.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.876 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 81.0 p -75.89 -16.62 60.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 6.0 m 54.5 42.05 31.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -128.55 156.76 42.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 26.5 m -95.81 120.43 36.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 8.1 pt -125.84 145.52 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 96.3 p -86.53 121.76 29.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 60.5 t -134.36 147.52 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.128 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.57 129.11 37.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 -48.95 -32.05 8.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -77.68 -41.04 39.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.898 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -60.77 -9.54 4.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.469 ' CD1' ' HB3' ' A' ' 732' ' ' ALA . 13.4 mt -101.56 122.18 43.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 97.5 m -98.8 101.33 12.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.142 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 3.1 p -44.68 118.24 1.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.157 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 4.1 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.895 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.832 0.349 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -73.7 -54.1 8.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.887 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 48.6 tp -66.12 -14.44 61.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 706' ' ' ILE . . . . . 0.523 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -64.11 107.2 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.105 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 120.91 -14.72 9.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.505 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -73.72 158.78 34.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.841 0.353 . . . . 0.0 110.939 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 82.1 m -95.28 107.65 19.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 24.4 m -112.0 157.1 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -125.12 110.66 14.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . 0.422 HG12 ' CD2' ' A' ' 750' ' ' LEU . 34.9 mt -60.45 108.32 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 3.4 m -109.33 31.53 5.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.898 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 714' ' ' GLN . . . . . 0.448 ' CB ' ' HG2' ' A' ' 749' ' ' ARG . 33.9 mt-30 -160.03 131.04 5.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 102.64 -163.86 16.4 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.482 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 716' ' ' PRO . . . . . 0.539 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 54.3 Cg_endo -69.71 -34.89 13.85 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.707 2.271 . . . . 0.0 112.339 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.539 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 48.3 m-85 -88.31 38.64 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.949 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -71.4 132.86 45.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.915 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.36 33.57 31.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.481 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 720' ' ' TYR . . . . . 0.471 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 13.2 m-85 -122.41 141.06 52.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.936 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 14.1 mm -98.03 148.88 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.133 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -167.28 161.58 35.4 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.556 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 46.6 t -104.74 127.55 59.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.83 0.347 . . . . 0.0 111.139 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 724' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 707' ' ' GLY . 60.7 t -64.01 109.66 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.161 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.84 -35.81 15.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -143.25 149.2 37.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -110.18 115.78 30.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.131 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 1.1 m -103.53 154.97 18.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.162 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -41.07 -75.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.848 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 61.8 m -104.31 25.37 10.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.85 173.17 17.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.152 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 732' ' ' ALA . . . . . 0.461 ' HB2' ' CD1' ' A' ' 750' ' ' LEU . . . -151.87 122.11 7.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.076 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 53.6 mmm-85 -76.56 99.19 4.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 734' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 735' ' ' GLU . 87.6 t -105.16 142.89 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.107 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 735' ' ' GLU . . . . . 0.428 ' N ' HG12 ' A' ' 734' ' ' VAL . 43.6 tt0 -103.22 105.62 15.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 736' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 39.4 mt -50.22 160.14 0.39 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -95.15 -24.07 17.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 13.4 m -83.98 -71.24 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 31.3 p -67.94 -16.88 64.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.153 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 8.8 m 55.71 41.9 29.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.836 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -125.9 148.82 49.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.93 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 29.1 m -89.29 129.22 35.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.156 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 7.0 pt -135.4 145.77 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.122 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 88.6 p -87.57 117.49 26.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.415 HG11 ' N ' ' A' ' 746' ' ' ASP . 81.2 t -131.05 143.06 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.089 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . 0.415 ' N ' HG11 ' A' ' 745' ' ' VAL . 4.0 t0 -48.94 132.82 18.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -52.31 -32.97 40.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -75.84 -42.44 49.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 749' ' ' ARG . . . . . 0.448 ' HG2' ' CB ' ' A' ' 714' ' ' GLN . 90.6 mtt180 -58.06 -11.86 2.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.461 ' CD1' ' HB2' ' A' ' 732' ' ' ALA . 14.4 mt -101.07 127.2 47.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.94 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 60.6 m -112.16 103.51 11.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.132 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 14.5 p -42.63 116.78 0.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.148 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 87.4 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.148 179.873 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 20.9 p30 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.782 0.325 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -85.38 -55.99 3.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 48.9 tp -60.87 -13.64 16.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.929 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 706' ' ' ILE . . . . . 0.587 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -66.31 109.83 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.141 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.18 -12.66 12.71 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.489 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -76.94 164.05 26.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.923 0.392 . . . . 0.0 110.877 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 53.4 m -99.23 110.04 22.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.159 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 21.1 m -113.34 152.87 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.109 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -123.5 114.01 19.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.827 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 714' ' ' GLN . 20.1 mt -56.64 133.04 21.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.166 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 12.8 t -107.97 -29.4 9.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 714' ' ' GLN . . . . . 0.415 ' O ' ' CG2' ' A' ' 712' ' ' ILE . 26.7 mm-40 -112.85 -179.64 3.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 76.42 -179.03 49.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.541 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 716' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -10.95 29.83 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.641 2.227 . . . . 0.0 112.383 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -107.67 35.03 3.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.949 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -65.95 107.16 1.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.856 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 107.19 30.42 4.17 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.463 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -117.92 147.87 42.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 0.0 110.899 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 30.5 mm -98.8 147.12 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.171 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -165.17 161.49 34.86 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.501 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 48.9 t -106.06 129.47 59.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.382 . . . . 0.0 111.125 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 39.3 t -64.68 109.19 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -86.19 -38.49 17.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -143.86 149.77 37.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -113.06 118.19 34.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.82 164.31 11.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.174 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -56.08 -54.88 39.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 59.5 m -118.13 17.16 14.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.878 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.69 173.25 14.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.143 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 732' ' ' ALA . . . . . 0.463 ' HB1' ' CD1' ' A' ' 750' ' ' LEU . . . -150.98 120.46 6.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.076 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -79.02 97.38 6.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.837 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 99.3 t -102.28 144.32 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.167 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -104.84 101.99 11.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.866 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 31.3 mt -50.78 158.68 0.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.954 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -87.6 -55.4 3.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 22.2 t -61.31 -68.61 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 61.7 p -59.96 -30.26 68.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.101 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 12.0 t 59.54 48.36 9.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.901 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -133.7 149.28 51.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 17.0 m -88.53 110.86 21.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.17 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 743' ' ' ILE . . . . . 0.455 HD13 ' CG2' ' A' ' 745' ' ' VAL . 7.5 pt -118.69 147.75 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 95.5 p -89.97 126.25 35.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.455 ' CG2' HD13 ' A' ' 743' ' ' ILE . 57.6 t -138.21 141.87 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.138 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . 0.436 ' HB2' ' CG ' ' A' ' 749' ' ' ARG . 0.7 OUTLIER -48.54 127.58 13.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 26.2 mtm180 -45.36 -36.47 4.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.869 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -77.26 -44.42 29.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.958 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 749' ' ' ARG . . . . . 0.436 ' CG ' ' HB2' ' A' ' 746' ' ' ASP . 56.0 mtt180 -49.35 -28.18 4.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.463 ' CD1' ' HB1' ' A' ' 732' ' ' ALA . 13.6 mt -79.88 139.56 37.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 50.7 m -116.6 91.95 3.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.165 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 11.9 p -42.57 117.97 1.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.125 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 78.6 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 179.914 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 10.5 p30 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.783 0.325 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -85.94 -56.83 3.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . 0.429 HD11 ' CG ' ' A' ' 708' ' ' GLN . 47.6 tp -59.99 -13.25 10.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.901 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 706' ' ' ILE . . . . . 0.523 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -62.88 108.95 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 117.04 -13.82 14.03 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.49 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 708' ' ' GLN . . . . . 0.429 ' CG ' HD11 ' A' ' 705' ' ' LEU . 55.7 mm-40 -73.77 161.15 30.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.902 0.382 . . . . 0.0 110.895 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 709' ' ' THR . . . . . 0.458 HG22 ' CG2' ' A' ' 753' ' ' VAL . 97.2 m -97.64 106.85 19.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.167 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 27.1 m -112.69 156.64 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.151 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -127.27 115.13 18.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 44.6 mt -60.27 128.85 21.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.123 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 4.5 t -126.4 11.99 7.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.811 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 714' ' ' GLN . . . . . 0.464 ' CB ' ' HG2' ' A' ' 749' ' ' ARG . 24.5 mt-30 -138.72 128.08 24.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.948 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 105.85 -162.38 14.14 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.474 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 716' ' ' PRO . . . . . 0.55 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.5 Cg_endo -69.82 -32.88 17.47 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.735 2.29 . . . . 0.0 112.327 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.55 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 50.4 m-85 -91.82 42.72 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.957 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 39.5 tttm -78.24 97.4 5.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 120.96 34.67 0.88 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.505 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 720' ' ' TYR . . . . . 0.43 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 14.4 m-85 -127.51 147.57 50.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.857 0.36 . . . . 0.0 110.919 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 28.7 mm -98.22 154.11 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.093 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -172.44 151.43 14.44 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.461 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 41.2 t -94.89 129.29 45.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 111.134 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 38.4 t -63.79 109.08 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.143 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.0 mmpt? -85.37 -40.76 16.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -143.14 149.47 38.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.824 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -110.97 119.79 40.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.47 160.95 14.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.155 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -52.13 -62.17 1.81 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 38.3 m -111.57 22.43 15.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.829 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -158.17 173.23 17.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 732' ' ' ALA . . . . . 0.462 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -151.41 119.44 6.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -75.96 102.03 5.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 93.9 t -107.46 145.98 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -108.47 104.55 13.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 736' ' ' LEU . . . . . 0.43 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 38.0 mt -50.88 161.36 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -95.41 -27.89 15.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 3.9 m -82.39 -74.07 0.36 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 28.2 p -62.43 -19.2 63.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.152 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.2 m 57.09 41.63 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -123.78 146.72 48.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.906 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 18.4 m -90.78 108.2 19.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.118 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 9.5 pt -111.76 154.1 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.186 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 84.6 p -97.41 124.8 41.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.845 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 62.0 t -136.88 145.32 30.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.094 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -53.07 128.29 27.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 10.0 mtm105 -45.57 -34.77 3.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -77.05 -40.06 47.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 749' ' ' ARG . . . . . 0.464 ' HG2' ' CB ' ' A' ' 714' ' ' GLN . 63.9 mtt180 -56.8 -21.96 32.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.856 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.462 ' CD1' ' HB3' ' A' ' 732' ' ' ALA . 10.6 mt -88.83 139.22 30.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 88.8 m -119.46 96.03 5.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.167 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 7.3 p -39.81 118.25 0.84 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.165 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 753' ' ' VAL . . . . . 0.458 ' CG2' HG22 ' A' ' 709' ' ' THR . 98.6 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.124 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.773 0.32 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -75.45 -58.68 3.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 45.4 tp -60.08 -14.31 16.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 706' ' ' ILE . . . . . 0.52 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -64.17 108.55 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.62 -12.91 12.0 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -74.72 166.43 23.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.86 0.362 . . . . 0.0 110.937 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 709' ' ' THR . . . . . 0.466 HG22 ' CG2' ' A' ' 753' ' ' VAL . 62.7 m -100.39 110.19 22.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.182 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 26.3 m -114.25 158.48 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.169 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 23.4 ttm-85 -131.76 112.46 12.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 15.7 mt -57.22 133.34 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.131 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 15.9 t -109.21 -29.79 8.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -112.12 178.72 4.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 76.09 178.05 43.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.513 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 716' ' ' PRO . . . . . 0.51 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.9 Cg_endo -69.71 -11.06 30.12 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.652 2.234 . . . . 0.0 112.326 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.51 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 52.9 m-85 -103.9 29.12 6.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.927 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -62.04 135.29 57.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.901 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 77.33 37.39 31.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.48 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 720' ' ' TYR . . . . . 0.459 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 24.6 m-85 -124.1 140.22 53.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.845 0.355 . . . . 0.0 110.981 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 11.5 mm -98.81 148.76 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.134 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -167.98 169.66 41.49 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.449 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 53.3 t -112.13 126.87 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.88 0.371 . . . . 0.0 111.104 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 99.1 t -62.66 108.01 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.147 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -84.18 -40.21 18.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -142.63 150.28 40.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -108.57 118.52 36.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.066 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.11 156.97 17.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 729' ' ' GLU . . . . . 0.442 ' O ' ' NE ' ' A' ' 747' ' ' ARG . 6.3 tp10 -42.89 -75.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 25.1 m -103.0 18.92 20.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.72 173.36 14.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.178 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 732' ' ' ALA . . . . . 0.458 ' HB2' ' CD1' ' A' ' 750' ' ' LEU . . . -151.0 120.43 6.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.09 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 49.1 mmm-85 -75.53 101.46 4.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 87.1 t -107.47 144.23 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.159 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -104.32 104.18 14.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 736' ' ' LEU . . . . . 0.459 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 40.4 mt -52.69 161.43 0.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.949 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -90.66 -48.7 6.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.853 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 3.6 m -61.0 -72.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 77.4 p -61.2 -27.0 68.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.145 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 13.8 t 59.91 49.41 7.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -138.52 151.55 47.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 21.1 m -83.37 137.43 33.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.153 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 13.2 pt -142.79 148.52 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 81.0 p -92.12 119.39 31.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.449 HG11 ' N ' ' A' ' 746' ' ' ASP . 32.4 t -133.72 142.42 41.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . 0.449 ' N ' HG11 ' A' ' 745' ' ' VAL . 29.4 t0 -49.7 132.01 21.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 747' ' ' ARG . . . . . 0.442 ' NE ' ' O ' ' A' ' 729' ' ' GLU . 36.7 mtm180 -54.04 -20.44 6.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -87.89 -44.05 11.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 -56.88 -17.23 8.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.458 ' CD1' ' HB2' ' A' ' 732' ' ' ALA . 19.3 mt -89.83 134.32 34.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.978 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 21.6 m -115.02 90.85 3.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.097 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 16.2 p -41.84 118.56 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.097 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 753' ' ' VAL . . . . . 0.466 ' CG2' HG22 ' A' ' 709' ' ' THR . 98.3 t . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.189 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.836 0.35 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -53.41 -16.32 1.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 30.4 tp -101.8 -17.07 16.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.917 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 706' ' ' ILE . . . . . 0.504 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -67.46 103.12 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 123.21 -7.02 9.26 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.517 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -78.58 168.24 20.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.857 0.36 . . . . 0.0 110.921 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 52.8 m -102.91 105.45 15.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.115 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 35.8 m -109.86 158.47 9.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.114 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 14.4 ttm-85 -128.54 115.9 18.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.863 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 49.1 mt -59.26 142.64 14.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.151 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 18.0 t -118.84 -30.57 5.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 36.8 mm-40 -112.09 172.12 7.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 80.87 179.57 53.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.493 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 716' ' ' PRO . . . . . 0.481 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.7 Cg_endo -69.7 -8.39 23.47 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.755 2.303 . . . . 0.0 112.321 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.481 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 63.6 m-85 -106.94 27.43 8.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -60.89 130.94 48.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.26 37.8 20.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.473 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -125.65 142.77 51.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 0.0 110.906 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 26.4 mm -96.43 146.65 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.095 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -163.49 165.0 36.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.483 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 29.3 t -110.28 128.01 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 0.0 111.171 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 33.9 t -64.8 108.93 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -85.28 -38.34 18.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.881 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -145.12 149.48 35.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -108.32 117.67 34.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.158 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.03 155.75 18.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.151 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 729' ' ' GLU . . . . . 0.482 ' O ' ' NE ' ' A' ' 747' ' ' ARG . 24.7 tt0 -43.09 -74.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.914 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 58.5 m -103.24 24.6 10.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -158.05 173.2 17.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.161 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 732' ' ' ALA . . . . . 0.464 ' HB2' ' CD1' ' A' ' 750' ' ' LEU . . . -151.09 121.58 7.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.12 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -76.75 98.75 4.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 57.4 t -103.95 150.85 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.151 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -111.7 102.67 10.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.828 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 31.9 mt -50.88 157.39 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -95.34 -23.12 17.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.841 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 3.7 t -82.26 -68.68 0.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 34.4 p -70.97 -17.41 62.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.159 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 55.6 m 58.28 40.58 24.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.864 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -125.3 153.91 42.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 26.2 m -96.88 121.19 38.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 7.9 pt -126.36 155.46 36.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.131 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 92.0 p -97.44 121.13 38.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.43 144.62 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.152 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -48.98 131.16 18.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 747' ' ' ARG . . . . . 0.482 ' NE ' ' O ' ' A' ' 729' ' ' GLU . 36.9 mtm180 -50.74 -17.83 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -90.53 -37.42 13.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 31.4 mtm180 -61.96 -8.58 5.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.464 ' CD1' ' HB2' ' A' ' 732' ' ' ALA . 14.6 mt -100.77 135.6 41.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.968 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 33.1 m -118.7 93.63 4.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.168 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 6.4 p -39.9 121.23 1.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.098 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 96.4 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.152 179.851 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 9.5 m120 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.815 0.341 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -76.03 -55.21 5.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 52.0 tp -62.45 -16.07 53.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.959 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 706' ' ' ILE . . . . . 0.524 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -61.59 109.52 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 120.84 -20.69 8.6 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.486 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -73.0 157.45 37.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.897 0.38 . . . . 0.0 110.895 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 55.1 m -90.61 110.28 21.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.178 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . 0.436 HG13 ' CG2' ' A' ' 724' ' ' VAL . 33.1 m -111.65 146.94 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.129 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 711' ' ' ARG . . . . . 0.405 ' HB3' ' NH1' ' A' ' 711' ' ' ARG . 12.8 ttp-105 -117.44 113.14 21.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' A' ' 714' ' ' GLN . 35.6 mt -58.73 127.35 17.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 26.2 t -105.66 -26.51 11.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 714' ' ' GLN . . . . . 0.439 ' O ' ' CG2' ' A' ' 712' ' ' ILE . 9.8 mm-40 -113.95 175.53 5.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.882 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 77.41 177.27 46.11 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.516 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 716' ' ' PRO . . . . . 0.558 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 54.5 Cg_endo -69.69 -0.06 6.3 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.684 2.256 . . . . 0.0 112.398 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.558 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 58.0 m-85 -115.34 33.89 5.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.962 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -66.39 137.11 56.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 77.66 28.48 57.12 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.513 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -117.92 141.38 48.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 0.0 110.926 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 27.2 mm -96.67 155.01 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.147 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -173.81 157.78 26.29 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.489 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 44.1 t -100.95 129.91 51.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.881 0.372 . . . . 0.0 111.158 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 724' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 707' ' ' GLY . 23.1 t -65.14 113.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.123 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -91.49 -39.6 11.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -141.9 149.65 40.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 727' ' ' ALA . . . . . 0.465 ' CB ' HD12 ' A' ' 706' ' ' ILE . . . -110.57 115.88 30.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.44 157.51 16.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.157 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -45.96 -70.39 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.913 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 2.7 m -106.19 23.68 13.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.854 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.71 173.27 17.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 732' ' ' ALA . . . . . 0.445 ' HB1' ' CD1' ' A' ' 750' ' ' LEU . . . -151.36 119.6 6.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 25.1 mmt-85 -75.37 97.07 3.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.9 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 734' ' ' VAL . . . . . 0.417 HG22 ' CG2' ' A' ' 710' ' ' VAL . 69.6 t -103.89 145.23 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.16 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -104.24 101.36 11.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 32.5 mt -49.82 160.8 0.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -89.46 -62.8 1.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 2.1 t -53.85 -70.27 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.832 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 71.0 p -58.61 -35.09 71.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.142 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 6.6 t 65.77 41.31 3.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -128.7 145.79 51.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 20.7 m -85.1 133.3 34.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.144 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 743' ' ' ILE . . . . . 0.41 HD11 ' CG2' ' A' ' 745' ' ' VAL . 7.6 pt -141.61 149.46 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.189 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 97.5 p -91.5 117.93 30.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.41 ' CG2' HD11 ' A' ' 743' ' ' ILE . 21.5 t -130.46 142.77 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.152 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . 0.471 ' HB3' ' CG ' ' A' ' 749' ' ' ARG . 7.9 t0 -46.96 126.42 8.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.823 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -48.87 -35.09 13.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -76.96 -41.82 41.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 749' ' ' ARG . . . . . 0.471 ' CG ' ' HB3' ' A' ' 746' ' ' ASP . 79.2 mtt180 -57.21 -18.51 16.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.445 ' CD1' ' HB1' ' A' ' 732' ' ' ALA . 21.3 mt -89.07 127.67 35.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.956 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 18.3 m -101.11 97.99 8.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.132 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 4.6 p -43.36 118.69 1.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 5.8 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 179.881 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.793 0.33 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -73.49 -54.13 8.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.0 -12.48 18.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.899 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 706' ' ' ILE . . . . . 0.586 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -66.8 111.41 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.149 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.6 -17.39 11.14 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.473 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -73.62 154.12 39.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.857 0.361 . . . . 0.0 110.884 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 63.9 m -90.67 111.12 22.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.16 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 31.6 m -115.29 156.88 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.15 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -125.72 115.97 20.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 26.2 mt -56.33 142.98 10.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 713' ' ' SER . . . . . 0.55 ' C ' ' NE2' ' A' ' 714' ' ' GLN . 41.8 t -116.76 -36.77 3.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 714' ' ' GLN . . . . . 0.55 ' NE2' ' C ' ' A' ' 713' ' ' SER . 0.4 OUTLIER -105.37 -175.71 2.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.916 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 69.48 175.05 12.67 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.513 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 716' ' ' PRO . . . . . 0.562 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.2 Cg_endo -69.81 -4.38 13.95 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.677 2.252 . . . . 0.0 112.323 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.562 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 45.4 m-85 -108.2 29.42 7.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -64.06 136.74 57.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.933 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 77.53 32.12 47.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -118.59 145.91 45.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.81 0.338 . . . . 0.0 110.955 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 48.7 mm -97.0 147.8 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.149 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -170.47 148.72 11.78 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.467 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . 0.417 ' C ' HG12 ' A' ' 734' ' ' VAL . 55.1 t -97.3 126.26 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.367 . . . . 0.0 111.159 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 41.8 t -59.97 113.27 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -90.47 -39.08 12.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -142.51 144.89 33.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.847 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -106.11 118.03 35.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.091 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.38 155.35 20.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 729' ' ' GLU . . . . . 0.402 ' O ' ' NE ' ' A' ' 747' ' ' ARG . 15.6 tp10 -45.07 -71.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 73.5 m -106.91 26.29 10.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.826 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.44 173.37 17.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.16 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 732' ' ' ALA . . . . . 0.452 ' HB2' ' CD1' ' A' ' 750' ' ' LEU . . . -155.73 119.96 4.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.065 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 733' ' ' ARG . . . . . 0.458 ' HB3' ' CG2' ' A' ' 742' ' ' THR . 1.5 mpt_? -84.82 98.36 10.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 734' ' ' VAL . . . . . 0.417 HG12 ' C ' ' A' ' 723' ' ' VAL . 55.8 t -103.62 146.05 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.113 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -100.8 102.13 13.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 31.3 mt -49.84 157.61 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -85.47 -43.8 13.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 48.1 m -71.78 -72.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 67.9 p -58.64 -18.13 27.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.177 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 9.2 t 48.97 47.95 21.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -138.66 155.18 48.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 742' ' ' THR . . . . . 0.458 ' CG2' ' HB3' ' A' ' 733' ' ' ARG . 66.4 m -84.67 133.09 34.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.15 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 7.3 pt -135.62 138.3 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.159 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 45.8 p -80.84 120.94 25.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.896 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.45 HG13 ' CZ ' ' A' ' 749' ' ' ARG . 98.2 t -138.89 144.15 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.143 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -54.36 127.93 29.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 747' ' ' ARG . . . . . 0.402 ' NE ' ' O ' ' A' ' 729' ' ' GLU . 30.0 mtm180 -45.39 -40.14 7.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -71.7 -46.01 60.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 749' ' ' ARG . . . . . 0.45 ' CZ ' HG13 ' A' ' 745' ' ' VAL . 39.1 mtp180 -49.84 -26.49 4.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.452 ' CD1' ' HB2' ' A' ' 732' ' ' ALA . 16.5 mt -82.65 129.39 34.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.932 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 20.1 m -111.0 98.73 7.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.157 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 20.6 p -42.11 117.68 1.02 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.166 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 83.7 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.137 179.923 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 15.1 p30 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.823 0.344 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -73.91 -61.01 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 46.9 tp -62.44 -11.97 19.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.882 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 706' ' ' ILE . . . . . 0.535 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -65.5 108.65 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.115 179.872 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 119.69 -15.52 10.5 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.472 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -76.72 156.28 32.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.914 0.388 . . . . 0.0 110.934 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 53.9 m -89.3 113.95 25.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . 0.42 ' CA ' HG23 ' A' ' 753' ' ' VAL . 33.9 m -117.83 154.12 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 711' ' ' ARG . . . . . 0.443 ' HB2' ' CD1' ' A' ' 721' ' ' ILE . 31.2 ttm-85 -126.02 113.89 17.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . 0.449 HG12 ' CD2' ' A' ' 750' ' ' LEU . 40.8 mt -64.02 110.36 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.147 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 5.8 t -107.95 20.79 18.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.818 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 714' ' ' GLN . . . . . 0.408 ' CB ' ' HG2' ' A' ' 749' ' ' ARG . 13.5 mm100 -149.18 134.37 18.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.941 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 101.3 -164.77 18.09 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.51 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 716' ' ' PRO . . . . . 0.552 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 54.0 Cg_endo -69.76 -30.56 22.1 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.665 2.244 . . . . 0.0 112.359 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.552 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 44.7 m-85 -91.21 38.82 0.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -73.0 126.35 29.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.902 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 87.62 35.38 9.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.486 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -128.06 144.31 51.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 110.956 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 711' ' ' ARG . 39.1 mm -97.98 156.82 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.16 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -174.1 155.18 21.11 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.518 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 38.3 t -98.4 129.18 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.862 0.363 . . . . 0.0 111.174 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 724' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 707' ' ' GLY . 21.8 t -67.31 112.28 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.151 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.49 -39.97 10.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -137.63 146.55 44.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.856 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -115.73 116.42 28.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.147 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -100.48 169.43 9.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.094 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -66.65 -42.44 86.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 60.5 m -125.32 18.31 8.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.879 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -159.9 173.59 15.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.178 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 732' ' ' ALA . . . . . 0.468 ' HB1' ' CD1' ' A' ' 750' ' ' LEU . . . -153.52 122.31 6.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.102 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 733' ' ' ARG . . . . . 0.473 ' HD3' ' CB ' ' A' ' 744' ' ' SER . 11.1 mmt85 -79.11 98.33 6.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.99 138.81 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.165 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -98.01 101.92 13.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 57.9 mt -50.9 160.55 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.962 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -100.09 -38.47 8.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 4.6 m -66.68 -52.72 41.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 74.1 p -87.32 -23.58 24.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.137 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.7 m 63.77 41.78 6.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.865 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -126.95 154.21 44.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.939 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 21.3 m -92.23 122.13 34.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.153 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 6.8 pt -133.84 142.13 42.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.107 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 744' ' ' SER . . . . . 0.473 ' CB ' ' HD3' ' A' ' 733' ' ' ARG . 3.1 t -87.51 132.62 33.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 81.9 t -143.26 148.58 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.101 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -50.28 119.8 4.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -38.73 -44.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.843 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -65.92 -47.84 73.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 749' ' ' ARG . . . . . 0.408 ' HG2' ' CB ' ' A' ' 714' ' ' GLN . 91.4 mtt180 -49.53 -20.53 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.468 ' CD1' ' HB1' ' A' ' 732' ' ' ALA . 12.9 mt -92.34 122.7 35.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.937 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 39.4 m -103.17 107.19 17.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.187 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 1.6 p -44.63 121.08 2.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.14 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 753' ' ' VAL . . . . . 0.42 HG23 ' CA ' ' A' ' 710' ' ' VAL . 22.0 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.133 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 2.9 p30 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.784 0.326 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -79.67 -58.05 3.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 45.5 tp -59.99 -15.31 21.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.904 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 706' ' ' ILE . . . . . 0.529 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -62.08 108.84 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 120.13 -16.25 10.05 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.501 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -73.82 163.58 27.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.878 0.37 . . . . 0.0 110.922 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 44.9 m -99.49 110.2 22.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.158 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.48 157.38 14.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -127.01 110.43 12.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.869 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . 0.414 HG12 ' CD2' ' A' ' 750' ' ' LEU . 40.7 mt -60.63 105.5 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 55.2 m -103.4 24.39 11.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 714' ' ' GLN . . . . . 0.408 ' CB ' ' HG2' ' A' ' 749' ' ' ARG . 14.4 mp0 -152.75 147.29 25.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.884 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 90.44 -166.69 32.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.502 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 716' ' ' PRO . . . . . 0.543 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.9 Cg_endo -69.77 -29.95 23.0 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.697 2.265 . . . . 0.0 112.362 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.543 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 55.0 m-85 -93.15 45.46 1.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -75.02 135.79 41.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 75.95 39.65 32.51 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.458 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -125.98 140.68 52.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.854 0.359 . . . . 0.0 110.935 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 31.3 mm -96.63 149.2 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.119 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -169.05 158.71 31.44 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.5 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 48.5 t -101.88 130.96 50.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 0.0 111.131 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 42.8 t -67.32 107.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.083 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 725' ' ' LYS . . . . . 0.416 ' HA ' ' NZ ' ' A' ' 725' ' ' LYS . 0.0 OUTLIER -84.53 -38.9 19.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -147.05 145.61 29.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -104.86 121.45 43.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -106.51 158.96 16.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.146 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -45.35 -71.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 74.3 m -106.23 18.71 21.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.58 173.32 14.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 732' ' ' ALA . . . . . 0.47 ' HB1' ' CD1' ' A' ' 750' ' ' LEU . . . -150.19 120.32 7.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 -75.69 97.66 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 93.3 t -105.36 145.33 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.157 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -107.21 101.58 10.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 45.8 mt -49.64 158.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -89.32 -54.27 4.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 1.5 t -62.32 -67.94 0.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 81.8 p -61.72 -25.34 67.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.124 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 11.7 t 55.1 51.65 13.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.873 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -136.16 145.55 45.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.931 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 19.7 m -89.04 112.68 23.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 6.8 pt -121.48 155.67 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.157 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 90.9 p -97.39 124.2 41.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 50.1 t -134.52 149.9 30.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.17 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -54.98 126.58 25.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -45.06 -31.5 1.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.848 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -79.39 -42.38 25.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.891 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 749' ' ' ARG . . . . . 0.408 ' HG2' ' CB ' ' A' ' 714' ' ' GLN . 76.7 mtt180 -55.55 -13.8 1.75 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.93 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.47 ' CD1' ' HB1' ' A' ' 732' ' ' ALA . 17.8 mt -98.66 125.94 44.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 29.2 m -107.77 97.46 7.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.105 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 16.4 p -40.75 119.04 1.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.119 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 91.0 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.094 179.94 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.773 0.321 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -70.32 -47.24 62.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 17.5 tp -70.49 -15.47 62.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.94 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 706' ' ' ILE . . . . . 0.52 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -63.34 104.47 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 179.796 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 122.86 -13.42 8.59 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.491 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 49.6 mm-40 -75.99 161.65 28.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.89 0.376 . . . . 0.0 110.914 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 709' ' ' THR . . . . . 0.452 HG22 ' CG2' ' A' ' 753' ' ' VAL . 52.1 m -95.04 105.32 17.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 32.5 m -109.16 148.86 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -120.01 114.2 21.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . 0.436 HG23 ' N ' ' A' ' 713' ' ' SER . 27.6 mt -57.81 134.2 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 713' ' ' SER . . . . . 0.436 ' N ' HG23 ' A' ' 712' ' ' ILE . 61.5 p -109.12 -32.15 7.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -110.49 177.84 4.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 77.34 174.79 41.76 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.495 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 716' ' ' PRO . . . . . 0.519 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.6 Cg_endo -69.74 0.39 5.7 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.74 2.293 . . . . 0.0 112.319 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.519 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 67.4 m-85 -115.74 31.87 6.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 19.3 tttp -65.87 135.16 54.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.907 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.19 34.16 30.44 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.481 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -123.11 144.72 49.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.874 0.369 . . . . 0.0 110.952 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 25.4 mm -99.24 146.51 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.116 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -164.75 157.94 30.53 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.512 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . 0.415 ' C ' HG11 ' A' ' 734' ' ' VAL . 22.2 t -101.19 124.71 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.883 0.373 . . . . 0.0 111.154 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 40.7 t -61.78 112.76 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.141 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.58 -36.78 15.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -146.26 144.29 29.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.835 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -112.85 117.43 32.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.54 171.21 8.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.153 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 729' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 730' ' ' SER . 12.6 pt-20 -62.25 -47.92 82.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.424 ' N ' ' HG3' ' A' ' 729' ' ' GLU . 69.9 m -123.92 16.26 9.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.817 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.51 173.36 14.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.177 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 732' ' ' ALA . . . . . 0.459 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -154.86 117.46 4.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.105 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 733' ' ' ARG . . . . . 0.478 ' N ' ' HD3' ' A' ' 733' ' ' ARG . 0.9 OUTLIER -81.87 98.21 8.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.84 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 734' ' ' VAL . . . . . 0.415 HG11 ' C ' ' A' ' 723' ' ' VAL . 69.6 t -103.14 142.79 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.168 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -97.5 102.38 14.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 40.7 mt -52.17 157.54 1.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -88.36 -36.4 16.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 61.2 m -73.98 -72.09 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 60.0 p -62.71 -17.45 60.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.184 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 3.3 m 53.0 39.36 29.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -133.58 151.72 51.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 742' ' ' THR . . . . . 0.456 ' CG2' ' HB3' ' A' ' 733' ' ' ARG . 53.7 m -80.99 143.1 32.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.11 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 743' ' ' ILE . . . . . 0.418 HD11 ' CG2' ' A' ' 745' ' ' VAL . 11.6 pt -143.71 141.82 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.183 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 58.3 p -85.17 117.35 24.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.833 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.426 HG11 ' N ' ' A' ' 746' ' ' ASP . 39.2 t -134.79 141.19 43.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.132 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . 0.426 ' N ' HG11 ' A' ' 745' ' ' VAL . 19.3 t70 -51.4 128.14 21.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -46.51 -27.46 1.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -81.6 -45.35 15.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -53.32 -16.99 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.459 ' CD1' ' HB3' ' A' ' 732' ' ' ALA . 24.7 mt -89.21 135.96 33.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 89.8 m -118.06 93.59 4.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.091 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 3.4 p -41.44 135.33 2.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 753' ' ' VAL . . . . . 0.452 ' CG2' HG22 ' A' ' 709' ' ' THR . 97.2 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.104 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.799 0.333 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -82.0 -58.44 2.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . 0.414 HD13 ' CG ' ' A' ' 708' ' ' GLN . 51.3 tp -65.09 -11.55 40.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.925 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 706' ' ' ILE . . . . . 0.534 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -65.05 106.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.099 179.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 124.75 -17.31 7.28 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 708' ' ' GLN . . . . . 0.414 ' CG ' HD13 ' A' ' 705' ' ' LEU . 36.6 mm-40 -77.6 154.64 32.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.36 . . . . 0.0 110.931 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 68.2 m -86.4 112.95 21.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.182 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 29.4 m -114.87 148.13 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.15 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -122.81 113.39 19.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 31.0 mt -61.1 107.82 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 3.5 m -101.46 12.3 37.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -145.82 140.59 27.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 99.9 -168.58 21.44 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.497 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 716' ' ' PRO . . . . . 0.544 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.6 Cg_endo -69.77 -23.88 30.24 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.697 2.265 . . . . 0.0 112.354 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.544 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 55.3 m-85 -94.36 32.82 1.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.939 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -66.58 112.85 4.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.869 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 100.98 27.67 7.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.478 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 720' ' ' TYR . . . . . 0.453 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 10.9 m-85 -119.23 137.28 53.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 110.915 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.42 HG21 ' N ' ' A' ' 722' ' ' GLY . 12.4 mm -96.07 153.23 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.154 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 722' ' ' GLY . . . . . 0.42 ' N ' HG21 ' A' ' 721' ' ' ILE . . . -172.27 157.79 27.79 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.468 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 48.9 t -98.84 124.87 52.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.866 0.365 . . . . 0.0 111.12 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 43.8 t -60.54 108.63 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.133 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.12 -41.16 17.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.951 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -141.35 146.87 37.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -111.5 120.37 41.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.11 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.9 163.02 13.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.181 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.99 -46.74 87.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 69.8 m -124.33 19.68 8.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.883 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.29 173.31 17.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.168 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 732' ' ' ALA . . . . . 0.427 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -157.28 117.59 3.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.064 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 733' ' ' ARG . . . . . 0.462 ' N ' ' HD3' ' A' ' 733' ' ' ARG . 0.9 OUTLIER -80.48 98.72 7.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 61.2 t -102.81 142.27 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -98.15 102.61 14.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 736' ' ' LEU . . . . . 0.453 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 34.9 mt -52.47 157.08 1.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.9 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -91.27 -23.22 20.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 13.8 m -83.6 -70.48 0.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 70.3 p -73.32 -2.58 22.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.155 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.2 m 40.01 45.93 1.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -132.44 151.91 51.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 742' ' ' THR . . . . . 0.444 ' CG2' ' HB3' ' A' ' 733' ' ' ARG . 54.9 m -84.66 133.95 34.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.124 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 14.7 pt -136.43 140.46 43.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.137 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 54.7 p -83.0 118.16 23.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 48.9 t -135.79 143.9 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.132 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.54 128.61 32.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 27.5 mtm180 -46.53 -37.76 8.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -71.17 -44.33 65.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -54.86 -16.14 2.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.427 ' CD1' ' HB3' ' A' ' 732' ' ' ALA . 12.3 mt -98.14 126.37 43.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.934 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 92.1 m -103.95 102.85 12.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 10.4 p -42.63 121.16 1.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.116 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 10.8 t . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.166 179.927 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 13.5 p30 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.768 0.318 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.69 -37.62 65.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 48.0 tp -83.85 -14.84 50.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.935 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 706' ' ' ILE . . . . . 0.538 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -63.87 108.35 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.103 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 118.18 -14.84 12.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.438 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -73.16 162.23 29.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 0.0 110.891 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 709' ' ' THR . . . . . 0.462 HG22 ' CG2' ' A' ' 753' ' ' VAL . 95.5 m -96.66 109.78 22.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . 0.449 HG12 ' CG2' ' A' ' 724' ' ' VAL . 34.5 m -114.01 156.08 15.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.144 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 -123.98 117.43 24.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 23.4 mt -60.49 143.72 14.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.11 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 43.7 t -115.18 -34.78 4.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -113.37 179.98 3.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 78.34 177.09 47.87 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.526 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 716' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 1.79 4.13 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.726 2.284 . . . . 0.0 112.304 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.556 ' CD1' HD13 ' A' ' 736' ' ' LEU . 84.4 m-85 -120.33 35.82 4.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -67.5 139.3 57.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.883 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 71.76 32.96 63.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.466 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -119.21 158.52 25.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.843 0.354 . . . . 0.0 110.941 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 22.3 mm -107.88 147.55 12.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -163.23 162.21 34.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.491 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 37.1 t -106.35 129.72 59.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 0.0 111.157 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 724' ' ' VAL . . . . . 0.449 ' CG2' HG12 ' A' ' 710' ' ' VAL . 41.1 t -66.48 108.27 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.104 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -85.24 -41.12 15.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.921 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -143.06 151.24 40.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -111.94 116.88 31.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.65 158.85 16.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -50.0 -64.59 0.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.888 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 48.8 m -109.53 24.06 13.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.856 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -160.03 173.29 16.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.17 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 732' ' ' ALA . . . . . 0.441 ' HB2' ' CD1' ' A' ' 750' ' ' LEU . . . -152.61 121.42 6.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 11.3 mmt85 -74.43 102.3 4.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.837 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 56.0 t -108.93 139.27 32.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.106 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -106.65 106.01 16.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 736' ' ' LEU . . . . . 0.556 HD13 ' CD1' ' A' ' 717' ' ' TYR . 30.4 mt -53.57 157.5 2.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -87.66 -37.12 17.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 14.3 m -73.64 -66.32 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.808 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 20.0 p -68.06 -15.99 63.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.131 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.7 m 49.15 42.07 20.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -129.09 148.72 51.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 4.5 m -87.66 144.29 26.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.136 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 7.8 pt -151.79 144.72 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.154 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 91.3 p -87.56 118.88 27.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 65.4 t -133.47 143.13 39.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.127 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.23 129.71 21.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 24.1 mtm105 -49.58 -36.24 23.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.87 -45.03 65.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -53.86 -24.54 16.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.441 ' CD1' ' HB2' ' A' ' 732' ' ' ALA . 21.3 mt -84.03 144.65 28.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 6.3 m -124.42 99.24 6.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 9.1 p -47.83 118.99 2.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.113 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 753' ' ' VAL . . . . . 0.462 ' CG2' HG22 ' A' ' 709' ' ' THR . 95.8 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.104 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.79 0.328 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -74.55 -55.63 5.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . 0.4 HD13 ' CG ' ' A' ' 708' ' ' GLN . 48.1 tp -64.04 -12.24 36.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.904 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 706' ' ' ILE . . . . . 0.516 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -65.18 108.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 122.06 -13.08 9.11 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.519 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 708' ' ' GLN . . . . . 0.4 ' CG ' HD13 ' A' ' 705' ' ' LEU . 40.4 mm-40 -77.71 160.91 28.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 0.0 110.937 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 87.1 m -93.65 107.35 19.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.12 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 34.2 m -112.05 150.96 14.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.131 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 711' ' ' ARG . . . . . 0.444 ' CZ ' HD11 ' A' ' 721' ' ' ILE . 23.1 ttm-85 -122.21 115.69 22.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.845 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 713' ' ' SER . 25.8 mt -62.41 142.1 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.1 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 713' ' ' SER . . . . . 0.45 ' N ' HG22 ' A' ' 712' ' ' ILE . 29.1 t -122.21 -22.38 5.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.791 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -110.04 177.64 4.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 67.45 -179.54 15.72 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.463 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 716' ' ' PRO . . . . . 0.559 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.1 Cg_endo -69.82 -8.24 23.11 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.694 2.262 . . . . 0.0 112.299 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.559 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 38.4 m-85 -103.56 29.89 5.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.919 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -65.22 137.43 57.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 74.26 36.12 51.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.486 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 720' ' ' TYR . . . . . 0.453 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 6.3 m-85 -123.81 145.01 49.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.889 0.376 . . . . 0.0 110.89 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.444 HD11 ' CZ ' ' A' ' 711' ' ' ARG . 21.7 mm -98.58 154.04 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.144 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -173.79 161.02 31.35 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.478 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 54.3 t -105.16 125.1 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 111.145 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.41 108.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.119 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -84.79 -40.41 17.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.928 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -140.79 149.82 42.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.827 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 727' ' ' ALA . . . . . 0.447 ' CB ' HD11 ' A' ' 706' ' ' ILE . . . -113.5 118.66 35.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.081 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.73 164.37 11.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.149 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -57.16 -52.08 66.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 5.1 m -120.16 16.44 12.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.837 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.4 173.28 14.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.136 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 732' ' ' ALA . . . . . 0.435 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -151.93 121.02 6.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.11 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -80.53 98.4 7.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.866 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 90.0 t -103.32 140.72 20.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.123 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 735' ' ' GLU . . . . . 0.402 ' O ' ' CD ' ' A' ' 735' ' ' GLU . 6.5 tm-20 -99.34 99.43 10.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.849 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 736' ' ' LEU . . . . . 0.453 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 27.6 mt -49.71 157.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.948 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -90.34 -31.86 16.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.879 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 58.8 m -75.09 -65.12 0.92 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 71.8 p -74.09 -8.53 56.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.103 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 3.3 m 44.75 43.17 6.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -132.68 155.62 48.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 20.0 m -87.95 141.26 28.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.107 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 11.8 pt -146.53 145.06 20.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.157 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 89.5 p -87.66 118.1 26.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 92.9 t -132.71 142.86 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.147 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.55 128.57 17.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -49.62 -28.4 5.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.846 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -81.36 -42.55 20.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -55.25 -19.15 7.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.823 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.435 ' CD1' ' HB3' ' A' ' 732' ' ' ALA . 18.0 mt -88.85 134.86 33.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 751' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 752' ' ' THR . 86.4 m -116.07 89.7 3.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.147 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 752' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 751' ' ' THR . 9.4 p -36.52 118.09 0.53 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.135 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 87.7 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.101 179.942 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.83 0.348 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -71.85 -60.83 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 18.9 tp -62.26 -16.45 53.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.943 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 706' ' ' ILE . . . . . 0.523 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -60.84 110.41 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.083 179.838 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.86 -19.93 10.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.483 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -66.85 166.66 12.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 110.951 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 71.8 m -99.92 109.19 21.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.151 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . 0.445 HG11 ' CG2' ' A' ' 724' ' ' VAL . 35.7 m -113.12 151.5 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.161 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -123.39 114.44 20.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 34.7 mt -61.72 134.73 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 4.2 t -112.79 -31.66 6.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -102.01 176.37 5.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 71.7 177.95 28.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 716' ' ' PRO . . . . . 0.553 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.5 Cg_endo -69.78 -6.93 19.79 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.706 2.27 . . . . 0.0 112.307 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.553 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 44.5 m-85 -105.89 33.24 3.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -68.87 138.11 54.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.93 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 77.17 30.92 54.15 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.483 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -120.77 144.59 48.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.79 0.329 . . . . 0.0 110.948 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 38.7 mm -97.4 150.38 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.09 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -166.48 161.81 35.49 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.461 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 63.8 t -107.55 126.74 63.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.845 0.355 . . . . 0.0 111.175 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 724' ' ' VAL . . . . . 0.445 ' CG2' HG11 ' A' ' 710' ' ' VAL . 50.2 t -63.73 104.73 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -80.58 -41.66 23.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.894 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -143.34 146.6 33.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.89 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -106.17 115.33 30.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.121 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.18 160.65 14.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.114 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -47.03 -70.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 3.2 m -106.09 16.9 24.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.87 173.32 13.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 732' ' ' ALA . . . . . 0.468 ' HB2' ' CD1' ' A' ' 750' ' ' LEU . . . -150.68 120.91 7.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 54.9 mmm-85 -76.65 98.43 4.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 71.5 t -104.78 144.76 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -105.3 101.6 11.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 52.5 mt -50.55 161.18 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.904 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -95.5 -44.98 7.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 40.5 t -67.55 -64.7 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 82.1 p -70.75 -21.85 62.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 17.2 m 55.56 43.66 28.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.838 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -127.21 145.13 50.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.936 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 17.3 m -85.2 116.83 23.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.143 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 11.5 pt -124.37 149.62 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 82.2 p -94.23 118.19 31.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 62.0 t -127.85 144.92 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.15 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -50.72 125.93 14.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -44.61 -24.1 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -89.31 -42.86 11.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -53.85 -18.54 3.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.468 ' CD1' ' HB2' ' A' ' 732' ' ' ALA . 12.6 mt -91.25 134.41 34.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 19.6 m -112.39 90.76 3.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 10.2 p -41.13 118.31 0.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.099 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 86.0 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.078 179.939 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.768 0.318 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -77.08 -55.55 5.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . 0.405 HD11 ' CG ' ' A' ' 708' ' ' GLN . 45.6 tp -62.03 -14.12 32.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.894 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 706' ' ' ILE . . . . . 0.532 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -64.81 107.19 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 121.65 -16.09 9.03 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.482 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 708' ' ' GLN . . . . . 0.405 ' CG ' HD11 ' A' ' 705' ' ' LEU . 51.6 mm-40 -74.58 155.54 37.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.878 0.371 . . . . 0.0 110.907 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 55.9 m -92.34 110.43 21.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.162 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.3 161.97 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 711' ' ' ARG . . . . . 0.454 ' HB2' ' CD1' ' A' ' 721' ' ' ILE . 23.6 ttt-85 -129.85 117.89 20.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 26.5 mt -62.36 111.21 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.127 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 1.1 t -107.55 18.47 21.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -153.11 130.48 11.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.933 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 109.48 -171.79 15.48 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.467 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 716' ' ' PRO . . . . . 0.55 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 54.0 Cg_endo -69.73 -19.92 35.63 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.667 2.245 . . . . 0.0 112.384 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.55 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 70.3 m-85 -99.81 31.35 3.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 19.0 tttp -64.93 133.31 51.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.904 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 719' ' ' GLY . . . . . 0.434 ' HA2' ' CZ ' ' A' ' 711' ' ' ARG . . . 84.9 23.83 47.81 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.466 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -116.15 143.68 45.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.906 0.384 . . . . 0.0 110.911 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 711' ' ' ARG . 44.9 mm -97.82 162.46 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.162 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 722' ' ' GLY . . . . . 0.448 ' N ' ' CG2' ' A' ' 721' ' ' ILE . . . 178.2 153.07 10.83 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.501 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 42.7 t -97.57 129.75 47.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 111.124 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 48.1 t -64.89 108.84 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -85.42 -40.28 16.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -141.86 146.01 35.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.844 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -106.6 119.0 38.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.073 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.86 156.61 18.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.148 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -42.31 -74.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 58.6 m -103.53 19.68 19.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.16 173.34 14.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.122 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 732' ' ' ALA . . . . . 0.437 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -152.2 122.5 7.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.072 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 6.1 mmt85 -77.84 98.66 5.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.49 142.38 18.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.131 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -104.24 105.38 15.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 66.7 mt -49.76 157.66 0.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -88.74 -57.99 2.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.808 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 8.9 t -59.0 -70.8 0.14 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.849 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 69.6 p -58.39 -34.46 70.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.125 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 3.9 t 66.57 47.36 1.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -130.73 147.89 52.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 22.9 m -89.65 129.11 36.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.126 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 9.2 pt -137.32 150.75 26.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.161 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 744' ' ' SER . . . . . 0.402 ' C ' HG22 ' A' ' 745' ' ' VAL . 78.6 p -95.25 121.65 37.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 746' ' ' ASP . 19.0 t -134.54 143.87 36.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.119 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . 0.436 ' N ' HG13 ' A' ' 745' ' ' VAL . 2.7 t70 -49.51 126.18 12.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.921 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 -43.96 -29.55 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -81.12 -43.08 19.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 -53.4 -16.4 1.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' A' ' 732' ' ' ALA . 14.6 mt -92.17 145.38 24.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 90.5 m -125.86 95.68 4.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 3.3 p -38.39 118.46 0.72 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 93.6 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.105 179.912 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 2.4 m120 . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.831 0.348 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -76.61 -62.49 1.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . 0.45 HD12 ' CG ' ' A' ' 708' ' ' GLN . 33.9 tp -60.59 -10.91 5.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 706' ' ' ILE . . . . . 0.517 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -63.41 110.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 118.3 -21.28 10.1 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 708' ' ' GLN . . . . . 0.45 ' CG ' HD12 ' A' ' 705' ' ' LEU . 38.5 mm-40 -70.6 158.65 35.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.908 0.385 . . . . 0.0 110.945 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 87.6 m -91.28 109.47 20.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.127 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 26.9 m -112.51 146.6 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 711' ' ' ARG . . . . . 0.446 ' HB2' ' CD1' ' A' ' 721' ' ' ILE . 52.5 ttt180 -121.53 113.63 20.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 20.8 mt -56.86 143.67 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.161 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 17.0 t -118.25 -28.02 5.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -116.39 177.14 4.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.94 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 76.64 179.01 47.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.448 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 716' ' ' PRO . . . . . 0.495 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.3 Cg_endo -69.78 -1.94 9.34 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.679 2.252 . . . . 0.0 112.317 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.495 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 75.5 m-85 -115.02 31.66 6.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.975 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -65.95 131.41 46.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.904 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.79 29.06 44.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.447 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 720' ' ' TYR . . . . . 0.406 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 8.0 m-85 -116.16 142.58 46.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.832 0.349 . . . . 0.0 110.951 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 711' ' ' ARG . 30.9 mm -98.52 152.53 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.156 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 722' ' ' GLY . . . . . 0.407 ' N ' HG23 ' A' ' 721' ' ' ILE . . . -169.93 164.14 37.55 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.52 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 55.1 t -106.34 123.17 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.84 0.352 . . . . 0.0 111.137 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 724' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 707' ' ' GLY . 45.8 t -63.49 112.18 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -91.05 -37.06 13.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -142.69 144.21 32.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 727' ' ' ALA . . . . . 0.417 ' N ' HD12 ' A' ' 706' ' ' ILE . . . -113.49 113.77 25.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.142 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 1.2 m -96.21 170.29 9.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.168 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 729' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 730' ' ' SER . 14.4 pt-20 -63.15 -49.08 75.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.447 ' N ' ' HG3' ' A' ' 729' ' ' GLU . 60.4 m -120.68 14.2 11.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.89 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.6 173.27 14.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.127 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 732' ' ' ALA . . . . . 0.469 ' HB2' ' CD1' ' A' ' 750' ' ' LEU . . . -155.32 117.54 4.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.086 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 733' ' ' ARG . . . . . 0.46 ' N ' ' HD3' ' A' ' 733' ' ' ARG . 0.9 OUTLIER -81.36 102.99 10.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 53.4 t -111.7 137.55 43.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -90.11 101.61 14.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 736' ' ' LEU . . . . . 0.412 HD13 ' CD2' ' A' ' 717' ' ' TYR . 23.5 mt -50.89 156.37 1.0 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.896 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -85.12 -40.35 16.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 54.7 m -70.44 -70.55 0.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 43.5 p -61.74 -24.61 66.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.0 m 59.33 38.43 23.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -134.9 155.36 50.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.928 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 742' ' ' THR . . . . . 0.456 ' CG2' ' HB3' ' A' ' 733' ' ' ARG . 54.9 m -81.7 138.95 35.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.138 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 8.4 pt -141.18 143.25 28.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 84.2 p -85.13 112.33 20.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 47.9 t -127.29 147.22 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.097 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -58.04 127.64 33.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.905 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -48.16 -25.68 1.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -84.72 -43.54 14.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -58.5 -11.63 3.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.469 ' CD1' ' HB2' ' A' ' 732' ' ' ALA . 18.5 mt -96.1 127.4 42.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 20.4 m -104.47 103.58 13.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.117 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 2.3 p -47.88 121.3 4.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 6.3 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 179.938 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 2.2 m120 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.758 0.313 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -82.2 -49.19 10.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.915 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 37.7 tp -65.2 -10.44 31.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 706' ' ' ILE . . . . . 0.608 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.5 OUTLIER -70.04 108.69 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 179.86 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 120.4 -15.76 9.91 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.449 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -74.62 158.63 33.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.39 . . . . 0.0 110.918 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 98.6 m -94.76 107.33 19.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 31.6 m -111.02 160.68 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -130.43 108.74 10.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.84 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 72.0 mt -55.78 102.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.144 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 5.3 m -97.61 23.23 7.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 714' ' ' GLN . . . . . 0.418 ' CB ' ' HG2' ' A' ' 749' ' ' ARG . 12.2 mp0 -149.59 -179.23 6.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 59.82 -167.56 8.7 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.478 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 716' ' ' PRO . . . . . 0.566 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.2 Cg_endo -69.79 -33.38 16.59 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.679 2.252 . . . . 0.0 112.328 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 717' ' ' TYR . . . . . 0.566 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 50.1 m-85 -85.11 44.9 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -73.42 131.21 41.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.854 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.66 37.42 20.03 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.469 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -124.35 139.6 53.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.866 0.365 . . . . 0.0 110.901 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 39.1 mm -95.95 145.41 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.158 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -165.02 160.1 33.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 41.6 t -104.61 128.34 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 111.111 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.51 111.03 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.087 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.37 -34.54 15.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -146.44 146.98 30.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -108.12 115.55 30.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.11 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.64 159.06 15.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.173 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -47.68 -67.24 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 75.3 m -109.5 25.55 11.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.84 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.04 173.22 16.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.155 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 732' ' ' ALA . . . . . 0.47 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -150.8 120.02 6.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.102 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -73.79 96.52 2.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 95.9 t -103.61 140.19 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.135 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -100.69 100.82 11.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 51.5 mt -50.6 160.68 0.4 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -96.81 -37.51 10.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 35.4 t -70.51 -59.13 3.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 68.5 p -78.38 -23.27 46.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.149 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 5.0 m 60.42 40.42 17.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -125.34 150.17 47.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 26.9 m -91.03 111.61 23.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 6.9 pt -119.64 150.2 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.085 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 82.9 p -90.84 124.1 34.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . 0.417 HG13 ' N ' ' A' ' 746' ' ' ASP . 74.5 t -136.66 143.04 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.092 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 746' ' ' ASP . . . . . 0.417 ' N ' HG13 ' A' ' 745' ' ' VAL . 39.3 t0 -49.03 129.84 17.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 12.1 mtm105 -50.07 -29.44 8.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -79.32 -44.76 20.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 749' ' ' ARG . . . . . 0.418 ' HG2' ' CB ' ' A' ' 714' ' ' GLN . 37.5 mtm180 -54.87 -15.57 2.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 750' ' ' LEU . . . . . 0.47 ' CD1' ' HB3' ' A' ' 732' ' ' ALA . 23.8 mt -92.93 128.64 38.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 85.7 m -112.06 103.09 11.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 16.7 p -43.94 116.66 1.03 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 96.6 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 179.872 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 32.2 t -87.51 83.39 7.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.873 0.368 . . . . 0.0 110.823 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 1.5 t -120.1 149.97 41.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.872 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -154.7 174.55 33.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.464 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 1.3 t -81.8 125.04 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.882 0.372 . . . . 0.0 110.894 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 23.0 t -40.33 -48.13 2.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . -101.83 140.4 14.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.48 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -104.21 41.27 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.814 0.34 . . . . 0.0 110.885 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 82.5 p -118.16 125.26 49.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -103.04 -55.75 2.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.857 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -130.55 148.1 18.55 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.512 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 8.5 mtt85 -72.97 -62.08 1.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.804 0.335 . . . . 0.0 110.875 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -96.93 -127.93 5.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.506 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -107.52 103.4 12.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.83 0.348 . . . . 0.0 110.869 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 38.0 mtp85 -55.58 144.33 26.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -10.85 58.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -96.94 21.07 10.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -72.87 -52.97 12.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.922 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 38.9 tp -65.45 -12.73 55.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 706' ' ' ILE . . . . . 0.527 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -65.78 108.22 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.195 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 122.95 -17.67 8.08 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.493 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -77.81 155.27 31.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.875 0.369 . . . . 0.0 110.868 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 64.6 m -85.6 112.33 20.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 33.7 m -112.84 145.7 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 22.0 ttp85 -119.71 112.23 19.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . 0.438 HG23 ' N ' ' A' ' 713' ' ' SER . 20.9 mt -57.81 138.13 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.148 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 713' ' ' SER . . . . . 0.438 ' N ' HG23 ' A' ' 712' ' ' ILE . 12.4 t -114.43 -28.39 7.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -113.99 177.13 4.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 75.42 179.56 44.59 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.456 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 716' ' ' PRO . . . . . 0.513 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.4 Cg_endo -69.86 -4.7 14.63 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.682 2.255 . . . . 0.0 112.315 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.513 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 56.1 m-85 -109.47 29.74 7.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.923 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -64.84 124.41 21.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.922 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 89.14 19.59 49.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.501 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 720' ' ' TYR . . . . . 0.451 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 18.4 m-85 -108.47 143.07 37.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.861 0.362 . . . . 0.0 110.921 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 27.9 mm -98.13 153.85 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.129 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -173.43 158.54 28.0 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.508 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 40.8 t -101.67 125.26 55.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.388 . . . . 0.0 111.136 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 27.0 t -61.47 111.12 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -90.46 -37.18 14.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.938 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -142.12 148.8 38.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.826 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -114.71 118.62 34.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.161 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -102.84 167.9 9.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.145 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -65.35 -42.7 92.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 73.6 m -125.25 19.36 8.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.853 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.05 173.19 16.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.182 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 732' ' ' ALA . . . . . 0.451 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -150.86 118.2 6.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.088 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 733' ' ' ARG . . . . . 0.421 ' HD3' ' CB ' ' A' ' 744' ' ' SER . 25.2 mmt180 -75.98 101.53 5.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 734' ' ' VAL . . . . . 0.46 HG11 ' N ' ' A' ' 735' ' ' GLU . 82.2 t -108.21 141.62 23.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 735' ' ' GLU . . . . . 0.46 ' N ' HG11 ' A' ' 734' ' ' VAL . 21.6 tt0 -102.95 104.2 14.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.86 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 736' ' ' LEU . . . . . 0.451 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 47.8 mt -51.79 159.3 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -91.1 -43.77 9.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.838 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 57.0 m -73.05 -69.15 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 43.0 p -65.7 -7.47 15.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.151 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 29.6 p 40.28 47.28 2.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -125.01 148.85 48.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 23.2 m -94.32 104.94 16.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.153 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 6.9 pt -115.12 146.9 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 744' ' ' SER . . . . . 0.421 ' CB ' ' HD3' ' A' ' 733' ' ' ARG . 2.5 t -94.87 132.13 40.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 40.2 t -142.73 147.35 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.1 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . 0.455 ' HB3' ' CG ' ' A' ' 749' ' ' ARG . 10.7 t0 -46.78 127.73 10.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.868 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 26.9 mtm180 -48.86 -37.01 18.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -74.72 -44.13 51.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.944 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 749' ' ' ARG . . . . . 0.455 ' CG ' ' HB3' ' A' ' 746' ' ' ASP . 84.0 mtt180 -55.11 -14.45 1.61 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.451 ' CD1' ' HB3' ' A' ' 732' ' ' ALA . 28.3 mt -92.84 129.21 38.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 22.2 m -101.6 95.66 6.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 2.8 p -43.46 118.82 1.45 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.162 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 11.2 t -81.22 165.03 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.178 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 755' ' ' SER . . . -179.63 101.89 0.16 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.486 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 755' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 754' ' ' GLY . 59.5 p -35.46 131.74 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.902 0.382 . . . . 0.0 110.842 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -133.35 -177.31 4.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.852 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.869 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 48.3 t -102.45 143.0 32.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.856 0.36 . . . . 0.0 110.831 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 4.3 t -165.69 111.06 0.87 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.852 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -128.93 163.36 22.32 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.478 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 96.1 p -87.65 113.47 23.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 0.0 110.835 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 45.9 p -110.25 -50.43 2.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.852 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 138.07 -172.62 22.82 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.479 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 19.0 mtt -136.1 149.22 48.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.794 0.33 . . . . 0.0 110.878 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 2.3 m -129.52 166.81 18.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.872 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -74.95 168.9 19.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.873 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -96.17 107.47 3.52 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.463 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 698' ' ' ARG . . . . . 0.429 ' HD2' ' N ' ' A' ' 699' ' ' GLY . 6.1 ppt_? -100.03 -33.24 10.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.821 0.344 . . . . 0.0 110.87 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . 0.429 ' N ' ' HD2' ' A' ' 698' ' ' ARG . . . -72.5 -177.54 31.12 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.496 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.93 130.29 42.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.343 . . . . 0.0 110.872 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -48.74 106.73 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -76.93 98.97 5.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.847 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -117.44 27.97 8.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.56 -61.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 21.4 tp -61.6 -15.59 40.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.967 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 706' ' ' ILE . . . . . 0.531 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -63.67 105.41 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.189 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 119.64 -12.09 11.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.493 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -75.68 160.89 29.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.927 0.394 . . . . 0.0 110.881 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 87.2 m -94.67 106.5 18.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 29.4 m -111.03 155.44 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.13 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -125.19 113.57 17.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . 0.469 HG12 ' CD2' ' A' ' 750' ' ' LEU . 64.3 mt -63.24 104.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.085 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 3.2 m -104.07 28.25 6.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.877 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -161.14 142.07 11.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 97.04 -166.08 23.26 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.525 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 716' ' ' PRO . . . . . 0.562 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.6 Cg_endo -69.75 -27.94 25.93 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.679 2.253 . . . . 0.0 112.342 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.562 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 53.7 m-85 -96.88 44.38 1.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.964 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -71.97 136.0 46.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.897 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 73.6 40.07 47.62 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.474 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 720' ' ' TYR . . . . . 0.458 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 17.7 m-85 -127.09 140.57 52.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.346 . . . . 0.0 110.966 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 36.2 mm -96.53 153.62 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.145 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -170.24 164.21 37.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.437 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 53.2 t -108.68 123.05 64.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 111.08 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 724' ' ' VAL . . . . . 0.494 ' O ' ' N ' ' A' ' 707' ' ' GLY . 46.7 t -65.17 111.68 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -93.09 -30.01 15.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -143.84 144.41 31.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.841 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 727' ' ' ALA . . . . . 0.443 ' CB ' HD11 ' A' ' 706' ' ' ILE . . . -108.61 114.89 29.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.07 157.24 17.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.099 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 729' ' ' GLU . . . . . 0.47 ' O ' ' NE ' ' A' ' 747' ' ' ARG . 27.6 tt0 -44.23 -73.8 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 43.5 m -103.35 20.78 17.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.74 173.26 16.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 732' ' ' ALA . . . . . 0.423 ' HB1' ' CD1' ' A' ' 750' ' ' LEU . . . -152.72 122.81 7.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.083 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 34.8 mmm-85 -75.0 96.62 3.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.888 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 734' ' ' VAL . . . . . 0.417 HG11 ' N ' ' A' ' 735' ' ' GLU . 73.7 t -100.76 145.7 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.145 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 735' ' ' GLU . . . . . 0.417 ' N ' HG11 ' A' ' 734' ' ' VAL . 10.0 tt0 -106.95 101.86 11.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.929 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 736' ' ' LEU . . . . . 0.458 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 53.5 mt -49.71 158.4 0.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -87.69 -48.62 7.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 68.5 m -61.67 -74.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 81.5 p -58.59 -28.9 66.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.135 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.8 m 61.81 49.3 4.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -137.57 152.07 49.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 18.9 m -84.98 137.69 32.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 13.1 pt -143.39 142.93 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.155 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 94.6 p -86.68 112.16 21.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.834 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.417 ' CG1' HD21 ' A' ' 750' ' ' LEU . 72.6 t -127.07 148.06 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.16 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -54.94 131.98 45.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 747' ' ' ARG . . . . . 0.47 ' NE ' ' O ' ' A' ' 729' ' ' GLU . 48.8 mtm180 -52.73 -28.82 23.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.875 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -77.55 -44.65 27.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.94 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -58.29 -14.41 7.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.469 ' CD2' HG12 ' A' ' 712' ' ' ILE . 14.4 mt -99.07 128.25 45.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.907 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 29.0 m -113.51 102.94 10.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.085 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 18.4 p -45.17 119.42 2.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.151 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 85.0 t -63.47 -43.18 98.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.16 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -78.0 123.11 6.22 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.487 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 5.2 m -134.52 174.9 10.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.37 . . . . 0.0 110.852 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -117.94 162.57 17.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.913 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.871 -179.898 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 31.7 p -143.41 154.32 43.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.9 0.381 . . . . 0.0 110.846 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 62.6 m -123.3 149.49 44.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 107.43 72.96 0.81 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.506 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 12.1 t -94.93 112.68 24.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.373 . . . . 0.0 110.855 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 39.3 t -44.42 119.99 2.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.899 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 179.35 87.4 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.488 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -83.26 -37.91 22.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.764 0.316 . . . . 0.0 110.865 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 2.5 t -139.5 117.86 12.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -111.26 140.89 45.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -138.4 125.6 3.23 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.5 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 5.2 tpt85 -120.97 152.48 38.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.829 0.347 . . . . 0.0 110.892 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -66.4 -124.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.496 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -106.83 43.09 1.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 110.84 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -74.79 83.5 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -115.9 103.29 10.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -132.48 40.95 3.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -78.88 -66.31 0.88 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . 0.432 HD12 ' CG ' ' A' ' 708' ' ' GLN . 27.2 tp -59.62 -14.1 12.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.914 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 706' ' ' ILE . . . . . 0.529 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -62.83 104.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.128 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 125.21 -16.03 7.22 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.472 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 708' ' ' GLN . . . . . 0.432 ' CG ' HD12 ' A' ' 705' ' ' LEU . 48.7 mm-40 -77.32 158.78 29.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.0 110.875 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 62.3 m -90.71 110.23 21.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 29.4 m -112.54 144.98 19.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.097 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 711' ' ' ARG . . . . . 0.462 ' CZ ' ' HA2' ' A' ' 719' ' ' GLY . 29.1 ttt85 -116.99 110.89 18.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.837 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 51.2 mt -59.62 114.3 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 42.4 p -108.4 18.05 21.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -147.98 137.44 22.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 99.99 -173.67 25.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.525 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 716' ' ' PRO . . . . . 0.566 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.4 Cg_endo -69.7 -16.75 37.96 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.764 2.309 . . . . 0.0 112.315 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.566 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 35.2 m-85 -98.2 23.22 8.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -58.36 135.61 57.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.855 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 719' ' ' GLY . . . . . 0.462 ' HA2' ' CZ ' ' A' ' 711' ' ' ARG . . . 79.15 28.62 53.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.475 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -116.6 142.68 46.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.905 0.384 . . . . 0.0 110.917 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 12.5 mm -101.94 148.96 6.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.132 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -167.26 160.67 34.4 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.487 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 54.8 t -101.56 123.19 54.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.899 0.38 . . . . 0.0 111.156 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 59.2 t -60.43 105.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.187 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -83.56 -37.4 23.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -143.11 148.96 37.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 727' ' ' ALA . . . . . 0.416 ' CB ' HD11 ' A' ' 706' ' ' ILE . . . -115.4 116.43 28.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -100.68 168.2 9.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.111 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -64.54 -45.72 85.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 72.6 m -122.97 19.4 10.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -159.87 173.32 16.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 732' ' ' ALA . . . . . 0.469 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -151.64 121.2 6.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.138 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -79.73 97.16 6.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 66.5 t -101.3 147.81 7.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -107.25 100.6 10.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 67.0 mt -50.76 159.43 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -95.6 -31.19 13.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 3.6 t -76.1 -62.43 1.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.876 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 81.0 p -75.89 -16.62 60.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 6.0 m 54.5 42.05 31.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -128.55 156.76 42.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 26.5 m -95.81 120.43 36.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 8.1 pt -125.84 145.52 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 96.3 p -86.53 121.76 29.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 60.5 t -134.36 147.52 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.128 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.57 129.11 37.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 -48.95 -32.05 8.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -77.68 -41.04 39.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.898 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -60.77 -9.54 4.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.469 ' CD1' ' HB3' ' A' ' 732' ' ' ALA . 13.4 mt -101.56 122.18 43.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 97.5 m -98.8 101.33 12.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.142 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 3.1 p -44.68 118.24 1.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.157 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 4.1 t -80.54 168.6 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -74.96 145.46 33.69 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.523 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 49.7 m -105.78 143.95 33.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 110.844 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 -88.7 121.0 30.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.886 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.833 -179.865 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 78.9 p -143.71 132.59 22.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.876 0.369 . . . . 0.0 110.897 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 4.8 m -104.21 124.42 49.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -46.49 158.4 0.39 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.53 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 29.9 p -144.54 123.72 12.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.905 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 65.8 m -120.29 158.48 26.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.839 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 151.25 -111.56 0.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.468 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 24.5 mtm -41.49 132.06 2.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.808 0.337 . . . . 0.0 110.833 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 30.8 t -132.0 127.91 37.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 3.0 tpt85 -40.69 -60.92 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -48.89 124.97 13.5 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.472 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 10.6 mmt85 -38.87 137.53 0.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 110.877 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -116.78 112.81 2.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.465 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -43.47 148.79 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.771 0.32 . . . . 0.0 110.891 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.05 142.29 27.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.885 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -123.78 77.98 1.57 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.825 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -107.42 32.59 4.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -73.7 -54.1 8.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.887 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 48.6 tp -66.12 -14.44 61.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 706' ' ' ILE . . . . . 0.523 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -64.11 107.2 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.105 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 120.91 -14.72 9.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.505 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 -73.72 158.78 34.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.841 0.353 . . . . 0.0 110.939 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 82.1 m -95.28 107.65 19.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 24.4 m -112.0 157.1 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -125.12 110.66 14.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . 0.422 HG12 ' CD2' ' A' ' 750' ' ' LEU . 34.9 mt -60.45 108.32 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 3.4 m -109.33 31.53 5.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.898 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 714' ' ' GLN . . . . . 0.448 ' CB ' ' HG2' ' A' ' 749' ' ' ARG . 33.9 mt-30 -160.03 131.04 5.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 102.64 -163.86 16.4 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.482 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 716' ' ' PRO . . . . . 0.539 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 54.3 Cg_endo -69.71 -34.89 13.85 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.707 2.271 . . . . 0.0 112.339 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.539 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 48.3 m-85 -88.31 38.64 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.949 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -71.4 132.86 45.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.915 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.36 33.57 31.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.481 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 720' ' ' TYR . . . . . 0.471 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 13.2 m-85 -122.41 141.06 52.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.936 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 14.1 mm -98.03 148.88 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.133 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -167.28 161.58 35.4 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.556 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 46.6 t -104.74 127.55 59.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.83 0.347 . . . . 0.0 111.139 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 724' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 707' ' ' GLY . 60.7 t -64.01 109.66 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.161 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.84 -35.81 15.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -143.25 149.2 37.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -110.18 115.78 30.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.131 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 1.1 m -103.53 154.97 18.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.162 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -41.07 -75.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.848 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 61.8 m -104.31 25.37 10.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -157.85 173.17 17.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.152 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 732' ' ' ALA . . . . . 0.461 ' HB2' ' CD1' ' A' ' 750' ' ' LEU . . . -151.87 122.11 7.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.076 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 53.6 mmm-85 -76.56 99.19 4.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 734' ' ' VAL . . . . . 0.428 HG12 ' N ' ' A' ' 735' ' ' GLU . 87.6 t -105.16 142.89 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.107 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 735' ' ' GLU . . . . . 0.428 ' N ' HG12 ' A' ' 734' ' ' VAL . 43.6 tt0 -103.22 105.62 15.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 736' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 39.4 mt -50.22 160.14 0.39 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -95.15 -24.07 17.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 13.4 m -83.98 -71.24 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 31.3 p -67.94 -16.88 64.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.153 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 8.8 m 55.71 41.9 29.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.836 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -125.9 148.82 49.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.93 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 29.1 m -89.29 129.22 35.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.156 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 7.0 pt -135.4 145.77 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.122 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 88.6 p -87.57 117.49 26.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.415 HG11 ' N ' ' A' ' 746' ' ' ASP . 81.2 t -131.05 143.06 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.089 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . 0.415 ' N ' HG11 ' A' ' 745' ' ' VAL . 4.0 t0 -48.94 132.82 18.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -52.31 -32.97 40.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -75.84 -42.44 49.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 749' ' ' ARG . . . . . 0.448 ' HG2' ' CB ' ' A' ' 714' ' ' GLN . 90.6 mtt180 -58.06 -11.86 2.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.461 ' CD1' ' HB2' ' A' ' 732' ' ' ALA . 14.4 mt -101.07 127.2 47.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.94 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 60.6 m -112.16 103.51 11.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.132 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 14.5 p -42.63 116.78 0.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.148 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 87.4 t -62.23 -50.15 81.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.148 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 101.0 -157.98 19.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 34.1 m -97.94 148.91 22.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 0.0 110.844 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -74.51 121.26 21.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.863 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.888 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.539 -0.225 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 92.3 p -113.9 109.88 19.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.909 0.385 . . . . 0.0 110.887 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 94.1 p -172.7 166.12 5.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.8 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -155.6 95.91 0.15 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.51 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 3.0 m -152.71 151.94 31.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.913 0.387 . . . . 0.0 110.865 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 99.3 p -113.22 86.07 2.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.875 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 84.89 119.83 0.9 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.521 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -79.55 -39.93 30.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 0.0 110.909 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 79.4 p -88.41 111.7 22.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.805 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 11.7 mtm-85 -94.66 108.04 20.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -41.8 135.84 3.15 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.457 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -111.61 81.08 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.795 0.331 . . . . 0.0 110.893 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 700' ' ' ARG . . . -100.87 -142.89 13.31 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.522 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 700' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 699' ' ' GLY . 0.0 OUTLIER -34.98 149.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.825 0.345 . . . . 0.0 110.838 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 52.6 mmm-85 -126.57 100.05 6.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -97.32 79.86 2.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -88.45 34.51 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -85.38 -55.99 3.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 48.9 tp -60.87 -13.64 16.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.929 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 706' ' ' ILE . . . . . 0.587 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -66.31 109.83 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.141 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.18 -12.66 12.71 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.489 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -76.94 164.05 26.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.923 0.392 . . . . 0.0 110.877 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 53.4 m -99.23 110.04 22.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.159 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 21.1 m -113.34 152.87 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.109 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -123.5 114.01 19.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.827 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 714' ' ' GLN . 20.1 mt -56.64 133.04 21.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.166 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 12.8 t -107.97 -29.4 9.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 714' ' ' GLN . . . . . 0.415 ' O ' ' CG2' ' A' ' 712' ' ' ILE . 26.7 mm-40 -112.85 -179.64 3.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 76.42 -179.03 49.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.541 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 716' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -10.95 29.83 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.641 2.227 . . . . 0.0 112.383 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -107.67 35.03 3.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.949 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -65.95 107.16 1.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.856 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 107.19 30.42 4.17 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.463 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -117.92 147.87 42.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 0.0 110.899 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 30.5 mm -98.8 147.12 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.171 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -165.17 161.49 34.86 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.501 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 48.9 t -106.06 129.47 59.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.382 . . . . 0.0 111.125 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 39.3 t -64.68 109.19 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -86.19 -38.49 17.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -143.86 149.77 37.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -113.06 118.19 34.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.82 164.31 11.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.174 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -56.08 -54.88 39.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 59.5 m -118.13 17.16 14.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.878 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.69 173.25 14.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.143 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 732' ' ' ALA . . . . . 0.463 ' HB1' ' CD1' ' A' ' 750' ' ' LEU . . . -150.98 120.46 6.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.076 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -79.02 97.38 6.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.837 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 99.3 t -102.28 144.32 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.167 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -104.84 101.99 11.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.866 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 31.3 mt -50.78 158.68 0.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.954 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -87.6 -55.4 3.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 22.2 t -61.31 -68.61 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 61.7 p -59.96 -30.26 68.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.101 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 12.0 t 59.54 48.36 9.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.901 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -133.7 149.28 51.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 17.0 m -88.53 110.86 21.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.17 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 743' ' ' ILE . . . . . 0.455 HD13 ' CG2' ' A' ' 745' ' ' VAL . 7.5 pt -118.69 147.75 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 95.5 p -89.97 126.25 35.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.455 ' CG2' HD13 ' A' ' 743' ' ' ILE . 57.6 t -138.21 141.87 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.138 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . 0.436 ' HB2' ' CG ' ' A' ' 749' ' ' ARG . 0.7 OUTLIER -48.54 127.58 13.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 26.2 mtm180 -45.36 -36.47 4.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.869 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -77.26 -44.42 29.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.958 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 749' ' ' ARG . . . . . 0.436 ' CG ' ' HB2' ' A' ' 746' ' ' ASP . 56.0 mtt180 -49.35 -28.18 4.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.463 ' CD1' ' HB1' ' A' ' 732' ' ' ALA . 13.6 mt -79.88 139.56 37.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 50.7 m -116.6 91.95 3.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.165 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 11.9 p -42.57 117.97 1.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.125 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 78.6 t -65.53 -51.34 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -57.91 169.21 4.63 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.475 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 2.2 t -109.0 132.02 54.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.899 0.38 . . . . 0.0 110.866 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 14.5 tpp85 -91.22 85.95 6.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.855 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 27.3 m -58.64 -47.08 85.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.897 0.38 . . . . 0.0 110.85 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 99.2 p -124.71 122.65 38.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.875 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -115.91 83.46 0.34 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.504 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 4.0 t -105.48 -59.33 1.78 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.875 0.369 . . . . 0.0 110.902 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 20.4 t 46.84 42.09 11.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.851 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 70.67 131.44 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.512 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 2.3 ttt -134.2 -49.99 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.738 0.304 . . . . 0.0 110.84 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 6.9 t -71.1 118.28 13.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.907 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -110.85 112.76 24.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -128.84 157.2 21.45 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.491 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -83.39 141.45 31.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.936 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -122.36 137.45 11.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.468 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -53.6 -46.92 70.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 110.867 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 701' ' ' ARG . . . . . 0.418 ' NH1' ' HB2' ' A' ' 701' ' ' ARG . 7.6 mtp-105 -56.07 141.66 39.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.5 97.43 10.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -112.29 34.71 4.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -85.94 -56.83 3.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . 0.429 HD11 ' CG ' ' A' ' 708' ' ' GLN . 47.6 tp -59.99 -13.25 10.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.901 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 706' ' ' ILE . . . . . 0.523 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -62.88 108.95 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 117.04 -13.82 14.03 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.49 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 708' ' ' GLN . . . . . 0.429 ' CG ' HD11 ' A' ' 705' ' ' LEU . 55.7 mm-40 -73.77 161.15 30.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.902 0.382 . . . . 0.0 110.895 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 709' ' ' THR . . . . . 0.458 HG22 ' CG2' ' A' ' 753' ' ' VAL . 97.2 m -97.64 106.85 19.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.167 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 27.1 m -112.69 156.64 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.151 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -127.27 115.13 18.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 44.6 mt -60.27 128.85 21.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.123 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 4.5 t -126.4 11.99 7.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.811 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 714' ' ' GLN . . . . . 0.464 ' CB ' ' HG2' ' A' ' 749' ' ' ARG . 24.5 mt-30 -138.72 128.08 24.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.948 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 105.85 -162.38 14.14 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.474 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 716' ' ' PRO . . . . . 0.55 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.5 Cg_endo -69.82 -32.88 17.47 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.735 2.29 . . . . 0.0 112.327 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.55 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 50.4 m-85 -91.82 42.72 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.957 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 39.5 tttm -78.24 97.4 5.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 120.96 34.67 0.88 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.505 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 720' ' ' TYR . . . . . 0.43 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 14.4 m-85 -127.51 147.57 50.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.857 0.36 . . . . 0.0 110.919 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 28.7 mm -98.22 154.11 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.093 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -172.44 151.43 14.44 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.461 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 41.2 t -94.89 129.29 45.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 111.134 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 38.4 t -63.79 109.08 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.143 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.0 mmpt? -85.37 -40.76 16.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -143.14 149.47 38.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.824 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -110.97 119.79 40.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.47 160.95 14.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.155 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -52.13 -62.17 1.81 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 38.3 m -111.57 22.43 15.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.829 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -158.17 173.23 17.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 732' ' ' ALA . . . . . 0.462 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -151.41 119.44 6.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -75.96 102.03 5.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 93.9 t -107.46 145.98 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -108.47 104.55 13.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 736' ' ' LEU . . . . . 0.43 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 38.0 mt -50.88 161.36 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -95.41 -27.89 15.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 3.9 m -82.39 -74.07 0.36 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 28.2 p -62.43 -19.2 63.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.152 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.2 m 57.09 41.63 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -123.78 146.72 48.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.906 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 18.4 m -90.78 108.2 19.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.118 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 9.5 pt -111.76 154.1 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.186 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 84.6 p -97.41 124.8 41.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.845 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 62.0 t -136.88 145.32 30.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.094 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -53.07 128.29 27.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 10.0 mtm105 -45.57 -34.77 3.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -77.05 -40.06 47.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 749' ' ' ARG . . . . . 0.464 ' HG2' ' CB ' ' A' ' 714' ' ' GLN . 63.9 mtt180 -56.8 -21.96 32.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.856 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.462 ' CD1' ' HB3' ' A' ' 732' ' ' ALA . 10.6 mt -88.83 139.22 30.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 88.8 m -119.46 96.03 5.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.167 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 7.3 p -39.81 118.25 0.84 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.165 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 753' ' ' VAL . . . . . 0.458 ' CG2' HG22 ' A' ' 709' ' ' THR . 98.6 t -56.74 -44.3 81.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.124 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 171.66 73.7 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.511 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 58.2 m -83.82 84.93 7.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.877 0.37 . . . . 0.0 110.863 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -108.28 15.11 24.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.883 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.871 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 70.7 m -114.34 94.34 4.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.837 0.351 . . . . 0.0 110.808 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 3.0 m -140.98 137.86 33.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.814 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 145.06 117.65 1.14 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.477 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 56.0 p -169.04 167.34 10.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.854 0.359 . . . . 0.0 110.86 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 3.0 t -117.82 100.73 7.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.838 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . -132.79 -109.16 1.14 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.489 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 19.8 mmt -44.55 128.56 6.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.739 0.304 . . . . 0.0 110.888 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 4.0 m -128.84 92.14 3.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.861 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 28.1 ttt85 -57.28 104.2 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -43.92 -63.29 2.32 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.474 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -93.49 90.38 6.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 0.0 110.882 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -77.82 148.7 33.77 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.43 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -76.57 158.81 30.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.811 0.338 . . . . 0.0 110.877 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 701' ' ' ARG . . . . . 0.444 ' HD2' ' N ' ' A' ' 701' ' ' ARG . 1.7 mpt_? -72.39 104.01 3.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -120.36 48.4 1.59 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -86.92 34.52 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -75.45 -58.68 3.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 45.4 tp -60.08 -14.31 16.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 706' ' ' ILE . . . . . 0.52 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -64.17 108.55 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.62 -12.91 12.0 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -74.72 166.43 23.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.86 0.362 . . . . 0.0 110.937 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 709' ' ' THR . . . . . 0.466 HG22 ' CG2' ' A' ' 753' ' ' VAL . 62.7 m -100.39 110.19 22.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.182 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 26.3 m -114.25 158.48 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.169 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 23.4 ttm-85 -131.76 112.46 12.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 15.7 mt -57.22 133.34 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.131 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 15.9 t -109.21 -29.79 8.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -112.12 178.72 4.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 76.09 178.05 43.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.513 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 716' ' ' PRO . . . . . 0.51 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.9 Cg_endo -69.71 -11.06 30.12 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.652 2.234 . . . . 0.0 112.326 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.51 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 52.9 m-85 -103.9 29.12 6.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.927 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -62.04 135.29 57.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.901 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 77.33 37.39 31.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.48 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 720' ' ' TYR . . . . . 0.459 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 24.6 m-85 -124.1 140.22 53.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.845 0.355 . . . . 0.0 110.981 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 11.5 mm -98.81 148.76 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.134 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -167.98 169.66 41.49 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.449 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 53.3 t -112.13 126.87 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.88 0.371 . . . . 0.0 111.104 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 99.1 t -62.66 108.01 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.147 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -84.18 -40.21 18.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -142.63 150.28 40.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -108.57 118.52 36.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.066 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.11 156.97 17.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 729' ' ' GLU . . . . . 0.442 ' O ' ' NE ' ' A' ' 747' ' ' ARG . 6.3 tp10 -42.89 -75.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 25.1 m -103.0 18.92 20.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.72 173.36 14.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.178 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 732' ' ' ALA . . . . . 0.458 ' HB2' ' CD1' ' A' ' 750' ' ' LEU . . . -151.0 120.43 6.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.09 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 49.1 mmm-85 -75.53 101.46 4.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 87.1 t -107.47 144.23 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.159 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -104.32 104.18 14.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 736' ' ' LEU . . . . . 0.459 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 40.4 mt -52.69 161.43 0.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.949 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -90.66 -48.7 6.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.853 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 3.6 m -61.0 -72.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 77.4 p -61.2 -27.0 68.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.145 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 13.8 t 59.91 49.41 7.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -138.52 151.55 47.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 21.1 m -83.37 137.43 33.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.153 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 13.2 pt -142.79 148.52 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 81.0 p -92.12 119.39 31.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.449 HG11 ' N ' ' A' ' 746' ' ' ASP . 32.4 t -133.72 142.42 41.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . 0.449 ' N ' HG11 ' A' ' 745' ' ' VAL . 29.4 t0 -49.7 132.01 21.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 747' ' ' ARG . . . . . 0.442 ' NE ' ' O ' ' A' ' 729' ' ' GLU . 36.7 mtm180 -54.04 -20.44 6.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -87.89 -44.05 11.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 -56.88 -17.23 8.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.458 ' CD1' ' HB2' ' A' ' 732' ' ' ALA . 19.3 mt -89.83 134.32 34.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.978 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 21.6 m -115.02 90.85 3.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.097 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 16.2 p -41.84 118.56 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.097 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 753' ' ' VAL . . . . . 0.466 ' CG2' HG22 ' A' ' 709' ' ' THR . 98.3 t -59.14 -55.96 20.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.189 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 755' ' ' SER . . . -62.27 -148.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.52 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 755' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 754' ' ' GLY . 72.4 m -37.88 142.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.819 0.342 . . . . 0.0 110.872 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -105.49 125.45 51.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.89 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 -179.885 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 24.5 p -72.02 122.84 21.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 110.881 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 14.4 t -59.2 135.18 57.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.84 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 171.37 102.64 0.16 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.509 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 70.1 m -124.01 150.51 44.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.889 0.376 . . . . 0.0 110.861 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 9.2 m -76.12 133.15 40.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.914 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . -83.5 161.89 39.29 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.522 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.67 173.04 7.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.807 0.337 . . . . 0.0 110.889 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 70.0 m -75.58 147.61 39.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.837 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.02 -3.64 8.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.862 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -112.58 -152.98 11.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.449 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -101.91 43.54 1.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.859 0.361 . . . . 0.0 110.84 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -93.11 88.13 1.25 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.511 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -114.71 140.87 48.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.765 0.317 . . . . 0.0 110.887 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 701' ' ' ARG . . . . . 0.407 ' NH1' ' HB2' ' A' ' 701' ' ' ARG . 20.4 mtm105 -125.44 165.7 17.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -110.87 -27.36 8.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 11.0 p-10 -62.49 -13.61 32.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.922 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -53.41 -16.32 1.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 30.4 tp -101.8 -17.07 16.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.917 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 706' ' ' ILE . . . . . 0.504 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -67.46 103.12 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 123.21 -7.02 9.26 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.517 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -78.58 168.24 20.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.857 0.36 . . . . 0.0 110.921 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 52.8 m -102.91 105.45 15.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.115 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 35.8 m -109.86 158.47 9.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.114 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 14.4 ttm-85 -128.54 115.9 18.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.863 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 49.1 mt -59.26 142.64 14.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.151 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 18.0 t -118.84 -30.57 5.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 36.8 mm-40 -112.09 172.12 7.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 80.87 179.57 53.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.493 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 716' ' ' PRO . . . . . 0.481 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.7 Cg_endo -69.7 -8.39 23.47 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.755 2.303 . . . . 0.0 112.321 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.481 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 63.6 m-85 -106.94 27.43 8.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -60.89 130.94 48.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.26 37.8 20.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.473 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -125.65 142.77 51.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 0.0 110.906 -179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 26.4 mm -96.43 146.65 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.095 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -163.49 165.0 36.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.483 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 29.3 t -110.28 128.01 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 0.0 111.171 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 33.9 t -64.8 108.93 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -85.28 -38.34 18.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.881 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -145.12 149.48 35.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -108.32 117.67 34.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.158 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.03 155.75 18.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.151 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 729' ' ' GLU . . . . . 0.482 ' O ' ' NE ' ' A' ' 747' ' ' ARG . 24.7 tt0 -43.09 -74.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.914 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 58.5 m -103.24 24.6 10.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -158.05 173.2 17.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.161 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 732' ' ' ALA . . . . . 0.464 ' HB2' ' CD1' ' A' ' 750' ' ' LEU . . . -151.09 121.58 7.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.12 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -76.75 98.75 4.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 57.4 t -103.95 150.85 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.151 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -111.7 102.67 10.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.828 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 31.9 mt -50.88 157.39 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 18.6 m170 -95.34 -23.12 17.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.841 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 3.7 t -82.26 -68.68 0.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 34.4 p -70.97 -17.41 62.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.159 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 55.6 m 58.28 40.58 24.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.864 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -125.3 153.91 42.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 26.2 m -96.88 121.19 38.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 7.9 pt -126.36 155.46 36.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.131 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 92.0 p -97.44 121.13 38.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 21.7 t -134.43 144.62 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.152 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -48.98 131.16 18.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 747' ' ' ARG . . . . . 0.482 ' NE ' ' O ' ' A' ' 729' ' ' GLU . 36.9 mtm180 -50.74 -17.83 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -90.53 -37.42 13.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 31.4 mtm180 -61.96 -8.58 5.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.464 ' CD1' ' HB2' ' A' ' 732' ' ' ALA . 14.6 mt -100.77 135.6 41.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.968 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 33.1 m -118.7 93.63 4.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.168 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 6.4 p -39.9 121.23 1.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.098 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 96.4 t -67.42 -55.4 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.152 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -57.79 131.98 52.32 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.454 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 44.5 m -79.99 122.23 26.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.908 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 -89.63 8.21 32.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.844 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.943 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 71.3 p -65.17 164.82 12.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.87 0.367 . . . . 0.0 110.85 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 89.6 p -107.73 117.97 35.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.901 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 61.78 62.53 5.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.473 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 67.1 p -83.37 138.02 33.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 110.823 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 40.9 p -157.78 166.79 31.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.848 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 167.42 167.82 28.67 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.471 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.36 173.67 11.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.783 0.325 . . . . 0.0 110.895 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 695' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 696' ' ' ARG . 40.4 t -72.9 -54.42 8.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 695' ' ' SER . 17.9 ttm-85 -36.16 -67.4 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.86 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -45.21 -48.2 10.55 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.539 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -62.97 130.38 44.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.359 . . . . 0.0 110.857 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -86.24 104.93 2.93 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.487 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 2.9 ptp85 -44.19 135.5 4.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.745 0.307 . . . . 0.0 110.877 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -113.41 126.46 55.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.875 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.34 46.21 2.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -91.82 24.45 3.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -76.03 -55.21 5.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 52.0 tp -62.45 -16.07 53.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.959 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 706' ' ' ILE . . . . . 0.524 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -61.59 109.52 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 120.84 -20.69 8.6 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.486 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -73.0 157.45 37.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.897 0.38 . . . . 0.0 110.895 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 55.1 m -90.61 110.28 21.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.178 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . 0.436 HG13 ' CG2' ' A' ' 724' ' ' VAL . 33.1 m -111.65 146.94 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.129 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 711' ' ' ARG . . . . . 0.405 ' HB3' ' NH1' ' A' ' 711' ' ' ARG . 12.8 ttp-105 -117.44 113.14 21.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' A' ' 714' ' ' GLN . 35.6 mt -58.73 127.35 17.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 26.2 t -105.66 -26.51 11.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 714' ' ' GLN . . . . . 0.439 ' O ' ' CG2' ' A' ' 712' ' ' ILE . 9.8 mm-40 -113.95 175.53 5.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.882 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 77.41 177.27 46.11 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.516 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 716' ' ' PRO . . . . . 0.558 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 54.5 Cg_endo -69.69 -0.06 6.3 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.684 2.256 . . . . 0.0 112.398 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.558 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 58.0 m-85 -115.34 33.89 5.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.962 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -66.39 137.11 56.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 77.66 28.48 57.12 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.513 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -117.92 141.38 48.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 0.0 110.926 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 27.2 mm -96.67 155.01 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.147 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -173.81 157.78 26.29 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.489 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 44.1 t -100.95 129.91 51.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.881 0.372 . . . . 0.0 111.158 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 724' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 707' ' ' GLY . 23.1 t -65.14 113.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.123 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -91.49 -39.6 11.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -141.9 149.65 40.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 727' ' ' ALA . . . . . 0.465 ' CB ' HD12 ' A' ' 706' ' ' ILE . . . -110.57 115.88 30.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.44 157.51 16.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.157 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -45.96 -70.39 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.913 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 2.7 m -106.19 23.68 13.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.854 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.71 173.27 17.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 732' ' ' ALA . . . . . 0.445 ' HB1' ' CD1' ' A' ' 750' ' ' LEU . . . -151.36 119.6 6.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 25.1 mmt-85 -75.37 97.07 3.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.9 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 734' ' ' VAL . . . . . 0.417 HG22 ' CG2' ' A' ' 710' ' ' VAL . 69.6 t -103.89 145.23 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.16 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -104.24 101.36 11.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 32.5 mt -49.82 160.8 0.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -89.46 -62.8 1.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 2.1 t -53.85 -70.27 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.832 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 71.0 p -58.61 -35.09 71.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.142 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 6.6 t 65.77 41.31 3.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -128.7 145.79 51.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 20.7 m -85.1 133.3 34.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.144 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 743' ' ' ILE . . . . . 0.41 HD11 ' CG2' ' A' ' 745' ' ' VAL . 7.6 pt -141.61 149.46 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.189 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 97.5 p -91.5 117.93 30.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.41 ' CG2' HD11 ' A' ' 743' ' ' ILE . 21.5 t -130.46 142.77 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.152 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . 0.471 ' HB3' ' CG ' ' A' ' 749' ' ' ARG . 7.9 t0 -46.96 126.42 8.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.823 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -48.87 -35.09 13.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -76.96 -41.82 41.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 749' ' ' ARG . . . . . 0.471 ' CG ' ' HB3' ' A' ' 746' ' ' ASP . 79.2 mtt180 -57.21 -18.51 16.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.445 ' CD1' ' HB1' ' A' ' 732' ' ' ALA . 21.3 mt -89.07 127.67 35.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.956 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 18.3 m -101.11 97.99 8.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.132 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 4.6 p -43.36 118.69 1.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 5.8 t -81.08 167.45 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 130.87 129.05 3.03 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.521 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 6.4 t -85.72 122.16 29.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.818 0.342 . . . . 0.0 110.884 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.0 132.0 49.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.932 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 14.1 m -125.06 87.36 2.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.853 0.359 . . . . 0.0 110.866 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 13.6 m -94.64 94.31 8.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -76.95 -175.55 42.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.516 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 49.7 m -111.97 139.97 47.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.898 0.38 . . . . 0.0 110.85 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 9.1 t -98.93 174.69 6.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.883 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . -164.49 106.46 0.27 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.493 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 59.0 mtp -56.91 106.75 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.778 0.323 . . . . 0.0 110.873 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 16.6 m -109.47 119.37 39.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -114.38 42.51 2.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.86 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -134.24 -166.93 11.38 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.466 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -105.92 43.13 1.16 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.856 0.36 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -71.04 -39.31 63.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.474 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -91.02 155.1 18.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.752 0.311 . . . . 0.0 110.924 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 43.3 mtt85 -108.91 155.32 20.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -63.11 95.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.856 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -116.35 20.74 14.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -73.49 -54.13 8.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.0 -12.48 18.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.899 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 706' ' ' ILE . . . . . 0.586 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -66.8 111.41 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.149 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.6 -17.39 11.14 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.473 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -73.62 154.12 39.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.857 0.361 . . . . 0.0 110.884 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 63.9 m -90.67 111.12 22.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.16 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 31.6 m -115.29 156.88 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.15 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -125.72 115.97 20.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 26.2 mt -56.33 142.98 10.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 713' ' ' SER . . . . . 0.55 ' C ' ' NE2' ' A' ' 714' ' ' GLN . 41.8 t -116.76 -36.77 3.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 714' ' ' GLN . . . . . 0.55 ' NE2' ' C ' ' A' ' 713' ' ' SER . 0.4 OUTLIER -105.37 -175.71 2.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.916 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 69.48 175.05 12.67 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.513 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 716' ' ' PRO . . . . . 0.562 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.2 Cg_endo -69.81 -4.38 13.95 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.677 2.252 . . . . 0.0 112.323 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.562 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 45.4 m-85 -108.2 29.42 7.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -64.06 136.74 57.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.933 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 77.53 32.12 47.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -118.59 145.91 45.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.81 0.338 . . . . 0.0 110.955 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 48.7 mm -97.0 147.8 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.149 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -170.47 148.72 11.78 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.467 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . 0.417 ' C ' HG12 ' A' ' 734' ' ' VAL . 55.1 t -97.3 126.26 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.367 . . . . 0.0 111.159 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 41.8 t -59.97 113.27 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -90.47 -39.08 12.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -142.51 144.89 33.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.847 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -106.11 118.03 35.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.091 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.38 155.35 20.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 729' ' ' GLU . . . . . 0.402 ' O ' ' NE ' ' A' ' 747' ' ' ARG . 15.6 tp10 -45.07 -71.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 73.5 m -106.91 26.29 10.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.826 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.44 173.37 17.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.16 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 732' ' ' ALA . . . . . 0.452 ' HB2' ' CD1' ' A' ' 750' ' ' LEU . . . -155.73 119.96 4.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.065 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 733' ' ' ARG . . . . . 0.458 ' HB3' ' CG2' ' A' ' 742' ' ' THR . 1.5 mpt_? -84.82 98.36 10.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 734' ' ' VAL . . . . . 0.417 HG12 ' C ' ' A' ' 723' ' ' VAL . 55.8 t -103.62 146.05 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.113 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -100.8 102.13 13.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 31.3 mt -49.84 157.61 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -85.47 -43.8 13.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 48.1 m -71.78 -72.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 67.9 p -58.64 -18.13 27.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.177 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 9.2 t 48.97 47.95 21.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -138.66 155.18 48.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 742' ' ' THR . . . . . 0.458 ' CG2' ' HB3' ' A' ' 733' ' ' ARG . 66.4 m -84.67 133.09 34.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.15 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 7.3 pt -135.62 138.3 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.159 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 45.8 p -80.84 120.94 25.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.896 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.45 HG13 ' CZ ' ' A' ' 749' ' ' ARG . 98.2 t -138.89 144.15 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.143 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -54.36 127.93 29.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 747' ' ' ARG . . . . . 0.402 ' NE ' ' O ' ' A' ' 729' ' ' GLU . 30.0 mtm180 -45.39 -40.14 7.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -71.7 -46.01 60.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 749' ' ' ARG . . . . . 0.45 ' CZ ' HG13 ' A' ' 745' ' ' VAL . 39.1 mtp180 -49.84 -26.49 4.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.452 ' CD1' ' HB2' ' A' ' 732' ' ' ALA . 16.5 mt -82.65 129.39 34.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.932 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 20.1 m -111.0 98.73 7.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.157 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 20.6 p -42.11 117.68 1.02 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.166 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 83.7 t -65.38 -45.25 93.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.137 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -40.54 117.97 1.06 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 70.5 m -92.56 177.82 6.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.89 0.376 . . . . 0.0 110.835 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -134.73 177.11 8.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.829 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 -179.852 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 5.1 m 47.23 46.87 16.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.878 0.37 . . . . 0.0 110.859 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 12.4 m -102.91 41.08 1.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -167.47 -106.7 0.19 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.447 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 7.4 t -70.11 152.11 44.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.877 0.37 . . . . 0.0 110.862 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 3.6 m -164.19 176.18 9.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.882 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . -123.73 144.57 15.59 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 7.8 ttt -126.35 86.47 2.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.754 0.312 . . . . 0.0 110.891 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 46.6 p -80.53 175.73 10.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.852 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 35.4 mtp85 -81.68 40.57 0.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -101.81 113.49 4.65 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.477 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 62.9 mtt-85 -80.69 80.64 7.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.36 . . . . 0.0 110.869 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -131.27 -111.47 1.39 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.438 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 700' ' ' ARG . . . . . 0.415 ' HB2' ' NH1' ' A' ' 700' ' ' ARG . 8.8 ttm105 -59.22 134.94 57.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.798 0.332 . . . . 0.0 110.881 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 701' ' ' ARG . . . . . 0.587 ' NE ' ' H ' ' A' ' 701' ' ' ARG . 0.0 OUTLIER -116.27 -179.76 3.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -74.5 98.53 3.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -109.33 24.3 13.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.867 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -73.91 -61.01 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 46.9 tp -62.44 -11.97 19.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.882 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 706' ' ' ILE . . . . . 0.535 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -65.5 108.65 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.115 179.872 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 119.69 -15.52 10.5 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.472 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -76.72 156.28 32.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.914 0.388 . . . . 0.0 110.934 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 53.9 m -89.3 113.95 25.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . 0.42 ' CA ' HG23 ' A' ' 753' ' ' VAL . 33.9 m -117.83 154.12 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 711' ' ' ARG . . . . . 0.443 ' HB2' ' CD1' ' A' ' 721' ' ' ILE . 31.2 ttm-85 -126.02 113.89 17.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . 0.449 HG12 ' CD2' ' A' ' 750' ' ' LEU . 40.8 mt -64.02 110.36 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.147 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 5.8 t -107.95 20.79 18.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.818 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 714' ' ' GLN . . . . . 0.408 ' CB ' ' HG2' ' A' ' 749' ' ' ARG . 13.5 mm100 -149.18 134.37 18.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.941 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 101.3 -164.77 18.09 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.51 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 716' ' ' PRO . . . . . 0.552 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 54.0 Cg_endo -69.76 -30.56 22.1 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.665 2.244 . . . . 0.0 112.359 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.552 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 44.7 m-85 -91.21 38.82 0.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -73.0 126.35 29.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.902 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 87.62 35.38 9.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.486 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -128.06 144.31 51.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 110.956 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 711' ' ' ARG . 39.1 mm -97.98 156.82 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.16 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -174.1 155.18 21.11 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.518 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 38.3 t -98.4 129.18 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.862 0.363 . . . . 0.0 111.174 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 724' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 707' ' ' GLY . 21.8 t -67.31 112.28 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.151 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.49 -39.97 10.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -137.63 146.55 44.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.856 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -115.73 116.42 28.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.147 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -100.48 169.43 9.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.094 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -66.65 -42.44 86.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 60.5 m -125.32 18.31 8.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.879 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -159.9 173.59 15.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.178 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 732' ' ' ALA . . . . . 0.468 ' HB1' ' CD1' ' A' ' 750' ' ' LEU . . . -153.52 122.31 6.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.102 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 733' ' ' ARG . . . . . 0.473 ' HD3' ' CB ' ' A' ' 744' ' ' SER . 11.1 mmt85 -79.11 98.33 6.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.99 138.81 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.165 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -98.01 101.92 13.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 57.9 mt -50.9 160.55 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.962 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -100.09 -38.47 8.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 4.6 m -66.68 -52.72 41.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 74.1 p -87.32 -23.58 24.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.137 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.7 m 63.77 41.78 6.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.865 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -126.95 154.21 44.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.939 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 21.3 m -92.23 122.13 34.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.153 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 6.8 pt -133.84 142.13 42.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.107 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 744' ' ' SER . . . . . 0.473 ' CB ' ' HD3' ' A' ' 733' ' ' ARG . 3.1 t -87.51 132.62 33.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 81.9 t -143.26 148.58 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.101 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -50.28 119.8 4.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -38.73 -44.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.843 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -65.92 -47.84 73.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 749' ' ' ARG . . . . . 0.408 ' HG2' ' CB ' ' A' ' 714' ' ' GLN . 91.4 mtt180 -49.53 -20.53 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.468 ' CD1' ' HB1' ' A' ' 732' ' ' ALA . 12.9 mt -92.34 122.7 35.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.937 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 39.4 m -103.17 107.19 17.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.187 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 1.6 p -44.63 121.08 2.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.14 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 753' ' ' VAL . . . . . 0.42 HG23 ' CA ' ' A' ' 710' ' ' VAL . 22.0 t -82.45 19.74 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.133 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 165.18 74.38 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 89.8 p -93.47 169.34 10.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.863 0.363 . . . . 0.0 110.862 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 1.6 ptt-85 -49.56 162.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.841 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 46.8 p -169.53 177.62 4.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.351 . . . . 0.0 110.849 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 4.8 m -145.9 174.96 10.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -151.42 151.45 23.4 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.494 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 5.7 t -153.2 132.37 12.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.872 0.367 . . . . 0.0 110.846 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 84.3 p -132.33 -47.28 0.91 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.848 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 93.65 143.47 13.47 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.467 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -139.75 135.49 33.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.765 0.317 . . . . 0.0 110.863 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 18.1 m -90.01 93.4 9.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -132.98 134.77 44.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -60.35 -97.62 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.473 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -59.37 166.25 2.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.865 0.364 . . . . 0.0 110.905 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -129.19 -162.73 11.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.446 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -97.2 172.92 7.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 0.0 110.891 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -64.19 119.63 10.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -118.1 91.97 3.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -113.19 27.98 9.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.911 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -79.67 -58.05 3.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 45.5 tp -59.99 -15.31 21.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.904 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 706' ' ' ILE . . . . . 0.529 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -62.08 108.84 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 120.13 -16.25 10.05 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.501 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 46.6 mm-40 -73.82 163.58 27.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.878 0.37 . . . . 0.0 110.922 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 44.9 m -99.49 110.2 22.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.158 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.48 157.38 14.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -127.01 110.43 12.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.869 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . 0.414 HG12 ' CD2' ' A' ' 750' ' ' LEU . 40.7 mt -60.63 105.5 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 55.2 m -103.4 24.39 11.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 714' ' ' GLN . . . . . 0.408 ' CB ' ' HG2' ' A' ' 749' ' ' ARG . 14.4 mp0 -152.75 147.29 25.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.884 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 90.44 -166.69 32.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.502 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 716' ' ' PRO . . . . . 0.543 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.9 Cg_endo -69.77 -29.95 23.0 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.697 2.265 . . . . 0.0 112.362 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.543 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 55.0 m-85 -93.15 45.46 1.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -75.02 135.79 41.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 75.95 39.65 32.51 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.458 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -125.98 140.68 52.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.854 0.359 . . . . 0.0 110.935 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 31.3 mm -96.63 149.2 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.119 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -169.05 158.71 31.44 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.5 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 48.5 t -101.88 130.96 50.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 0.0 111.131 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 42.8 t -67.32 107.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.083 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . 0.416 ' HA ' ' NZ ' ' A' ' 725' ' ' LYS . 0.0 OUTLIER -84.53 -38.9 19.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -147.05 145.61 29.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -104.86 121.45 43.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -106.51 158.96 16.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.146 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -45.35 -71.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 74.3 m -106.23 18.71 21.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.58 173.32 14.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 732' ' ' ALA . . . . . 0.47 ' HB1' ' CD1' ' A' ' 750' ' ' LEU . . . -150.19 120.32 7.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 -75.69 97.66 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 93.3 t -105.36 145.33 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.157 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -107.21 101.58 10.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 45.8 mt -49.64 158.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -89.32 -54.27 4.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 1.5 t -62.32 -67.94 0.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 81.8 p -61.72 -25.34 67.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.124 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 11.7 t 55.1 51.65 13.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.873 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -136.16 145.55 45.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.931 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 19.7 m -89.04 112.68 23.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 6.8 pt -121.48 155.67 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.157 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 90.9 p -97.39 124.2 41.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 50.1 t -134.52 149.9 30.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.17 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -54.98 126.58 25.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -45.06 -31.5 1.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.848 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -79.39 -42.38 25.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.891 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 749' ' ' ARG . . . . . 0.408 ' HG2' ' CB ' ' A' ' 714' ' ' GLN . 76.7 mtt180 -55.55 -13.8 1.75 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.93 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.47 ' CD1' ' HB1' ' A' ' 732' ' ' ALA . 17.8 mt -98.66 125.94 44.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 29.2 m -107.77 97.46 7.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.105 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 16.4 p -40.75 119.04 1.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.119 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 91.0 t -64.9 -60.44 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.094 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -52.62 156.25 4.67 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.538 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 46.4 p -119.43 164.7 15.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.807 0.337 . . . . 0.0 110.884 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -107.42 120.41 42.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 -179.931 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.454 -0.259 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 30.8 t -168.46 105.17 0.45 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.875 0.369 . . . . 0.0 110.828 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 65.3 m -113.59 132.52 55.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.843 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.03 179.11 7.12 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.451 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 3.0 m -144.59 174.68 10.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.875 0.369 . . . . 0.0 110.873 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 52.4 p -146.3 118.53 8.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.844 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . -133.71 69.46 0.53 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.507 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 8.8 mtm -104.58 149.81 25.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.769 0.319 . . . . 0.0 110.845 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 2.1 m -122.16 139.53 53.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.828 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -64.25 -51.9 61.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -105.18 69.91 0.24 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.486 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -55.99 -49.22 74.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.0 110.86 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -61.23 135.33 48.32 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.457 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 71.8 mtt-85 -83.07 130.35 35.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.854 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -106.62 46.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.875 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -123.64 40.87 3.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -104.18 28.93 6.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.862 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -70.32 -47.24 62.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 17.5 tp -70.49 -15.47 62.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.94 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 706' ' ' ILE . . . . . 0.52 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -63.34 104.47 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 179.796 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 122.86 -13.42 8.59 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.491 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 49.6 mm-40 -75.99 161.65 28.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.89 0.376 . . . . 0.0 110.914 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 709' ' ' THR . . . . . 0.452 HG22 ' CG2' ' A' ' 753' ' ' VAL . 52.1 m -95.04 105.32 17.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 32.5 m -109.16 148.86 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -120.01 114.2 21.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . 0.436 HG23 ' N ' ' A' ' 713' ' ' SER . 27.6 mt -57.81 134.2 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 713' ' ' SER . . . . . 0.436 ' N ' HG23 ' A' ' 712' ' ' ILE . 61.5 p -109.12 -32.15 7.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -110.49 177.84 4.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 77.34 174.79 41.76 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.495 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 716' ' ' PRO . . . . . 0.519 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.6 Cg_endo -69.74 0.39 5.7 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.74 2.293 . . . . 0.0 112.319 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.519 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 67.4 m-85 -115.74 31.87 6.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 19.3 tttp -65.87 135.16 54.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.907 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.19 34.16 30.44 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.481 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -123.11 144.72 49.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.874 0.369 . . . . 0.0 110.952 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 25.4 mm -99.24 146.51 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.116 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -164.75 157.94 30.53 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.512 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . 0.415 ' C ' HG11 ' A' ' 734' ' ' VAL . 22.2 t -101.19 124.71 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.883 0.373 . . . . 0.0 111.154 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 40.7 t -61.78 112.76 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.141 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.58 -36.78 15.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -146.26 144.29 29.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.835 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -112.85 117.43 32.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.54 171.21 8.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.153 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 729' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 730' ' ' SER . 12.6 pt-20 -62.25 -47.92 82.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.424 ' N ' ' HG3' ' A' ' 729' ' ' GLU . 69.9 m -123.92 16.26 9.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.817 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.51 173.36 14.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.177 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 732' ' ' ALA . . . . . 0.459 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -154.86 117.46 4.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.105 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 733' ' ' ARG . . . . . 0.478 ' N ' ' HD3' ' A' ' 733' ' ' ARG . 0.9 OUTLIER -81.87 98.21 8.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.84 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 734' ' ' VAL . . . . . 0.415 HG11 ' C ' ' A' ' 723' ' ' VAL . 69.6 t -103.14 142.79 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.168 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -97.5 102.38 14.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 40.7 mt -52.17 157.54 1.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -88.36 -36.4 16.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 61.2 m -73.98 -72.09 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 60.0 p -62.71 -17.45 60.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.184 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 3.3 m 53.0 39.36 29.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -133.58 151.72 51.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 742' ' ' THR . . . . . 0.456 ' CG2' ' HB3' ' A' ' 733' ' ' ARG . 53.7 m -80.99 143.1 32.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.11 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 743' ' ' ILE . . . . . 0.418 HD11 ' CG2' ' A' ' 745' ' ' VAL . 11.6 pt -143.71 141.82 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.183 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 58.3 p -85.17 117.35 24.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.833 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.426 HG11 ' N ' ' A' ' 746' ' ' ASP . 39.2 t -134.79 141.19 43.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.132 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . 0.426 ' N ' HG11 ' A' ' 745' ' ' VAL . 19.3 t70 -51.4 128.14 21.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -46.51 -27.46 1.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -81.6 -45.35 15.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -53.32 -16.99 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.459 ' CD1' ' HB3' ' A' ' 732' ' ' ALA . 24.7 mt -89.21 135.96 33.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 89.8 m -118.06 93.59 4.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.091 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 3.4 p -41.44 135.33 2.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 753' ' ' VAL . . . . . 0.452 ' CG2' HG22 ' A' ' 709' ' ' THR . 97.2 t -80.1 -54.29 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.104 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -73.16 75.53 0.95 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.487 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 10.6 m -47.03 -49.58 20.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 0.0 110.828 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -66.38 177.1 1.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.808 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.851 -179.886 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.445 -0.262 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 26.8 m 48.67 41.91 18.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 0.0 110.841 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 3.0 t -78.59 -48.81 14.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.857 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 79.41 -45.1 2.79 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.506 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 27.7 t -80.57 161.77 24.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 0.0 110.873 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 49.8 m -130.42 -56.07 1.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.857 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 161.33 132.68 1.37 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.478 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 50.8 mtp -85.33 116.7 23.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.81 0.338 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 2.6 m -123.31 122.04 37.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.96 9.4 14.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -108.73 64.9 0.25 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.502 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 46.4 ttp85 -104.96 101.18 10.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.896 0.379 . . . . 0.0 110.865 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -119.51 39.84 2.39 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.525 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -138.42 143.11 39.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 0.0 110.854 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -109.0 118.03 35.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -97.8 117.86 33.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.834 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -127.04 33.89 4.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.908 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -82.0 -58.44 2.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . 0.414 HD13 ' CG ' ' A' ' 708' ' ' GLN . 51.3 tp -65.09 -11.55 40.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.925 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 706' ' ' ILE . . . . . 0.534 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -65.05 106.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.099 179.867 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 124.75 -17.31 7.28 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 708' ' ' GLN . . . . . 0.414 ' CG ' HD13 ' A' ' 705' ' ' LEU . 36.6 mm-40 -77.6 154.64 32.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.36 . . . . 0.0 110.931 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 68.2 m -86.4 112.95 21.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.182 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 29.4 m -114.87 148.13 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.15 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -122.81 113.39 19.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 31.0 mt -61.1 107.82 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 3.5 m -101.46 12.3 37.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -145.82 140.59 27.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 99.9 -168.58 21.44 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.497 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 716' ' ' PRO . . . . . 0.544 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.6 Cg_endo -69.77 -23.88 30.24 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.697 2.265 . . . . 0.0 112.354 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.544 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 55.3 m-85 -94.36 32.82 1.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.939 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -66.58 112.85 4.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.869 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 100.98 27.67 7.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.478 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 720' ' ' TYR . . . . . 0.453 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 10.9 m-85 -119.23 137.28 53.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 110.915 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.42 HG21 ' N ' ' A' ' 722' ' ' GLY . 12.4 mm -96.07 153.23 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.154 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 722' ' ' GLY . . . . . 0.42 ' N ' HG21 ' A' ' 721' ' ' ILE . . . -172.27 157.79 27.79 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.468 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 48.9 t -98.84 124.87 52.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.866 0.365 . . . . 0.0 111.12 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 43.8 t -60.54 108.63 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.133 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.12 -41.16 17.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.951 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -141.35 146.87 37.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -111.5 120.37 41.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.11 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.9 163.02 13.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.181 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.99 -46.74 87.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 69.8 m -124.33 19.68 8.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.883 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.29 173.31 17.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.168 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 732' ' ' ALA . . . . . 0.427 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -157.28 117.59 3.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.064 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 733' ' ' ARG . . . . . 0.462 ' N ' ' HD3' ' A' ' 733' ' ' ARG . 0.9 OUTLIER -80.48 98.72 7.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 61.2 t -102.81 142.27 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -98.15 102.61 14.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 736' ' ' LEU . . . . . 0.453 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 34.9 mt -52.47 157.08 1.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.9 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -91.27 -23.22 20.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 13.8 m -83.6 -70.48 0.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 70.3 p -73.32 -2.58 22.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.155 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.2 m 40.01 45.93 1.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -132.44 151.91 51.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 742' ' ' THR . . . . . 0.444 ' CG2' ' HB3' ' A' ' 733' ' ' ARG . 54.9 m -84.66 133.95 34.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.124 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 14.7 pt -136.43 140.46 43.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.137 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 54.7 p -83.0 118.16 23.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 48.9 t -135.79 143.9 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.132 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.54 128.61 32.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 27.5 mtm180 -46.53 -37.76 8.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -71.17 -44.33 65.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -54.86 -16.14 2.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.427 ' CD1' ' HB3' ' A' ' 732' ' ' ALA . 12.3 mt -98.14 126.37 43.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.934 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 92.1 m -103.95 102.85 12.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 10.4 p -42.63 121.16 1.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.116 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 10.8 t -81.03 168.67 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.166 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -80.22 157.33 40.68 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.504 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 95.6 p -122.71 100.91 7.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.828 0.347 . . . . 0.0 110.856 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -121.82 148.33 44.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 27.3 p -105.74 175.66 5.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.902 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 68.2 p -166.66 176.14 7.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.881 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 112.68 76.08 0.76 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.487 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 79.0 p -71.28 -49.8 39.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.89 0.376 . . . . 0.0 110.832 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 88.1 p -55.86 140.72 41.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . -112.02 -105.17 2.78 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.534 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.77 159.61 35.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 0.0 110.864 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 6.2 m -131.73 161.77 32.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . 0.429 ' N ' ' HD3' ' A' ' 696' ' ' ARG . 0.0 OUTLIER -117.81 137.49 52.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.87 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -130.7 -167.57 12.03 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.522 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -130.68 89.25 2.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -130.62 169.64 21.33 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.457 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 24.0 ttp180 -73.11 152.43 41.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.766 0.317 . . . . 0.0 110.878 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 16.7 mtm-85 -69.31 115.15 8.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -109.17 108.97 19.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -117.42 28.8 8.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.69 -37.62 65.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 48.0 tp -83.85 -14.84 50.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.935 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 706' ' ' ILE . . . . . 0.538 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -63.87 108.35 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.103 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 118.18 -14.84 12.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.438 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -73.16 162.23 29.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 0.0 110.891 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 709' ' ' THR . . . . . 0.462 HG22 ' CG2' ' A' ' 753' ' ' VAL . 95.5 m -96.66 109.78 22.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . 0.449 HG12 ' CG2' ' A' ' 724' ' ' VAL . 34.5 m -114.01 156.08 15.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.144 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 -123.98 117.43 24.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 23.4 mt -60.49 143.72 14.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.11 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 43.7 t -115.18 -34.78 4.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -113.37 179.98 3.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 78.34 177.09 47.87 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.526 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 716' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 1.79 4.13 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.726 2.284 . . . . 0.0 112.304 -179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.556 ' CD1' HD13 ' A' ' 736' ' ' LEU . 84.4 m-85 -120.33 35.82 4.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -67.5 139.3 57.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.883 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 71.76 32.96 63.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.466 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -119.21 158.52 25.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.843 0.354 . . . . 0.0 110.941 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 22.3 mm -107.88 147.55 12.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -163.23 162.21 34.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.491 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 37.1 t -106.35 129.72 59.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 0.0 111.157 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 724' ' ' VAL . . . . . 0.449 ' CG2' HG12 ' A' ' 710' ' ' VAL . 41.1 t -66.48 108.27 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.104 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -85.24 -41.12 15.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.921 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -143.06 151.24 40.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -111.94 116.88 31.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.65 158.85 16.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -50.0 -64.59 0.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.888 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 48.8 m -109.53 24.06 13.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.856 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -160.03 173.29 16.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.17 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 732' ' ' ALA . . . . . 0.441 ' HB2' ' CD1' ' A' ' 750' ' ' LEU . . . -152.61 121.42 6.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 11.3 mmt85 -74.43 102.3 4.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.837 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 56.0 t -108.93 139.27 32.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.106 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -106.65 106.01 16.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 736' ' ' LEU . . . . . 0.556 HD13 ' CD1' ' A' ' 717' ' ' TYR . 30.4 mt -53.57 157.5 2.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -87.66 -37.12 17.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 14.3 m -73.64 -66.32 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.808 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 20.0 p -68.06 -15.99 63.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.131 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.7 m 49.15 42.07 20.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 2.5 pp0? -129.09 148.72 51.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 4.5 m -87.66 144.29 26.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.136 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 7.8 pt -151.79 144.72 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.154 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 91.3 p -87.56 118.88 27.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 65.4 t -133.47 143.13 39.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.127 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.23 129.71 21.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 24.1 mtm105 -49.58 -36.24 23.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.87 -45.03 65.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -53.86 -24.54 16.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.441 ' CD1' ' HB2' ' A' ' 732' ' ' ALA . 21.3 mt -84.03 144.65 28.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 6.3 m -124.42 99.24 6.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 9.1 p -47.83 118.99 2.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.113 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 753' ' ' VAL . . . . . 0.462 ' CG2' HG22 ' A' ' 709' ' ' THR . 95.8 t -62.14 -44.56 99.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.104 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 154.8 -116.52 0.73 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.489 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 87.3 p -135.1 126.76 29.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.827 0.346 . . . . 0.0 110.899 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.31 166.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.828 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 15.9 mtt180 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.861 -179.914 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 1.7 t -101.11 41.83 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.878 0.37 . . . . 0.0 110.829 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 1.5 t -163.07 140.64 7.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -72.81 93.04 0.64 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.5 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 78.6 p -137.23 117.96 14.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.906 0.384 . . . . 0.0 110.828 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 39.9 t -144.16 159.64 42.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.874 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 49.81 44.4 39.65 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.465 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 7.5 ttt -131.05 115.7 16.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 110.872 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 3.0 t -46.98 105.73 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.81 137.1 57.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.89 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -100.03 82.31 0.53 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.477 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 24.1 mmm-85 -85.71 101.48 12.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 110.843 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -102.33 -81.78 1.59 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.507 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -102.07 123.64 46.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 0.0 110.866 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 701' ' ' ARG . . . . . 0.407 ' C ' ' HD2' ' A' ' 701' ' ' ARG . 0.5 OUTLIER -55.75 147.48 18.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.66 41.75 3.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.826 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -100.68 25.83 7.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.894 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -74.55 -55.63 5.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . 0.4 HD13 ' CG ' ' A' ' 708' ' ' GLN . 48.1 tp -64.04 -12.24 36.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.904 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 706' ' ' ILE . . . . . 0.516 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -65.18 108.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 122.06 -13.08 9.11 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.519 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 708' ' ' GLN . . . . . 0.4 ' CG ' HD13 ' A' ' 705' ' ' LEU . 40.4 mm-40 -77.71 160.91 28.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 0.0 110.937 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 87.1 m -93.65 107.35 19.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.12 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 34.2 m -112.05 150.96 14.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.131 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 711' ' ' ARG . . . . . 0.444 ' CZ ' HD11 ' A' ' 721' ' ' ILE . 23.1 ttm-85 -122.21 115.69 22.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.845 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . 0.45 HG22 ' N ' ' A' ' 713' ' ' SER . 25.8 mt -62.41 142.1 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.1 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 713' ' ' SER . . . . . 0.45 ' N ' HG22 ' A' ' 712' ' ' ILE . 29.1 t -122.21 -22.38 5.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.791 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -110.04 177.64 4.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 67.45 -179.54 15.72 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.463 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 716' ' ' PRO . . . . . 0.559 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.1 Cg_endo -69.82 -8.24 23.11 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.694 2.262 . . . . 0.0 112.299 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.559 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 38.4 m-85 -103.56 29.89 5.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.919 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -65.22 137.43 57.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 74.26 36.12 51.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.486 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 720' ' ' TYR . . . . . 0.453 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 6.3 m-85 -123.81 145.01 49.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.889 0.376 . . . . 0.0 110.89 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.444 HD11 ' CZ ' ' A' ' 711' ' ' ARG . 21.7 mm -98.58 154.04 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.144 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -173.79 161.02 31.35 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.478 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 54.3 t -105.16 125.1 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 111.145 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.41 108.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.119 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -84.79 -40.41 17.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.928 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -140.79 149.82 42.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.827 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 727' ' ' ALA . . . . . 0.447 ' CB ' HD11 ' A' ' 706' ' ' ILE . . . -113.5 118.66 35.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.081 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.73 164.37 11.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.149 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -57.16 -52.08 66.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 5.1 m -120.16 16.44 12.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.837 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.4 173.28 14.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.136 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 732' ' ' ALA . . . . . 0.435 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -151.93 121.02 6.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.11 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -80.53 98.4 7.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.866 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 90.0 t -103.32 140.72 20.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.123 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 735' ' ' GLU . . . . . 0.402 ' O ' ' CD ' ' A' ' 735' ' ' GLU . 6.5 tm-20 -99.34 99.43 10.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.849 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 736' ' ' LEU . . . . . 0.453 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 27.6 mt -49.71 157.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.948 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -90.34 -31.86 16.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.879 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 58.8 m -75.09 -65.12 0.92 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 71.8 p -74.09 -8.53 56.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.103 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 3.3 m 44.75 43.17 6.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -132.68 155.62 48.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 20.0 m -87.95 141.26 28.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.107 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 11.8 pt -146.53 145.06 20.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.157 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 89.5 p -87.66 118.1 26.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 92.9 t -132.71 142.86 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.147 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.55 128.57 17.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -49.62 -28.4 5.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.846 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -81.36 -42.55 20.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -55.25 -19.15 7.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.823 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.435 ' CD1' ' HB3' ' A' ' 732' ' ' ALA . 18.0 mt -88.85 134.86 33.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 751' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 752' ' ' THR . 86.4 m -116.07 89.7 3.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.147 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 752' ' ' THR . . . . . 0.408 ' C ' ' O ' ' A' ' 751' ' ' THR . 9.4 p -36.52 118.09 0.53 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.135 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 87.7 t -66.37 -65.11 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.101 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -64.29 122.33 25.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.486 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 86.5 p -126.18 113.92 17.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.859 0.362 . . . . 0.0 110.825 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 756' ' ' ARG . . . . . 0.425 ' HB2' ' NH1' ' A' ' 756' ' ' ARG . 0.2 OUTLIER -91.2 127.6 36.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.891 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.921 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 25.4 m 60.69 42.18 14.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.877 0.37 . . . . 0.0 110.877 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 28.7 p -148.65 163.4 37.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.849 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -175.12 167.43 39.52 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 39.2 t -78.62 100.68 7.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 0.0 110.884 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 69.6 p -83.53 -45.68 13.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.827 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 94.72 101.15 1.74 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.487 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 12.8 mmm -89.94 -59.64 2.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.809 0.338 . . . . 0.0 110.884 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 3.2 t -114.57 109.05 17.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.817 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -93.13 115.41 28.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.838 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -133.22 130.29 5.69 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.467 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -60.1 -44.93 94.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.861 0.362 . . . . 0.0 110.872 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -41.65 140.84 1.48 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.506 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -56.37 178.08 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 0.0 110.879 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -100.76 49.37 0.89 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.918 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -95.9 41.61 1.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.884 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -95.84 28.81 2.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -71.85 -60.83 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 18.9 tp -62.26 -16.45 53.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.943 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 706' ' ' ILE . . . . . 0.523 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -60.84 110.41 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.083 179.838 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.86 -19.93 10.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.483 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -66.85 166.66 12.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 110.951 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 71.8 m -99.92 109.19 21.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.151 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . 0.445 HG11 ' CG2' ' A' ' 724' ' ' VAL . 35.7 m -113.12 151.5 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.161 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -123.39 114.44 20.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 34.7 mt -61.72 134.73 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 4.2 t -112.79 -31.66 6.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -102.01 176.37 5.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 71.7 177.95 28.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 716' ' ' PRO . . . . . 0.553 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.5 Cg_endo -69.78 -6.93 19.79 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.706 2.27 . . . . 0.0 112.307 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.553 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 44.5 m-85 -105.89 33.24 3.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -68.87 138.11 54.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.93 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 77.17 30.92 54.15 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.483 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -120.77 144.59 48.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.79 0.329 . . . . 0.0 110.948 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 38.7 mm -97.4 150.38 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.09 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -166.48 161.81 35.49 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.461 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 63.8 t -107.55 126.74 63.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.845 0.355 . . . . 0.0 111.175 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 724' ' ' VAL . . . . . 0.445 ' CG2' HG11 ' A' ' 710' ' ' VAL . 50.2 t -63.73 104.73 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -80.58 -41.66 23.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.894 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -143.34 146.6 33.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.89 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -106.17 115.33 30.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.121 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.18 160.65 14.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.114 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -47.03 -70.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 3.2 m -106.09 16.9 24.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.87 173.32 13.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 732' ' ' ALA . . . . . 0.468 ' HB2' ' CD1' ' A' ' 750' ' ' LEU . . . -150.68 120.91 7.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 54.9 mmm-85 -76.65 98.43 4.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 71.5 t -104.78 144.76 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -105.3 101.6 11.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 52.5 mt -50.55 161.18 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.904 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -95.5 -44.98 7.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 40.5 t -67.55 -64.7 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 82.1 p -70.75 -21.85 62.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 17.2 m 55.56 43.66 28.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.838 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -127.21 145.13 50.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.936 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 17.3 m -85.2 116.83 23.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.143 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 11.5 pt -124.37 149.62 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 82.2 p -94.23 118.19 31.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 62.0 t -127.85 144.92 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.15 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -50.72 125.93 14.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -44.61 -24.1 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -89.31 -42.86 11.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -53.85 -18.54 3.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.468 ' CD1' ' HB2' ' A' ' 732' ' ' ALA . 12.6 mt -91.25 134.41 34.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 19.6 m -112.39 90.76 3.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 10.2 p -41.13 118.31 0.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.099 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 86.0 t -61.29 -45.47 98.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.078 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 90.8 -167.37 32.02 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.489 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 19.7 m -100.72 147.53 25.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.917 0.389 . . . . 0.0 110.82 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 16.5 ptt85 -123.96 -1.48 8.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.911 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.823 -179.868 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 19.3 m -81.38 107.07 13.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.871 0.367 . . . . 0.0 110.889 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 4.4 t -91.63 -61.46 1.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.856 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 134.64 -167.83 23.78 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.518 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 58.2 m -81.57 89.86 6.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 0.0 110.831 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 8.1 t -59.96 -57.94 10.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.835 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . -132.98 74.22 0.44 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.487 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -58.14 -61.14 2.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.796 0.332 . . . . 0.0 110.861 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 6.0 t -75.73 102.44 5.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 26.0 mmt-85 -118.41 88.81 3.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.841 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -62.15 -47.64 88.4 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.522 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 8.2 mmp_? -125.33 156.83 38.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.828 0.347 . . . . 0.0 110.903 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -123.89 166.82 16.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.508 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.02 -13.13 14.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.859 0.362 . . . . 0.0 110.912 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 2.2 tpp85 -136.56 146.74 46.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.76 98.28 4.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -105.99 26.12 10.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -77.08 -55.55 5.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . 0.405 HD11 ' CG ' ' A' ' 708' ' ' GLN . 45.6 tp -62.03 -14.12 32.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.894 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 706' ' ' ILE . . . . . 0.532 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -64.81 107.19 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 121.65 -16.09 9.03 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.482 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 708' ' ' GLN . . . . . 0.405 ' CG ' HD11 ' A' ' 705' ' ' LEU . 51.6 mm-40 -74.58 155.54 37.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.878 0.371 . . . . 0.0 110.907 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 55.9 m -92.34 110.43 21.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.162 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 35.4 m -113.3 161.97 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 711' ' ' ARG . . . . . 0.454 ' HB2' ' CD1' ' A' ' 721' ' ' ILE . 23.6 ttt-85 -129.85 117.89 20.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 26.5 mt -62.36 111.21 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.127 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 1.1 t -107.55 18.47 21.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -153.11 130.48 11.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.933 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 109.48 -171.79 15.48 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.467 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 716' ' ' PRO . . . . . 0.55 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 54.0 Cg_endo -69.73 -19.92 35.63 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.667 2.245 . . . . 0.0 112.384 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.55 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 70.3 m-85 -99.81 31.35 3.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 19.0 tttp -64.93 133.31 51.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.904 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 719' ' ' GLY . . . . . 0.434 ' HA2' ' CZ ' ' A' ' 711' ' ' ARG . . . 84.9 23.83 47.81 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.466 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -116.15 143.68 45.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.906 0.384 . . . . 0.0 110.911 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.454 ' CD1' ' HB2' ' A' ' 711' ' ' ARG . 44.9 mm -97.82 162.46 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.162 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 722' ' ' GLY . . . . . 0.448 ' N ' ' CG2' ' A' ' 721' ' ' ILE . . . 178.2 153.07 10.83 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.501 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 42.7 t -97.57 129.75 47.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 111.124 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 48.1 t -64.89 108.84 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -85.42 -40.28 16.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -141.86 146.01 35.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.844 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -106.6 119.0 38.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.073 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.86 156.61 18.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.148 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -42.31 -74.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 58.6 m -103.53 19.68 19.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.16 173.34 14.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.122 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 732' ' ' ALA . . . . . 0.437 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -152.2 122.5 7.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.072 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 6.1 mmt85 -77.84 98.66 5.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.49 142.38 18.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.131 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -104.24 105.38 15.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 66.7 mt -49.76 157.66 0.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -88.74 -57.99 2.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.808 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 8.9 t -59.0 -70.8 0.14 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.849 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 69.6 p -58.39 -34.46 70.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.125 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 3.9 t 66.57 47.36 1.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -130.73 147.89 52.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 22.9 m -89.65 129.11 36.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.126 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 9.2 pt -137.32 150.75 26.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.161 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 744' ' ' SER . . . . . 0.402 ' C ' HG22 ' A' ' 745' ' ' VAL . 78.6 p -95.25 121.65 37.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.436 HG13 ' N ' ' A' ' 746' ' ' ASP . 19.0 t -134.54 143.87 36.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.119 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . 0.436 ' N ' HG13 ' A' ' 745' ' ' VAL . 2.7 t70 -49.51 126.18 12.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.921 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 -43.96 -29.55 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -81.12 -43.08 19.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 76.5 mtt180 -53.4 -16.4 1.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.437 ' CD1' ' HB3' ' A' ' 732' ' ' ALA . 14.6 mt -92.17 145.38 24.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 90.5 m -125.86 95.68 4.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 3.3 p -38.39 118.46 0.72 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 93.6 t -71.24 -42.31 74.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.105 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -43.58 -48.47 7.24 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.5 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 29.8 t -93.06 -73.69 0.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.84 0.352 . . . . 0.0 110.857 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 28.9 mtp85 -73.62 165.01 25.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.83 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 757' ' ' ARG . . . . . 0.417 ' C ' ' HD3' ' A' ' 757' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.841 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 69.8 m -104.52 127.52 52.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.914 0.388 . . . . 0.0 110.849 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 19.1 t -100.97 -55.13 2.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.856 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 136.68 -61.77 0.6 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.469 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 67.3 p 40.36 42.21 1.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 110.858 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 20.4 m -71.51 175.4 5.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.841 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 158.95 97.33 0.12 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.532 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -126.09 150.64 48.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.737 0.303 . . . . 0.0 110.912 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 20.7 m -102.33 151.23 22.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.841 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -113.0 -52.34 2.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.85 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -67.61 98.02 0.44 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.499 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 8.7 tpm_? -75.05 89.68 2.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.85 0.357 . . . . 0.0 110.875 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -137.82 -154.53 6.59 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.515 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -104.58 142.86 33.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.798 0.332 . . . . 0.0 110.859 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -115.09 107.57 15.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -105.97 48.55 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -99.58 43.93 1.04 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -76.61 -62.49 1.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . 0.45 HD12 ' CG ' ' A' ' 708' ' ' GLN . 33.9 tp -60.59 -10.91 5.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 706' ' ' ILE . . . . . 0.517 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -63.41 110.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 118.3 -21.28 10.1 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 708' ' ' GLN . . . . . 0.45 ' CG ' HD12 ' A' ' 705' ' ' LEU . 38.5 mm-40 -70.6 158.65 35.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.908 0.385 . . . . 0.0 110.945 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 87.6 m -91.28 109.47 20.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.127 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 26.9 m -112.51 146.6 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 711' ' ' ARG . . . . . 0.446 ' HB2' ' CD1' ' A' ' 721' ' ' ILE . 52.5 ttt180 -121.53 113.63 20.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 20.8 mt -56.86 143.67 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.161 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 17.0 t -118.25 -28.02 5.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -116.39 177.14 4.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.94 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 76.64 179.01 47.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.448 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 716' ' ' PRO . . . . . 0.495 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.3 Cg_endo -69.78 -1.94 9.34 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.679 2.252 . . . . 0.0 112.317 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.495 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 75.5 m-85 -115.02 31.66 6.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.975 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -65.95 131.41 46.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.904 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.79 29.06 44.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.447 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 720' ' ' TYR . . . . . 0.406 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 8.0 m-85 -116.16 142.58 46.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.832 0.349 . . . . 0.0 110.951 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 711' ' ' ARG . 30.9 mm -98.52 152.53 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.156 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 722' ' ' GLY . . . . . 0.407 ' N ' HG23 ' A' ' 721' ' ' ILE . . . -169.93 164.14 37.55 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.52 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 55.1 t -106.34 123.17 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.84 0.352 . . . . 0.0 111.137 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 724' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 707' ' ' GLY . 45.8 t -63.49 112.18 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -91.05 -37.06 13.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -142.69 144.21 32.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 727' ' ' ALA . . . . . 0.417 ' N ' HD12 ' A' ' 706' ' ' ILE . . . -113.49 113.77 25.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.142 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 1.2 m -96.21 170.29 9.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.168 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 729' ' ' GLU . . . . . 0.447 ' HG3' ' N ' ' A' ' 730' ' ' SER . 14.4 pt-20 -63.15 -49.08 75.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.447 ' N ' ' HG3' ' A' ' 729' ' ' GLU . 60.4 m -120.68 14.2 11.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.89 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.6 173.27 14.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.127 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 732' ' ' ALA . . . . . 0.469 ' HB2' ' CD1' ' A' ' 750' ' ' LEU . . . -155.32 117.54 4.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.086 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 733' ' ' ARG . . . . . 0.46 ' N ' ' HD3' ' A' ' 733' ' ' ARG . 0.9 OUTLIER -81.36 102.99 10.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 53.4 t -111.7 137.55 43.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -90.11 101.61 14.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 736' ' ' LEU . . . . . 0.412 HD13 ' CD2' ' A' ' 717' ' ' TYR . 23.5 mt -50.89 156.37 1.0 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.896 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -85.12 -40.35 16.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 54.7 m -70.44 -70.55 0.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 43.5 p -61.74 -24.61 66.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.0 m 59.33 38.43 23.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -134.9 155.36 50.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.928 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 742' ' ' THR . . . . . 0.456 ' CG2' ' HB3' ' A' ' 733' ' ' ARG . 54.9 m -81.7 138.95 35.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.138 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 8.4 pt -141.18 143.25 28.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 84.2 p -85.13 112.33 20.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 47.9 t -127.29 147.22 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.097 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -58.04 127.64 33.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.905 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -48.16 -25.68 1.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -84.72 -43.54 14.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -58.5 -11.63 3.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.469 ' CD1' ' HB2' ' A' ' 732' ' ' ALA . 18.5 mt -96.1 127.4 42.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 20.4 m -104.47 103.58 13.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.117 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 2.3 p -47.88 121.3 4.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 6.3 t -83.06 168.81 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -126.37 157.64 20.26 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.499 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 57.5 p -61.05 -63.64 1.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.881 0.372 . . . . 0.0 110.847 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 756' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 757' ' ' ARG . 14.4 ptm180 -62.19 169.79 2.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.868 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 757' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 756' ' ' ARG . 11.3 mtp85 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.432 -0.267 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 61.6 p -99.6 119.07 37.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.925 0.393 . . . . 0.0 110.866 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 81.4 p -96.68 176.96 5.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.845 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 175.64 154.06 11.02 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.515 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 15.0 m -73.25 142.12 47.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.916 0.389 . . . . 0.0 110.789 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 14.8 t -145.38 174.86 10.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.837 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 154.19 93.87 0.1 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.472 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 2.9 mmm -96.18 -43.56 7.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.774 0.321 . . . . 0.0 110.917 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 16.6 m -48.16 136.71 11.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.835 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.81 164.97 12.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.843 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -131.2 -142.71 5.1 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 698' ' ' ARG . . . . . 0.428 ' H ' ' NE ' ' A' ' 698' ' ' ARG . 0.0 OUTLIER -84.24 26.62 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.843 0.354 . . . . 0.0 110.844 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -80.8 85.8 1.36 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.487 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -80.75 -43.64 19.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 0.0 110.904 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -136.48 112.23 9.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.854 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -111.01 48.17 0.94 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -84.49 35.2 0.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.842 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -82.2 -49.19 10.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.915 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 37.7 tp -65.2 -10.44 31.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 706' ' ' ILE . . . . . 0.608 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.5 OUTLIER -70.04 108.69 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 179.86 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 120.4 -15.76 9.91 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.449 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -74.62 158.63 33.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.39 . . . . 0.0 110.918 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 98.6 m -94.76 107.33 19.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 31.6 m -111.02 160.68 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 26.9 ttt180 -130.43 108.74 10.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.84 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 72.0 mt -55.78 102.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.144 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 5.3 m -97.61 23.23 7.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 714' ' ' GLN . . . . . 0.418 ' CB ' ' HG2' ' A' ' 749' ' ' ARG . 12.2 mp0 -149.59 -179.23 6.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 59.82 -167.56 8.7 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.478 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 716' ' ' PRO . . . . . 0.566 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.2 Cg_endo -69.79 -33.38 16.59 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.679 2.252 . . . . 0.0 112.328 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 717' ' ' TYR . . . . . 0.566 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 50.1 m-85 -85.11 44.9 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -73.42 131.21 41.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.854 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.66 37.42 20.03 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.469 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -124.35 139.6 53.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.866 0.365 . . . . 0.0 110.901 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 39.1 mm -95.95 145.41 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.158 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -165.02 160.1 33.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 41.6 t -104.61 128.34 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 111.111 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.51 111.03 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.087 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.37 -34.54 15.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -146.44 146.98 30.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -108.12 115.55 30.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.11 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.64 159.06 15.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.173 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -47.68 -67.24 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 75.3 m -109.5 25.55 11.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.84 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.04 173.22 16.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.155 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 732' ' ' ALA . . . . . 0.47 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -150.8 120.02 6.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.102 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -73.79 96.52 2.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 95.9 t -103.61 140.19 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.135 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -100.69 100.82 11.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 51.5 mt -50.6 160.68 0.4 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -96.81 -37.51 10.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 35.4 t -70.51 -59.13 3.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 68.5 p -78.38 -23.27 46.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.149 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 5.0 m 60.42 40.42 17.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -125.34 150.17 47.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 26.9 m -91.03 111.61 23.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 6.9 pt -119.64 150.2 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.085 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 82.9 p -90.84 124.1 34.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . 0.417 HG13 ' N ' ' A' ' 746' ' ' ASP . 74.5 t -136.66 143.04 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.092 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 746' ' ' ASP . . . . . 0.417 ' N ' HG13 ' A' ' 745' ' ' VAL . 39.3 t0 -49.03 129.84 17.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 12.1 mtm105 -50.07 -29.44 8.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -79.32 -44.76 20.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 749' ' ' ARG . . . . . 0.418 ' HG2' ' CB ' ' A' ' 714' ' ' GLN . 37.5 mtm180 -54.87 -15.57 2.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 750' ' ' LEU . . . . . 0.47 ' CD1' ' HB3' ' A' ' 732' ' ' ALA . 23.8 mt -92.93 128.64 38.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 85.7 m -112.06 103.09 11.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 16.7 p -43.94 116.66 1.03 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 96.6 t -63.26 -45.72 97.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -39.96 141.3 0.76 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.482 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 11.0 t -120.4 -52.01 2.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.852 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -129.34 -3.39 4.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 180.0 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 3.9 m120 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.758 0.313 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -72.87 -52.97 12.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.922 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 38.9 tp -65.45 -12.73 55.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 706' ' ' ILE . . . . . 0.527 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -65.78 108.22 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.195 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 122.95 -17.67 8.08 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.493 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -77.81 155.27 31.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.875 0.369 . . . . 0.0 110.868 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 709' ' ' THR . . . . . 0.436 HG22 HG21 ' A' ' 753' ' ' VAL . 64.6 m -85.6 112.33 20.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 710' ' ' VAL . . . . . 0.449 HG21 HG21 ' A' ' 734' ' ' VAL . 33.7 m -112.84 145.7 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 22.0 ttp85 -119.71 112.23 19.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 20.9 mt -57.81 138.13 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.148 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 12.4 t -114.43 -28.39 7.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -113.99 177.13 4.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 75.42 179.56 44.59 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.456 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 716' ' ' PRO . . . . . 0.513 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.4 Cg_endo -69.86 -4.7 14.63 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.682 2.255 . . . . 0.0 112.315 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.513 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 56.1 m-85 -109.47 29.74 7.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.923 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -64.84 124.41 21.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.922 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 89.14 19.59 49.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.501 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 720' ' ' TYR . . . . . 0.463 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 18.4 m-85 -108.47 143.07 37.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.861 0.362 . . . . 0.0 110.921 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.426 HG22 ' N ' ' A' ' 722' ' ' GLY . 27.9 mm -98.13 153.85 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.129 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 722' ' ' GLY . . . . . 0.426 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -173.43 158.54 28.0 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.508 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 40.8 t -101.67 125.26 55.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.388 . . . . 0.0 111.136 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 27.0 t -61.47 111.12 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -90.46 -37.18 14.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.938 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -142.12 148.8 38.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.826 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 727' ' ' ALA . . . . . 0.444 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -114.71 118.62 34.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.161 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 728' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 729' ' ' GLU . 0.7 OUTLIER -102.84 167.9 9.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.145 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 729' ' ' GLU . . . . . 0.452 ' H ' HG22 ' A' ' 728' ' ' THR . 13.6 pt-20 -65.35 -42.7 92.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 731' ' ' THR . 73.6 m -125.25 19.36 8.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.853 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 731' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -160.05 173.19 16.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.182 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 732' ' ' ALA . . . . . 0.605 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -150.86 118.2 6.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.088 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 733' ' ' ARG . . . . . 0.438 ' HD3' ' CB ' ' A' ' 744' ' ' SER . 25.2 mmt180 -75.98 101.53 5.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 734' ' ' VAL . . . . . 0.449 HG21 HG21 ' A' ' 710' ' ' VAL . 82.2 t -108.21 141.62 23.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -102.95 104.2 14.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.86 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 736' ' ' LEU . . . . . 0.463 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 47.8 mt -51.79 159.3 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -91.1 -43.77 9.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.838 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 57.0 m -73.05 -69.15 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 43.0 p -65.7 -7.47 15.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.151 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 29.6 p 40.28 47.28 2.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -125.01 148.85 48.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 23.2 m -94.32 104.94 16.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.153 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 6.9 pt -115.12 146.9 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 744' ' ' SER . . . . . 0.438 ' CB ' ' HD3' ' A' ' 733' ' ' ARG . 2.5 t -94.87 132.13 40.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 40.2 t -142.73 147.35 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.1 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 746' ' ' ASP . . . . . 0.462 ' HB3' ' CG ' ' A' ' 749' ' ' ARG . 10.7 t0 -46.78 127.73 10.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.868 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 747' ' ' ARG . . . . . 0.453 ' HG2' ' HB2' ' A' ' 732' ' ' ALA . 26.9 mtm180 -48.86 -37.01 18.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -74.72 -44.13 51.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.944 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 749' ' ' ARG . . . . . 0.462 ' CG ' ' HB3' ' A' ' 746' ' ' ASP . 84.0 mtt180 -55.11 -14.45 1.61 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 732' ' ' ALA . 28.3 mt -92.84 129.21 38.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 22.2 m -101.6 95.66 6.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 2.8 p -43.46 118.82 1.45 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.162 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 753' ' ' VAL . . . . . 0.436 HG21 HG22 ' A' ' 709' ' ' THR . 11.2 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.178 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 10.4 p30 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.783 0.325 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.56 -61.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 705' ' ' LEU . . . . . 0.466 HD12 ' HB2' ' A' ' 708' ' ' GLN . 21.4 tp -61.6 -15.59 40.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.967 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 706' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 727' ' ' ALA . 0.6 OUTLIER -63.67 105.41 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.189 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 707' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 119.64 -12.09 11.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.493 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 708' ' ' GLN . . . . . 0.466 ' HB2' HD12 ' A' ' 705' ' ' LEU . 50.4 mm-40 -75.68 160.89 29.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.927 0.394 . . . . 0.0 110.881 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 87.2 m -94.67 106.5 18.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 29.4 m -111.03 155.44 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.13 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -125.19 113.57 17.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 712' ' ' ILE . . . . . 0.533 HG12 HD23 ' A' ' 750' ' ' LEU . 64.3 mt -63.24 104.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.085 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 3.2 m -104.07 28.25 6.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.877 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -161.14 142.07 11.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 97.04 -166.08 23.26 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.525 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 716' ' ' PRO . . . . . 0.569 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.6 Cg_endo -69.75 -27.94 25.93 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.679 2.253 . . . . 0.0 112.342 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.569 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 53.7 m-85 -96.88 44.38 1.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.964 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -71.97 136.0 46.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.897 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 73.6 40.07 47.62 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.474 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 720' ' ' TYR . . . . . 0.467 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 17.7 m-85 -127.09 140.57 52.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.346 . . . . 0.0 110.966 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 722' ' ' GLY . 36.2 mm -96.53 153.62 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.145 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 722' ' ' GLY . . . . . 0.422 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -170.24 164.21 37.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.437 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 53.2 t -108.68 123.05 64.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 111.08 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 724' ' ' VAL . . . . . 0.707 HG22 HG22 ' A' ' 734' ' ' VAL . 46.7 t -65.17 111.68 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -93.09 -30.01 15.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -143.84 144.41 31.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.841 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 727' ' ' ALA . . . . . 0.608 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -108.61 114.89 29.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.07 157.24 17.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.099 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 729' ' ' GLU . . . . . 0.47 ' O ' ' NE ' ' A' ' 747' ' ' ARG . 27.6 tt0 -44.23 -73.8 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 43.5 m -103.35 20.78 17.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.74 173.26 16.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 732' ' ' ALA . . . . . 0.459 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -152.72 122.81 7.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.083 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 34.8 mmm-85 -75.0 96.62 3.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.888 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 734' ' ' VAL . . . . . 0.707 HG22 HG22 ' A' ' 724' ' ' VAL . 73.7 t -100.76 145.7 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.145 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -106.95 101.86 11.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.929 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 736' ' ' LEU . . . . . 0.467 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 53.5 mt -49.71 158.4 0.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -87.69 -48.62 7.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 68.5 m -61.67 -74.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 81.5 p -58.59 -28.9 66.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.135 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.8 m 61.81 49.3 4.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -137.57 152.07 49.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 18.9 m -84.98 137.69 32.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 13.1 pt -143.39 142.93 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.155 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 94.6 p -86.68 112.16 21.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.834 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.512 ' HB ' HD21 ' A' ' 750' ' ' LEU . 72.6 t -127.07 148.06 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.16 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -54.94 131.98 45.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 747' ' ' ARG . . . . . 0.47 ' NE ' ' O ' ' A' ' 729' ' ' GLU . 48.8 mtm180 -52.73 -28.82 23.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.875 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -77.55 -44.65 27.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.94 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -58.29 -14.41 7.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.533 HD23 HG12 ' A' ' 712' ' ' ILE . 14.4 mt -99.07 128.25 45.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.907 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 29.0 m -113.51 102.94 10.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.085 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 18.4 p -45.17 119.42 2.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.151 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 85.0 t . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.16 179.89 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 7.8 p30 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.804 0.335 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -78.88 -66.31 0.88 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 705' ' ' LEU . . . . . 0.514 HD12 ' HB2' ' A' ' 708' ' ' GLN . 27.2 tp -59.62 -14.1 12.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.914 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 706' ' ' ILE . . . . . 0.548 HD11 ' HB2' ' A' ' 727' ' ' ALA . 0.6 OUTLIER -62.83 104.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.128 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 125.21 -16.03 7.22 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.472 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 708' ' ' GLN . . . . . 0.514 ' HB2' HD12 ' A' ' 705' ' ' LEU . 48.7 mm-40 -77.32 158.78 29.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.0 110.875 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 709' ' ' THR . . . . . 0.53 ' O ' HG23 ' A' ' 753' ' ' VAL . 62.3 m -90.71 110.23 21.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 710' ' ' VAL . . . . . 0.544 ' HA ' HG23 ' A' ' 753' ' ' VAL . 29.4 m -112.54 144.98 19.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.097 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 711' ' ' ARG . . . . . 0.474 ' CZ ' ' HA2' ' A' ' 719' ' ' GLY . 29.1 ttt85 -116.99 110.89 18.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.837 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 712' ' ' ILE . . . . . 0.421 HG12 HD23 ' A' ' 750' ' ' LEU . 51.2 mt -59.62 114.3 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 42.4 p -108.4 18.05 21.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -147.98 137.44 22.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 99.99 -173.67 25.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.525 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 716' ' ' PRO . . . . . 0.57 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.4 Cg_endo -69.7 -16.75 37.96 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.764 2.309 . . . . 0.0 112.315 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.57 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 35.2 m-85 -98.2 23.22 8.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -58.36 135.61 57.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.855 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 719' ' ' GLY . . . . . 0.474 ' HA2' ' CZ ' ' A' ' 711' ' ' ARG . . . 79.15 28.62 53.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.475 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -116.6 142.68 46.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.905 0.384 . . . . 0.0 110.917 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.424 HD13 ' HB2' ' A' ' 711' ' ' ARG . 12.5 mm -101.94 148.96 6.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.132 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -167.26 160.67 34.4 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.487 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 54.8 t -101.56 123.19 54.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.899 0.38 . . . . 0.0 111.156 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 59.2 t -60.43 105.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.187 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -83.56 -37.4 23.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -143.11 148.96 37.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 727' ' ' ALA . . . . . 0.548 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -115.4 116.43 28.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 728' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 729' ' ' GLU . 0.4 OUTLIER -100.68 168.2 9.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.111 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 729' ' ' GLU . . . . . 0.453 ' H ' HG22 ' A' ' 728' ' ' THR . 18.8 pt-20 -64.54 -45.72 85.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.483 ' O ' HG23 ' A' ' 731' ' ' THR . 72.6 m -122.97 19.4 10.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 731' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -159.87 173.32 16.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 732' ' ' ALA . . . . . 0.559 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -151.64 121.2 6.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.138 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -79.73 97.16 6.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 66.5 t -101.3 147.81 7.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -107.25 100.6 10.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 67.0 mt -50.76 159.43 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -95.6 -31.19 13.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 3.6 t -76.1 -62.43 1.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.876 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 81.0 p -75.89 -16.62 60.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 6.0 m 54.5 42.05 31.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -128.55 156.76 42.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 26.5 m -95.81 120.43 36.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 8.1 pt -125.84 145.52 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 96.3 p -86.53 121.76 29.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.499 ' HB ' HD21 ' A' ' 750' ' ' LEU . 60.5 t -134.36 147.52 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.128 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.57 129.11 37.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 -48.95 -32.05 8.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -77.68 -41.04 39.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.898 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -60.77 -9.54 4.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.559 HD11 ' HB3' ' A' ' 732' ' ' ALA . 13.4 mt -101.56 122.18 43.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 97.5 m -98.8 101.33 12.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.142 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 3.1 p -44.68 118.24 1.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.157 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 753' ' ' VAL . . . . . 0.544 HG23 ' HA ' ' A' ' 710' ' ' VAL . 4.1 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.832 0.349 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -73.7 -54.1 8.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.887 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 705' ' ' LEU . . . . . 0.401 HD12 ' CG ' ' A' ' 708' ' ' GLN . 48.6 tp -66.12 -14.44 61.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 706' ' ' ILE . . . . . 0.523 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -64.11 107.2 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.105 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 707' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 120.91 -14.72 9.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.505 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 708' ' ' GLN . . . . . 0.401 ' CG ' HD12 ' A' ' 705' ' ' LEU . 65.0 mm-40 -73.72 158.78 34.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.841 0.353 . . . . 0.0 110.939 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 82.1 m -95.28 107.65 19.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 24.4 m -112.0 157.1 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -125.12 110.66 14.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 712' ' ' ILE . . . . . 0.525 HG12 HD23 ' A' ' 750' ' ' LEU . 34.9 mt -60.45 108.32 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 3.4 m -109.33 31.53 5.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.898 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 714' ' ' GLN . . . . . 0.441 ' CB ' ' HG2' ' A' ' 749' ' ' ARG . 33.9 mt-30 -160.03 131.04 5.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 102.64 -163.86 16.4 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.482 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 716' ' ' PRO . . . . . 0.547 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 54.3 Cg_endo -69.71 -34.89 13.85 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.707 2.271 . . . . 0.0 112.339 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.547 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 48.3 m-85 -88.31 38.64 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.949 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -71.4 132.86 45.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.915 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.36 33.57 31.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.481 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 720' ' ' TYR . . . . . 0.484 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 13.2 m-85 -122.41 141.06 52.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.936 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 14.1 mm -98.03 148.88 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.133 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -167.28 161.58 35.4 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.556 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.446 HG23 ' NE2' ' A' ' 737' ' ' HIS . 46.6 t -104.74 127.55 59.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.83 0.347 . . . . 0.0 111.139 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 724' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 707' ' ' GLY . 60.7 t -64.01 109.66 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.161 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.84 -35.81 15.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -143.25 149.2 37.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 727' ' ' ALA . . . . . 0.509 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -110.18 115.78 30.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.131 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 1.1 m -103.53 154.97 18.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.162 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -41.07 -75.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.848 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.414 ' O ' HG23 ' A' ' 731' ' ' THR . 61.8 m -104.31 25.37 10.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 731' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -157.85 173.17 17.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.152 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 732' ' ' ALA . . . . . 0.502 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -151.87 122.11 7.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.076 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 53.6 mmm-85 -76.56 99.19 4.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.16 142.89 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.107 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -103.22 105.62 15.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 736' ' ' LEU . . . . . 0.484 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 39.4 mt -50.22 160.14 0.39 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 737' ' ' HIS . . . . . 0.446 ' NE2' HG23 ' A' ' 723' ' ' VAL . 9.8 m170 -95.15 -24.07 17.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 13.4 m -83.98 -71.24 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 31.3 p -67.94 -16.88 64.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.153 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 8.8 m 55.71 41.9 29.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.836 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -125.9 148.82 49.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.93 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 29.1 m -89.29 129.22 35.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.156 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 7.0 pt -135.4 145.77 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.122 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 88.6 p -87.57 117.49 26.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 81.2 t -131.05 143.06 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.089 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -48.94 132.82 18.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -52.31 -32.97 40.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -75.84 -42.44 49.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 749' ' ' ARG . . . . . 0.441 ' HG2' ' CB ' ' A' ' 714' ' ' GLN . 90.6 mtt180 -58.06 -11.86 2.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.525 HD23 HG12 ' A' ' 712' ' ' ILE . 14.4 mt -101.07 127.2 47.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.94 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 60.6 m -112.16 103.51 11.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.132 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 14.5 p -42.63 116.78 0.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.148 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 87.4 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.148 179.873 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 20.9 p30 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.782 0.325 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -85.38 -55.99 3.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 705' ' ' LEU . . . . . 0.437 ' HG ' HG21 ' A' ' 724' ' ' VAL . 48.9 tp -60.87 -13.64 16.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.929 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 706' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -66.31 109.83 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.141 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.18 -12.66 12.71 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.489 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -76.94 164.05 26.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.923 0.392 . . . . 0.0 110.877 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 53.4 m -99.23 110.04 22.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.159 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 21.1 m -113.34 152.87 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.109 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -123.5 114.01 19.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.827 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 712' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 714' ' ' GLN . 20.1 mt -56.64 133.04 21.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.166 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 12.8 t -107.97 -29.4 9.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 714' ' ' GLN . . . . . 0.415 ' O ' ' CG2' ' A' ' 712' ' ' ILE . 26.7 mm-40 -112.85 -179.64 3.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 76.42 -179.03 49.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.541 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 716' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -10.95 29.83 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.641 2.227 . . . . 0.0 112.383 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -107.67 35.03 3.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.949 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -65.95 107.16 1.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.856 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 107.19 30.42 4.17 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.463 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -117.92 147.87 42.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 0.0 110.899 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 30.5 mm -98.8 147.12 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.171 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -165.17 161.49 34.86 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.501 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 48.9 t -106.06 129.47 59.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.382 . . . . 0.0 111.125 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 724' ' ' VAL . . . . . 0.437 HG21 ' HG ' ' A' ' 705' ' ' LEU . 39.3 t -64.68 109.19 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -86.19 -38.49 17.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -143.86 149.77 37.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -113.06 118.19 34.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.82 164.31 11.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.174 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -56.08 -54.88 39.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 59.5 m -118.13 17.16 14.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.878 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.69 173.25 14.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.143 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 732' ' ' ALA . . . . . 0.722 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -150.98 120.46 6.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.076 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -79.02 97.38 6.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.837 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 99.3 t -102.28 144.32 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.167 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -104.84 101.99 11.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.866 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 31.3 mt -50.78 158.68 0.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.954 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -87.6 -55.4 3.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 22.2 t -61.31 -68.61 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 61.7 p -59.96 -30.26 68.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.101 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 12.0 t 59.54 48.36 9.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.901 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -133.7 149.28 51.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 17.0 m -88.53 110.86 21.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.17 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 7.5 pt -118.69 147.75 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 95.5 p -89.97 126.25 35.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.6 ' HB ' HD21 ' A' ' 750' ' ' LEU . 57.6 t -138.21 141.87 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.138 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 746' ' ' ASP . . . . . 0.453 ' HB2' ' CG ' ' A' ' 749' ' ' ARG . 0.7 OUTLIER -48.54 127.58 13.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 26.2 mtm180 -45.36 -36.47 4.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.869 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -77.26 -44.42 29.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.958 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 749' ' ' ARG . . . . . 0.453 ' CG ' ' HB2' ' A' ' 746' ' ' ASP . 56.0 mtt180 -49.35 -28.18 4.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.722 HD11 ' HB3' ' A' ' 732' ' ' ALA . 13.6 mt -79.88 139.56 37.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 50.7 m -116.6 91.95 3.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.165 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 11.9 p -42.57 117.97 1.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.125 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 78.6 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 179.914 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 10.5 p30 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.783 0.325 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -85.94 -56.83 3.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 705' ' ' LEU . . . . . 0.51 ' HG ' HG21 ' A' ' 724' ' ' VAL . 47.6 tp -59.99 -13.25 10.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.901 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 706' ' ' ILE . . . . . 0.523 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -62.88 108.95 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 117.04 -13.82 14.03 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.49 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 708' ' ' GLN . . . . . 0.488 ' CG ' HD12 ' A' ' 705' ' ' LEU . 55.7 mm-40 -73.77 161.15 30.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.902 0.382 . . . . 0.0 110.895 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 709' ' ' THR . . . . . 0.674 HG22 HG21 ' A' ' 753' ' ' VAL . 97.2 m -97.64 106.85 19.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.167 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 27.1 m -112.69 156.64 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.151 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 711' ' ' ARG . . . . . 0.556 ' HB2' HD13 ' A' ' 721' ' ' ILE . 23.2 ttp180 -127.27 115.13 18.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 44.6 mt -60.27 128.85 21.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.123 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 4.5 t -126.4 11.99 7.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.811 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 714' ' ' GLN . . . . . 0.45 ' CB ' ' HG2' ' A' ' 749' ' ' ARG . 24.5 mt-30 -138.72 128.08 24.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.948 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 105.85 -162.38 14.14 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.474 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 716' ' ' PRO . . . . . 0.558 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.5 Cg_endo -69.82 -32.88 17.47 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.735 2.29 . . . . 0.0 112.327 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.558 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 50.4 m-85 -91.82 42.72 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.957 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 39.5 tttm -78.24 97.4 5.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 120.96 34.67 0.88 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.505 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 720' ' ' TYR . . . . . 0.442 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 14.4 m-85 -127.51 147.57 50.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.857 0.36 . . . . 0.0 110.919 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.556 HD13 ' HB2' ' A' ' 711' ' ' ARG . 28.7 mm -98.22 154.11 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.093 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 722' ' ' GLY . . . . . 0.429 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -172.44 151.43 14.44 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.461 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 41.2 t -94.89 129.29 45.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 111.134 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 724' ' ' VAL . . . . . 0.51 HG21 ' HG ' ' A' ' 705' ' ' LEU . 38.4 t -63.79 109.08 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.143 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.0 mmpt? -85.37 -40.76 16.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -143.14 149.47 38.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.824 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 727' ' ' ALA . . . . . 0.464 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -110.97 119.79 40.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.47 160.95 14.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.155 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -52.13 -62.17 1.81 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.428 ' O ' HG23 ' A' ' 731' ' ' THR . 38.3 m -111.57 22.43 15.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.829 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 731' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -158.17 173.23 17.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 732' ' ' ALA . . . . . 0.629 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -151.41 119.44 6.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -75.96 102.03 5.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 93.9 t -107.46 145.98 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -108.47 104.55 13.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 736' ' ' LEU . . . . . 0.442 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 38.0 mt -50.88 161.36 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -95.41 -27.89 15.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 3.9 m -82.39 -74.07 0.36 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 28.2 p -62.43 -19.2 63.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.152 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.2 m 57.09 41.63 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -123.78 146.72 48.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.906 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 18.4 m -90.78 108.2 19.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.118 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 9.5 pt -111.76 154.1 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.186 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 84.6 p -97.41 124.8 41.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.845 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.68 ' HB ' HD21 ' A' ' 750' ' ' LEU . 62.0 t -136.88 145.32 30.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.094 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -53.07 128.29 27.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 10.0 mtm105 -45.57 -34.77 3.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -77.05 -40.06 47.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 749' ' ' ARG . . . . . 0.45 ' HG2' ' CB ' ' A' ' 714' ' ' GLN . 63.9 mtt180 -56.8 -21.96 32.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.856 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.68 HD21 ' HB ' ' A' ' 745' ' ' VAL . 10.6 mt -88.83 139.22 30.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 88.8 m -119.46 96.03 5.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.167 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 7.3 p -39.81 118.25 0.84 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.165 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 753' ' ' VAL . . . . . 0.674 HG21 HG22 ' A' ' 709' ' ' THR . 98.6 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.124 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.773 0.32 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -75.45 -58.68 3.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 45.4 tp -60.08 -14.31 16.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 706' ' ' ILE . . . . . 0.587 HD11 ' HB2' ' A' ' 727' ' ' ALA . 0.7 OUTLIER -64.17 108.55 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.62 -12.91 12.0 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -74.72 166.43 23.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.86 0.362 . . . . 0.0 110.937 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 709' ' ' THR . . . . . 0.609 HG22 HG21 ' A' ' 753' ' ' VAL . 62.7 m -100.39 110.19 22.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.182 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 710' ' ' VAL . . . . . 0.423 HG12 HG22 ' A' ' 752' ' ' THR . 26.3 m -114.25 158.48 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.169 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 711' ' ' ARG . . . . . 0.503 ' HB2' HD13 ' A' ' 721' ' ' ILE . 23.4 ttm-85 -131.76 112.46 12.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 15.7 mt -57.22 133.34 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.131 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 15.9 t -109.21 -29.79 8.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -112.12 178.72 4.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 76.09 178.05 43.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.513 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 716' ' ' PRO . . . . . 0.52 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.9 Cg_endo -69.71 -11.06 30.12 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.652 2.234 . . . . 0.0 112.326 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.52 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 52.9 m-85 -103.9 29.12 6.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.927 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -62.04 135.29 57.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.901 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 77.33 37.39 31.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.48 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 720' ' ' TYR . . . . . 0.473 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 24.6 m-85 -124.1 140.22 53.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.845 0.355 . . . . 0.0 110.981 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.503 HD13 ' HB2' ' A' ' 711' ' ' ARG . 11.5 mm -98.81 148.76 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.134 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -167.98 169.66 41.49 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.449 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 53.3 t -112.13 126.87 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.88 0.371 . . . . 0.0 111.104 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 724' ' ' VAL . . . . . 0.46 HG22 HG22 ' A' ' 734' ' ' VAL . 99.1 t -62.66 108.01 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.147 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -84.18 -40.21 18.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -142.63 150.28 40.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 727' ' ' ALA . . . . . 0.587 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -108.57 118.52 36.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.066 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.11 156.97 17.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 729' ' ' GLU . . . . . 0.442 ' O ' ' NE ' ' A' ' 747' ' ' ARG . 6.3 tp10 -42.89 -75.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 25.1 m -103.0 18.92 20.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.72 173.36 14.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.178 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 732' ' ' ALA . . . . . 0.497 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -151.0 120.43 6.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.09 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 49.1 mmm-85 -75.53 101.46 4.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 734' ' ' VAL . . . . . 0.46 HG22 HG22 ' A' ' 724' ' ' VAL . 87.1 t -107.47 144.23 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.159 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -104.32 104.18 14.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 736' ' ' LEU . . . . . 0.473 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 40.4 mt -52.69 161.43 0.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.949 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -90.66 -48.7 6.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.853 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 3.6 m -61.0 -72.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 77.4 p -61.2 -27.0 68.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.145 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 13.8 t 59.91 49.41 7.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -138.52 151.55 47.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 21.1 m -83.37 137.43 33.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.153 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 13.2 pt -142.79 148.52 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 81.0 p -92.12 119.39 31.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.495 ' HB ' HD21 ' A' ' 750' ' ' LEU . 32.4 t -133.72 142.42 41.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -49.7 132.01 21.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 747' ' ' ARG . . . . . 0.442 ' NE ' ' O ' ' A' ' 729' ' ' GLU . 36.7 mtm180 -54.04 -20.44 6.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -87.89 -44.05 11.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 -56.88 -17.23 8.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 732' ' ' ALA . 19.3 mt -89.83 134.32 34.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.978 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 21.6 m -115.02 90.85 3.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.097 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 752' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 710' ' ' VAL . 16.2 p -41.84 118.56 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.097 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 753' ' ' VAL . . . . . 0.609 HG21 HG22 ' A' ' 709' ' ' THR . 98.3 t . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.189 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 703' ' ' ASN . . . . . 0.404 ' HA ' HD13 ' A' ' 706' ' ' ILE . 11.0 p-10 . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.836 0.35 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -53.41 -16.32 1.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 30.4 tp -101.8 -17.07 16.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.917 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 706' ' ' ILE . . . . . 0.504 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -67.46 103.12 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 123.21 -7.02 9.26 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.517 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -78.58 168.24 20.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.857 0.36 . . . . 0.0 110.921 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 52.8 m -102.91 105.45 15.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.115 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 710' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 752' ' ' THR . 35.8 m -109.86 158.47 9.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.114 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 711' ' ' ARG . . . . . 0.54 ' HB2' HD13 ' A' ' 721' ' ' ILE . 14.4 ttm-85 -128.54 115.9 18.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.863 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 49.1 mt -59.26 142.64 14.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.151 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 18.0 t -118.84 -30.57 5.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 36.8 mm-40 -112.09 172.12 7.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 80.87 179.57 53.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.493 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 716' ' ' PRO . . . . . 0.481 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.7 Cg_endo -69.7 -8.39 23.47 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.755 2.303 . . . . 0.0 112.321 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.481 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 63.6 m-85 -106.94 27.43 8.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -60.89 130.94 48.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.26 37.8 20.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.473 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 720' ' ' TYR . . . . . 0.4 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 10.5 m-85 -125.65 142.77 51.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 0.0 110.906 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.54 HD13 ' HB2' ' A' ' 711' ' ' ARG . 26.4 mm -96.43 146.65 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.095 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -163.49 165.0 36.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.483 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.513 HG23 ' NE2' ' A' ' 737' ' ' HIS . 29.3 t -110.28 128.01 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 0.0 111.171 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 33.9 t -64.8 108.93 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -85.28 -38.34 18.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.881 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -145.12 149.48 35.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 727' ' ' ALA . . . . . 0.477 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -108.32 117.67 34.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.158 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.03 155.75 18.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.151 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 729' ' ' GLU . . . . . 0.482 ' O ' ' NE ' ' A' ' 747' ' ' ARG . 24.7 tt0 -43.09 -74.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.914 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 731' ' ' THR . 58.5 m -103.24 24.6 10.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 731' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -158.05 173.2 17.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.161 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 732' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -151.09 121.58 7.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.12 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -76.75 98.75 4.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 57.4 t -103.95 150.85 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.151 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -111.7 102.67 10.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.828 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 736' ' ' LEU . . . . . 0.4 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 31.9 mt -50.88 157.39 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 737' ' ' HIS . . . . . 0.513 ' NE2' HG23 ' A' ' 723' ' ' VAL . 18.6 m170 -95.34 -23.12 17.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.841 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 3.7 t -82.26 -68.68 0.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 34.4 p -70.97 -17.41 62.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.159 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 55.6 m 58.28 40.58 24.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.864 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -125.3 153.91 42.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 26.2 m -96.88 121.19 38.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 7.9 pt -126.36 155.46 36.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.131 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 92.0 p -97.44 121.13 38.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.67 HG12 ' HB2' ' A' ' 749' ' ' ARG . 21.7 t -134.43 144.62 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.152 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -48.98 131.16 18.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 747' ' ' ARG . . . . . 0.482 ' NE ' ' O ' ' A' ' 729' ' ' GLU . 36.9 mtm180 -50.74 -17.83 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -90.53 -37.42 13.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 749' ' ' ARG . . . . . 0.67 ' HB2' HG12 ' A' ' 745' ' ' VAL . 31.4 mtm180 -61.96 -8.58 5.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.558 HD11 ' HB3' ' A' ' 732' ' ' ALA . 14.6 mt -100.77 135.6 41.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.968 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 33.1 m -118.7 93.63 4.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.168 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 752' ' ' THR . . . . . 0.539 ' HA ' HG12 ' A' ' 710' ' ' VAL . 6.4 p -39.9 121.23 1.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.098 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 753' ' ' VAL . . . . . 0.429 HG21 HD12 ' A' ' 721' ' ' ILE . 96.4 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.152 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 9.5 m120 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.815 0.341 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -76.03 -55.21 5.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 705' ' ' LEU . . . . . 0.501 ' HG ' HG21 ' A' ' 724' ' ' VAL . 52.0 tp -62.45 -16.07 53.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.959 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 706' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 727' ' ' ALA . 0.7 OUTLIER -61.59 109.52 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 707' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 120.84 -20.69 8.6 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.486 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -73.0 157.45 37.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.897 0.38 . . . . 0.0 110.895 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 709' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 753' ' ' VAL . 55.1 m -90.61 110.28 21.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.178 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 710' ' ' VAL . . . . . 0.491 ' HA ' HG23 ' A' ' 753' ' ' VAL . 33.1 m -111.65 146.94 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.129 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 711' ' ' ARG . . . . . 0.495 ' HB2' HD13 ' A' ' 721' ' ' ILE . 12.8 ttp-105 -117.44 113.14 21.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 712' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' A' ' 714' ' ' GLN . 35.6 mt -58.73 127.35 17.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 26.2 t -105.66 -26.51 11.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 714' ' ' GLN . . . . . 0.439 ' O ' ' CG2' ' A' ' 712' ' ' ILE . 9.8 mm-40 -113.95 175.53 5.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.882 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 77.41 177.27 46.11 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.516 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 716' ' ' PRO . . . . . 0.573 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 54.5 Cg_endo -69.69 -0.06 6.3 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.684 2.256 . . . . 0.0 112.398 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.573 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 58.0 m-85 -115.34 33.89 5.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.962 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -66.39 137.11 56.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 77.66 28.48 57.12 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.513 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -117.92 141.38 48.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 0.0 110.926 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.495 HD13 ' HB2' ' A' ' 711' ' ' ARG . 27.2 mm -96.67 155.01 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.147 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 722' ' ' GLY . . . . . 0.451 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -173.81 157.78 26.29 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.489 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 44.1 t -100.95 129.91 51.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.881 0.372 . . . . 0.0 111.158 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 724' ' ' VAL . . . . . 0.501 HG21 ' HG ' ' A' ' 705' ' ' LEU . 23.1 t -65.14 113.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.123 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -91.49 -39.6 11.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -141.9 149.65 40.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 727' ' ' ALA . . . . . 0.629 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -110.57 115.88 30.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.44 157.51 16.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.157 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -45.96 -70.39 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.913 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.41 ' O ' HG23 ' A' ' 731' ' ' THR . 2.7 m -106.19 23.68 13.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.854 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 731' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 730' ' ' SER . 0.7 OUTLIER -157.71 173.27 17.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 732' ' ' ALA . . . . . 0.482 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -151.36 119.6 6.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 25.1 mmt-85 -75.37 97.07 3.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.9 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 734' ' ' VAL . . . . . 0.454 HG21 HG21 ' A' ' 710' ' ' VAL . 69.6 t -103.89 145.23 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.16 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -104.24 101.36 11.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 32.5 mt -49.82 160.8 0.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -89.46 -62.8 1.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 2.1 t -53.85 -70.27 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.832 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 71.0 p -58.61 -35.09 71.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.142 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 6.6 t 65.77 41.31 3.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -128.7 145.79 51.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 20.7 m -85.1 133.3 34.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.144 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 7.6 pt -141.61 149.46 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.189 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 97.5 p -91.5 117.93 30.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.46 142.77 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.152 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 746' ' ' ASP . . . . . 0.477 ' HB3' ' CG ' ' A' ' 749' ' ' ARG . 7.9 t0 -46.96 126.42 8.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.823 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -48.87 -35.09 13.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -76.96 -41.82 41.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 749' ' ' ARG . . . . . 0.477 ' CG ' ' HB3' ' A' ' 746' ' ' ASP . 79.2 mtt180 -57.21 -18.51 16.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.482 ' CD1' ' HB3' ' A' ' 732' ' ' ALA . 21.3 mt -89.07 127.67 35.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.956 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 18.3 m -101.11 97.99 8.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.132 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 4.6 p -43.36 118.69 1.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 753' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 709' ' ' THR . 5.8 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.793 0.33 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -73.49 -54.13 8.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.0 -12.48 18.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.899 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 706' ' ' ILE . . . . . 0.586 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -66.8 111.41 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.149 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.6 -17.39 11.14 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.473 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -73.62 154.12 39.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.857 0.361 . . . . 0.0 110.884 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 63.9 m -90.67 111.12 22.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.16 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 710' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 752' ' ' THR . 31.6 m -115.29 156.88 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.15 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -125.72 115.97 20.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 712' ' ' ILE . . . . . 0.675 HD11 HD11 ' A' ' 743' ' ' ILE . 26.2 mt -56.33 142.98 10.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 713' ' ' SER . . . . . 0.475 ' HB3' ' NE2' ' A' ' 714' ' ' GLN . 41.8 t -116.76 -36.77 3.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 714' ' ' GLN . . . . . 0.475 ' NE2' ' HB3' ' A' ' 713' ' ' SER . 1.6 mp0 -105.37 -175.71 2.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.916 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 69.48 175.05 12.67 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.513 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 716' ' ' PRO . . . . . 0.576 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.2 Cg_endo -69.81 -4.38 13.95 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.677 2.252 . . . . 0.0 112.323 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.576 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 45.4 m-85 -108.2 29.42 7.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -64.06 136.74 57.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.933 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 77.53 32.12 47.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -118.59 145.91 45.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.81 0.338 . . . . 0.0 110.955 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 48.7 mm -97.0 147.8 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.149 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -170.47 148.72 11.78 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.467 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.498 ' C ' HG13 ' A' ' 734' ' ' VAL . 55.1 t -97.3 126.26 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.367 . . . . 0.0 111.159 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 724' ' ' VAL . . . . . 0.808 ' HA ' HG22 ' A' ' 734' ' ' VAL . 41.8 t -59.97 113.27 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -90.47 -39.08 12.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -142.51 144.89 33.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.847 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -106.11 118.03 35.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.091 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.38 155.35 20.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 729' ' ' GLU . . . . . 0.402 ' O ' ' NE ' ' A' ' 747' ' ' ARG . 15.6 tp10 -45.07 -71.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 73.5 m -106.91 26.29 10.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.826 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.44 173.37 17.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.16 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 732' ' ' ALA . . . . . 0.669 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -155.73 119.96 4.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.065 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 733' ' ' ARG . . . . . 0.457 ' HB3' ' CG2' ' A' ' 742' ' ' THR . 1.5 mpt_? -84.82 98.36 10.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 734' ' ' VAL . . . . . 0.808 HG22 ' HA ' ' A' ' 724' ' ' VAL . 55.8 t -103.62 146.05 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.113 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -100.8 102.13 13.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 31.3 mt -49.84 157.61 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -85.47 -43.8 13.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 48.1 m -71.78 -72.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 67.9 p -58.64 -18.13 27.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.177 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 9.2 t 48.97 47.95 21.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -138.66 155.18 48.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 742' ' ' THR . . . . . 0.457 ' CG2' ' HB3' ' A' ' 733' ' ' ARG . 66.4 m -84.67 133.09 34.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.15 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 743' ' ' ILE . . . . . 0.675 HD11 HD11 ' A' ' 712' ' ' ILE . 7.3 pt -135.62 138.3 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.159 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 45.8 p -80.84 120.94 25.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.896 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.46 HG13 ' CZ ' ' A' ' 749' ' ' ARG . 98.2 t -138.89 144.15 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.143 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -54.36 127.93 29.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 747' ' ' ARG . . . . . 0.402 ' NE ' ' O ' ' A' ' 729' ' ' GLU . 30.0 mtm180 -45.39 -40.14 7.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -71.7 -46.01 60.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 749' ' ' ARG . . . . . 0.46 ' CZ ' HG13 ' A' ' 745' ' ' VAL . 39.1 mtp180 -49.84 -26.49 4.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.669 HD11 ' HB3' ' A' ' 732' ' ' ALA . 16.5 mt -82.65 129.39 34.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.932 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 20.1 m -111.0 98.73 7.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.157 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 752' ' ' THR . . . . . 0.437 ' HA ' HG12 ' A' ' 710' ' ' VAL . 20.6 p -42.11 117.68 1.02 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.166 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 83.7 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.137 179.923 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 15.1 p30 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.823 0.344 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -73.91 -61.01 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 46.9 tp -62.44 -11.97 19.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.882 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 706' ' ' ILE . . . . . 0.535 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -65.5 108.65 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.115 179.872 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 707' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 119.69 -15.52 10.5 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.472 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -76.72 156.28 32.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.914 0.388 . . . . 0.0 110.934 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 709' ' ' THR . . . . . 0.439 HG22 ' HB ' ' A' ' 753' ' ' VAL . 53.9 m -89.3 113.95 25.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 710' ' ' VAL . . . . . 0.449 ' HA ' HG23 ' A' ' 753' ' ' VAL . 33.9 m -117.83 154.12 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 711' ' ' ARG . . . . . 0.626 ' CZ ' HD11 ' A' ' 721' ' ' ILE . 31.2 ttm-85 -126.02 113.89 17.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 712' ' ' ILE . . . . . 0.53 HG12 HD23 ' A' ' 750' ' ' LEU . 40.8 mt -64.02 110.36 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.147 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 5.8 t -107.95 20.79 18.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.818 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -149.18 134.37 18.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.941 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 101.3 -164.77 18.09 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.51 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 716' ' ' PRO . . . . . 0.557 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 54.0 Cg_endo -69.76 -30.56 22.1 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.665 2.244 . . . . 0.0 112.359 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.557 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 44.7 m-85 -91.21 38.82 0.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -73.0 126.35 29.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.902 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 87.62 35.38 9.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.486 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -128.06 144.31 51.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 110.956 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.626 HD11 ' CZ ' ' A' ' 711' ' ' ARG . 39.1 mm -97.98 156.82 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.16 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 722' ' ' GLY . . . . . 0.478 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -174.1 155.18 21.11 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.518 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.464 HG23 ' NE2' ' A' ' 737' ' ' HIS . 38.3 t -98.4 129.18 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.862 0.363 . . . . 0.0 111.174 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 724' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 707' ' ' GLY . 21.8 t -67.31 112.28 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.151 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.49 -39.97 10.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -137.63 146.55 44.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.856 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 727' ' ' ALA . . . . . 0.431 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -115.73 116.42 28.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.147 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 728' ' ' THR . . . . . 0.491 HG22 ' H ' ' A' ' 729' ' ' GLU . 0.4 OUTLIER -100.48 169.43 9.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.094 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 729' ' ' GLU . . . . . 0.491 ' H ' HG22 ' A' ' 728' ' ' THR . 15.6 pt-20 -66.65 -42.44 86.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.482 ' O ' HG23 ' A' ' 731' ' ' THR . 60.5 m -125.32 18.31 8.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.879 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 731' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -159.9 173.59 15.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.178 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 732' ' ' ALA . . . . . 0.546 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -153.52 122.31 6.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.102 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 733' ' ' ARG . . . . . 0.492 ' HD3' ' CB ' ' A' ' 744' ' ' SER . 11.1 mmt85 -79.11 98.33 6.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.99 138.81 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.165 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -98.01 101.92 13.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 57.9 mt -50.9 160.55 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.962 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 737' ' ' HIS . . . . . 0.464 ' NE2' HG23 ' A' ' 723' ' ' VAL . 15.0 m170 -100.09 -38.47 8.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 4.6 m -66.68 -52.72 41.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 74.1 p -87.32 -23.58 24.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.137 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.7 m 63.77 41.78 6.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.865 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -126.95 154.21 44.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.939 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 21.3 m -92.23 122.13 34.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.153 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 6.8 pt -133.84 142.13 42.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.107 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 744' ' ' SER . . . . . 0.492 ' CB ' ' HD3' ' A' ' 733' ' ' ARG . 3.1 t -87.51 132.62 33.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.615 ' HB ' HD21 ' A' ' 750' ' ' LEU . 81.9 t -143.26 148.58 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.101 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 746' ' ' ASP . . . . . 0.408 ' HB2' ' CG ' ' A' ' 749' ' ' ARG . 20.1 m-20 -50.28 119.8 4.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -38.73 -44.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.843 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -65.92 -47.84 73.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 749' ' ' ARG . . . . . 0.408 ' CG ' ' HB2' ' A' ' 746' ' ' ASP . 91.4 mtt180 -49.53 -20.53 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.615 HD21 ' HB ' ' A' ' 745' ' ' VAL . 12.9 mt -92.34 122.7 35.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.937 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 39.4 m -103.17 107.19 17.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.187 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 1.6 p -44.63 121.08 2.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.14 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 753' ' ' VAL . . . . . 0.653 HG12 ' O ' ' A' ' 753' ' ' VAL . 22.0 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.133 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 2.9 p30 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.784 0.326 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -79.67 -58.05 3.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 705' ' ' LEU . . . . . 0.457 HD12 ' CG ' ' A' ' 708' ' ' GLN . 45.5 tp -59.99 -15.31 21.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.904 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 706' ' ' ILE . . . . . 0.529 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -62.08 108.84 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 120.13 -16.25 10.05 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.501 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 708' ' ' GLN . . . . . 0.457 ' CG ' HD12 ' A' ' 705' ' ' LEU . 46.6 mm-40 -73.82 163.58 27.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.878 0.37 . . . . 0.0 110.922 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 709' ' ' THR . . . . . 0.423 HG22 ' CG2' ' A' ' 753' ' ' VAL . 44.9 m -99.49 110.2 22.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.158 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.48 157.38 14.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -127.01 110.43 12.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.869 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 712' ' ' ILE . . . . . 0.534 HG12 HD23 ' A' ' 750' ' ' LEU . 40.7 mt -60.63 105.5 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 55.2 m -103.4 24.39 11.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 714' ' ' GLN . . . . . 0.404 ' CB ' ' HG2' ' A' ' 749' ' ' ARG . 14.4 mp0 -152.75 147.29 25.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.884 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 90.44 -166.69 32.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.502 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 716' ' ' PRO . . . . . 0.554 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.9 Cg_endo -69.77 -29.95 23.0 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.697 2.265 . . . . 0.0 112.362 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.554 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 55.0 m-85 -93.15 45.46 1.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -75.02 135.79 41.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 75.95 39.65 32.51 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.458 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 720' ' ' TYR . . . . . 0.401 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 16.7 m-85 -125.98 140.68 52.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.854 0.359 . . . . 0.0 110.935 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 31.3 mm -96.63 149.2 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.119 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -169.05 158.71 31.44 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.5 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 48.5 t -101.88 130.96 50.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 0.0 111.131 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 42.8 t -67.32 107.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.083 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 725' ' ' LYS . . . . . 0.426 ' HA ' ' NZ ' ' A' ' 725' ' ' LYS . 0.0 OUTLIER -84.53 -38.9 19.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -147.05 145.61 29.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -104.86 121.45 43.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -106.51 158.96 16.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.146 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -45.35 -71.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 74.3 m -106.23 18.71 21.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.58 173.32 14.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 732' ' ' ALA . . . . . 0.494 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -150.19 120.32 7.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 -75.69 97.66 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 93.3 t -105.36 145.33 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.157 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -107.21 101.58 10.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 736' ' ' LEU . . . . . 0.401 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 45.8 mt -49.64 158.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.912 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -89.32 -54.27 4.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 1.5 t -62.32 -67.94 0.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 81.8 p -61.72 -25.34 67.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.124 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 11.7 t 55.1 51.65 13.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.873 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -136.16 145.55 45.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.931 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 19.7 m -89.04 112.68 23.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 6.8 pt -121.48 155.67 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.157 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 90.9 p -97.39 124.2 41.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.433 HG12 ' HB2' ' A' ' 749' ' ' ARG . 50.1 t -134.52 149.9 30.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.17 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -54.98 126.58 25.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -45.06 -31.5 1.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.848 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -79.39 -42.38 25.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.891 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 749' ' ' ARG . . . . . 0.433 ' HB2' HG12 ' A' ' 745' ' ' VAL . 76.7 mtt180 -55.55 -13.8 1.75 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.93 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.534 HD23 HG12 ' A' ' 712' ' ' ILE . 17.8 mt -98.66 125.94 44.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 29.2 m -107.77 97.46 7.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.105 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 16.4 p -40.75 119.04 1.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.119 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 753' ' ' VAL . . . . . 0.423 ' CG2' HG22 ' A' ' 709' ' ' THR . 91.0 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.094 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.773 0.321 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -70.32 -47.24 62.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 705' ' ' LEU . . . . . 0.447 HD12 ' HB2' ' A' ' 708' ' ' GLN . 17.5 tp -70.49 -15.47 62.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.94 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 706' ' ' ILE . . . . . 0.52 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -63.34 104.47 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 179.796 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 122.86 -13.42 8.59 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.491 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 708' ' ' GLN . . . . . 0.447 ' HB2' HD12 ' A' ' 705' ' ' LEU . 49.6 mm-40 -75.99 161.65 28.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.89 0.376 . . . . 0.0 110.914 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 709' ' ' THR . . . . . 0.508 HG22 HG21 ' A' ' 753' ' ' VAL . 52.1 m -95.04 105.32 17.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 32.5 m -109.16 148.86 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -120.01 114.2 21.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 712' ' ' ILE . . . . . 0.567 HD11 HD11 ' A' ' 743' ' ' ILE . 27.6 mt -57.81 134.2 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 61.5 p -109.12 -32.15 7.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -110.49 177.84 4.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 77.34 174.79 41.76 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.495 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 716' ' ' PRO . . . . . 0.53 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.6 Cg_endo -69.74 0.39 5.7 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.74 2.293 . . . . 0.0 112.319 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.53 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 67.4 m-85 -115.74 31.87 6.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 19.3 tttp -65.87 135.16 54.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.907 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.19 34.16 30.44 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.481 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -123.11 144.72 49.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.874 0.369 . . . . 0.0 110.952 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 25.4 mm -99.24 146.51 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.116 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -164.75 157.94 30.53 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.512 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.417 ' C ' HG13 ' A' ' 734' ' ' VAL . 22.2 t -101.19 124.71 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.883 0.373 . . . . 0.0 111.154 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 724' ' ' VAL . . . . . 0.427 HG22 HG22 ' A' ' 734' ' ' VAL . 40.7 t -61.78 112.76 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.141 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.58 -36.78 15.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -146.26 144.29 29.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.835 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -112.85 117.43 32.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 728' ' ' THR . . . . . 0.548 HG22 ' H ' ' A' ' 729' ' ' GLU . 0.6 OUTLIER -98.54 171.21 8.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.153 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 729' ' ' GLU . . . . . 0.548 ' H ' HG22 ' A' ' 728' ' ' THR . 12.6 pt-20 -62.25 -47.92 82.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.436 ' N ' ' HG3' ' A' ' 729' ' ' GLU . 69.9 m -123.92 16.26 9.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.817 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.51 173.36 14.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.177 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 732' ' ' ALA . . . . . 0.657 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -154.86 117.46 4.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.105 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 733' ' ' ARG . . . . . 0.469 ' HD3' ' N ' ' A' ' 733' ' ' ARG . 0.9 OUTLIER -81.87 98.21 8.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.84 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 734' ' ' VAL . . . . . 0.427 HG22 HG22 ' A' ' 724' ' ' VAL . 69.6 t -103.14 142.79 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.168 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -97.5 102.38 14.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 40.7 mt -52.17 157.54 1.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -88.36 -36.4 16.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 61.2 m -73.98 -72.09 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 60.0 p -62.71 -17.45 60.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.184 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 3.3 m 53.0 39.36 29.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -133.58 151.72 51.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 742' ' ' THR . . . . . 0.457 ' CG2' ' HB3' ' A' ' 733' ' ' ARG . 53.7 m -80.99 143.1 32.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.11 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 743' ' ' ILE . . . . . 0.567 HD11 HD11 ' A' ' 712' ' ' ILE . 11.6 pt -143.71 141.82 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.183 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 58.3 p -85.17 117.35 24.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.833 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 39.2 t -134.79 141.19 43.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.132 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -51.4 128.14 21.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -46.51 -27.46 1.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -81.6 -45.35 15.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -53.32 -16.99 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.657 HD11 ' HB3' ' A' ' 732' ' ' ALA . 24.7 mt -89.21 135.96 33.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 89.8 m -118.06 93.59 4.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.091 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 3.4 p -41.44 135.33 2.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 753' ' ' VAL . . . . . 0.508 HG21 HG22 ' A' ' 709' ' ' THR . 97.2 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.104 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.799 0.333 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -82.0 -58.44 2.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 705' ' ' LEU . . . . . 0.419 HD12 ' CG ' ' A' ' 708' ' ' GLN . 51.3 tp -65.09 -11.55 40.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.925 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 706' ' ' ILE . . . . . 0.534 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -65.05 106.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.099 179.867 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 124.75 -17.31 7.28 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 708' ' ' GLN . . . . . 0.419 ' CG ' HD12 ' A' ' 705' ' ' LEU . 36.6 mm-40 -77.6 154.64 32.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.36 . . . . 0.0 110.931 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 709' ' ' THR . . . . . 0.5 HG22 HG21 ' A' ' 753' ' ' VAL . 68.2 m -86.4 112.95 21.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.182 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 710' ' ' VAL . . . . . 0.538 ' HA ' HG23 ' A' ' 753' ' ' VAL . 29.4 m -114.87 148.13 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.15 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 711' ' ' ARG . . . . . 0.448 ' HB2' HD13 ' A' ' 721' ' ' ILE . 19.3 ttt180 -122.81 113.39 19.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 712' ' ' ILE . . . . . 0.504 HG12 HD23 ' A' ' 750' ' ' LEU . 31.0 mt -61.1 107.82 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 3.5 m -101.46 12.3 37.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -145.82 140.59 27.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 99.9 -168.58 21.44 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.497 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 716' ' ' PRO . . . . . 0.554 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.6 Cg_endo -69.77 -23.88 30.24 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.697 2.265 . . . . 0.0 112.354 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.554 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 55.3 m-85 -94.36 32.82 1.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.939 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -66.58 112.85 4.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.869 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 100.98 27.67 7.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.478 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 720' ' ' TYR . . . . . 0.468 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 10.9 m-85 -119.23 137.28 53.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 110.915 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.448 HD13 ' HB2' ' A' ' 711' ' ' ARG . 12.4 mm -96.07 153.23 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.154 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -172.27 157.79 27.79 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.468 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 48.9 t -98.84 124.87 52.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.866 0.365 . . . . 0.0 111.12 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 43.8 t -60.54 108.63 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.133 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.12 -41.16 17.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.951 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -141.35 146.87 37.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 727' ' ' ALA . . . . . 0.418 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -111.5 120.37 41.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.11 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.9 163.02 13.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.181 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.99 -46.74 87.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 69.8 m -124.33 19.68 8.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.883 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.29 173.31 17.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.168 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 732' ' ' ALA . . . . . 0.477 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -157.28 117.59 3.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.064 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 733' ' ' ARG . . . . . 0.455 ' HD3' ' N ' ' A' ' 733' ' ' ARG . 0.9 OUTLIER -80.48 98.72 7.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 61.2 t -102.81 142.27 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -98.15 102.61 14.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 736' ' ' LEU . . . . . 0.468 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 34.9 mt -52.47 157.08 1.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.9 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -91.27 -23.22 20.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 13.8 m -83.6 -70.48 0.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 70.3 p -73.32 -2.58 22.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.155 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.2 m 40.01 45.93 1.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -132.44 151.91 51.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 742' ' ' THR . . . . . 0.443 ' CG2' ' HB3' ' A' ' 733' ' ' ARG . 54.9 m -84.66 133.95 34.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.124 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 14.7 pt -136.43 140.46 43.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.137 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 54.7 p -83.0 118.16 23.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 48.9 t -135.79 143.9 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.132 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.54 128.61 32.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 747' ' ' ARG . . . . . 0.407 ' HG2' ' HB2' ' A' ' 732' ' ' ALA . 27.5 mtm180 -46.53 -37.76 8.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -71.17 -44.33 65.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -54.86 -16.14 2.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.504 HD23 HG12 ' A' ' 712' ' ' ILE . 12.3 mt -98.14 126.37 43.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.934 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 92.1 m -103.95 102.85 12.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 10.4 p -42.63 121.16 1.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.116 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 753' ' ' VAL . . . . . 0.538 HG23 ' HA ' ' A' ' 710' ' ' VAL . 10.8 t . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.166 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 13.5 p30 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.768 0.318 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.69 -37.62 65.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 705' ' ' LEU . . . . . 0.454 ' HG ' HG21 ' A' ' 724' ' ' VAL . 48.0 tp -83.85 -14.84 50.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.935 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 706' ' ' ILE . . . . . 0.538 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -63.87 108.35 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.103 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 707' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 118.18 -14.84 12.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.438 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -73.16 162.23 29.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 0.0 110.891 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 709' ' ' THR . . . . . 0.511 HG22 HG21 ' A' ' 753' ' ' VAL . 95.5 m -96.66 109.78 22.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 34.5 m -114.01 156.08 15.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.144 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 -123.98 117.43 24.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 23.4 mt -60.49 143.72 14.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.11 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 43.7 t -115.18 -34.78 4.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -113.37 179.98 3.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 78.34 177.09 47.87 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.526 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 716' ' ' PRO . . . . . 0.405 ' HG2' ' CE2' ' A' ' 717' ' ' TYR . 53.4 Cg_endo -69.78 1.79 4.13 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.726 2.284 . . . . 0.0 112.304 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.538 ' CD1' HD11 ' A' ' 736' ' ' LEU . 84.4 m-85 -120.33 35.82 4.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -67.5 139.3 57.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.883 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 71.76 32.96 63.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.466 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -119.21 158.52 25.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.843 0.354 . . . . 0.0 110.941 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 22.3 mm -107.88 147.55 12.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -163.23 162.21 34.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.491 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 37.1 t -106.35 129.72 59.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 0.0 111.157 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 724' ' ' VAL . . . . . 0.454 HG21 ' HG ' ' A' ' 705' ' ' LEU . 41.1 t -66.48 108.27 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.104 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -85.24 -41.12 15.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.921 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -143.06 151.24 40.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -111.94 116.88 31.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.65 158.85 16.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -50.0 -64.59 0.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.888 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 731' ' ' THR . 48.8 m -109.53 24.06 13.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.856 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 731' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 730' ' ' SER . 0.7 OUTLIER -160.03 173.29 16.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.17 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 732' ' ' ALA . . . . . 0.587 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -152.61 121.42 6.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 11.3 mmt85 -74.43 102.3 4.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.837 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 56.0 t -108.93 139.27 32.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.106 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -106.65 106.01 16.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 736' ' ' LEU . . . . . 0.538 HD11 ' CD1' ' A' ' 717' ' ' TYR . 30.4 mt -53.57 157.5 2.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -87.66 -37.12 17.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 14.3 m -73.64 -66.32 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.808 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 20.0 p -68.06 -15.99 63.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.131 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.7 m 49.15 42.07 20.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 741' ' ' GLN . . . . . 0.405 HE22 ' CG2' ' A' ' 743' ' ' ILE . 2.5 pp0? -129.09 148.72 51.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 4.5 m -87.66 144.29 26.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.136 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 743' ' ' ILE . . . . . 0.405 ' CG2' HE22 ' A' ' 741' ' ' GLN . 7.8 pt -151.79 144.72 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.154 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 91.3 p -87.56 118.88 27.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 65.4 t -133.47 143.13 39.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.127 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.23 129.71 21.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 24.1 mtm105 -49.58 -36.24 23.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.87 -45.03 65.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -53.86 -24.54 16.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 732' ' ' ALA . 21.3 mt -84.03 144.65 28.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 6.3 m -124.42 99.24 6.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 9.1 p -47.83 118.99 2.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.113 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 753' ' ' VAL . . . . . 0.511 HG21 HG22 ' A' ' 709' ' ' THR . 95.8 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.104 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.79 0.328 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -74.55 -55.63 5.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 705' ' ' LEU . . . . . 0.409 HD12 ' CG ' ' A' ' 708' ' ' GLN . 48.1 tp -64.04 -12.24 36.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.904 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 706' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' A' ' 727' ' ' ALA . 0.6 OUTLIER -65.18 108.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 122.06 -13.08 9.11 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.519 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 708' ' ' GLN . . . . . 0.409 ' CG ' HD12 ' A' ' 705' ' ' LEU . 40.4 mm-40 -77.71 160.91 28.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 0.0 110.937 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 87.1 m -93.65 107.35 19.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.12 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 710' ' ' VAL . . . . . 0.422 HG12 ' HA ' ' A' ' 752' ' ' THR . 34.2 m -112.05 150.96 14.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.131 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 711' ' ' ARG . . . . . 0.421 ' HB2' HD13 ' A' ' 721' ' ' ILE . 23.1 ttm-85 -122.21 115.69 22.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.845 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 25.8 mt -62.41 142.1 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.1 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 29.1 t -122.21 -22.38 5.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.791 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -110.04 177.64 4.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 67.45 -179.54 15.72 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.463 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 716' ' ' PRO . . . . . 0.575 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.1 Cg_endo -69.82 -8.24 23.11 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.694 2.262 . . . . 0.0 112.299 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.575 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 38.4 m-85 -103.56 29.89 5.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.919 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -65.22 137.43 57.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 74.26 36.12 51.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.486 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 720' ' ' TYR . . . . . 0.466 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 6.3 m-85 -123.81 145.01 49.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.889 0.376 . . . . 0.0 110.89 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.421 HD13 ' HB2' ' A' ' 711' ' ' ARG . 21.7 mm -98.58 154.04 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.144 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 722' ' ' GLY . . . . . 0.421 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -173.79 161.02 31.35 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.478 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 54.3 t -105.16 125.1 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 111.145 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.41 108.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.119 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -84.79 -40.41 17.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.928 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -140.79 149.82 42.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.827 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 727' ' ' ALA . . . . . 0.617 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -113.5 118.66 35.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.081 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.73 164.37 11.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.149 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -57.16 -52.08 66.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 5.1 m -120.16 16.44 12.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.837 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.4 173.28 14.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.136 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 732' ' ' ALA . . . . . 0.658 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -151.93 121.02 6.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.11 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -80.53 98.4 7.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.866 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 90.0 t -103.32 140.72 20.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.123 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 735' ' ' GLU . . . . . 0.402 ' CD ' ' O ' ' A' ' 735' ' ' GLU . 6.5 tm-20 -99.34 99.43 10.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.849 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 736' ' ' LEU . . . . . 0.466 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 27.6 mt -49.71 157.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.948 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -90.34 -31.86 16.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.879 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 58.8 m -75.09 -65.12 0.92 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 71.8 p -74.09 -8.53 56.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.103 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 3.3 m 44.75 43.17 6.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -132.68 155.62 48.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 20.0 m -87.95 141.26 28.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.107 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 11.8 pt -146.53 145.06 20.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.157 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 89.5 p -87.66 118.1 26.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 92.9 t -132.71 142.86 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.147 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.55 128.57 17.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -49.62 -28.4 5.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.846 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -81.36 -42.55 20.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -55.25 -19.15 7.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.823 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.658 HD11 ' HB3' ' A' ' 732' ' ' ALA . 18.0 mt -88.85 134.86 33.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 751' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 752' ' ' THR . 86.4 m -116.07 89.7 3.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.147 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 752' ' ' THR . . . . . 0.422 ' HA ' HG12 ' A' ' 710' ' ' VAL . 9.4 p -36.52 118.09 0.53 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.135 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 87.7 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.101 179.942 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.83 0.348 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -71.85 -60.83 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 18.9 tp -62.26 -16.45 53.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.943 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 706' ' ' ILE . . . . . 0.523 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -60.84 110.41 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.083 179.838 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.86 -19.93 10.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.483 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -66.85 166.66 12.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 110.951 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 709' ' ' THR . . . . . 0.402 HG22 ' CG2' ' A' ' 753' ' ' VAL . 71.8 m -99.92 109.19 21.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.151 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 710' ' ' VAL . . . . . 0.48 HG12 HG22 ' A' ' 752' ' ' THR . 35.7 m -113.12 151.5 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.161 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 711' ' ' ARG . . . . . 0.479 ' HB2' HD13 ' A' ' 721' ' ' ILE . 29.6 ttt180 -123.39 114.44 20.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 712' ' ' ILE . . . . . 0.409 HD12 HD21 ' A' ' 736' ' ' LEU . 34.7 mt -61.72 134.73 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 4.2 t -112.79 -31.66 6.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -102.01 176.37 5.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 71.7 177.95 28.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 716' ' ' PRO . . . . . 0.569 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.5 Cg_endo -69.78 -6.93 19.79 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.706 2.27 . . . . 0.0 112.307 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.569 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 44.5 m-85 -105.89 33.24 3.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -68.87 138.11 54.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.93 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 77.17 30.92 54.15 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.483 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -120.77 144.59 48.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.79 0.329 . . . . 0.0 110.948 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 711' ' ' ARG . 38.7 mm -97.4 150.38 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.09 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -166.48 161.81 35.49 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.461 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 63.8 t -107.55 126.74 63.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.845 0.355 . . . . 0.0 111.175 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 50.2 t -63.73 104.73 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -80.58 -41.66 23.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.894 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -143.34 146.6 33.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.89 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 727' ' ' ALA . . . . . 0.447 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -106.17 115.33 30.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.121 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.18 160.65 14.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.114 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -47.03 -70.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 3.2 m -106.09 16.9 24.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.87 173.32 13.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 732' ' ' ALA . . . . . 0.601 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -150.68 120.91 7.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 54.9 mmm-85 -76.65 98.43 4.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 71.5 t -104.78 144.76 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -105.3 101.6 11.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 736' ' ' LEU . . . . . 0.409 HD21 HD12 ' A' ' 712' ' ' ILE . 52.5 mt -50.55 161.18 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.904 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -95.5 -44.98 7.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 40.5 t -67.55 -64.7 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 82.1 p -70.75 -21.85 62.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 17.2 m 55.56 43.66 28.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.838 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -127.21 145.13 50.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.936 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 17.3 m -85.2 116.83 23.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.143 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 11.5 pt -124.37 149.62 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 82.2 p -94.23 118.19 31.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.818 ' HB ' HD21 ' A' ' 750' ' ' LEU . 62.0 t -127.85 144.92 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.15 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -50.72 125.93 14.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -44.61 -24.1 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -89.31 -42.86 11.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -53.85 -18.54 3.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.818 HD21 ' HB ' ' A' ' 745' ' ' VAL . 12.6 mt -91.25 134.41 34.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 19.6 m -112.39 90.76 3.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 752' ' ' THR . . . . . 0.48 HG22 HG12 ' A' ' 710' ' ' VAL . 10.2 p -41.13 118.31 0.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.099 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 753' ' ' VAL . . . . . 0.402 ' CG2' HG22 ' A' ' 709' ' ' THR . 86.0 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.078 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.768 0.318 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -77.08 -55.55 5.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 705' ' ' LEU . . . . . 0.426 HD12 ' CG ' ' A' ' 708' ' ' GLN . 45.6 tp -62.03 -14.12 32.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.894 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 706' ' ' ILE . . . . . 0.532 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -64.81 107.19 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 121.65 -16.09 9.03 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.482 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 708' ' ' GLN . . . . . 0.426 ' CG ' HD12 ' A' ' 705' ' ' LEU . 51.6 mm-40 -74.58 155.54 37.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.878 0.371 . . . . 0.0 110.907 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 55.9 m -92.34 110.43 21.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.162 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 710' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 752' ' ' THR . 35.4 m -113.3 161.97 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 711' ' ' ARG . . . . . 0.497 ' HB2' HD13 ' A' ' 721' ' ' ILE . 23.6 ttt-85 -129.85 117.89 20.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 712' ' ' ILE . . . . . 0.429 HD11 HD11 ' A' ' 743' ' ' ILE . 26.5 mt -62.36 111.21 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.127 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 1.1 t -107.55 18.47 21.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -153.11 130.48 11.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.933 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 109.48 -171.79 15.48 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.467 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 716' ' ' PRO . . . . . 0.553 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 54.0 Cg_endo -69.73 -19.92 35.63 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.667 2.245 . . . . 0.0 112.384 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.553 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 70.3 m-85 -99.81 31.35 3.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 19.0 tttp -64.93 133.31 51.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.904 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 719' ' ' GLY . . . . . 0.44 ' HA2' ' CZ ' ' A' ' 711' ' ' ARG . . . 84.9 23.83 47.81 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.466 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -116.15 143.68 45.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.906 0.384 . . . . 0.0 110.911 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.59 HD12 HG21 ' A' ' 753' ' ' VAL . 44.9 mm -97.82 162.46 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.162 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 722' ' ' GLY . . . . . 0.588 ' N ' HG22 ' A' ' 721' ' ' ILE . . . 178.2 153.07 10.83 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.501 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 42.7 t -97.57 129.75 47.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 111.124 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 48.1 t -64.89 108.84 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -85.42 -40.28 16.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -141.86 146.01 35.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.844 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 727' ' ' ALA . . . . . 0.445 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -106.6 119.0 38.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.073 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.86 156.61 18.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.148 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -42.31 -74.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 58.6 m -103.53 19.68 19.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.16 173.34 14.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.122 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 732' ' ' ALA . . . . . 0.687 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -152.2 122.5 7.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.072 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 6.1 mmt85 -77.84 98.66 5.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.49 142.38 18.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.131 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -104.24 105.38 15.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 66.7 mt -49.76 157.66 0.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -88.74 -57.99 2.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.808 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 8.9 t -59.0 -70.8 0.14 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.849 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 69.6 p -58.39 -34.46 70.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.125 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 3.9 t 66.57 47.36 1.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -130.73 147.89 52.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 22.9 m -89.65 129.11 36.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.126 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 743' ' ' ILE . . . . . 0.429 HD11 HD11 ' A' ' 712' ' ' ILE . 9.2 pt -137.32 150.75 26.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.161 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 78.6 p -95.25 121.65 37.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.587 HG12 ' HB2' ' A' ' 749' ' ' ARG . 19.0 t -134.54 143.87 36.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.119 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -49.51 126.18 12.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.921 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 -43.96 -29.55 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -81.12 -43.08 19.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 749' ' ' ARG . . . . . 0.587 ' HB2' HG12 ' A' ' 745' ' ' VAL . 76.5 mtt180 -53.4 -16.4 1.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.687 HD11 ' HB3' ' A' ' 732' ' ' ALA . 14.6 mt -92.17 145.38 24.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 90.5 m -125.86 95.68 4.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 752' ' ' THR . . . . . 0.454 ' HA ' HG12 ' A' ' 710' ' ' VAL . 3.3 p -38.39 118.46 0.72 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 753' ' ' VAL . . . . . 0.59 HG21 HD12 ' A' ' 721' ' ' ILE . 93.6 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.105 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 703' ' ' ASN . . . . . 0.505 ' N ' HD21 ' A' ' 703' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.831 0.348 . . . . 0.0 110.885 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -76.61 -62.49 1.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 705' ' ' LEU . . . . . 0.482 HD12 ' CG ' ' A' ' 708' ' ' GLN . 33.9 tp -60.59 -10.91 5.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 706' ' ' ILE . . . . . 0.517 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -63.41 110.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 707' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 118.3 -21.28 10.1 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 708' ' ' GLN . . . . . 0.482 ' CG ' HD12 ' A' ' 705' ' ' LEU . 38.5 mm-40 -70.6 158.65 35.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.908 0.385 . . . . 0.0 110.945 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 709' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 753' ' ' VAL . 87.6 m -91.28 109.47 20.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.127 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 710' ' ' VAL . . . . . 0.535 HG21 HG21 ' A' ' 734' ' ' VAL . 26.9 m -112.51 146.6 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 711' ' ' ARG . . . . . 0.549 ' HB2' HD13 ' A' ' 721' ' ' ILE . 52.5 ttt180 -121.53 113.63 20.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 20.8 mt -56.86 143.67 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.161 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 17.0 t -118.25 -28.02 5.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -116.39 177.14 4.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.94 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 76.64 179.01 47.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.448 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 716' ' ' PRO . . . . . 0.493 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.3 Cg_endo -69.78 -1.94 9.34 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.679 2.252 . . . . 0.0 112.317 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.493 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 75.5 m-85 -115.02 31.66 6.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.975 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -65.95 131.41 46.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.904 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.79 29.06 44.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.447 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 720' ' ' TYR . . . . . 0.42 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 8.0 m-85 -116.16 142.58 46.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.832 0.349 . . . . 0.0 110.951 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 721' ' ' ILE . . . . . 0.549 HD13 ' HB2' ' A' ' 711' ' ' ARG . 30.9 mm -98.52 152.53 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.156 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 722' ' ' GLY . . . . . 0.41 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -169.93 164.14 37.55 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.52 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 723' ' ' VAL . . . . . 0.474 ' C ' HG13 ' A' ' 734' ' ' VAL . 55.1 t -106.34 123.17 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.84 0.352 . . . . 0.0 111.137 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 724' ' ' VAL . . . . . 0.824 ' HA ' HG22 ' A' ' 734' ' ' VAL . 45.8 t -63.49 112.18 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -91.05 -37.06 13.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -142.69 144.21 32.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 727' ' ' ALA . . . . . 0.429 ' N ' HD11 ' A' ' 706' ' ' ILE . . . -113.49 113.77 25.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.142 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 728' ' ' THR . . . . . 0.545 HG22 ' H ' ' A' ' 729' ' ' GLU . 1.2 m -96.21 170.29 9.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.168 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 729' ' ' GLU . . . . . 0.545 ' H ' HG22 ' A' ' 728' ' ' THR . 14.4 pt-20 -63.15 -49.08 75.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.458 ' N ' ' HG3' ' A' ' 729' ' ' GLU . 60.4 m -120.68 14.2 11.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.89 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.6 173.27 14.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.127 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 732' ' ' ALA . . . . . 0.562 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -155.32 117.54 4.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.086 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 733' ' ' ARG . . . . . 0.454 ' HB3' ' CG2' ' A' ' 742' ' ' THR . 0.9 OUTLIER -81.36 102.99 10.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 734' ' ' VAL . . . . . 0.824 HG22 ' HA ' ' A' ' 724' ' ' VAL . 53.4 t -111.7 137.55 43.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -90.11 101.61 14.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 736' ' ' LEU . . . . . 0.42 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 23.5 mt -50.89 156.37 1.0 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.896 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -85.12 -40.35 16.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 54.7 m -70.44 -70.55 0.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 43.5 p -61.74 -24.61 66.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.0 m 59.33 38.43 23.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -134.9 155.36 50.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.928 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 742' ' ' THR . . . . . 0.454 ' CG2' ' HB3' ' A' ' 733' ' ' ARG . 54.9 m -81.7 138.95 35.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.138 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 8.4 pt -141.18 143.25 28.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 84.2 p -85.13 112.33 20.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 745' ' ' VAL . . . . . 0.546 ' HB ' HD21 ' A' ' 750' ' ' LEU . 47.9 t -127.29 147.22 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.097 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -58.04 127.64 33.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.905 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -48.16 -25.68 1.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -84.72 -43.54 14.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -58.5 -11.63 3.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.562 HD11 ' HB3' ' A' ' 732' ' ' ALA . 18.5 mt -96.1 127.4 42.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 20.4 m -104.47 103.58 13.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.117 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 2.3 p -47.88 121.3 4.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 753' ' ' VAL . . . . . 0.528 HG23 ' HA ' ' A' ' 710' ' ' VAL . 6.3 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 2.2 m120 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.758 0.313 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -82.2 -49.19 10.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.915 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 37.7 tp -65.2 -10.44 31.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 706' ' ' ILE . . . . . 0.608 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.5 OUTLIER -70.04 108.69 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 179.86 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 120.4 -15.76 9.91 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.449 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -74.62 158.63 33.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.39 . . . . 0.0 110.918 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 709' ' ' THR . . . . . 0.473 HG22 HG21 ' A' ' 753' ' ' VAL . 98.6 m -94.76 107.33 19.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 31.6 m -111.02 160.68 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 711' ' ' ARG . . . . . 0.405 ' HB2' HG22 ' A' ' 753' ' ' VAL . 26.9 ttt180 -130.43 108.74 10.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.84 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 712' ' ' ILE . . . . . 0.466 HG12 HD23 ' A' ' 750' ' ' LEU . 72.0 mt -55.78 102.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.144 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 5.3 m -97.61 23.23 7.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 714' ' ' GLN . . . . . 0.402 ' CB ' ' HG2' ' A' ' 749' ' ' ARG . 12.2 mp0 -149.59 -179.23 6.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 59.82 -167.56 8.7 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.478 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 716' ' ' PRO . . . . . 0.576 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.2 Cg_endo -69.79 -33.38 16.59 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.679 2.252 . . . . 0.0 112.328 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 717' ' ' TYR . . . . . 0.576 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 50.1 m-85 -85.11 44.9 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -73.42 131.21 41.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.854 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.66 37.42 20.03 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.469 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -124.35 139.6 53.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.866 0.365 . . . . 0.0 110.901 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 39.1 mm -95.95 145.41 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.158 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -165.02 160.1 33.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 41.6 t -104.61 128.34 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 111.111 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.51 111.03 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.087 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.37 -34.54 15.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -146.44 146.98 30.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 727' ' ' ALA . . . . . 0.431 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -108.12 115.55 30.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.11 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.64 159.06 15.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.173 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -47.68 -67.24 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.482 ' O ' HG23 ' A' ' 731' ' ' THR . 75.3 m -109.5 25.55 11.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.84 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 731' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -160.04 173.22 16.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.155 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 732' ' ' ALA . . . . . 0.518 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -150.8 120.02 6.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.102 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -73.79 96.52 2.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 95.9 t -103.61 140.19 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.135 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -100.69 100.82 11.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 51.5 mt -50.6 160.68 0.4 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -96.81 -37.51 10.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 35.4 t -70.51 -59.13 3.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 68.5 p -78.38 -23.27 46.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.149 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 5.0 m 60.42 40.42 17.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -125.34 150.17 47.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 26.9 m -91.03 111.61 23.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 6.9 pt -119.64 150.2 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.085 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 82.9 p -90.84 124.1 34.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 74.5 t -136.66 143.04 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.092 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -49.03 129.84 17.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 12.1 mtm105 -50.07 -29.44 8.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -79.32 -44.76 20.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 749' ' ' ARG . . . . . 0.402 ' HG2' ' CB ' ' A' ' 714' ' ' GLN . 37.5 mtm180 -54.87 -15.57 2.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 750' ' ' LEU . . . . . 0.518 HD11 ' HB3' ' A' ' 732' ' ' ALA . 23.8 mt -92.93 128.64 38.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 85.7 m -112.06 103.09 11.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 16.7 p -43.94 116.66 1.03 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 753' ' ' VAL . . . . . 0.473 HG21 HG22 ' A' ' 709' ' ' THR . 96.6 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 32.2 t -87.51 83.39 7.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.873 0.368 . . . . 0.0 110.823 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 1.5 t -120.1 149.97 41.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.872 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -154.7 174.55 33.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.464 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 1.3 t -81.8 125.04 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.882 0.372 . . . . 0.0 110.894 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 23.0 t -40.33 -48.13 2.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . -101.83 140.4 14.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.48 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -104.21 41.27 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.814 0.34 . . . . 0.0 110.885 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 82.5 p -118.16 125.26 49.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -103.04 -55.75 2.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.857 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -130.55 148.1 18.55 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.512 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 8.5 mtt85 -72.97 -62.08 1.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.804 0.335 . . . . 0.0 110.875 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -96.93 -127.93 5.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.506 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -107.52 103.4 12.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.83 0.348 . . . . 0.0 110.869 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 38.0 mtp85 -55.58 144.33 26.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -10.85 58.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -96.94 21.07 10.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -72.87 -52.97 12.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.922 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 38.9 tp -65.45 -12.73 55.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 706' ' ' ILE . . . . . 0.527 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -65.78 108.22 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.195 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 122.95 -17.67 8.08 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.493 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -77.81 155.27 31.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.875 0.369 . . . . 0.0 110.868 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 709' ' ' THR . . . . . 0.436 HG22 HG21 ' A' ' 753' ' ' VAL . 64.6 m -85.6 112.33 20.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 710' ' ' VAL . . . . . 0.449 HG21 HG21 ' A' ' 734' ' ' VAL . 33.7 m -112.84 145.7 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 22.0 ttp85 -119.71 112.23 19.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 20.9 mt -57.81 138.13 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.148 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 12.4 t -114.43 -28.39 7.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -113.99 177.13 4.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 75.42 179.56 44.59 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.456 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 716' ' ' PRO . . . . . 0.513 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.4 Cg_endo -69.86 -4.7 14.63 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.682 2.255 . . . . 0.0 112.315 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.513 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 56.1 m-85 -109.47 29.74 7.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.923 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -64.84 124.41 21.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.922 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 89.14 19.59 49.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.501 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 720' ' ' TYR . . . . . 0.463 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 18.4 m-85 -108.47 143.07 37.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.861 0.362 . . . . 0.0 110.921 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.426 HG22 ' N ' ' A' ' 722' ' ' GLY . 27.9 mm -98.13 153.85 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.129 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 722' ' ' GLY . . . . . 0.426 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -173.43 158.54 28.0 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.508 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 40.8 t -101.67 125.26 55.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.388 . . . . 0.0 111.136 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 27.0 t -61.47 111.12 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -90.46 -37.18 14.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.938 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -142.12 148.8 38.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.826 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 727' ' ' ALA . . . . . 0.444 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -114.71 118.62 34.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.161 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 728' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 729' ' ' GLU . 0.7 OUTLIER -102.84 167.9 9.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.145 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 729' ' ' GLU . . . . . 0.452 ' H ' HG22 ' A' ' 728' ' ' THR . 13.6 pt-20 -65.35 -42.7 92.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 731' ' ' THR . 73.6 m -125.25 19.36 8.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.853 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 731' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -160.05 173.19 16.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.182 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 732' ' ' ALA . . . . . 0.605 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -150.86 118.2 6.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.088 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 733' ' ' ARG . . . . . 0.438 ' HD3' ' CB ' ' A' ' 744' ' ' SER . 25.2 mmt180 -75.98 101.53 5.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 734' ' ' VAL . . . . . 0.449 HG21 HG21 ' A' ' 710' ' ' VAL . 82.2 t -108.21 141.62 23.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -102.95 104.2 14.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.86 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 736' ' ' LEU . . . . . 0.463 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 47.8 mt -51.79 159.3 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -91.1 -43.77 9.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.838 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 57.0 m -73.05 -69.15 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 43.0 p -65.7 -7.47 15.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.151 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 29.6 p 40.28 47.28 2.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -125.01 148.85 48.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 23.2 m -94.32 104.94 16.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.153 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 6.9 pt -115.12 146.9 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 744' ' ' SER . . . . . 0.438 ' CB ' ' HD3' ' A' ' 733' ' ' ARG . 2.5 t -94.87 132.13 40.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 40.2 t -142.73 147.35 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.1 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 746' ' ' ASP . . . . . 0.462 ' HB3' ' CG ' ' A' ' 749' ' ' ARG . 10.7 t0 -46.78 127.73 10.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.868 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 747' ' ' ARG . . . . . 0.453 ' HG2' ' HB2' ' A' ' 732' ' ' ALA . 26.9 mtm180 -48.86 -37.01 18.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -74.72 -44.13 51.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.944 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 749' ' ' ARG . . . . . 0.462 ' CG ' ' HB3' ' A' ' 746' ' ' ASP . 84.0 mtt180 -55.11 -14.45 1.61 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 732' ' ' ALA . 28.3 mt -92.84 129.21 38.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 22.2 m -101.6 95.66 6.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 2.8 p -43.46 118.82 1.45 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.162 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 753' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 754' ' ' GLY . 11.2 t -81.22 165.03 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.178 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 754' ' ' GLY . . . . . 0.543 ' N ' HG12 ' A' ' 753' ' ' VAL . . . -179.63 101.89 0.16 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.486 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 755' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 754' ' ' GLY . 59.5 p -35.46 131.74 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.902 0.382 . . . . 0.0 110.842 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -133.35 -177.31 4.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.852 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.869 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 48.3 t -102.45 143.0 32.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.856 0.36 . . . . 0.0 110.831 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 4.3 t -165.69 111.06 0.87 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.852 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -128.93 163.36 22.32 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.478 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 96.1 p -87.65 113.47 23.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 0.0 110.835 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 45.9 p -110.25 -50.43 2.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.852 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 138.07 -172.62 22.82 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.479 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 19.0 mtt -136.1 149.22 48.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.794 0.33 . . . . 0.0 110.878 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 2.3 m -129.52 166.81 18.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.872 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -74.95 168.9 19.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.873 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -96.17 107.47 3.52 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.463 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 698' ' ' ARG . . . . . 0.427 ' HD2' ' N ' ' A' ' 699' ' ' GLY . 6.1 ppt_? -100.03 -33.24 10.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.821 0.344 . . . . 0.0 110.87 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 699' ' ' GLY . . . . . 0.427 ' N ' ' HD2' ' A' ' 698' ' ' ARG . . . -72.5 -177.54 31.12 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.496 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.93 130.29 42.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.343 . . . . 0.0 110.872 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -48.74 106.73 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -76.93 98.97 5.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.847 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -117.44 27.97 8.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.56 -61.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 705' ' ' LEU . . . . . 0.466 HD12 ' HB2' ' A' ' 708' ' ' GLN . 21.4 tp -61.6 -15.59 40.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.967 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 706' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 727' ' ' ALA . 0.6 OUTLIER -63.67 105.41 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.189 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 707' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 119.64 -12.09 11.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.493 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 708' ' ' GLN . . . . . 0.466 ' HB2' HD12 ' A' ' 705' ' ' LEU . 50.4 mm-40 -75.68 160.89 29.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.927 0.394 . . . . 0.0 110.881 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 87.2 m -94.67 106.5 18.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 29.4 m -111.03 155.44 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.13 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -125.19 113.57 17.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 712' ' ' ILE . . . . . 0.533 HG12 HD23 ' A' ' 750' ' ' LEU . 64.3 mt -63.24 104.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.085 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 3.2 m -104.07 28.25 6.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.877 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -161.14 142.07 11.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 97.04 -166.08 23.26 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.525 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 716' ' ' PRO . . . . . 0.569 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.6 Cg_endo -69.75 -27.94 25.93 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.679 2.253 . . . . 0.0 112.342 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.569 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 53.7 m-85 -96.88 44.38 1.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.964 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -71.97 136.0 46.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.897 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 73.6 40.07 47.62 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.474 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 720' ' ' TYR . . . . . 0.467 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 17.7 m-85 -127.09 140.57 52.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.346 . . . . 0.0 110.966 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 722' ' ' GLY . 36.2 mm -96.53 153.62 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.145 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 722' ' ' GLY . . . . . 0.422 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -170.24 164.21 37.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.437 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 53.2 t -108.68 123.05 64.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 111.08 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 724' ' ' VAL . . . . . 0.707 HG22 HG22 ' A' ' 734' ' ' VAL . 46.7 t -65.17 111.68 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -93.09 -30.01 15.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -143.84 144.41 31.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.841 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 727' ' ' ALA . . . . . 0.608 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -108.61 114.89 29.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.07 157.24 17.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.099 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 729' ' ' GLU . . . . . 0.47 ' O ' ' NE ' ' A' ' 747' ' ' ARG . 27.6 tt0 -44.23 -73.8 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 43.5 m -103.35 20.78 17.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.74 173.26 16.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 732' ' ' ALA . . . . . 0.459 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -152.72 122.81 7.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.083 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 34.8 mmm-85 -75.0 96.62 3.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.888 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 734' ' ' VAL . . . . . 0.707 HG22 HG22 ' A' ' 724' ' ' VAL . 73.7 t -100.76 145.7 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.145 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -106.95 101.86 11.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.929 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 736' ' ' LEU . . . . . 0.467 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 53.5 mt -49.71 158.4 0.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -87.69 -48.62 7.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 68.5 m -61.67 -74.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 81.5 p -58.59 -28.9 66.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.135 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.8 m 61.81 49.3 4.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -137.57 152.07 49.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 18.9 m -84.98 137.69 32.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 13.1 pt -143.39 142.93 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.155 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 94.6 p -86.68 112.16 21.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.834 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.512 ' HB ' HD21 ' A' ' 750' ' ' LEU . 72.6 t -127.07 148.06 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.16 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -54.94 131.98 45.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 747' ' ' ARG . . . . . 0.47 ' NE ' ' O ' ' A' ' 729' ' ' GLU . 48.8 mtm180 -52.73 -28.82 23.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.875 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -77.55 -44.65 27.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.94 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -58.29 -14.41 7.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.533 HD23 HG12 ' A' ' 712' ' ' ILE . 14.4 mt -99.07 128.25 45.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.907 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 29.0 m -113.51 102.94 10.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.085 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 18.4 p -45.17 119.42 2.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.151 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 85.0 t -63.47 -43.18 98.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.16 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -78.0 123.11 6.22 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.487 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 5.2 m -134.52 174.9 10.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.37 . . . . 0.0 110.852 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -117.94 162.57 17.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.913 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.871 -179.898 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 31.7 p -143.41 154.32 43.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.9 0.381 . . . . 0.0 110.846 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 62.6 m -123.3 149.49 44.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 107.43 72.96 0.81 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.506 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 12.1 t -94.93 112.68 24.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.373 . . . . 0.0 110.855 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 39.3 t -44.42 119.99 2.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.899 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 179.35 87.4 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.488 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -83.26 -37.91 22.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.764 0.316 . . . . 0.0 110.865 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 2.5 t -139.5 117.86 12.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -111.26 140.89 45.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -138.4 125.6 3.23 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.5 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 5.2 tpt85 -120.97 152.48 38.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.829 0.347 . . . . 0.0 110.892 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -66.4 -124.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.496 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -106.83 43.09 1.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 110.84 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -74.79 83.5 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -115.9 103.29 10.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -132.48 40.95 3.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -78.88 -66.31 0.88 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 705' ' ' LEU . . . . . 0.514 HD12 ' HB2' ' A' ' 708' ' ' GLN . 27.2 tp -59.62 -14.1 12.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.914 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 706' ' ' ILE . . . . . 0.548 HD11 ' HB2' ' A' ' 727' ' ' ALA . 0.6 OUTLIER -62.83 104.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.128 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 125.21 -16.03 7.22 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.472 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 708' ' ' GLN . . . . . 0.514 ' HB2' HD12 ' A' ' 705' ' ' LEU . 48.7 mm-40 -77.32 158.78 29.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.0 110.875 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 709' ' ' THR . . . . . 0.53 ' O ' HG23 ' A' ' 753' ' ' VAL . 62.3 m -90.71 110.23 21.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 710' ' ' VAL . . . . . 0.544 ' HA ' HG23 ' A' ' 753' ' ' VAL . 29.4 m -112.54 144.98 19.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.097 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 711' ' ' ARG . . . . . 0.474 ' CZ ' ' HA2' ' A' ' 719' ' ' GLY . 29.1 ttt85 -116.99 110.89 18.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.837 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 712' ' ' ILE . . . . . 0.421 HG12 HD23 ' A' ' 750' ' ' LEU . 51.2 mt -59.62 114.3 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 42.4 p -108.4 18.05 21.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -147.98 137.44 22.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 99.99 -173.67 25.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.525 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 716' ' ' PRO . . . . . 0.57 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.4 Cg_endo -69.7 -16.75 37.96 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.764 2.309 . . . . 0.0 112.315 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.57 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 35.2 m-85 -98.2 23.22 8.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -58.36 135.61 57.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.855 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 719' ' ' GLY . . . . . 0.474 ' HA2' ' CZ ' ' A' ' 711' ' ' ARG . . . 79.15 28.62 53.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.475 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -116.6 142.68 46.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.905 0.384 . . . . 0.0 110.917 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.424 HD13 ' HB2' ' A' ' 711' ' ' ARG . 12.5 mm -101.94 148.96 6.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.132 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -167.26 160.67 34.4 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.487 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 54.8 t -101.56 123.19 54.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.899 0.38 . . . . 0.0 111.156 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 59.2 t -60.43 105.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.187 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -83.56 -37.4 23.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -143.11 148.96 37.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 727' ' ' ALA . . . . . 0.548 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -115.4 116.43 28.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 728' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 729' ' ' GLU . 0.4 OUTLIER -100.68 168.2 9.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.111 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 729' ' ' GLU . . . . . 0.453 ' H ' HG22 ' A' ' 728' ' ' THR . 18.8 pt-20 -64.54 -45.72 85.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.483 ' O ' HG23 ' A' ' 731' ' ' THR . 72.6 m -122.97 19.4 10.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 731' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -159.87 173.32 16.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 732' ' ' ALA . . . . . 0.559 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -151.64 121.2 6.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.138 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -79.73 97.16 6.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 66.5 t -101.3 147.81 7.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -107.25 100.6 10.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 67.0 mt -50.76 159.43 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -95.6 -31.19 13.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 3.6 t -76.1 -62.43 1.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.876 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 81.0 p -75.89 -16.62 60.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 6.0 m 54.5 42.05 31.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -128.55 156.76 42.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 26.5 m -95.81 120.43 36.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 8.1 pt -125.84 145.52 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 96.3 p -86.53 121.76 29.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.499 ' HB ' HD21 ' A' ' 750' ' ' LEU . 60.5 t -134.36 147.52 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.128 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.57 129.11 37.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 -48.95 -32.05 8.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -77.68 -41.04 39.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.898 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -60.77 -9.54 4.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.559 HD11 ' HB3' ' A' ' 732' ' ' ALA . 13.4 mt -101.56 122.18 43.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 97.5 m -98.8 101.33 12.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.142 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 3.1 p -44.68 118.24 1.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.157 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 753' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 754' ' ' GLY . 4.1 t -80.54 168.6 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 754' ' ' GLY . . . . . 0.567 ' H ' HG12 ' A' ' 753' ' ' VAL . . . -74.96 145.46 33.69 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.523 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 49.7 m -105.78 143.95 33.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 110.844 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 -88.7 121.0 30.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.886 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.833 -179.865 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 78.9 p -143.71 132.59 22.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.876 0.369 . . . . 0.0 110.897 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 4.8 m -104.21 124.42 49.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -46.49 158.4 0.39 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.53 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 29.9 p -144.54 123.72 12.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.905 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 65.8 m -120.29 158.48 26.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.839 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 151.25 -111.56 0.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.468 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 24.5 mtm -41.49 132.06 2.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.808 0.337 . . . . 0.0 110.833 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 30.8 t -132.0 127.91 37.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 3.0 tpt85 -40.69 -60.92 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -48.89 124.97 13.5 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.472 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 10.6 mmt85 -38.87 137.53 0.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 110.877 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -116.78 112.81 2.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.465 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -43.47 148.79 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.771 0.32 . . . . 0.0 110.891 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.05 142.29 27.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.885 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -123.78 77.98 1.57 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.825 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -107.42 32.59 4.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -73.7 -54.1 8.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.887 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 705' ' ' LEU . . . . . 0.401 HD12 ' CG ' ' A' ' 708' ' ' GLN . 48.6 tp -66.12 -14.44 61.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 706' ' ' ILE . . . . . 0.523 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -64.11 107.2 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.105 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 707' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 120.91 -14.72 9.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.505 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 708' ' ' GLN . . . . . 0.401 ' CG ' HD12 ' A' ' 705' ' ' LEU . 65.0 mm-40 -73.72 158.78 34.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.841 0.353 . . . . 0.0 110.939 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 82.1 m -95.28 107.65 19.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 24.4 m -112.0 157.1 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -125.12 110.66 14.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 712' ' ' ILE . . . . . 0.525 HG12 HD23 ' A' ' 750' ' ' LEU . 34.9 mt -60.45 108.32 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 3.4 m -109.33 31.53 5.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.898 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 714' ' ' GLN . . . . . 0.441 ' CB ' ' HG2' ' A' ' 749' ' ' ARG . 33.9 mt-30 -160.03 131.04 5.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 102.64 -163.86 16.4 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.482 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 716' ' ' PRO . . . . . 0.547 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 54.3 Cg_endo -69.71 -34.89 13.85 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.707 2.271 . . . . 0.0 112.339 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.547 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 48.3 m-85 -88.31 38.64 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.949 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -71.4 132.86 45.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.915 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.36 33.57 31.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.481 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 720' ' ' TYR . . . . . 0.484 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 13.2 m-85 -122.41 141.06 52.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.936 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 14.1 mm -98.03 148.88 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.133 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -167.28 161.58 35.4 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.556 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.446 HG23 ' NE2' ' A' ' 737' ' ' HIS . 46.6 t -104.74 127.55 59.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.83 0.347 . . . . 0.0 111.139 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 724' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 707' ' ' GLY . 60.7 t -64.01 109.66 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.161 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.84 -35.81 15.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -143.25 149.2 37.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 727' ' ' ALA . . . . . 0.509 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -110.18 115.78 30.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.131 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 1.1 m -103.53 154.97 18.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.162 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -41.07 -75.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.848 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.414 ' O ' HG23 ' A' ' 731' ' ' THR . 61.8 m -104.31 25.37 10.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 731' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -157.85 173.17 17.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.152 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 732' ' ' ALA . . . . . 0.502 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -151.87 122.11 7.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.076 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 53.6 mmm-85 -76.56 99.19 4.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.16 142.89 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.107 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -103.22 105.62 15.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 736' ' ' LEU . . . . . 0.484 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 39.4 mt -50.22 160.14 0.39 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 737' ' ' HIS . . . . . 0.446 ' NE2' HG23 ' A' ' 723' ' ' VAL . 9.8 m170 -95.15 -24.07 17.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 13.4 m -83.98 -71.24 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 31.3 p -67.94 -16.88 64.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.153 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 8.8 m 55.71 41.9 29.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.836 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -125.9 148.82 49.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.93 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 29.1 m -89.29 129.22 35.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.156 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 7.0 pt -135.4 145.77 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.122 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 88.6 p -87.57 117.49 26.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 81.2 t -131.05 143.06 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.089 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -48.94 132.82 18.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -52.31 -32.97 40.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -75.84 -42.44 49.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 749' ' ' ARG . . . . . 0.441 ' HG2' ' CB ' ' A' ' 714' ' ' GLN . 90.6 mtt180 -58.06 -11.86 2.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.525 HD23 HG12 ' A' ' 712' ' ' ILE . 14.4 mt -101.07 127.2 47.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.94 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 60.6 m -112.16 103.51 11.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.132 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 14.5 p -42.63 116.78 0.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.148 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 87.4 t -62.23 -50.15 81.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.148 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 101.0 -157.98 19.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 34.1 m -97.94 148.91 22.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 0.0 110.844 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -74.51 121.26 21.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.863 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.888 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.539 -0.225 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 92.3 p -113.9 109.88 19.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.909 0.385 . . . . 0.0 110.887 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 94.1 p -172.7 166.12 5.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.8 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -155.6 95.91 0.15 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.51 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 3.0 m -152.71 151.94 31.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.913 0.387 . . . . 0.0 110.865 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 99.3 p -113.22 86.07 2.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.875 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 84.89 119.83 0.9 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.521 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -79.55 -39.93 30.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 0.0 110.909 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 79.4 p -88.41 111.7 22.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.805 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 11.7 mtm-85 -94.66 108.04 20.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -41.8 135.84 3.15 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.457 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -111.61 81.08 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.795 0.331 . . . . 0.0 110.893 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 699' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 700' ' ' ARG . . . -100.87 -142.89 13.31 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.522 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 700' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 699' ' ' GLY . 0.0 OUTLIER -34.98 149.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.825 0.345 . . . . 0.0 110.838 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 52.6 mmm-85 -126.57 100.05 6.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -97.32 79.86 2.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -88.45 34.51 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -85.38 -55.99 3.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 705' ' ' LEU . . . . . 0.437 ' HG ' HG21 ' A' ' 724' ' ' VAL . 48.9 tp -60.87 -13.64 16.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.929 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 706' ' ' ILE . . . . . 0.587 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -66.31 109.83 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.141 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.18 -12.66 12.71 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.489 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -76.94 164.05 26.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.923 0.392 . . . . 0.0 110.877 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 53.4 m -99.23 110.04 22.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.159 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 21.1 m -113.34 152.87 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.109 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -123.5 114.01 19.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.827 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 712' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 714' ' ' GLN . 20.1 mt -56.64 133.04 21.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.166 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 12.8 t -107.97 -29.4 9.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 714' ' ' GLN . . . . . 0.415 ' O ' ' CG2' ' A' ' 712' ' ' ILE . 26.7 mm-40 -112.85 -179.64 3.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 76.42 -179.03 49.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.541 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 716' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -10.95 29.83 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.641 2.227 . . . . 0.0 112.383 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -107.67 35.03 3.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.949 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -65.95 107.16 1.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.856 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 107.19 30.42 4.17 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.463 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -117.92 147.87 42.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 0.0 110.899 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 30.5 mm -98.8 147.12 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.171 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -165.17 161.49 34.86 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.501 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 48.9 t -106.06 129.47 59.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.382 . . . . 0.0 111.125 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 724' ' ' VAL . . . . . 0.437 HG21 ' HG ' ' A' ' 705' ' ' LEU . 39.3 t -64.68 109.19 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -86.19 -38.49 17.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -143.86 149.77 37.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -113.06 118.19 34.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.82 164.31 11.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.174 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -56.08 -54.88 39.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 59.5 m -118.13 17.16 14.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.878 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.69 173.25 14.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.143 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 732' ' ' ALA . . . . . 0.722 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -150.98 120.46 6.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.076 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -79.02 97.38 6.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.837 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 99.3 t -102.28 144.32 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.167 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -104.84 101.99 11.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.866 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 31.3 mt -50.78 158.68 0.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.954 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -87.6 -55.4 3.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 22.2 t -61.31 -68.61 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 61.7 p -59.96 -30.26 68.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.101 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 12.0 t 59.54 48.36 9.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.901 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -133.7 149.28 51.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 17.0 m -88.53 110.86 21.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.17 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 7.5 pt -118.69 147.75 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 95.5 p -89.97 126.25 35.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.6 ' HB ' HD21 ' A' ' 750' ' ' LEU . 57.6 t -138.21 141.87 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.138 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 746' ' ' ASP . . . . . 0.453 ' HB2' ' CG ' ' A' ' 749' ' ' ARG . 0.7 OUTLIER -48.54 127.58 13.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 26.2 mtm180 -45.36 -36.47 4.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.869 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -77.26 -44.42 29.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.958 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 749' ' ' ARG . . . . . 0.453 ' CG ' ' HB2' ' A' ' 746' ' ' ASP . 56.0 mtt180 -49.35 -28.18 4.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.722 HD11 ' HB3' ' A' ' 732' ' ' ALA . 13.6 mt -79.88 139.56 37.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 50.7 m -116.6 91.95 3.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.165 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 11.9 p -42.57 117.97 1.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.125 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 78.6 t -65.53 -51.34 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -57.91 169.21 4.63 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.475 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 2.2 t -109.0 132.02 54.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.899 0.38 . . . . 0.0 110.866 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 14.5 tpp85 -91.22 85.95 6.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.855 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 27.3 m -58.64 -47.08 85.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.897 0.38 . . . . 0.0 110.85 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 99.2 p -124.71 122.65 38.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.875 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -115.91 83.46 0.34 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.504 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 4.0 t -105.48 -59.33 1.78 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.875 0.369 . . . . 0.0 110.902 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 20.4 t 46.84 42.09 11.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.851 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 70.67 131.44 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.512 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 2.3 ttt -134.2 -49.99 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.738 0.304 . . . . 0.0 110.84 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 6.9 t -71.1 118.28 13.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.907 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -110.85 112.76 24.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -128.84 157.2 21.45 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.491 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -83.39 141.45 31.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.936 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -122.36 137.45 11.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.468 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -53.6 -46.92 70.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 110.867 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 701' ' ' ARG . . . . . 0.431 ' NH1' ' HB2' ' A' ' 701' ' ' ARG . 7.6 mtp-105 -56.07 141.66 39.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.5 97.43 10.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -112.29 34.71 4.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -85.94 -56.83 3.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 705' ' ' LEU . . . . . 0.51 ' HG ' HG21 ' A' ' 724' ' ' VAL . 47.6 tp -59.99 -13.25 10.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.901 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 706' ' ' ILE . . . . . 0.523 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -62.88 108.95 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 117.04 -13.82 14.03 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.49 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 708' ' ' GLN . . . . . 0.488 ' CG ' HD12 ' A' ' 705' ' ' LEU . 55.7 mm-40 -73.77 161.15 30.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.902 0.382 . . . . 0.0 110.895 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 709' ' ' THR . . . . . 0.674 HG22 HG21 ' A' ' 753' ' ' VAL . 97.2 m -97.64 106.85 19.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.167 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 27.1 m -112.69 156.64 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.151 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 711' ' ' ARG . . . . . 0.556 ' HB2' HD13 ' A' ' 721' ' ' ILE . 23.2 ttp180 -127.27 115.13 18.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 44.6 mt -60.27 128.85 21.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.123 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 4.5 t -126.4 11.99 7.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.811 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 714' ' ' GLN . . . . . 0.45 ' CB ' ' HG2' ' A' ' 749' ' ' ARG . 24.5 mt-30 -138.72 128.08 24.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.948 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 105.85 -162.38 14.14 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.474 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 716' ' ' PRO . . . . . 0.558 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.5 Cg_endo -69.82 -32.88 17.47 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.735 2.29 . . . . 0.0 112.327 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.558 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 50.4 m-85 -91.82 42.72 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.957 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 39.5 tttm -78.24 97.4 5.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 120.96 34.67 0.88 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.505 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 720' ' ' TYR . . . . . 0.442 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 14.4 m-85 -127.51 147.57 50.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.857 0.36 . . . . 0.0 110.919 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.556 HD13 ' HB2' ' A' ' 711' ' ' ARG . 28.7 mm -98.22 154.11 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.093 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 722' ' ' GLY . . . . . 0.429 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -172.44 151.43 14.44 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.461 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 41.2 t -94.89 129.29 45.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 111.134 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 724' ' ' VAL . . . . . 0.51 HG21 ' HG ' ' A' ' 705' ' ' LEU . 38.4 t -63.79 109.08 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.143 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.0 mmpt? -85.37 -40.76 16.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -143.14 149.47 38.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.824 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 727' ' ' ALA . . . . . 0.464 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -110.97 119.79 40.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.47 160.95 14.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.155 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -52.13 -62.17 1.81 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.428 ' O ' HG23 ' A' ' 731' ' ' THR . 38.3 m -111.57 22.43 15.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.829 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 731' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -158.17 173.23 17.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 732' ' ' ALA . . . . . 0.629 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -151.41 119.44 6.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -75.96 102.03 5.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 93.9 t -107.46 145.98 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -108.47 104.55 13.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 736' ' ' LEU . . . . . 0.442 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 38.0 mt -50.88 161.36 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -95.41 -27.89 15.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 3.9 m -82.39 -74.07 0.36 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 28.2 p -62.43 -19.2 63.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.152 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.2 m 57.09 41.63 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -123.78 146.72 48.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.906 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 18.4 m -90.78 108.2 19.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.118 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 9.5 pt -111.76 154.1 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.186 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 84.6 p -97.41 124.8 41.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.845 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.68 ' HB ' HD21 ' A' ' 750' ' ' LEU . 62.0 t -136.88 145.32 30.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.094 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -53.07 128.29 27.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 10.0 mtm105 -45.57 -34.77 3.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -77.05 -40.06 47.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 749' ' ' ARG . . . . . 0.45 ' HG2' ' CB ' ' A' ' 714' ' ' GLN . 63.9 mtt180 -56.8 -21.96 32.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.856 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.68 HD21 ' HB ' ' A' ' 745' ' ' VAL . 10.6 mt -88.83 139.22 30.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 88.8 m -119.46 96.03 5.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.167 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 7.3 p -39.81 118.25 0.84 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.165 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 753' ' ' VAL . . . . . 0.674 HG21 HG22 ' A' ' 709' ' ' THR . 98.6 t -56.74 -44.3 81.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.124 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 171.66 73.7 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.511 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 58.2 m -83.82 84.93 7.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.877 0.37 . . . . 0.0 110.863 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -108.28 15.11 24.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.883 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.871 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 70.7 m -114.34 94.34 4.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.837 0.351 . . . . 0.0 110.808 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 3.0 m -140.98 137.86 33.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.814 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 145.06 117.65 1.14 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.477 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 56.0 p -169.04 167.34 10.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.854 0.359 . . . . 0.0 110.86 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 3.0 t -117.82 100.73 7.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.838 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . -132.79 -109.16 1.14 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.489 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 19.8 mmt -44.55 128.56 6.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.739 0.304 . . . . 0.0 110.888 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 4.0 m -128.84 92.14 3.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.861 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 28.1 ttt85 -57.28 104.2 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -43.92 -63.29 2.32 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.474 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -93.49 90.38 6.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 0.0 110.882 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -77.82 148.7 33.77 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.43 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -76.57 158.81 30.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.811 0.338 . . . . 0.0 110.877 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 701' ' ' ARG . . . . . 0.454 ' HD2' ' N ' ' A' ' 701' ' ' ARG . 1.7 mpt_? -72.39 104.01 3.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -120.36 48.4 1.59 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -86.92 34.52 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -75.45 -58.68 3.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 45.4 tp -60.08 -14.31 16.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 706' ' ' ILE . . . . . 0.587 HD11 ' HB2' ' A' ' 727' ' ' ALA . 0.7 OUTLIER -64.17 108.55 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.62 -12.91 12.0 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -74.72 166.43 23.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.86 0.362 . . . . 0.0 110.937 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 709' ' ' THR . . . . . 0.609 HG22 HG21 ' A' ' 753' ' ' VAL . 62.7 m -100.39 110.19 22.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.182 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 710' ' ' VAL . . . . . 0.423 HG12 HG22 ' A' ' 752' ' ' THR . 26.3 m -114.25 158.48 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.169 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 711' ' ' ARG . . . . . 0.503 ' HB2' HD13 ' A' ' 721' ' ' ILE . 23.4 ttm-85 -131.76 112.46 12.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 15.7 mt -57.22 133.34 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.131 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 15.9 t -109.21 -29.79 8.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -112.12 178.72 4.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 76.09 178.05 43.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.513 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 716' ' ' PRO . . . . . 0.52 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.9 Cg_endo -69.71 -11.06 30.12 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.652 2.234 . . . . 0.0 112.326 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.52 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 52.9 m-85 -103.9 29.12 6.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.927 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -62.04 135.29 57.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.901 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 77.33 37.39 31.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.48 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 720' ' ' TYR . . . . . 0.473 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 24.6 m-85 -124.1 140.22 53.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.845 0.355 . . . . 0.0 110.981 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.503 HD13 ' HB2' ' A' ' 711' ' ' ARG . 11.5 mm -98.81 148.76 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.134 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -167.98 169.66 41.49 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.449 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 53.3 t -112.13 126.87 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.88 0.371 . . . . 0.0 111.104 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 724' ' ' VAL . . . . . 0.46 HG22 HG22 ' A' ' 734' ' ' VAL . 99.1 t -62.66 108.01 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.147 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -84.18 -40.21 18.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -142.63 150.28 40.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 727' ' ' ALA . . . . . 0.587 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -108.57 118.52 36.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.066 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.11 156.97 17.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 729' ' ' GLU . . . . . 0.442 ' O ' ' NE ' ' A' ' 747' ' ' ARG . 6.3 tp10 -42.89 -75.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 25.1 m -103.0 18.92 20.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.72 173.36 14.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.178 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 732' ' ' ALA . . . . . 0.497 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -151.0 120.43 6.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.09 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 49.1 mmm-85 -75.53 101.46 4.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 734' ' ' VAL . . . . . 0.46 HG22 HG22 ' A' ' 724' ' ' VAL . 87.1 t -107.47 144.23 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.159 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -104.32 104.18 14.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 736' ' ' LEU . . . . . 0.473 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 40.4 mt -52.69 161.43 0.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.949 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -90.66 -48.7 6.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.853 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 3.6 m -61.0 -72.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 77.4 p -61.2 -27.0 68.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.145 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 13.8 t 59.91 49.41 7.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -138.52 151.55 47.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 21.1 m -83.37 137.43 33.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.153 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 13.2 pt -142.79 148.52 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 81.0 p -92.12 119.39 31.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.495 ' HB ' HD21 ' A' ' 750' ' ' LEU . 32.4 t -133.72 142.42 41.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -49.7 132.01 21.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 747' ' ' ARG . . . . . 0.442 ' NE ' ' O ' ' A' ' 729' ' ' GLU . 36.7 mtm180 -54.04 -20.44 6.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -87.89 -44.05 11.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 -56.88 -17.23 8.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 732' ' ' ALA . 19.3 mt -89.83 134.32 34.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.978 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 21.6 m -115.02 90.85 3.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.097 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 752' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 710' ' ' VAL . 16.2 p -41.84 118.56 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.097 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 753' ' ' VAL . . . . . 0.609 HG21 HG22 ' A' ' 709' ' ' THR . 98.3 t -59.14 -55.96 20.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.189 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 754' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 755' ' ' SER . . . -62.27 -148.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.52 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 755' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 754' ' ' GLY . 72.4 m -37.88 142.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.819 0.342 . . . . 0.0 110.872 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -105.49 125.45 51.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.89 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 -179.885 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 24.5 p -72.02 122.84 21.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 110.881 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 14.4 t -59.2 135.18 57.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.84 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 171.37 102.64 0.16 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.509 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 70.1 m -124.01 150.51 44.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.889 0.376 . . . . 0.0 110.861 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 9.2 m -76.12 133.15 40.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.914 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . -83.5 161.89 39.29 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.522 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.67 173.04 7.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.807 0.337 . . . . 0.0 110.889 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 70.0 m -75.58 147.61 39.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.837 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.02 -3.64 8.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.862 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -112.58 -152.98 11.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.449 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -101.91 43.54 1.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.859 0.361 . . . . 0.0 110.84 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -93.11 88.13 1.25 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.511 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -114.71 140.87 48.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.765 0.317 . . . . 0.0 110.887 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 701' ' ' ARG . . . . . 0.421 ' NH1' ' HB2' ' A' ' 701' ' ' ARG . 20.4 mtm105 -125.44 165.7 17.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -110.87 -27.36 8.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 703' ' ' ASN . . . . . 0.404 ' HA ' HD13 ' A' ' 706' ' ' ILE . 11.0 p-10 -62.49 -13.61 32.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.922 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -53.41 -16.32 1.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 30.4 tp -101.8 -17.07 16.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.917 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 706' ' ' ILE . . . . . 0.504 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -67.46 103.12 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 123.21 -7.02 9.26 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.517 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -78.58 168.24 20.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.857 0.36 . . . . 0.0 110.921 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 52.8 m -102.91 105.45 15.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.115 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 710' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 752' ' ' THR . 35.8 m -109.86 158.47 9.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.114 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 711' ' ' ARG . . . . . 0.54 ' HB2' HD13 ' A' ' 721' ' ' ILE . 14.4 ttm-85 -128.54 115.9 18.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.863 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 49.1 mt -59.26 142.64 14.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.151 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 18.0 t -118.84 -30.57 5.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 36.8 mm-40 -112.09 172.12 7.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 80.87 179.57 53.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.493 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 716' ' ' PRO . . . . . 0.481 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.7 Cg_endo -69.7 -8.39 23.47 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.755 2.303 . . . . 0.0 112.321 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.481 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 63.6 m-85 -106.94 27.43 8.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -60.89 130.94 48.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.26 37.8 20.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.473 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 720' ' ' TYR . . . . . 0.4 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 10.5 m-85 -125.65 142.77 51.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 0.0 110.906 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.54 HD13 ' HB2' ' A' ' 711' ' ' ARG . 26.4 mm -96.43 146.65 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.095 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -163.49 165.0 36.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.483 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.513 HG23 ' NE2' ' A' ' 737' ' ' HIS . 29.3 t -110.28 128.01 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 0.0 111.171 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 33.9 t -64.8 108.93 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -85.28 -38.34 18.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.881 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -145.12 149.48 35.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 727' ' ' ALA . . . . . 0.477 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -108.32 117.67 34.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.158 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.03 155.75 18.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.151 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 729' ' ' GLU . . . . . 0.482 ' O ' ' NE ' ' A' ' 747' ' ' ARG . 24.7 tt0 -43.09 -74.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.914 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 731' ' ' THR . 58.5 m -103.24 24.6 10.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 731' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -158.05 173.2 17.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.161 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 732' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -151.09 121.58 7.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.12 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -76.75 98.75 4.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 57.4 t -103.95 150.85 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.151 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -111.7 102.67 10.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.828 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 736' ' ' LEU . . . . . 0.4 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 31.9 mt -50.88 157.39 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 737' ' ' HIS . . . . . 0.513 ' NE2' HG23 ' A' ' 723' ' ' VAL . 18.6 m170 -95.34 -23.12 17.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.841 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 3.7 t -82.26 -68.68 0.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 34.4 p -70.97 -17.41 62.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.159 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 55.6 m 58.28 40.58 24.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.864 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -125.3 153.91 42.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 26.2 m -96.88 121.19 38.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 7.9 pt -126.36 155.46 36.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.131 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 92.0 p -97.44 121.13 38.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.67 HG12 ' HB2' ' A' ' 749' ' ' ARG . 21.7 t -134.43 144.62 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.152 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -48.98 131.16 18.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 747' ' ' ARG . . . . . 0.482 ' NE ' ' O ' ' A' ' 729' ' ' GLU . 36.9 mtm180 -50.74 -17.83 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -90.53 -37.42 13.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 749' ' ' ARG . . . . . 0.67 ' HB2' HG12 ' A' ' 745' ' ' VAL . 31.4 mtm180 -61.96 -8.58 5.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.558 HD11 ' HB3' ' A' ' 732' ' ' ALA . 14.6 mt -100.77 135.6 41.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.968 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 33.1 m -118.7 93.63 4.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.168 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 752' ' ' THR . . . . . 0.539 ' HA ' HG12 ' A' ' 710' ' ' VAL . 6.4 p -39.9 121.23 1.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.098 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 753' ' ' VAL . . . . . 0.429 HG21 HD12 ' A' ' 721' ' ' ILE . 96.4 t -67.42 -55.4 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.152 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -57.79 131.98 52.32 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.454 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 44.5 m -79.99 122.23 26.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.908 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 -89.63 8.21 32.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.844 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.943 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 71.3 p -65.17 164.82 12.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.87 0.367 . . . . 0.0 110.85 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 89.6 p -107.73 117.97 35.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.901 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 61.78 62.53 5.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.473 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 67.1 p -83.37 138.02 33.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 110.823 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 40.9 p -157.78 166.79 31.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.848 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 167.42 167.82 28.67 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.471 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.36 173.67 11.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.783 0.325 . . . . 0.0 110.895 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 695' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 696' ' ' ARG . 40.4 t -72.9 -54.42 8.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 696' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 695' ' ' SER . 17.9 ttm-85 -36.16 -67.4 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.86 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -45.21 -48.2 10.55 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.539 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -62.97 130.38 44.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.359 . . . . 0.0 110.857 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -86.24 104.93 2.93 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.487 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 2.9 ptp85 -44.19 135.5 4.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.745 0.307 . . . . 0.0 110.877 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -113.41 126.46 55.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.875 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.34 46.21 2.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -91.82 24.45 3.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -76.03 -55.21 5.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 705' ' ' LEU . . . . . 0.501 ' HG ' HG21 ' A' ' 724' ' ' VAL . 52.0 tp -62.45 -16.07 53.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.959 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 706' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 727' ' ' ALA . 0.7 OUTLIER -61.59 109.52 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 707' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 120.84 -20.69 8.6 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.486 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -73.0 157.45 37.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.897 0.38 . . . . 0.0 110.895 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 709' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 753' ' ' VAL . 55.1 m -90.61 110.28 21.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.178 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 710' ' ' VAL . . . . . 0.491 ' HA ' HG23 ' A' ' 753' ' ' VAL . 33.1 m -111.65 146.94 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.129 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 711' ' ' ARG . . . . . 0.495 ' HB2' HD13 ' A' ' 721' ' ' ILE . 12.8 ttp-105 -117.44 113.14 21.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 712' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' A' ' 714' ' ' GLN . 35.6 mt -58.73 127.35 17.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 26.2 t -105.66 -26.51 11.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 714' ' ' GLN . . . . . 0.439 ' O ' ' CG2' ' A' ' 712' ' ' ILE . 9.8 mm-40 -113.95 175.53 5.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.882 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 77.41 177.27 46.11 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.516 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 716' ' ' PRO . . . . . 0.573 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 54.5 Cg_endo -69.69 -0.06 6.3 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.684 2.256 . . . . 0.0 112.398 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.573 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 58.0 m-85 -115.34 33.89 5.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.962 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -66.39 137.11 56.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 77.66 28.48 57.12 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.513 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -117.92 141.38 48.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 0.0 110.926 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.495 HD13 ' HB2' ' A' ' 711' ' ' ARG . 27.2 mm -96.67 155.01 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.147 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 722' ' ' GLY . . . . . 0.451 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -173.81 157.78 26.29 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.489 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 44.1 t -100.95 129.91 51.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.881 0.372 . . . . 0.0 111.158 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 724' ' ' VAL . . . . . 0.501 HG21 ' HG ' ' A' ' 705' ' ' LEU . 23.1 t -65.14 113.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.123 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -91.49 -39.6 11.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -141.9 149.65 40.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 727' ' ' ALA . . . . . 0.629 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -110.57 115.88 30.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.44 157.51 16.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.157 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -45.96 -70.39 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.913 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.41 ' O ' HG23 ' A' ' 731' ' ' THR . 2.7 m -106.19 23.68 13.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.854 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 731' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 730' ' ' SER . 0.7 OUTLIER -157.71 173.27 17.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 732' ' ' ALA . . . . . 0.482 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -151.36 119.6 6.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 25.1 mmt-85 -75.37 97.07 3.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.9 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 734' ' ' VAL . . . . . 0.454 HG21 HG21 ' A' ' 710' ' ' VAL . 69.6 t -103.89 145.23 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.16 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -104.24 101.36 11.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 32.5 mt -49.82 160.8 0.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -89.46 -62.8 1.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 2.1 t -53.85 -70.27 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.832 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 71.0 p -58.61 -35.09 71.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.142 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 6.6 t 65.77 41.31 3.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -128.7 145.79 51.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 20.7 m -85.1 133.3 34.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.144 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 7.6 pt -141.61 149.46 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.189 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 97.5 p -91.5 117.93 30.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.46 142.77 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.152 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 746' ' ' ASP . . . . . 0.477 ' HB3' ' CG ' ' A' ' 749' ' ' ARG . 7.9 t0 -46.96 126.42 8.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.823 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -48.87 -35.09 13.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -76.96 -41.82 41.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 749' ' ' ARG . . . . . 0.477 ' CG ' ' HB3' ' A' ' 746' ' ' ASP . 79.2 mtt180 -57.21 -18.51 16.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.482 ' CD1' ' HB3' ' A' ' 732' ' ' ALA . 21.3 mt -89.07 127.67 35.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.956 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 18.3 m -101.11 97.99 8.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.132 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 4.6 p -43.36 118.69 1.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 753' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 754' ' ' GLY . 5.8 t -81.08 167.45 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 754' ' ' GLY . . . . . 0.542 ' N ' HG12 ' A' ' 753' ' ' VAL . . . 130.87 129.05 3.03 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.521 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 6.4 t -85.72 122.16 29.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.818 0.342 . . . . 0.0 110.884 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.0 132.0 49.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.932 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 14.1 m -125.06 87.36 2.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.853 0.359 . . . . 0.0 110.866 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 13.6 m -94.64 94.31 8.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -76.95 -175.55 42.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.516 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 49.7 m -111.97 139.97 47.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.898 0.38 . . . . 0.0 110.85 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 9.1 t -98.93 174.69 6.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.883 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . -164.49 106.46 0.27 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.493 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 59.0 mtp -56.91 106.75 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.778 0.323 . . . . 0.0 110.873 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 16.6 m -109.47 119.37 39.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -114.38 42.51 2.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.86 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -134.24 -166.93 11.38 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.466 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -105.92 43.13 1.16 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.856 0.36 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -71.04 -39.31 63.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.474 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -91.02 155.1 18.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.752 0.311 . . . . 0.0 110.924 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 43.3 mtt85 -108.91 155.32 20.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -63.11 95.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.856 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -116.35 20.74 14.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -73.49 -54.13 8.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.0 -12.48 18.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.899 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 706' ' ' ILE . . . . . 0.586 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -66.8 111.41 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.149 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.6 -17.39 11.14 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.473 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -73.62 154.12 39.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.857 0.361 . . . . 0.0 110.884 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 63.9 m -90.67 111.12 22.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.16 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 710' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 752' ' ' THR . 31.6 m -115.29 156.88 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.15 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -125.72 115.97 20.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 712' ' ' ILE . . . . . 0.675 HD11 HD11 ' A' ' 743' ' ' ILE . 26.2 mt -56.33 142.98 10.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 713' ' ' SER . . . . . 0.475 ' HB3' ' NE2' ' A' ' 714' ' ' GLN . 41.8 t -116.76 -36.77 3.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 714' ' ' GLN . . . . . 0.475 ' NE2' ' HB3' ' A' ' 713' ' ' SER . 1.6 mp0 -105.37 -175.71 2.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.916 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 69.48 175.05 12.67 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.513 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 716' ' ' PRO . . . . . 0.576 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.2 Cg_endo -69.81 -4.38 13.95 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.677 2.252 . . . . 0.0 112.323 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.576 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 45.4 m-85 -108.2 29.42 7.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -64.06 136.74 57.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.933 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 77.53 32.12 47.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -118.59 145.91 45.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.81 0.338 . . . . 0.0 110.955 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 48.7 mm -97.0 147.8 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.149 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -170.47 148.72 11.78 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.467 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.498 ' C ' HG13 ' A' ' 734' ' ' VAL . 55.1 t -97.3 126.26 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.367 . . . . 0.0 111.159 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 724' ' ' VAL . . . . . 0.808 ' HA ' HG22 ' A' ' 734' ' ' VAL . 41.8 t -59.97 113.27 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -90.47 -39.08 12.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -142.51 144.89 33.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.847 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -106.11 118.03 35.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.091 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.38 155.35 20.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 729' ' ' GLU . . . . . 0.402 ' O ' ' NE ' ' A' ' 747' ' ' ARG . 15.6 tp10 -45.07 -71.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 73.5 m -106.91 26.29 10.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.826 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.44 173.37 17.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.16 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 732' ' ' ALA . . . . . 0.669 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -155.73 119.96 4.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.065 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 733' ' ' ARG . . . . . 0.457 ' HB3' ' CG2' ' A' ' 742' ' ' THR . 1.5 mpt_? -84.82 98.36 10.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 734' ' ' VAL . . . . . 0.808 HG22 ' HA ' ' A' ' 724' ' ' VAL . 55.8 t -103.62 146.05 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.113 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -100.8 102.13 13.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 31.3 mt -49.84 157.61 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -85.47 -43.8 13.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 48.1 m -71.78 -72.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 67.9 p -58.64 -18.13 27.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.177 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 9.2 t 48.97 47.95 21.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -138.66 155.18 48.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 742' ' ' THR . . . . . 0.457 ' CG2' ' HB3' ' A' ' 733' ' ' ARG . 66.4 m -84.67 133.09 34.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.15 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 743' ' ' ILE . . . . . 0.675 HD11 HD11 ' A' ' 712' ' ' ILE . 7.3 pt -135.62 138.3 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.159 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 45.8 p -80.84 120.94 25.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.896 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.46 HG13 ' CZ ' ' A' ' 749' ' ' ARG . 98.2 t -138.89 144.15 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.143 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -54.36 127.93 29.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 747' ' ' ARG . . . . . 0.402 ' NE ' ' O ' ' A' ' 729' ' ' GLU . 30.0 mtm180 -45.39 -40.14 7.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -71.7 -46.01 60.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 749' ' ' ARG . . . . . 0.46 ' CZ ' HG13 ' A' ' 745' ' ' VAL . 39.1 mtp180 -49.84 -26.49 4.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.669 HD11 ' HB3' ' A' ' 732' ' ' ALA . 16.5 mt -82.65 129.39 34.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.932 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 20.1 m -111.0 98.73 7.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.157 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 752' ' ' THR . . . . . 0.437 ' HA ' HG12 ' A' ' 710' ' ' VAL . 20.6 p -42.11 117.68 1.02 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.166 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 83.7 t -65.38 -45.25 93.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.137 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -40.54 117.97 1.06 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 70.5 m -92.56 177.82 6.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.89 0.376 . . . . 0.0 110.835 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -134.73 177.11 8.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.829 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 -179.852 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 5.1 m 47.23 46.87 16.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.878 0.37 . . . . 0.0 110.859 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 12.4 m -102.91 41.08 1.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -167.47 -106.7 0.19 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.447 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 7.4 t -70.11 152.11 44.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.877 0.37 . . . . 0.0 110.862 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 3.6 m -164.19 176.18 9.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.882 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . -123.73 144.57 15.59 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 7.8 ttt -126.35 86.47 2.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.754 0.312 . . . . 0.0 110.891 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 46.6 p -80.53 175.73 10.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.852 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 35.4 mtp85 -81.68 40.57 0.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -101.81 113.49 4.65 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.477 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 62.9 mtt-85 -80.69 80.64 7.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.36 . . . . 0.0 110.869 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -131.27 -111.47 1.39 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.438 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 700' ' ' ARG . . . . . 0.429 ' NH1' ' HB2' ' A' ' 700' ' ' ARG . 8.8 ttm105 -59.22 134.94 57.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.798 0.332 . . . . 0.0 110.881 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 701' ' ' ARG . . . . . 0.657 ' H ' ' NE ' ' A' ' 701' ' ' ARG . 0.0 OUTLIER -116.27 -179.76 3.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -74.5 98.53 3.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -109.33 24.3 13.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.867 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -73.91 -61.01 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 46.9 tp -62.44 -11.97 19.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.882 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 706' ' ' ILE . . . . . 0.535 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -65.5 108.65 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.115 179.872 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 707' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 119.69 -15.52 10.5 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.472 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -76.72 156.28 32.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.914 0.388 . . . . 0.0 110.934 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 709' ' ' THR . . . . . 0.439 HG22 ' HB ' ' A' ' 753' ' ' VAL . 53.9 m -89.3 113.95 25.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 710' ' ' VAL . . . . . 0.449 ' HA ' HG23 ' A' ' 753' ' ' VAL . 33.9 m -117.83 154.12 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 711' ' ' ARG . . . . . 0.626 ' CZ ' HD11 ' A' ' 721' ' ' ILE . 31.2 ttm-85 -126.02 113.89 17.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 712' ' ' ILE . . . . . 0.53 HG12 HD23 ' A' ' 750' ' ' LEU . 40.8 mt -64.02 110.36 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.147 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 5.8 t -107.95 20.79 18.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.818 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -149.18 134.37 18.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.941 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 101.3 -164.77 18.09 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.51 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 716' ' ' PRO . . . . . 0.557 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 54.0 Cg_endo -69.76 -30.56 22.1 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.665 2.244 . . . . 0.0 112.359 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.557 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 44.7 m-85 -91.21 38.82 0.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -73.0 126.35 29.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.902 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 87.62 35.38 9.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.486 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -128.06 144.31 51.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 110.956 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.626 HD11 ' CZ ' ' A' ' 711' ' ' ARG . 39.1 mm -97.98 156.82 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.16 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 722' ' ' GLY . . . . . 0.478 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -174.1 155.18 21.11 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.518 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.464 HG23 ' NE2' ' A' ' 737' ' ' HIS . 38.3 t -98.4 129.18 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.862 0.363 . . . . 0.0 111.174 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 724' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 707' ' ' GLY . 21.8 t -67.31 112.28 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.151 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.49 -39.97 10.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -137.63 146.55 44.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.856 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 727' ' ' ALA . . . . . 0.431 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -115.73 116.42 28.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.147 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 728' ' ' THR . . . . . 0.491 HG22 ' H ' ' A' ' 729' ' ' GLU . 0.4 OUTLIER -100.48 169.43 9.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.094 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 729' ' ' GLU . . . . . 0.491 ' H ' HG22 ' A' ' 728' ' ' THR . 15.6 pt-20 -66.65 -42.44 86.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.482 ' O ' HG23 ' A' ' 731' ' ' THR . 60.5 m -125.32 18.31 8.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.879 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 731' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -159.9 173.59 15.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.178 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 732' ' ' ALA . . . . . 0.546 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -153.52 122.31 6.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.102 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 733' ' ' ARG . . . . . 0.492 ' HD3' ' CB ' ' A' ' 744' ' ' SER . 11.1 mmt85 -79.11 98.33 6.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.99 138.81 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.165 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -98.01 101.92 13.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 57.9 mt -50.9 160.55 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.962 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 737' ' ' HIS . . . . . 0.464 ' NE2' HG23 ' A' ' 723' ' ' VAL . 15.0 m170 -100.09 -38.47 8.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 4.6 m -66.68 -52.72 41.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 74.1 p -87.32 -23.58 24.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.137 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.7 m 63.77 41.78 6.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.865 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -126.95 154.21 44.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.939 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 21.3 m -92.23 122.13 34.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.153 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 6.8 pt -133.84 142.13 42.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.107 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 744' ' ' SER . . . . . 0.492 ' CB ' ' HD3' ' A' ' 733' ' ' ARG . 3.1 t -87.51 132.62 33.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.615 ' HB ' HD21 ' A' ' 750' ' ' LEU . 81.9 t -143.26 148.58 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.101 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 746' ' ' ASP . . . . . 0.408 ' HB2' ' CG ' ' A' ' 749' ' ' ARG . 20.1 m-20 -50.28 119.8 4.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -38.73 -44.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.843 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -65.92 -47.84 73.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 749' ' ' ARG . . . . . 0.408 ' CG ' ' HB2' ' A' ' 746' ' ' ASP . 91.4 mtt180 -49.53 -20.53 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.615 HD21 ' HB ' ' A' ' 745' ' ' VAL . 12.9 mt -92.34 122.7 35.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.937 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 39.4 m -103.17 107.19 17.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.187 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 1.6 p -44.63 121.08 2.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.14 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 753' ' ' VAL . . . . . 0.653 HG12 ' O ' ' A' ' 753' ' ' VAL . 22.0 t -82.45 19.74 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.133 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 165.18 74.38 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 89.8 p -93.47 169.34 10.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.863 0.363 . . . . 0.0 110.862 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 1.6 ptt-85 -49.56 162.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.841 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 46.8 p -169.53 177.62 4.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.351 . . . . 0.0 110.849 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 4.8 m -145.9 174.96 10.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -151.42 151.45 23.4 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.494 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 5.7 t -153.2 132.37 12.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.872 0.367 . . . . 0.0 110.846 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 84.3 p -132.33 -47.28 0.91 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.848 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 93.65 143.47 13.47 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.467 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -139.75 135.49 33.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.765 0.317 . . . . 0.0 110.863 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 18.1 m -90.01 93.4 9.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -132.98 134.77 44.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -60.35 -97.62 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.473 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -59.37 166.25 2.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.865 0.364 . . . . 0.0 110.905 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -129.19 -162.73 11.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.446 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -97.2 172.92 7.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 0.0 110.891 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -64.19 119.63 10.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -118.1 91.97 3.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -113.19 27.98 9.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.911 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -79.67 -58.05 3.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 705' ' ' LEU . . . . . 0.457 HD12 ' CG ' ' A' ' 708' ' ' GLN . 45.5 tp -59.99 -15.31 21.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.904 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 706' ' ' ILE . . . . . 0.529 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -62.08 108.84 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 120.13 -16.25 10.05 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.501 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 708' ' ' GLN . . . . . 0.457 ' CG ' HD12 ' A' ' 705' ' ' LEU . 46.6 mm-40 -73.82 163.58 27.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.878 0.37 . . . . 0.0 110.922 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 709' ' ' THR . . . . . 0.423 HG22 ' CG2' ' A' ' 753' ' ' VAL . 44.9 m -99.49 110.2 22.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.158 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.48 157.38 14.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -127.01 110.43 12.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.869 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 712' ' ' ILE . . . . . 0.534 HG12 HD23 ' A' ' 750' ' ' LEU . 40.7 mt -60.63 105.5 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 55.2 m -103.4 24.39 11.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 714' ' ' GLN . . . . . 0.404 ' CB ' ' HG2' ' A' ' 749' ' ' ARG . 14.4 mp0 -152.75 147.29 25.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.884 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 90.44 -166.69 32.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.502 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 716' ' ' PRO . . . . . 0.554 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.9 Cg_endo -69.77 -29.95 23.0 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.697 2.265 . . . . 0.0 112.362 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.554 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 55.0 m-85 -93.15 45.46 1.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -75.02 135.79 41.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 75.95 39.65 32.51 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.458 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 720' ' ' TYR . . . . . 0.401 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 16.7 m-85 -125.98 140.68 52.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.854 0.359 . . . . 0.0 110.935 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 31.3 mm -96.63 149.2 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.119 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -169.05 158.71 31.44 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.5 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 48.5 t -101.88 130.96 50.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 0.0 111.131 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 42.8 t -67.32 107.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.083 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 725' ' ' LYS . . . . . 0.426 ' HA ' ' NZ ' ' A' ' 725' ' ' LYS . 0.0 OUTLIER -84.53 -38.9 19.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -147.05 145.61 29.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -104.86 121.45 43.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -106.51 158.96 16.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.146 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -45.35 -71.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 74.3 m -106.23 18.71 21.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.58 173.32 14.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 732' ' ' ALA . . . . . 0.494 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -150.19 120.32 7.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 -75.69 97.66 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 93.3 t -105.36 145.33 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.157 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -107.21 101.58 10.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 736' ' ' LEU . . . . . 0.401 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 45.8 mt -49.64 158.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.912 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -89.32 -54.27 4.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 1.5 t -62.32 -67.94 0.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 81.8 p -61.72 -25.34 67.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.124 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 11.7 t 55.1 51.65 13.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.873 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -136.16 145.55 45.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.931 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 19.7 m -89.04 112.68 23.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 6.8 pt -121.48 155.67 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.157 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 90.9 p -97.39 124.2 41.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.433 HG12 ' HB2' ' A' ' 749' ' ' ARG . 50.1 t -134.52 149.9 30.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.17 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -54.98 126.58 25.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -45.06 -31.5 1.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.848 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -79.39 -42.38 25.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.891 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 749' ' ' ARG . . . . . 0.433 ' HB2' HG12 ' A' ' 745' ' ' VAL . 76.7 mtt180 -55.55 -13.8 1.75 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.93 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.534 HD23 HG12 ' A' ' 712' ' ' ILE . 17.8 mt -98.66 125.94 44.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 29.2 m -107.77 97.46 7.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.105 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 16.4 p -40.75 119.04 1.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.119 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 753' ' ' VAL . . . . . 0.423 ' CG2' HG22 ' A' ' 709' ' ' THR . 91.0 t -64.9 -60.44 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.094 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -52.62 156.25 4.67 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.538 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 46.4 p -119.43 164.7 15.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.807 0.337 . . . . 0.0 110.884 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -107.42 120.41 42.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 -179.931 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.454 -0.259 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 30.8 t -168.46 105.17 0.45 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.875 0.369 . . . . 0.0 110.828 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 65.3 m -113.59 132.52 55.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.843 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.03 179.11 7.12 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.451 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 3.0 m -144.59 174.68 10.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.875 0.369 . . . . 0.0 110.873 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 52.4 p -146.3 118.53 8.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.844 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . -133.71 69.46 0.53 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.507 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 8.8 mtm -104.58 149.81 25.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.769 0.319 . . . . 0.0 110.845 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 2.1 m -122.16 139.53 53.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.828 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -64.25 -51.9 61.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -105.18 69.91 0.24 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.486 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -55.99 -49.22 74.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.0 110.86 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -61.23 135.33 48.32 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.457 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 71.8 mtt-85 -83.07 130.35 35.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.854 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -106.62 46.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.875 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -123.64 40.87 3.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -104.18 28.93 6.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.862 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -70.32 -47.24 62.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 705' ' ' LEU . . . . . 0.447 HD12 ' HB2' ' A' ' 708' ' ' GLN . 17.5 tp -70.49 -15.47 62.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.94 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 706' ' ' ILE . . . . . 0.52 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -63.34 104.47 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 179.796 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 122.86 -13.42 8.59 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.491 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 708' ' ' GLN . . . . . 0.447 ' HB2' HD12 ' A' ' 705' ' ' LEU . 49.6 mm-40 -75.99 161.65 28.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.89 0.376 . . . . 0.0 110.914 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 709' ' ' THR . . . . . 0.508 HG22 HG21 ' A' ' 753' ' ' VAL . 52.1 m -95.04 105.32 17.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 32.5 m -109.16 148.86 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -120.01 114.2 21.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 712' ' ' ILE . . . . . 0.567 HD11 HD11 ' A' ' 743' ' ' ILE . 27.6 mt -57.81 134.2 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 61.5 p -109.12 -32.15 7.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -110.49 177.84 4.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 77.34 174.79 41.76 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.495 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 716' ' ' PRO . . . . . 0.53 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.6 Cg_endo -69.74 0.39 5.7 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.74 2.293 . . . . 0.0 112.319 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.53 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 67.4 m-85 -115.74 31.87 6.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 19.3 tttp -65.87 135.16 54.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.907 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.19 34.16 30.44 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.481 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -123.11 144.72 49.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.874 0.369 . . . . 0.0 110.952 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 25.4 mm -99.24 146.51 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.116 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -164.75 157.94 30.53 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.512 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.417 ' C ' HG13 ' A' ' 734' ' ' VAL . 22.2 t -101.19 124.71 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.883 0.373 . . . . 0.0 111.154 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 724' ' ' VAL . . . . . 0.427 HG22 HG22 ' A' ' 734' ' ' VAL . 40.7 t -61.78 112.76 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.141 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.58 -36.78 15.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -146.26 144.29 29.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.835 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -112.85 117.43 32.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 728' ' ' THR . . . . . 0.548 HG22 ' H ' ' A' ' 729' ' ' GLU . 0.6 OUTLIER -98.54 171.21 8.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.153 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 729' ' ' GLU . . . . . 0.548 ' H ' HG22 ' A' ' 728' ' ' THR . 12.6 pt-20 -62.25 -47.92 82.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.436 ' N ' ' HG3' ' A' ' 729' ' ' GLU . 69.9 m -123.92 16.26 9.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.817 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.51 173.36 14.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.177 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 732' ' ' ALA . . . . . 0.657 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -154.86 117.46 4.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.105 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 733' ' ' ARG . . . . . 0.469 ' HD3' ' N ' ' A' ' 733' ' ' ARG . 0.9 OUTLIER -81.87 98.21 8.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.84 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 734' ' ' VAL . . . . . 0.427 HG22 HG22 ' A' ' 724' ' ' VAL . 69.6 t -103.14 142.79 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.168 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -97.5 102.38 14.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 40.7 mt -52.17 157.54 1.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -88.36 -36.4 16.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 61.2 m -73.98 -72.09 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 60.0 p -62.71 -17.45 60.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.184 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 3.3 m 53.0 39.36 29.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -133.58 151.72 51.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 742' ' ' THR . . . . . 0.457 ' CG2' ' HB3' ' A' ' 733' ' ' ARG . 53.7 m -80.99 143.1 32.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.11 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 743' ' ' ILE . . . . . 0.567 HD11 HD11 ' A' ' 712' ' ' ILE . 11.6 pt -143.71 141.82 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.183 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 58.3 p -85.17 117.35 24.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.833 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 39.2 t -134.79 141.19 43.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.132 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -51.4 128.14 21.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -46.51 -27.46 1.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -81.6 -45.35 15.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -53.32 -16.99 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.657 HD11 ' HB3' ' A' ' 732' ' ' ALA . 24.7 mt -89.21 135.96 33.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 89.8 m -118.06 93.59 4.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.091 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 3.4 p -41.44 135.33 2.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 753' ' ' VAL . . . . . 0.508 HG21 HG22 ' A' ' 709' ' ' THR . 97.2 t -80.1 -54.29 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.104 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -73.16 75.53 0.95 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.487 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 10.6 m -47.03 -49.58 20.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 0.0 110.828 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -66.38 177.1 1.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.808 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.851 -179.886 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.445 -0.262 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 26.8 m 48.67 41.91 18.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 0.0 110.841 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 3.0 t -78.59 -48.81 14.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.857 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 79.41 -45.1 2.79 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.506 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 27.7 t -80.57 161.77 24.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 0.0 110.873 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 49.8 m -130.42 -56.07 1.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.857 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 161.33 132.68 1.37 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.478 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 50.8 mtp -85.33 116.7 23.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.81 0.338 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 2.6 m -123.31 122.04 37.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.96 9.4 14.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -108.73 64.9 0.25 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.502 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 46.4 ttp85 -104.96 101.18 10.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.896 0.379 . . . . 0.0 110.865 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -119.51 39.84 2.39 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.525 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -138.42 143.11 39.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 0.0 110.854 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -109.0 118.03 35.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -97.8 117.86 33.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.834 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -127.04 33.89 4.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.908 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -82.0 -58.44 2.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 705' ' ' LEU . . . . . 0.419 HD12 ' CG ' ' A' ' 708' ' ' GLN . 51.3 tp -65.09 -11.55 40.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.925 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 706' ' ' ILE . . . . . 0.534 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -65.05 106.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.099 179.867 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 124.75 -17.31 7.28 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 708' ' ' GLN . . . . . 0.419 ' CG ' HD12 ' A' ' 705' ' ' LEU . 36.6 mm-40 -77.6 154.64 32.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.36 . . . . 0.0 110.931 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 709' ' ' THR . . . . . 0.5 HG22 HG21 ' A' ' 753' ' ' VAL . 68.2 m -86.4 112.95 21.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.182 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 710' ' ' VAL . . . . . 0.538 ' HA ' HG23 ' A' ' 753' ' ' VAL . 29.4 m -114.87 148.13 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.15 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 711' ' ' ARG . . . . . 0.448 ' HB2' HD13 ' A' ' 721' ' ' ILE . 19.3 ttt180 -122.81 113.39 19.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 712' ' ' ILE . . . . . 0.504 HG12 HD23 ' A' ' 750' ' ' LEU . 31.0 mt -61.1 107.82 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 3.5 m -101.46 12.3 37.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -145.82 140.59 27.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 99.9 -168.58 21.44 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.497 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 716' ' ' PRO . . . . . 0.554 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.6 Cg_endo -69.77 -23.88 30.24 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.697 2.265 . . . . 0.0 112.354 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.554 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 55.3 m-85 -94.36 32.82 1.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.939 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -66.58 112.85 4.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.869 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 100.98 27.67 7.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.478 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 720' ' ' TYR . . . . . 0.468 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 10.9 m-85 -119.23 137.28 53.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 110.915 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.448 HD13 ' HB2' ' A' ' 711' ' ' ARG . 12.4 mm -96.07 153.23 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.154 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -172.27 157.79 27.79 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.468 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 48.9 t -98.84 124.87 52.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.866 0.365 . . . . 0.0 111.12 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 43.8 t -60.54 108.63 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.133 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.12 -41.16 17.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.951 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -141.35 146.87 37.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 727' ' ' ALA . . . . . 0.418 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -111.5 120.37 41.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.11 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.9 163.02 13.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.181 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.99 -46.74 87.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 69.8 m -124.33 19.68 8.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.883 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.29 173.31 17.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.168 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 732' ' ' ALA . . . . . 0.477 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -157.28 117.59 3.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.064 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 733' ' ' ARG . . . . . 0.455 ' HD3' ' N ' ' A' ' 733' ' ' ARG . 0.9 OUTLIER -80.48 98.72 7.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 61.2 t -102.81 142.27 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -98.15 102.61 14.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 736' ' ' LEU . . . . . 0.468 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 34.9 mt -52.47 157.08 1.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.9 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -91.27 -23.22 20.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 13.8 m -83.6 -70.48 0.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 70.3 p -73.32 -2.58 22.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.155 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.2 m 40.01 45.93 1.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -132.44 151.91 51.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 742' ' ' THR . . . . . 0.443 ' CG2' ' HB3' ' A' ' 733' ' ' ARG . 54.9 m -84.66 133.95 34.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.124 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 14.7 pt -136.43 140.46 43.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.137 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 54.7 p -83.0 118.16 23.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 48.9 t -135.79 143.9 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.132 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.54 128.61 32.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 747' ' ' ARG . . . . . 0.407 ' HG2' ' HB2' ' A' ' 732' ' ' ALA . 27.5 mtm180 -46.53 -37.76 8.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -71.17 -44.33 65.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -54.86 -16.14 2.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.504 HD23 HG12 ' A' ' 712' ' ' ILE . 12.3 mt -98.14 126.37 43.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.934 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 92.1 m -103.95 102.85 12.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 10.4 p -42.63 121.16 1.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.116 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 753' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 754' ' ' GLY . 10.8 t -81.03 168.67 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.166 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 754' ' ' GLY . . . . . 0.595 ' N ' HG12 ' A' ' 753' ' ' VAL . . . -80.22 157.33 40.68 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.504 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 95.6 p -122.71 100.91 7.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.828 0.347 . . . . 0.0 110.856 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -121.82 148.33 44.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 27.3 p -105.74 175.66 5.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.902 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 68.2 p -166.66 176.14 7.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.881 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 112.68 76.08 0.76 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.487 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 79.0 p -71.28 -49.8 39.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.89 0.376 . . . . 0.0 110.832 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 88.1 p -55.86 140.72 41.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . -112.02 -105.17 2.78 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.534 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.77 159.61 35.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 0.0 110.864 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 6.2 m -131.73 161.77 32.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 696' ' ' ARG . . . . . 0.423 ' N ' ' HD3' ' A' ' 696' ' ' ARG . 0.0 OUTLIER -117.81 137.49 52.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.87 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -130.7 -167.57 12.03 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.522 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -130.68 89.25 2.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -130.62 169.64 21.33 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.457 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 24.0 ttp180 -73.11 152.43 41.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.766 0.317 . . . . 0.0 110.878 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 16.7 mtm-85 -69.31 115.15 8.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -109.17 108.97 19.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -117.42 28.8 8.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.69 -37.62 65.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 705' ' ' LEU . . . . . 0.454 ' HG ' HG21 ' A' ' 724' ' ' VAL . 48.0 tp -83.85 -14.84 50.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.935 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 706' ' ' ILE . . . . . 0.538 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -63.87 108.35 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.103 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 707' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 118.18 -14.84 12.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.438 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -73.16 162.23 29.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 0.0 110.891 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 709' ' ' THR . . . . . 0.511 HG22 HG21 ' A' ' 753' ' ' VAL . 95.5 m -96.66 109.78 22.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 34.5 m -114.01 156.08 15.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.144 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 -123.98 117.43 24.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 23.4 mt -60.49 143.72 14.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.11 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 43.7 t -115.18 -34.78 4.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -113.37 179.98 3.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 78.34 177.09 47.87 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.526 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 716' ' ' PRO . . . . . 0.405 ' HG2' ' CE2' ' A' ' 717' ' ' TYR . 53.4 Cg_endo -69.78 1.79 4.13 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.726 2.284 . . . . 0.0 112.304 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.538 ' CD1' HD11 ' A' ' 736' ' ' LEU . 84.4 m-85 -120.33 35.82 4.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -67.5 139.3 57.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.883 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 71.76 32.96 63.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.466 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -119.21 158.52 25.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.843 0.354 . . . . 0.0 110.941 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 22.3 mm -107.88 147.55 12.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -163.23 162.21 34.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.491 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 37.1 t -106.35 129.72 59.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 0.0 111.157 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 724' ' ' VAL . . . . . 0.454 HG21 ' HG ' ' A' ' 705' ' ' LEU . 41.1 t -66.48 108.27 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.104 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -85.24 -41.12 15.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.921 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -143.06 151.24 40.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -111.94 116.88 31.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.65 158.85 16.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -50.0 -64.59 0.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.888 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 731' ' ' THR . 48.8 m -109.53 24.06 13.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.856 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 731' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 730' ' ' SER . 0.7 OUTLIER -160.03 173.29 16.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.17 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 732' ' ' ALA . . . . . 0.587 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -152.61 121.42 6.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 11.3 mmt85 -74.43 102.3 4.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.837 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 56.0 t -108.93 139.27 32.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.106 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -106.65 106.01 16.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 736' ' ' LEU . . . . . 0.538 HD11 ' CD1' ' A' ' 717' ' ' TYR . 30.4 mt -53.57 157.5 2.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -87.66 -37.12 17.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 14.3 m -73.64 -66.32 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.808 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 20.0 p -68.06 -15.99 63.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.131 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.7 m 49.15 42.07 20.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 741' ' ' GLN . . . . . 0.405 HE22 ' CG2' ' A' ' 743' ' ' ILE . 2.5 pp0? -129.09 148.72 51.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 4.5 m -87.66 144.29 26.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.136 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 743' ' ' ILE . . . . . 0.405 ' CG2' HE22 ' A' ' 741' ' ' GLN . 7.8 pt -151.79 144.72 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.154 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 91.3 p -87.56 118.88 27.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 65.4 t -133.47 143.13 39.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.127 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.23 129.71 21.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 24.1 mtm105 -49.58 -36.24 23.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.87 -45.03 65.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -53.86 -24.54 16.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 732' ' ' ALA . 21.3 mt -84.03 144.65 28.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 6.3 m -124.42 99.24 6.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 9.1 p -47.83 118.99 2.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.113 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 753' ' ' VAL . . . . . 0.511 HG21 HG22 ' A' ' 709' ' ' THR . 95.8 t -62.14 -44.56 99.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.104 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 154.8 -116.52 0.73 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.489 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 87.3 p -135.1 126.76 29.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.827 0.346 . . . . 0.0 110.899 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.31 166.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.828 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 15.9 mtt180 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.861 -179.914 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 1.7 t -101.11 41.83 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.878 0.37 . . . . 0.0 110.829 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 1.5 t -163.07 140.64 7.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -72.81 93.04 0.64 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.5 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 78.6 p -137.23 117.96 14.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.906 0.384 . . . . 0.0 110.828 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 39.9 t -144.16 159.64 42.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.874 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 49.81 44.4 39.65 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.465 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 7.5 ttt -131.05 115.7 16.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 110.872 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 3.0 t -46.98 105.73 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.81 137.1 57.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.89 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -100.03 82.31 0.53 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.477 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 24.1 mmm-85 -85.71 101.48 12.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 110.843 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -102.33 -81.78 1.59 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.507 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -102.07 123.64 46.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 0.0 110.866 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 701' ' ' ARG . . . . . 0.409 ' HD2' ' C ' ' A' ' 701' ' ' ARG . 0.5 OUTLIER -55.75 147.48 18.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.66 41.75 3.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.826 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -100.68 25.83 7.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.894 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -74.55 -55.63 5.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 705' ' ' LEU . . . . . 0.409 HD12 ' CG ' ' A' ' 708' ' ' GLN . 48.1 tp -64.04 -12.24 36.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.904 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 706' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' A' ' 727' ' ' ALA . 0.6 OUTLIER -65.18 108.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 122.06 -13.08 9.11 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.519 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 708' ' ' GLN . . . . . 0.409 ' CG ' HD12 ' A' ' 705' ' ' LEU . 40.4 mm-40 -77.71 160.91 28.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 0.0 110.937 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 87.1 m -93.65 107.35 19.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.12 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 710' ' ' VAL . . . . . 0.422 HG12 ' HA ' ' A' ' 752' ' ' THR . 34.2 m -112.05 150.96 14.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.131 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 711' ' ' ARG . . . . . 0.421 ' HB2' HD13 ' A' ' 721' ' ' ILE . 23.1 ttm-85 -122.21 115.69 22.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.845 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 25.8 mt -62.41 142.1 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.1 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 29.1 t -122.21 -22.38 5.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.791 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -110.04 177.64 4.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 67.45 -179.54 15.72 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.463 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 716' ' ' PRO . . . . . 0.575 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.1 Cg_endo -69.82 -8.24 23.11 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.694 2.262 . . . . 0.0 112.299 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.575 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 38.4 m-85 -103.56 29.89 5.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.919 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -65.22 137.43 57.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 74.26 36.12 51.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.486 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 720' ' ' TYR . . . . . 0.466 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 6.3 m-85 -123.81 145.01 49.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.889 0.376 . . . . 0.0 110.89 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.421 HD13 ' HB2' ' A' ' 711' ' ' ARG . 21.7 mm -98.58 154.04 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.144 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 722' ' ' GLY . . . . . 0.421 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -173.79 161.02 31.35 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.478 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 54.3 t -105.16 125.1 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 111.145 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.41 108.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.119 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -84.79 -40.41 17.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.928 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -140.79 149.82 42.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.827 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 727' ' ' ALA . . . . . 0.617 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -113.5 118.66 35.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.081 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.73 164.37 11.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.149 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -57.16 -52.08 66.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 5.1 m -120.16 16.44 12.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.837 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.4 173.28 14.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.136 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 732' ' ' ALA . . . . . 0.658 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -151.93 121.02 6.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.11 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -80.53 98.4 7.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.866 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 90.0 t -103.32 140.72 20.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.123 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 735' ' ' GLU . . . . . 0.402 ' CD ' ' O ' ' A' ' 735' ' ' GLU . 6.5 tm-20 -99.34 99.43 10.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.849 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 736' ' ' LEU . . . . . 0.466 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 27.6 mt -49.71 157.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.948 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -90.34 -31.86 16.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.879 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 58.8 m -75.09 -65.12 0.92 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 71.8 p -74.09 -8.53 56.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.103 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 3.3 m 44.75 43.17 6.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -132.68 155.62 48.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 20.0 m -87.95 141.26 28.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.107 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 11.8 pt -146.53 145.06 20.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.157 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 89.5 p -87.66 118.1 26.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 92.9 t -132.71 142.86 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.147 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.55 128.57 17.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -49.62 -28.4 5.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.846 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -81.36 -42.55 20.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -55.25 -19.15 7.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.823 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.658 HD11 ' HB3' ' A' ' 732' ' ' ALA . 18.0 mt -88.85 134.86 33.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 751' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 752' ' ' THR . 86.4 m -116.07 89.7 3.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.147 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 752' ' ' THR . . . . . 0.422 ' HA ' HG12 ' A' ' 710' ' ' VAL . 9.4 p -36.52 118.09 0.53 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.135 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 87.7 t -66.37 -65.11 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.101 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -64.29 122.33 25.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.486 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 86.5 p -126.18 113.92 17.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.859 0.362 . . . . 0.0 110.825 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 756' ' ' ARG . . . . . 0.414 ' NH1' ' HB2' ' A' ' 756' ' ' ARG . 0.2 OUTLIER -91.2 127.6 36.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.891 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.921 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 25.4 m 60.69 42.18 14.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.877 0.37 . . . . 0.0 110.877 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 28.7 p -148.65 163.4 37.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.849 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -175.12 167.43 39.52 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 39.2 t -78.62 100.68 7.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 0.0 110.884 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 69.6 p -83.53 -45.68 13.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.827 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 94.72 101.15 1.74 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.487 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 12.8 mmm -89.94 -59.64 2.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.809 0.338 . . . . 0.0 110.884 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 3.2 t -114.57 109.05 17.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.817 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -93.13 115.41 28.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.838 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -133.22 130.29 5.69 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.467 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -60.1 -44.93 94.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.861 0.362 . . . . 0.0 110.872 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -41.65 140.84 1.48 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.506 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -56.37 178.08 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 0.0 110.879 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -100.76 49.37 0.89 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.918 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -95.9 41.61 1.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.884 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -95.84 28.81 2.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -71.85 -60.83 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 18.9 tp -62.26 -16.45 53.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.943 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 706' ' ' ILE . . . . . 0.523 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -60.84 110.41 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.083 179.838 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.86 -19.93 10.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.483 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -66.85 166.66 12.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 110.951 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 709' ' ' THR . . . . . 0.402 HG22 ' CG2' ' A' ' 753' ' ' VAL . 71.8 m -99.92 109.19 21.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.151 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 710' ' ' VAL . . . . . 0.48 HG12 HG22 ' A' ' 752' ' ' THR . 35.7 m -113.12 151.5 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.161 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 711' ' ' ARG . . . . . 0.479 ' HB2' HD13 ' A' ' 721' ' ' ILE . 29.6 ttt180 -123.39 114.44 20.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 712' ' ' ILE . . . . . 0.409 HD12 HD21 ' A' ' 736' ' ' LEU . 34.7 mt -61.72 134.73 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 4.2 t -112.79 -31.66 6.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -102.01 176.37 5.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 71.7 177.95 28.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 716' ' ' PRO . . . . . 0.569 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.5 Cg_endo -69.78 -6.93 19.79 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.706 2.27 . . . . 0.0 112.307 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.569 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 44.5 m-85 -105.89 33.24 3.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -68.87 138.11 54.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.93 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 77.17 30.92 54.15 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.483 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -120.77 144.59 48.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.79 0.329 . . . . 0.0 110.948 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 711' ' ' ARG . 38.7 mm -97.4 150.38 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.09 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -166.48 161.81 35.49 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.461 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 63.8 t -107.55 126.74 63.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.845 0.355 . . . . 0.0 111.175 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 50.2 t -63.73 104.73 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -80.58 -41.66 23.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.894 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -143.34 146.6 33.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.89 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 727' ' ' ALA . . . . . 0.447 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -106.17 115.33 30.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.121 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.18 160.65 14.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.114 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -47.03 -70.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 3.2 m -106.09 16.9 24.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.87 173.32 13.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 732' ' ' ALA . . . . . 0.601 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -150.68 120.91 7.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 54.9 mmm-85 -76.65 98.43 4.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 71.5 t -104.78 144.76 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -105.3 101.6 11.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 736' ' ' LEU . . . . . 0.409 HD21 HD12 ' A' ' 712' ' ' ILE . 52.5 mt -50.55 161.18 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.904 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -95.5 -44.98 7.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 40.5 t -67.55 -64.7 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 82.1 p -70.75 -21.85 62.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 17.2 m 55.56 43.66 28.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.838 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -127.21 145.13 50.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.936 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 17.3 m -85.2 116.83 23.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.143 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 11.5 pt -124.37 149.62 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 82.2 p -94.23 118.19 31.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.818 ' HB ' HD21 ' A' ' 750' ' ' LEU . 62.0 t -127.85 144.92 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.15 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -50.72 125.93 14.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -44.61 -24.1 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -89.31 -42.86 11.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -53.85 -18.54 3.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.818 HD21 ' HB ' ' A' ' 745' ' ' VAL . 12.6 mt -91.25 134.41 34.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 19.6 m -112.39 90.76 3.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 752' ' ' THR . . . . . 0.48 HG22 HG12 ' A' ' 710' ' ' VAL . 10.2 p -41.13 118.31 0.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.099 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 753' ' ' VAL . . . . . 0.402 ' CG2' HG22 ' A' ' 709' ' ' THR . 86.0 t -61.29 -45.47 98.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.078 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 90.8 -167.37 32.02 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.489 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 19.7 m -100.72 147.53 25.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.917 0.389 . . . . 0.0 110.82 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 16.5 ptt85 -123.96 -1.48 8.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.911 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.823 -179.868 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 19.3 m -81.38 107.07 13.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.871 0.367 . . . . 0.0 110.889 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 4.4 t -91.63 -61.46 1.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.856 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 134.64 -167.83 23.78 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.518 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 58.2 m -81.57 89.86 6.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 0.0 110.831 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 8.1 t -59.96 -57.94 10.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.835 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . -132.98 74.22 0.44 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.487 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -58.14 -61.14 2.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.796 0.332 . . . . 0.0 110.861 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 6.0 t -75.73 102.44 5.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 26.0 mmt-85 -118.41 88.81 3.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.841 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -62.15 -47.64 88.4 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.522 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 8.2 mmp_? -125.33 156.83 38.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.828 0.347 . . . . 0.0 110.903 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -123.89 166.82 16.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.508 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.02 -13.13 14.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.859 0.362 . . . . 0.0 110.912 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 2.2 tpp85 -136.56 146.74 46.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.76 98.28 4.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -105.99 26.12 10.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -77.08 -55.55 5.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 705' ' ' LEU . . . . . 0.426 HD12 ' CG ' ' A' ' 708' ' ' GLN . 45.6 tp -62.03 -14.12 32.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.894 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 706' ' ' ILE . . . . . 0.532 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -64.81 107.19 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 121.65 -16.09 9.03 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.482 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 708' ' ' GLN . . . . . 0.426 ' CG ' HD12 ' A' ' 705' ' ' LEU . 51.6 mm-40 -74.58 155.54 37.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.878 0.371 . . . . 0.0 110.907 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 55.9 m -92.34 110.43 21.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.162 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 710' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 752' ' ' THR . 35.4 m -113.3 161.97 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 711' ' ' ARG . . . . . 0.497 ' HB2' HD13 ' A' ' 721' ' ' ILE . 23.6 ttt-85 -129.85 117.89 20.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 712' ' ' ILE . . . . . 0.429 HD11 HD11 ' A' ' 743' ' ' ILE . 26.5 mt -62.36 111.21 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.127 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 1.1 t -107.55 18.47 21.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -153.11 130.48 11.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.933 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 109.48 -171.79 15.48 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.467 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 716' ' ' PRO . . . . . 0.553 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 54.0 Cg_endo -69.73 -19.92 35.63 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.667 2.245 . . . . 0.0 112.384 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.553 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 70.3 m-85 -99.81 31.35 3.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 19.0 tttp -64.93 133.31 51.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.904 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 719' ' ' GLY . . . . . 0.44 ' HA2' ' CZ ' ' A' ' 711' ' ' ARG . . . 84.9 23.83 47.81 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.466 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -116.15 143.68 45.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.906 0.384 . . . . 0.0 110.911 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.59 HD12 HG21 ' A' ' 753' ' ' VAL . 44.9 mm -97.82 162.46 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.162 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 722' ' ' GLY . . . . . 0.588 ' N ' HG22 ' A' ' 721' ' ' ILE . . . 178.2 153.07 10.83 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.501 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 42.7 t -97.57 129.75 47.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 111.124 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 48.1 t -64.89 108.84 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -85.42 -40.28 16.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -141.86 146.01 35.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.844 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 727' ' ' ALA . . . . . 0.445 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -106.6 119.0 38.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.073 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.86 156.61 18.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.148 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -42.31 -74.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 58.6 m -103.53 19.68 19.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.16 173.34 14.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.122 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 732' ' ' ALA . . . . . 0.687 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -152.2 122.5 7.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.072 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 6.1 mmt85 -77.84 98.66 5.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.49 142.38 18.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.131 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -104.24 105.38 15.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 66.7 mt -49.76 157.66 0.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -88.74 -57.99 2.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.808 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 8.9 t -59.0 -70.8 0.14 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.849 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 69.6 p -58.39 -34.46 70.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.125 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 3.9 t 66.57 47.36 1.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -130.73 147.89 52.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 22.9 m -89.65 129.11 36.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.126 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 743' ' ' ILE . . . . . 0.429 HD11 HD11 ' A' ' 712' ' ' ILE . 9.2 pt -137.32 150.75 26.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.161 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 78.6 p -95.25 121.65 37.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.587 HG12 ' HB2' ' A' ' 749' ' ' ARG . 19.0 t -134.54 143.87 36.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.119 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -49.51 126.18 12.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.921 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 -43.96 -29.55 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -81.12 -43.08 19.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 749' ' ' ARG . . . . . 0.587 ' HB2' HG12 ' A' ' 745' ' ' VAL . 76.5 mtt180 -53.4 -16.4 1.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.687 HD11 ' HB3' ' A' ' 732' ' ' ALA . 14.6 mt -92.17 145.38 24.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 90.5 m -125.86 95.68 4.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 752' ' ' THR . . . . . 0.454 ' HA ' HG12 ' A' ' 710' ' ' VAL . 3.3 p -38.39 118.46 0.72 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 753' ' ' VAL . . . . . 0.59 HG21 HD12 ' A' ' 721' ' ' ILE . 93.6 t -71.24 -42.31 74.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.105 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -43.58 -48.47 7.24 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.5 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 29.8 t -93.06 -73.69 0.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.84 0.352 . . . . 0.0 110.857 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 28.9 mtp85 -73.62 165.01 25.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.83 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 757' ' ' ARG . . . . . 0.416 ' HD3' ' C ' ' A' ' 757' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.841 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 69.8 m -104.52 127.52 52.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.914 0.388 . . . . 0.0 110.849 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 19.1 t -100.97 -55.13 2.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.856 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 136.68 -61.77 0.6 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.469 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 67.3 p 40.36 42.21 1.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 110.858 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 20.4 m -71.51 175.4 5.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.841 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 158.95 97.33 0.12 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.532 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -126.09 150.64 48.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.737 0.303 . . . . 0.0 110.912 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 20.7 m -102.33 151.23 22.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.841 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -113.0 -52.34 2.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.85 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -67.61 98.02 0.44 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.499 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 8.7 tpm_? -75.05 89.68 2.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.85 0.357 . . . . 0.0 110.875 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -137.82 -154.53 6.59 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.515 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -104.58 142.86 33.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.798 0.332 . . . . 0.0 110.859 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -115.09 107.57 15.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -105.97 48.55 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -99.58 43.93 1.04 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -76.61 -62.49 1.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 705' ' ' LEU . . . . . 0.482 HD12 ' CG ' ' A' ' 708' ' ' GLN . 33.9 tp -60.59 -10.91 5.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 706' ' ' ILE . . . . . 0.517 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -63.41 110.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 707' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 118.3 -21.28 10.1 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 708' ' ' GLN . . . . . 0.482 ' CG ' HD12 ' A' ' 705' ' ' LEU . 38.5 mm-40 -70.6 158.65 35.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.908 0.385 . . . . 0.0 110.945 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 709' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 753' ' ' VAL . 87.6 m -91.28 109.47 20.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.127 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 710' ' ' VAL . . . . . 0.535 HG21 HG21 ' A' ' 734' ' ' VAL . 26.9 m -112.51 146.6 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 711' ' ' ARG . . . . . 0.549 ' HB2' HD13 ' A' ' 721' ' ' ILE . 52.5 ttt180 -121.53 113.63 20.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 20.8 mt -56.86 143.67 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.161 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 17.0 t -118.25 -28.02 5.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -116.39 177.14 4.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.94 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 76.64 179.01 47.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.448 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 716' ' ' PRO . . . . . 0.493 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.3 Cg_endo -69.78 -1.94 9.34 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.679 2.252 . . . . 0.0 112.317 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.493 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 75.5 m-85 -115.02 31.66 6.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.975 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -65.95 131.41 46.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.904 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.79 29.06 44.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.447 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 720' ' ' TYR . . . . . 0.42 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 8.0 m-85 -116.16 142.58 46.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.832 0.349 . . . . 0.0 110.951 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 721' ' ' ILE . . . . . 0.549 HD13 ' HB2' ' A' ' 711' ' ' ARG . 30.9 mm -98.52 152.53 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.156 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 722' ' ' GLY . . . . . 0.41 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -169.93 164.14 37.55 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.52 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 723' ' ' VAL . . . . . 0.474 ' C ' HG13 ' A' ' 734' ' ' VAL . 55.1 t -106.34 123.17 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.84 0.352 . . . . 0.0 111.137 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 724' ' ' VAL . . . . . 0.824 ' HA ' HG22 ' A' ' 734' ' ' VAL . 45.8 t -63.49 112.18 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -91.05 -37.06 13.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -142.69 144.21 32.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 727' ' ' ALA . . . . . 0.429 ' N ' HD11 ' A' ' 706' ' ' ILE . . . -113.49 113.77 25.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.142 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 728' ' ' THR . . . . . 0.545 HG22 ' H ' ' A' ' 729' ' ' GLU . 1.2 m -96.21 170.29 9.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.168 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 729' ' ' GLU . . . . . 0.545 ' H ' HG22 ' A' ' 728' ' ' THR . 14.4 pt-20 -63.15 -49.08 75.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.458 ' N ' ' HG3' ' A' ' 729' ' ' GLU . 60.4 m -120.68 14.2 11.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.89 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.6 173.27 14.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.127 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 732' ' ' ALA . . . . . 0.562 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -155.32 117.54 4.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.086 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 733' ' ' ARG . . . . . 0.454 ' HB3' ' CG2' ' A' ' 742' ' ' THR . 0.9 OUTLIER -81.36 102.99 10.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 734' ' ' VAL . . . . . 0.824 HG22 ' HA ' ' A' ' 724' ' ' VAL . 53.4 t -111.7 137.55 43.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -90.11 101.61 14.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 736' ' ' LEU . . . . . 0.42 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 23.5 mt -50.89 156.37 1.0 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.896 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -85.12 -40.35 16.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 54.7 m -70.44 -70.55 0.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 43.5 p -61.74 -24.61 66.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.0 m 59.33 38.43 23.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -134.9 155.36 50.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.928 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 742' ' ' THR . . . . . 0.454 ' CG2' ' HB3' ' A' ' 733' ' ' ARG . 54.9 m -81.7 138.95 35.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.138 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 8.4 pt -141.18 143.25 28.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 84.2 p -85.13 112.33 20.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 745' ' ' VAL . . . . . 0.546 ' HB ' HD21 ' A' ' 750' ' ' LEU . 47.9 t -127.29 147.22 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.097 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -58.04 127.64 33.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.905 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -48.16 -25.68 1.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -84.72 -43.54 14.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -58.5 -11.63 3.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.562 HD11 ' HB3' ' A' ' 732' ' ' ALA . 18.5 mt -96.1 127.4 42.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 20.4 m -104.47 103.58 13.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.117 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 2.3 p -47.88 121.3 4.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 753' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 754' ' ' GLY . 6.3 t -83.06 168.81 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 754' ' ' GLY . . . . . 0.572 ' N ' HG12 ' A' ' 753' ' ' VAL . . . -126.37 157.64 20.26 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.499 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 57.5 p -61.05 -63.64 1.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.881 0.372 . . . . 0.0 110.847 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 756' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 757' ' ' ARG . 14.4 ptm180 -62.19 169.79 2.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.868 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 757' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 756' ' ' ARG . 11.3 mtp85 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.432 -0.267 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 61.6 p -99.6 119.07 37.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.925 0.393 . . . . 0.0 110.866 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 81.4 p -96.68 176.96 5.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.845 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 175.64 154.06 11.02 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.515 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 15.0 m -73.25 142.12 47.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.916 0.389 . . . . 0.0 110.789 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 14.8 t -145.38 174.86 10.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.837 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 154.19 93.87 0.1 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.472 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 2.9 mmm -96.18 -43.56 7.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.774 0.321 . . . . 0.0 110.917 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 16.6 m -48.16 136.71 11.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.835 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.81 164.97 12.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.843 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -131.2 -142.71 5.1 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 698' ' ' ARG . . . . . 0.488 ' H ' ' NE ' ' A' ' 698' ' ' ARG . 0.0 OUTLIER -84.24 26.62 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.843 0.354 . . . . 0.0 110.844 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -80.8 85.8 1.36 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.487 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -80.75 -43.64 19.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 0.0 110.904 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -136.48 112.23 9.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.854 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -111.01 48.17 0.94 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -84.49 35.2 0.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.842 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -82.2 -49.19 10.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.915 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 37.7 tp -65.2 -10.44 31.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 706' ' ' ILE . . . . . 0.608 ' CD1' ' N ' ' A' ' 706' ' ' ILE . 0.5 OUTLIER -70.04 108.69 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 179.86 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 120.4 -15.76 9.91 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.449 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -74.62 158.63 33.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.39 . . . . 0.0 110.918 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 709' ' ' THR . . . . . 0.473 HG22 HG21 ' A' ' 753' ' ' VAL . 98.6 m -94.76 107.33 19.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 31.6 m -111.02 160.68 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 711' ' ' ARG . . . . . 0.405 ' HB2' HG22 ' A' ' 753' ' ' VAL . 26.9 ttt180 -130.43 108.74 10.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.84 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 712' ' ' ILE . . . . . 0.466 HG12 HD23 ' A' ' 750' ' ' LEU . 72.0 mt -55.78 102.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.144 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 5.3 m -97.61 23.23 7.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 714' ' ' GLN . . . . . 0.402 ' CB ' ' HG2' ' A' ' 749' ' ' ARG . 12.2 mp0 -149.59 -179.23 6.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 59.82 -167.56 8.7 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.478 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 716' ' ' PRO . . . . . 0.576 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.2 Cg_endo -69.79 -33.38 16.59 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.679 2.252 . . . . 0.0 112.328 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 717' ' ' TYR . . . . . 0.576 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 50.1 m-85 -85.11 44.9 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -73.42 131.21 41.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.854 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.66 37.42 20.03 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.469 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -124.35 139.6 53.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.866 0.365 . . . . 0.0 110.901 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 39.1 mm -95.95 145.41 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.158 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -165.02 160.1 33.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 41.6 t -104.61 128.34 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 111.111 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.51 111.03 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.087 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.37 -34.54 15.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -146.44 146.98 30.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 727' ' ' ALA . . . . . 0.431 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -108.12 115.55 30.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.11 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.64 159.06 15.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.173 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -47.68 -67.24 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.482 ' O ' HG23 ' A' ' 731' ' ' THR . 75.3 m -109.5 25.55 11.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.84 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 731' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -160.04 173.22 16.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.155 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 732' ' ' ALA . . . . . 0.518 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -150.8 120.02 6.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.102 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -73.79 96.52 2.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 95.9 t -103.61 140.19 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.135 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -100.69 100.82 11.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 51.5 mt -50.6 160.68 0.4 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -96.81 -37.51 10.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 35.4 t -70.51 -59.13 3.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 68.5 p -78.38 -23.27 46.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.149 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 5.0 m 60.42 40.42 17.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -125.34 150.17 47.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 26.9 m -91.03 111.61 23.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 6.9 pt -119.64 150.2 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.085 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 82.9 p -90.84 124.1 34.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 74.5 t -136.66 143.04 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.092 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -49.03 129.84 17.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 12.1 mtm105 -50.07 -29.44 8.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -79.32 -44.76 20.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 749' ' ' ARG . . . . . 0.402 ' HG2' ' CB ' ' A' ' 714' ' ' GLN . 37.5 mtm180 -54.87 -15.57 2.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 750' ' ' LEU . . . . . 0.518 HD11 ' HB3' ' A' ' 732' ' ' ALA . 23.8 mt -92.93 128.64 38.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 85.7 m -112.06 103.09 11.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 16.7 p -43.94 116.66 1.03 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 753' ' ' VAL . . . . . 0.473 HG21 HG22 ' A' ' 709' ' ' THR . 96.6 t -63.26 -45.72 97.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -39.96 141.3 0.76 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.482 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 11.0 t -120.4 -52.01 2.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.852 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -129.34 -3.39 4.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 180.0 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 3.9 m120 . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.758 0.313 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -72.87 -52.97 12.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.922 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 38.9 tp -65.45 -12.73 55.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 706' ' ' ILE . . . . . 0.527 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -65.78 108.22 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.195 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 122.95 -17.67 8.08 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.493 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -77.81 155.27 31.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.875 0.369 . . . . 0.0 110.868 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 709' ' ' THR . . . . . 0.436 HG22 HG21 ' A' ' 753' ' ' VAL . 64.6 m -85.6 112.33 20.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . 0.449 HG21 HG21 ' A' ' 734' ' ' VAL . 33.7 m -112.84 145.7 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 22.0 ttp85 -119.71 112.23 19.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 20.9 mt -57.81 138.13 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.148 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 12.4 t -114.43 -28.39 7.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -113.99 177.13 4.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 75.42 179.56 44.59 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.456 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 716' ' ' PRO . . . . . 0.513 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.4 Cg_endo -69.86 -4.7 14.63 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.682 2.255 . . . . 0.0 112.315 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.513 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 56.1 m-85 -109.47 29.74 7.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.923 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -64.84 124.41 21.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.922 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 89.14 19.59 49.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.501 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 720' ' ' TYR . . . . . 0.463 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 18.4 m-85 -108.47 143.07 37.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.861 0.362 . . . . 0.0 110.921 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.426 HG22 ' N ' ' A' ' 722' ' ' GLY . 27.9 mm -98.13 153.85 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.129 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 722' ' ' GLY . . . . . 0.426 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -173.43 158.54 28.0 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.508 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 40.8 t -101.67 125.26 55.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.388 . . . . 0.0 111.136 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 27.0 t -61.47 111.12 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -90.46 -37.18 14.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.938 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -142.12 148.8 38.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.826 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 727' ' ' ALA . . . . . 0.444 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -114.71 118.62 34.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.161 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 728' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 729' ' ' GLU . 0.7 OUTLIER -102.84 167.9 9.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.145 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 729' ' ' GLU . . . . . 0.452 ' H ' HG22 ' A' ' 728' ' ' THR . 13.6 pt-20 -65.35 -42.7 92.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 731' ' ' THR . 73.6 m -125.25 19.36 8.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.853 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 731' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -160.05 173.19 16.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.182 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 732' ' ' ALA . . . . . 0.605 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -150.86 118.2 6.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.088 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 733' ' ' ARG . . . . . 0.438 ' HD3' ' CB ' ' A' ' 744' ' ' SER . 25.2 mmt180 -75.98 101.53 5.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 734' ' ' VAL . . . . . 0.449 HG21 HG21 ' A' ' 710' ' ' VAL . 82.2 t -108.21 141.62 23.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -102.95 104.2 14.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.86 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 736' ' ' LEU . . . . . 0.463 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 47.8 mt -51.79 159.3 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -91.1 -43.77 9.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.838 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 57.0 m -73.05 -69.15 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 43.0 p -65.7 -7.47 15.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.151 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 29.6 p 40.28 47.28 2.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -125.01 148.85 48.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 23.2 m -94.32 104.94 16.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.153 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 6.9 pt -115.12 146.9 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . 0.438 ' CB ' ' HD3' ' A' ' 733' ' ' ARG . 2.5 t -94.87 132.13 40.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 40.2 t -142.73 147.35 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.1 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . 0.462 ' HB3' ' CG ' ' A' ' 749' ' ' ARG . 10.7 t0 -46.78 127.73 10.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.868 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 747' ' ' ARG . . . . . 0.453 ' HG2' ' HB2' ' A' ' 732' ' ' ALA . 26.9 mtm180 -48.86 -37.01 18.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -74.72 -44.13 51.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.944 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 749' ' ' ARG . . . . . 0.462 ' CG ' ' HB3' ' A' ' 746' ' ' ASP . 84.0 mtt180 -55.11 -14.45 1.61 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 732' ' ' ALA . 28.3 mt -92.84 129.21 38.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 22.2 m -101.6 95.66 6.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 2.8 p -43.46 118.82 1.45 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.162 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 753' ' ' VAL . . . . . 0.436 HG21 HG22 ' A' ' 709' ' ' THR . 11.2 t . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.178 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 10.4 p30 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.783 0.325 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.56 -61.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . 0.466 HD12 ' HB2' ' A' ' 708' ' ' GLN . 21.4 tp -61.6 -15.59 40.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.967 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 706' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 727' ' ' ALA . 0.6 OUTLIER -63.67 105.41 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.189 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 119.64 -12.09 11.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.493 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 708' ' ' GLN . . . . . 0.466 ' HB2' HD12 ' A' ' 705' ' ' LEU . 50.4 mm-40 -75.68 160.89 29.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.927 0.394 . . . . 0.0 110.881 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 87.2 m -94.67 106.5 18.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 29.4 m -111.03 155.44 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.13 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -125.19 113.57 17.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . 0.533 HG12 HD23 ' A' ' 750' ' ' LEU . 64.3 mt -63.24 104.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.085 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 3.2 m -104.07 28.25 6.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.877 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -161.14 142.07 11.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 97.04 -166.08 23.26 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.525 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 716' ' ' PRO . . . . . 0.569 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.6 Cg_endo -69.75 -27.94 25.93 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.679 2.253 . . . . 0.0 112.342 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.569 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 53.7 m-85 -96.88 44.38 1.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.964 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -71.97 136.0 46.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.897 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 73.6 40.07 47.62 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.474 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 720' ' ' TYR . . . . . 0.467 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 17.7 m-85 -127.09 140.57 52.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.346 . . . . 0.0 110.966 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 722' ' ' GLY . 36.2 mm -96.53 153.62 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.145 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 722' ' ' GLY . . . . . 0.422 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -170.24 164.21 37.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.437 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 53.2 t -108.68 123.05 64.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 111.08 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 724' ' ' VAL . . . . . 0.707 HG22 HG22 ' A' ' 734' ' ' VAL . 46.7 t -65.17 111.68 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -93.09 -30.01 15.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -143.84 144.41 31.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.841 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 727' ' ' ALA . . . . . 0.608 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -108.61 114.89 29.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.07 157.24 17.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.099 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 729' ' ' GLU . . . . . 0.47 ' O ' ' NE ' ' A' ' 747' ' ' ARG . 27.6 tt0 -44.23 -73.8 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 43.5 m -103.35 20.78 17.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.74 173.26 16.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 732' ' ' ALA . . . . . 0.459 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -152.72 122.81 7.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.083 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 34.8 mmm-85 -75.0 96.62 3.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.888 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 734' ' ' VAL . . . . . 0.707 HG22 HG22 ' A' ' 724' ' ' VAL . 73.7 t -100.76 145.7 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.145 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -106.95 101.86 11.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.929 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 736' ' ' LEU . . . . . 0.467 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 53.5 mt -49.71 158.4 0.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -87.69 -48.62 7.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 68.5 m -61.67 -74.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 81.5 p -58.59 -28.9 66.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.135 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.8 m 61.81 49.3 4.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -137.57 152.07 49.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 18.9 m -84.98 137.69 32.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 13.1 pt -143.39 142.93 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.155 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 94.6 p -86.68 112.16 21.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.834 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.512 ' HB ' HD21 ' A' ' 750' ' ' LEU . 72.6 t -127.07 148.06 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.16 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -54.94 131.98 45.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 747' ' ' ARG . . . . . 0.47 ' NE ' ' O ' ' A' ' 729' ' ' GLU . 48.8 mtm180 -52.73 -28.82 23.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.875 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -77.55 -44.65 27.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.94 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -58.29 -14.41 7.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.533 HD23 HG12 ' A' ' 712' ' ' ILE . 14.4 mt -99.07 128.25 45.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.907 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 29.0 m -113.51 102.94 10.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.085 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 18.4 p -45.17 119.42 2.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.151 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 85.0 t . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.16 179.89 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 7.8 p30 . . . . . 0 C--O 1.23 0.053 0 CA-C-O 120.804 0.335 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -78.88 -66.31 0.88 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . 0.514 HD12 ' HB2' ' A' ' 708' ' ' GLN . 27.2 tp -59.62 -14.1 12.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.914 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 706' ' ' ILE . . . . . 0.548 HD11 ' HB2' ' A' ' 727' ' ' ALA . 0.6 OUTLIER -62.83 104.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.128 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 125.21 -16.03 7.22 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.472 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 708' ' ' GLN . . . . . 0.514 ' HB2' HD12 ' A' ' 705' ' ' LEU . 48.7 mm-40 -77.32 158.78 29.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.0 110.875 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 709' ' ' THR . . . . . 0.53 ' O ' HG23 ' A' ' 753' ' ' VAL . 62.3 m -90.71 110.23 21.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . 0.544 ' HA ' HG23 ' A' ' 753' ' ' VAL . 29.4 m -112.54 144.98 19.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.097 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 711' ' ' ARG . . . . . 0.474 ' CZ ' ' HA2' ' A' ' 719' ' ' GLY . 29.1 ttt85 -116.99 110.89 18.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.837 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . 0.421 HG12 HD23 ' A' ' 750' ' ' LEU . 51.2 mt -59.62 114.3 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 42.4 p -108.4 18.05 21.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -147.98 137.44 22.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 99.99 -173.67 25.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.525 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 716' ' ' PRO . . . . . 0.57 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.4 Cg_endo -69.7 -16.75 37.96 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.764 2.309 . . . . 0.0 112.315 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.57 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 35.2 m-85 -98.2 23.22 8.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -58.36 135.61 57.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.855 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 719' ' ' GLY . . . . . 0.474 ' HA2' ' CZ ' ' A' ' 711' ' ' ARG . . . 79.15 28.62 53.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.475 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -116.6 142.68 46.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.905 0.384 . . . . 0.0 110.917 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.424 HD13 ' HB2' ' A' ' 711' ' ' ARG . 12.5 mm -101.94 148.96 6.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.132 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -167.26 160.67 34.4 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.487 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 54.8 t -101.56 123.19 54.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.899 0.38 . . . . 0.0 111.156 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 59.2 t -60.43 105.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.187 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -83.56 -37.4 23.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -143.11 148.96 37.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 727' ' ' ALA . . . . . 0.548 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -115.4 116.43 28.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 728' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 729' ' ' GLU . 0.4 OUTLIER -100.68 168.2 9.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.111 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 729' ' ' GLU . . . . . 0.453 ' H ' HG22 ' A' ' 728' ' ' THR . 18.8 pt-20 -64.54 -45.72 85.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.483 ' O ' HG23 ' A' ' 731' ' ' THR . 72.6 m -122.97 19.4 10.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 731' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -159.87 173.32 16.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 732' ' ' ALA . . . . . 0.559 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -151.64 121.2 6.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.138 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -79.73 97.16 6.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 66.5 t -101.3 147.81 7.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -107.25 100.6 10.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 67.0 mt -50.76 159.43 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -95.6 -31.19 13.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 3.6 t -76.1 -62.43 1.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.876 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 81.0 p -75.89 -16.62 60.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 6.0 m 54.5 42.05 31.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -128.55 156.76 42.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 26.5 m -95.81 120.43 36.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 8.1 pt -125.84 145.52 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 96.3 p -86.53 121.76 29.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.499 ' HB ' HD21 ' A' ' 750' ' ' LEU . 60.5 t -134.36 147.52 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.128 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.57 129.11 37.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 -48.95 -32.05 8.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -77.68 -41.04 39.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.898 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -60.77 -9.54 4.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.559 HD11 ' HB3' ' A' ' 732' ' ' ALA . 13.4 mt -101.56 122.18 43.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 97.5 m -98.8 101.33 12.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.142 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 3.1 p -44.68 118.24 1.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.157 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 753' ' ' VAL . . . . . 0.544 HG23 ' HA ' ' A' ' 710' ' ' VAL . 4.1 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 N--CA 1.458 -0.06 0 CA-C-O 120.832 0.349 . . . . 0.0 110.917 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -73.7 -54.1 8.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.887 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . 0.401 HD12 ' CG ' ' A' ' 708' ' ' GLN . 48.6 tp -66.12 -14.44 61.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 706' ' ' ILE . . . . . 0.523 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -64.11 107.2 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.105 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 120.91 -14.72 9.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.505 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 708' ' ' GLN . . . . . 0.401 ' CG ' HD12 ' A' ' 705' ' ' LEU . 65.0 mm-40 -73.72 158.78 34.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.841 0.353 . . . . 0.0 110.939 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 82.1 m -95.28 107.65 19.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 24.4 m -112.0 157.1 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -125.12 110.66 14.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . 0.525 HG12 HD23 ' A' ' 750' ' ' LEU . 34.9 mt -60.45 108.32 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 3.4 m -109.33 31.53 5.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.898 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 714' ' ' GLN . . . . . 0.441 ' CB ' ' HG2' ' A' ' 749' ' ' ARG . 33.9 mt-30 -160.03 131.04 5.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 102.64 -163.86 16.4 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.482 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 716' ' ' PRO . . . . . 0.547 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 54.3 Cg_endo -69.71 -34.89 13.85 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.707 2.271 . . . . 0.0 112.339 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.547 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 48.3 m-85 -88.31 38.64 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.949 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -71.4 132.86 45.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.915 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.36 33.57 31.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.481 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 720' ' ' TYR . . . . . 0.484 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 13.2 m-85 -122.41 141.06 52.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.936 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 14.1 mm -98.03 148.88 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.133 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -167.28 161.58 35.4 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.556 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.446 HG23 ' NE2' ' A' ' 737' ' ' HIS . 46.6 t -104.74 127.55 59.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.83 0.347 . . . . 0.0 111.139 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 724' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 707' ' ' GLY . 60.7 t -64.01 109.66 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.161 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.84 -35.81 15.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -143.25 149.2 37.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 727' ' ' ALA . . . . . 0.509 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -110.18 115.78 30.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.131 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 1.1 m -103.53 154.97 18.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.162 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -41.07 -75.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.848 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.414 ' O ' HG23 ' A' ' 731' ' ' THR . 61.8 m -104.31 25.37 10.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 731' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -157.85 173.17 17.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.152 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 732' ' ' ALA . . . . . 0.502 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -151.87 122.11 7.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.076 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 53.6 mmm-85 -76.56 99.19 4.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.16 142.89 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.107 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -103.22 105.62 15.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 736' ' ' LEU . . . . . 0.484 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 39.4 mt -50.22 160.14 0.39 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 737' ' ' HIS . . . . . 0.446 ' NE2' HG23 ' A' ' 723' ' ' VAL . 9.8 m170 -95.15 -24.07 17.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 13.4 m -83.98 -71.24 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 31.3 p -67.94 -16.88 64.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.153 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 8.8 m 55.71 41.9 29.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.836 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -125.9 148.82 49.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.93 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 29.1 m -89.29 129.22 35.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.156 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 7.0 pt -135.4 145.77 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.122 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 88.6 p -87.57 117.49 26.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 81.2 t -131.05 143.06 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.089 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -48.94 132.82 18.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -52.31 -32.97 40.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -75.84 -42.44 49.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 749' ' ' ARG . . . . . 0.441 ' HG2' ' CB ' ' A' ' 714' ' ' GLN . 90.6 mtt180 -58.06 -11.86 2.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.525 HD23 HG12 ' A' ' 712' ' ' ILE . 14.4 mt -101.07 127.2 47.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.94 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 60.6 m -112.16 103.51 11.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.132 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 14.5 p -42.63 116.78 0.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.148 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 87.4 t . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.148 179.873 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 20.9 p30 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.782 0.325 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -85.38 -55.99 3.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . 0.437 ' HG ' HG21 ' A' ' 724' ' ' VAL . 48.9 tp -60.87 -13.64 16.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.929 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 706' ' ' ILE . . . . . 0.587 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -66.31 109.83 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.141 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.18 -12.66 12.71 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.489 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -76.94 164.05 26.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.923 0.392 . . . . 0.0 110.877 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 53.4 m -99.23 110.04 22.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.159 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 21.1 m -113.34 152.87 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.109 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -123.5 114.01 19.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.827 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 714' ' ' GLN . 20.1 mt -56.64 133.04 21.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.166 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 12.8 t -107.97 -29.4 9.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 714' ' ' GLN . . . . . 0.415 ' O ' ' CG2' ' A' ' 712' ' ' ILE . 26.7 mm-40 -112.85 -179.64 3.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 76.42 -179.03 49.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.541 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 716' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -10.95 29.83 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.641 2.227 . . . . 0.0 112.383 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -107.67 35.03 3.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.949 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -65.95 107.16 1.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.856 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 107.19 30.42 4.17 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.463 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -117.92 147.87 42.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 0.0 110.899 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 30.5 mm -98.8 147.12 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.171 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -165.17 161.49 34.86 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.501 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 48.9 t -106.06 129.47 59.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.382 . . . . 0.0 111.125 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 724' ' ' VAL . . . . . 0.437 HG21 ' HG ' ' A' ' 705' ' ' LEU . 39.3 t -64.68 109.19 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -86.19 -38.49 17.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -143.86 149.77 37.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -113.06 118.19 34.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.82 164.31 11.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.174 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -56.08 -54.88 39.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 59.5 m -118.13 17.16 14.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.878 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.69 173.25 14.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.143 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 732' ' ' ALA . . . . . 0.722 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -150.98 120.46 6.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.076 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -79.02 97.38 6.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.837 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 99.3 t -102.28 144.32 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.167 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -104.84 101.99 11.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.866 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 31.3 mt -50.78 158.68 0.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.954 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -87.6 -55.4 3.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 22.2 t -61.31 -68.61 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 61.7 p -59.96 -30.26 68.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.101 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 12.0 t 59.54 48.36 9.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.901 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -133.7 149.28 51.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 17.0 m -88.53 110.86 21.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.17 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 7.5 pt -118.69 147.75 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 95.5 p -89.97 126.25 35.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.6 ' HB ' HD21 ' A' ' 750' ' ' LEU . 57.6 t -138.21 141.87 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.138 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . 0.453 ' HB2' ' CG ' ' A' ' 749' ' ' ARG . 0.7 OUTLIER -48.54 127.58 13.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 26.2 mtm180 -45.36 -36.47 4.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.869 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -77.26 -44.42 29.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.958 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 749' ' ' ARG . . . . . 0.453 ' CG ' ' HB2' ' A' ' 746' ' ' ASP . 56.0 mtt180 -49.35 -28.18 4.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.722 HD11 ' HB3' ' A' ' 732' ' ' ALA . 13.6 mt -79.88 139.56 37.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 50.7 m -116.6 91.95 3.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.165 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 11.9 p -42.57 117.97 1.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.125 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 78.6 t . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 179.914 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 10.5 p30 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.783 0.325 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -85.94 -56.83 3.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . 0.51 ' HG ' HG21 ' A' ' 724' ' ' VAL . 47.6 tp -59.99 -13.25 10.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.901 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 706' ' ' ILE . . . . . 0.523 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -62.88 108.95 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 117.04 -13.82 14.03 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.49 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 708' ' ' GLN . . . . . 0.488 ' CG ' HD12 ' A' ' 705' ' ' LEU . 55.7 mm-40 -73.77 161.15 30.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.902 0.382 . . . . 0.0 110.895 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 709' ' ' THR . . . . . 0.674 HG22 HG21 ' A' ' 753' ' ' VAL . 97.2 m -97.64 106.85 19.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.167 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 27.1 m -112.69 156.64 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.151 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 711' ' ' ARG . . . . . 0.556 ' HB2' HD13 ' A' ' 721' ' ' ILE . 23.2 ttp180 -127.27 115.13 18.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 44.6 mt -60.27 128.85 21.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.123 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 4.5 t -126.4 11.99 7.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.811 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 714' ' ' GLN . . . . . 0.45 ' CB ' ' HG2' ' A' ' 749' ' ' ARG . 24.5 mt-30 -138.72 128.08 24.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.948 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 105.85 -162.38 14.14 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.474 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 716' ' ' PRO . . . . . 0.558 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.5 Cg_endo -69.82 -32.88 17.47 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.735 2.29 . . . . 0.0 112.327 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.558 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 50.4 m-85 -91.82 42.72 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.957 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 39.5 tttm -78.24 97.4 5.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 120.96 34.67 0.88 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.505 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 720' ' ' TYR . . . . . 0.442 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 14.4 m-85 -127.51 147.57 50.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.857 0.36 . . . . 0.0 110.919 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.556 HD13 ' HB2' ' A' ' 711' ' ' ARG . 28.7 mm -98.22 154.11 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.093 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 722' ' ' GLY . . . . . 0.429 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -172.44 151.43 14.44 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.461 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 41.2 t -94.89 129.29 45.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 111.134 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 724' ' ' VAL . . . . . 0.51 HG21 ' HG ' ' A' ' 705' ' ' LEU . 38.4 t -63.79 109.08 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.143 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.0 mmpt? -85.37 -40.76 16.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -143.14 149.47 38.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.824 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 727' ' ' ALA . . . . . 0.464 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -110.97 119.79 40.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.47 160.95 14.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.155 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -52.13 -62.17 1.81 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.428 ' O ' HG23 ' A' ' 731' ' ' THR . 38.3 m -111.57 22.43 15.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.829 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 731' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -158.17 173.23 17.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 732' ' ' ALA . . . . . 0.629 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -151.41 119.44 6.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -75.96 102.03 5.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 93.9 t -107.46 145.98 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -108.47 104.55 13.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 736' ' ' LEU . . . . . 0.442 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 38.0 mt -50.88 161.36 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -95.41 -27.89 15.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 3.9 m -82.39 -74.07 0.36 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 28.2 p -62.43 -19.2 63.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.152 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.2 m 57.09 41.63 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -123.78 146.72 48.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.906 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 18.4 m -90.78 108.2 19.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.118 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 9.5 pt -111.76 154.1 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.186 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 84.6 p -97.41 124.8 41.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.845 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.68 ' HB ' HD21 ' A' ' 750' ' ' LEU . 62.0 t -136.88 145.32 30.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.094 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -53.07 128.29 27.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 10.0 mtm105 -45.57 -34.77 3.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -77.05 -40.06 47.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 749' ' ' ARG . . . . . 0.45 ' HG2' ' CB ' ' A' ' 714' ' ' GLN . 63.9 mtt180 -56.8 -21.96 32.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.856 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.68 HD21 ' HB ' ' A' ' 745' ' ' VAL . 10.6 mt -88.83 139.22 30.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 88.8 m -119.46 96.03 5.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.167 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 7.3 p -39.81 118.25 0.84 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.165 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 753' ' ' VAL . . . . . 0.674 HG21 HG22 ' A' ' 709' ' ' THR . 98.6 t . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.124 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.773 0.32 . . . . 0.0 110.893 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -75.45 -58.68 3.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 45.4 tp -60.08 -14.31 16.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 706' ' ' ILE . . . . . 0.587 HD11 ' HB2' ' A' ' 727' ' ' ALA . 0.7 OUTLIER -64.17 108.55 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.62 -12.91 12.0 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -74.72 166.43 23.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.86 0.362 . . . . 0.0 110.937 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 709' ' ' THR . . . . . 0.609 HG22 HG21 ' A' ' 753' ' ' VAL . 62.7 m -100.39 110.19 22.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.182 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . 0.423 HG12 HG22 ' A' ' 752' ' ' THR . 26.3 m -114.25 158.48 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.169 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 711' ' ' ARG . . . . . 0.503 ' HB2' HD13 ' A' ' 721' ' ' ILE . 23.4 ttm-85 -131.76 112.46 12.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 15.7 mt -57.22 133.34 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.131 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 15.9 t -109.21 -29.79 8.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -112.12 178.72 4.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 76.09 178.05 43.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.513 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 716' ' ' PRO . . . . . 0.52 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.9 Cg_endo -69.71 -11.06 30.12 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.652 2.234 . . . . 0.0 112.326 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.52 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 52.9 m-85 -103.9 29.12 6.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.927 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -62.04 135.29 57.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.901 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 77.33 37.39 31.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.48 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 720' ' ' TYR . . . . . 0.473 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 24.6 m-85 -124.1 140.22 53.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.845 0.355 . . . . 0.0 110.981 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.503 HD13 ' HB2' ' A' ' 711' ' ' ARG . 11.5 mm -98.81 148.76 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.134 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -167.98 169.66 41.49 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.449 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 53.3 t -112.13 126.87 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.88 0.371 . . . . 0.0 111.104 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 724' ' ' VAL . . . . . 0.46 HG22 HG22 ' A' ' 734' ' ' VAL . 99.1 t -62.66 108.01 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.147 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -84.18 -40.21 18.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -142.63 150.28 40.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 727' ' ' ALA . . . . . 0.587 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -108.57 118.52 36.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.066 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.11 156.97 17.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 729' ' ' GLU . . . . . 0.442 ' O ' ' NE ' ' A' ' 747' ' ' ARG . 6.3 tp10 -42.89 -75.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 25.1 m -103.0 18.92 20.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.72 173.36 14.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.178 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 732' ' ' ALA . . . . . 0.497 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -151.0 120.43 6.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.09 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 49.1 mmm-85 -75.53 101.46 4.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 734' ' ' VAL . . . . . 0.46 HG22 HG22 ' A' ' 724' ' ' VAL . 87.1 t -107.47 144.23 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.159 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -104.32 104.18 14.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 736' ' ' LEU . . . . . 0.473 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 40.4 mt -52.69 161.43 0.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.949 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -90.66 -48.7 6.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.853 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 3.6 m -61.0 -72.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 77.4 p -61.2 -27.0 68.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.145 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 13.8 t 59.91 49.41 7.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -138.52 151.55 47.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 21.1 m -83.37 137.43 33.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.153 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 13.2 pt -142.79 148.52 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 81.0 p -92.12 119.39 31.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.495 ' HB ' HD21 ' A' ' 750' ' ' LEU . 32.4 t -133.72 142.42 41.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -49.7 132.01 21.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 747' ' ' ARG . . . . . 0.442 ' NE ' ' O ' ' A' ' 729' ' ' GLU . 36.7 mtm180 -54.04 -20.44 6.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -87.89 -44.05 11.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 -56.88 -17.23 8.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 732' ' ' ALA . 19.3 mt -89.83 134.32 34.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.978 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 21.6 m -115.02 90.85 3.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.097 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 710' ' ' VAL . 16.2 p -41.84 118.56 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.097 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 753' ' ' VAL . . . . . 0.609 HG21 HG22 ' A' ' 709' ' ' THR . 98.3 t . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.189 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 703' ' ' ASN . . . . . 0.404 ' HA ' HD13 ' A' ' 706' ' ' ILE . 11.0 p-10 . . . . . 0 N--CA 1.458 -0.071 0 CA-C-O 120.836 0.35 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -53.41 -16.32 1.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 30.4 tp -101.8 -17.07 16.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.917 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 706' ' ' ILE . . . . . 0.504 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -67.46 103.12 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 123.21 -7.02 9.26 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.517 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -78.58 168.24 20.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.857 0.36 . . . . 0.0 110.921 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 52.8 m -102.91 105.45 15.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.115 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 752' ' ' THR . 35.8 m -109.86 158.47 9.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.114 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 711' ' ' ARG . . . . . 0.54 ' HB2' HD13 ' A' ' 721' ' ' ILE . 14.4 ttm-85 -128.54 115.9 18.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.863 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 49.1 mt -59.26 142.64 14.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.151 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 18.0 t -118.84 -30.57 5.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 36.8 mm-40 -112.09 172.12 7.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 80.87 179.57 53.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.493 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 716' ' ' PRO . . . . . 0.481 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.7 Cg_endo -69.7 -8.39 23.47 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.755 2.303 . . . . 0.0 112.321 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.481 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 63.6 m-85 -106.94 27.43 8.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -60.89 130.94 48.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.26 37.8 20.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.473 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 720' ' ' TYR . . . . . 0.4 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 10.5 m-85 -125.65 142.77 51.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 0.0 110.906 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.54 HD13 ' HB2' ' A' ' 711' ' ' ARG . 26.4 mm -96.43 146.65 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.095 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -163.49 165.0 36.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.483 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.513 HG23 ' NE2' ' A' ' 737' ' ' HIS . 29.3 t -110.28 128.01 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 0.0 111.171 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 33.9 t -64.8 108.93 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -85.28 -38.34 18.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.881 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -145.12 149.48 35.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 727' ' ' ALA . . . . . 0.477 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -108.32 117.67 34.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.158 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.03 155.75 18.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.151 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 729' ' ' GLU . . . . . 0.482 ' O ' ' NE ' ' A' ' 747' ' ' ARG . 24.7 tt0 -43.09 -74.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.914 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 731' ' ' THR . 58.5 m -103.24 24.6 10.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 731' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -158.05 173.2 17.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.161 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 732' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -151.09 121.58 7.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.12 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -76.75 98.75 4.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 57.4 t -103.95 150.85 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.151 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -111.7 102.67 10.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.828 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 736' ' ' LEU . . . . . 0.4 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 31.9 mt -50.88 157.39 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 737' ' ' HIS . . . . . 0.513 ' NE2' HG23 ' A' ' 723' ' ' VAL . 18.6 m170 -95.34 -23.12 17.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.841 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 3.7 t -82.26 -68.68 0.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 34.4 p -70.97 -17.41 62.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.159 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 55.6 m 58.28 40.58 24.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.864 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -125.3 153.91 42.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 26.2 m -96.88 121.19 38.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 7.9 pt -126.36 155.46 36.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.131 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 92.0 p -97.44 121.13 38.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.67 HG12 ' HB2' ' A' ' 749' ' ' ARG . 21.7 t -134.43 144.62 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.152 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -48.98 131.16 18.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 747' ' ' ARG . . . . . 0.482 ' NE ' ' O ' ' A' ' 729' ' ' GLU . 36.9 mtm180 -50.74 -17.83 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -90.53 -37.42 13.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 749' ' ' ARG . . . . . 0.67 ' HB2' HG12 ' A' ' 745' ' ' VAL . 31.4 mtm180 -61.96 -8.58 5.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.558 HD11 ' HB3' ' A' ' 732' ' ' ALA . 14.6 mt -100.77 135.6 41.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.968 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 33.1 m -118.7 93.63 4.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.168 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . 0.539 ' HA ' HG12 ' A' ' 710' ' ' VAL . 6.4 p -39.9 121.23 1.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.098 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 753' ' ' VAL . . . . . 0.429 HG21 HD12 ' A' ' 721' ' ' ILE . 96.4 t . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.152 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 9.5 m120 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.815 0.341 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -76.03 -55.21 5.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . 0.501 ' HG ' HG21 ' A' ' 724' ' ' VAL . 52.0 tp -62.45 -16.07 53.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.959 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 706' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 727' ' ' ALA . 0.7 OUTLIER -61.59 109.52 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 120.84 -20.69 8.6 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.486 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -73.0 157.45 37.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.897 0.38 . . . . 0.0 110.895 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 709' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 753' ' ' VAL . 55.1 m -90.61 110.28 21.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.178 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . 0.491 ' HA ' HG23 ' A' ' 753' ' ' VAL . 33.1 m -111.65 146.94 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.129 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 711' ' ' ARG . . . . . 0.495 ' HB2' HD13 ' A' ' 721' ' ' ILE . 12.8 ttp-105 -117.44 113.14 21.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' A' ' 714' ' ' GLN . 35.6 mt -58.73 127.35 17.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 26.2 t -105.66 -26.51 11.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 714' ' ' GLN . . . . . 0.439 ' O ' ' CG2' ' A' ' 712' ' ' ILE . 9.8 mm-40 -113.95 175.53 5.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.882 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 77.41 177.27 46.11 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.516 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 716' ' ' PRO . . . . . 0.573 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 54.5 Cg_endo -69.69 -0.06 6.3 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.684 2.256 . . . . 0.0 112.398 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.573 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 58.0 m-85 -115.34 33.89 5.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.962 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -66.39 137.11 56.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 77.66 28.48 57.12 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.513 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -117.92 141.38 48.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 0.0 110.926 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.495 HD13 ' HB2' ' A' ' 711' ' ' ARG . 27.2 mm -96.67 155.01 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.147 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 722' ' ' GLY . . . . . 0.451 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -173.81 157.78 26.29 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.489 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 44.1 t -100.95 129.91 51.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.881 0.372 . . . . 0.0 111.158 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 724' ' ' VAL . . . . . 0.501 HG21 ' HG ' ' A' ' 705' ' ' LEU . 23.1 t -65.14 113.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.123 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -91.49 -39.6 11.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -141.9 149.65 40.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 727' ' ' ALA . . . . . 0.629 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -110.57 115.88 30.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.44 157.51 16.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.157 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -45.96 -70.39 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.913 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.41 ' O ' HG23 ' A' ' 731' ' ' THR . 2.7 m -106.19 23.68 13.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.854 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 731' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 730' ' ' SER . 0.7 OUTLIER -157.71 173.27 17.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 732' ' ' ALA . . . . . 0.482 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -151.36 119.6 6.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 25.1 mmt-85 -75.37 97.07 3.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.9 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 734' ' ' VAL . . . . . 0.454 HG21 HG21 ' A' ' 710' ' ' VAL . 69.6 t -103.89 145.23 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.16 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -104.24 101.36 11.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 32.5 mt -49.82 160.8 0.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -89.46 -62.8 1.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 2.1 t -53.85 -70.27 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.832 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 71.0 p -58.61 -35.09 71.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.142 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 6.6 t 65.77 41.31 3.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -128.7 145.79 51.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 20.7 m -85.1 133.3 34.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.144 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 7.6 pt -141.61 149.46 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.189 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 97.5 p -91.5 117.93 30.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.46 142.77 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.152 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . 0.477 ' HB3' ' CG ' ' A' ' 749' ' ' ARG . 7.9 t0 -46.96 126.42 8.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.823 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -48.87 -35.09 13.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -76.96 -41.82 41.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 749' ' ' ARG . . . . . 0.477 ' CG ' ' HB3' ' A' ' 746' ' ' ASP . 79.2 mtt180 -57.21 -18.51 16.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.482 ' CD1' ' HB3' ' A' ' 732' ' ' ALA . 21.3 mt -89.07 127.67 35.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.956 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 18.3 m -101.11 97.99 8.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.132 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 4.6 p -43.36 118.69 1.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 753' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 709' ' ' THR . 5.8 t . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.793 0.33 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -73.49 -54.13 8.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.0 -12.48 18.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.899 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 706' ' ' ILE . . . . . 0.586 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -66.8 111.41 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.149 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.6 -17.39 11.14 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.473 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -73.62 154.12 39.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.857 0.361 . . . . 0.0 110.884 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 63.9 m -90.67 111.12 22.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.16 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 752' ' ' THR . 31.6 m -115.29 156.88 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.15 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -125.72 115.97 20.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . 0.675 HD11 HD11 ' A' ' 743' ' ' ILE . 26.2 mt -56.33 142.98 10.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . 0.55 ' C ' ' NE2' ' A' ' 714' ' ' GLN . 41.8 t -116.76 -36.77 3.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 714' ' ' GLN . . . . . 0.55 ' NE2' ' C ' ' A' ' 713' ' ' SER . 0.4 OUTLIER -105.37 -175.71 2.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.916 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 69.48 175.05 12.67 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.513 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 716' ' ' PRO . . . . . 0.576 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.2 Cg_endo -69.81 -4.38 13.95 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.677 2.252 . . . . 0.0 112.323 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.576 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 45.4 m-85 -108.2 29.42 7.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -64.06 136.74 57.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.933 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 77.53 32.12 47.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -118.59 145.91 45.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.81 0.338 . . . . 0.0 110.955 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 48.7 mm -97.0 147.8 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.149 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -170.47 148.72 11.78 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.467 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.498 ' C ' HG13 ' A' ' 734' ' ' VAL . 55.1 t -97.3 126.26 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.367 . . . . 0.0 111.159 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 724' ' ' VAL . . . . . 0.808 ' HA ' HG22 ' A' ' 734' ' ' VAL . 41.8 t -59.97 113.27 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -90.47 -39.08 12.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -142.51 144.89 33.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.847 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -106.11 118.03 35.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.091 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.38 155.35 20.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 729' ' ' GLU . . . . . 0.402 ' O ' ' NE ' ' A' ' 747' ' ' ARG . 15.6 tp10 -45.07 -71.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 73.5 m -106.91 26.29 10.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.826 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.44 173.37 17.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.16 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 732' ' ' ALA . . . . . 0.669 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -155.73 119.96 4.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.065 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 733' ' ' ARG . . . . . 0.457 ' HB3' ' CG2' ' A' ' 742' ' ' THR . 1.5 mpt_? -84.82 98.36 10.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 734' ' ' VAL . . . . . 0.808 HG22 ' HA ' ' A' ' 724' ' ' VAL . 55.8 t -103.62 146.05 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.113 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -100.8 102.13 13.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 31.3 mt -49.84 157.61 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -85.47 -43.8 13.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 48.1 m -71.78 -72.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 67.9 p -58.64 -18.13 27.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.177 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 9.2 t 48.97 47.95 21.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -138.66 155.18 48.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 742' ' ' THR . . . . . 0.457 ' CG2' ' HB3' ' A' ' 733' ' ' ARG . 66.4 m -84.67 133.09 34.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.15 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 743' ' ' ILE . . . . . 0.675 HD11 HD11 ' A' ' 712' ' ' ILE . 7.3 pt -135.62 138.3 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.159 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 45.8 p -80.84 120.94 25.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.896 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.46 HG13 ' CZ ' ' A' ' 749' ' ' ARG . 98.2 t -138.89 144.15 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.143 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -54.36 127.93 29.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 747' ' ' ARG . . . . . 0.402 ' NE ' ' O ' ' A' ' 729' ' ' GLU . 30.0 mtm180 -45.39 -40.14 7.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -71.7 -46.01 60.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 749' ' ' ARG . . . . . 0.46 ' CZ ' HG13 ' A' ' 745' ' ' VAL . 39.1 mtp180 -49.84 -26.49 4.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.669 HD11 ' HB3' ' A' ' 732' ' ' ALA . 16.5 mt -82.65 129.39 34.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.932 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 20.1 m -111.0 98.73 7.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.157 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . 0.437 ' HA ' HG12 ' A' ' 710' ' ' VAL . 20.6 p -42.11 117.68 1.02 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.166 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 83.7 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.137 179.923 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 15.1 p30 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.823 0.344 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -73.91 -61.01 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 46.9 tp -62.44 -11.97 19.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.882 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 706' ' ' ILE . . . . . 0.535 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -65.5 108.65 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.115 179.872 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 119.69 -15.52 10.5 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.472 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -76.72 156.28 32.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.914 0.388 . . . . 0.0 110.934 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 709' ' ' THR . . . . . 0.439 HG22 ' HB ' ' A' ' 753' ' ' VAL . 53.9 m -89.3 113.95 25.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . 0.449 ' HA ' HG23 ' A' ' 753' ' ' VAL . 33.9 m -117.83 154.12 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 711' ' ' ARG . . . . . 0.626 ' CZ ' HD11 ' A' ' 721' ' ' ILE . 31.2 ttm-85 -126.02 113.89 17.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . 0.53 HG12 HD23 ' A' ' 750' ' ' LEU . 40.8 mt -64.02 110.36 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.147 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 5.8 t -107.95 20.79 18.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.818 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -149.18 134.37 18.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.941 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 101.3 -164.77 18.09 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.51 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 716' ' ' PRO . . . . . 0.557 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 54.0 Cg_endo -69.76 -30.56 22.1 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.665 2.244 . . . . 0.0 112.359 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.557 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 44.7 m-85 -91.21 38.82 0.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -73.0 126.35 29.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.902 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 87.62 35.38 9.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.486 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -128.06 144.31 51.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 110.956 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.626 HD11 ' CZ ' ' A' ' 711' ' ' ARG . 39.1 mm -97.98 156.82 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.16 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 722' ' ' GLY . . . . . 0.478 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -174.1 155.18 21.11 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.518 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.464 HG23 ' NE2' ' A' ' 737' ' ' HIS . 38.3 t -98.4 129.18 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.862 0.363 . . . . 0.0 111.174 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 724' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 707' ' ' GLY . 21.8 t -67.31 112.28 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.151 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.49 -39.97 10.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -137.63 146.55 44.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.856 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 727' ' ' ALA . . . . . 0.431 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -115.73 116.42 28.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.147 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 728' ' ' THR . . . . . 0.491 HG22 ' H ' ' A' ' 729' ' ' GLU . 0.4 OUTLIER -100.48 169.43 9.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.094 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 729' ' ' GLU . . . . . 0.491 ' H ' HG22 ' A' ' 728' ' ' THR . 15.6 pt-20 -66.65 -42.44 86.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.482 ' O ' HG23 ' A' ' 731' ' ' THR . 60.5 m -125.32 18.31 8.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.879 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 731' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -159.9 173.59 15.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.178 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 732' ' ' ALA . . . . . 0.546 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -153.52 122.31 6.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.102 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 733' ' ' ARG . . . . . 0.492 ' HD3' ' CB ' ' A' ' 744' ' ' SER . 11.1 mmt85 -79.11 98.33 6.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.99 138.81 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.165 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -98.01 101.92 13.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 57.9 mt -50.9 160.55 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.962 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 737' ' ' HIS . . . . . 0.464 ' NE2' HG23 ' A' ' 723' ' ' VAL . 15.0 m170 -100.09 -38.47 8.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 4.6 m -66.68 -52.72 41.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 74.1 p -87.32 -23.58 24.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.137 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.7 m 63.77 41.78 6.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.865 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -126.95 154.21 44.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.939 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 21.3 m -92.23 122.13 34.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.153 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 6.8 pt -133.84 142.13 42.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.107 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . 0.492 ' CB ' ' HD3' ' A' ' 733' ' ' ARG . 3.1 t -87.51 132.62 33.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.615 ' HB ' HD21 ' A' ' 750' ' ' LEU . 81.9 t -143.26 148.58 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.101 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . 0.408 ' HB2' ' CG ' ' A' ' 749' ' ' ARG . 20.1 m-20 -50.28 119.8 4.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -38.73 -44.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.843 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -65.92 -47.84 73.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 749' ' ' ARG . . . . . 0.408 ' CG ' ' HB2' ' A' ' 746' ' ' ASP . 91.4 mtt180 -49.53 -20.53 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.615 HD21 ' HB ' ' A' ' 745' ' ' VAL . 12.9 mt -92.34 122.7 35.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.937 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 39.4 m -103.17 107.19 17.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.187 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 1.6 p -44.63 121.08 2.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.14 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 753' ' ' VAL . . . . . 0.653 HG12 ' O ' ' A' ' 753' ' ' VAL . 22.0 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.133 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 2.9 p30 . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.784 0.326 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -79.67 -58.05 3.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . 0.457 HD12 ' CG ' ' A' ' 708' ' ' GLN . 45.5 tp -59.99 -15.31 21.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.904 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 706' ' ' ILE . . . . . 0.529 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -62.08 108.84 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 120.13 -16.25 10.05 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.501 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 708' ' ' GLN . . . . . 0.457 ' CG ' HD12 ' A' ' 705' ' ' LEU . 46.6 mm-40 -73.82 163.58 27.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.878 0.37 . . . . 0.0 110.922 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 709' ' ' THR . . . . . 0.423 HG22 ' CG2' ' A' ' 753' ' ' VAL . 44.9 m -99.49 110.2 22.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.158 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.48 157.38 14.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -127.01 110.43 12.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.869 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . 0.534 HG12 HD23 ' A' ' 750' ' ' LEU . 40.7 mt -60.63 105.5 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 55.2 m -103.4 24.39 11.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 714' ' ' GLN . . . . . 0.404 ' CB ' ' HG2' ' A' ' 749' ' ' ARG . 14.4 mp0 -152.75 147.29 25.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.884 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 90.44 -166.69 32.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.502 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 716' ' ' PRO . . . . . 0.554 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.9 Cg_endo -69.77 -29.95 23.0 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.697 2.265 . . . . 0.0 112.362 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.554 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 55.0 m-85 -93.15 45.46 1.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -75.02 135.79 41.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 75.95 39.65 32.51 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.458 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 720' ' ' TYR . . . . . 0.401 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 16.7 m-85 -125.98 140.68 52.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.854 0.359 . . . . 0.0 110.935 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 31.3 mm -96.63 149.2 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.119 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -169.05 158.71 31.44 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.5 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 48.5 t -101.88 130.96 50.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 0.0 111.131 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 42.8 t -67.32 107.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.083 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 725' ' ' LYS . . . . . 0.426 ' HA ' ' NZ ' ' A' ' 725' ' ' LYS . 0.0 OUTLIER -84.53 -38.9 19.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -147.05 145.61 29.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -104.86 121.45 43.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -106.51 158.96 16.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.146 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -45.35 -71.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 74.3 m -106.23 18.71 21.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.58 173.32 14.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 732' ' ' ALA . . . . . 0.494 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -150.19 120.32 7.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 -75.69 97.66 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 93.3 t -105.36 145.33 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.157 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -107.21 101.58 10.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 736' ' ' LEU . . . . . 0.401 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 45.8 mt -49.64 158.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.912 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -89.32 -54.27 4.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 1.5 t -62.32 -67.94 0.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 81.8 p -61.72 -25.34 67.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.124 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 11.7 t 55.1 51.65 13.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.873 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -136.16 145.55 45.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.931 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 19.7 m -89.04 112.68 23.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 6.8 pt -121.48 155.67 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.157 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 90.9 p -97.39 124.2 41.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.433 HG12 ' HB2' ' A' ' 749' ' ' ARG . 50.1 t -134.52 149.9 30.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.17 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -54.98 126.58 25.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -45.06 -31.5 1.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.848 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -79.39 -42.38 25.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.891 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 749' ' ' ARG . . . . . 0.433 ' HB2' HG12 ' A' ' 745' ' ' VAL . 76.7 mtt180 -55.55 -13.8 1.75 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.93 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.534 HD23 HG12 ' A' ' 712' ' ' ILE . 17.8 mt -98.66 125.94 44.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 29.2 m -107.77 97.46 7.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.105 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 16.4 p -40.75 119.04 1.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.119 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 753' ' ' VAL . . . . . 0.423 ' CG2' HG22 ' A' ' 709' ' ' THR . 91.0 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.094 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.773 0.321 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -70.32 -47.24 62.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . 0.447 HD12 ' HB2' ' A' ' 708' ' ' GLN . 17.5 tp -70.49 -15.47 62.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.94 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 706' ' ' ILE . . . . . 0.52 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -63.34 104.47 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 179.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 122.86 -13.42 8.59 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.491 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 708' ' ' GLN . . . . . 0.447 ' HB2' HD12 ' A' ' 705' ' ' LEU . 49.6 mm-40 -75.99 161.65 28.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.89 0.376 . . . . 0.0 110.914 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 709' ' ' THR . . . . . 0.508 HG22 HG21 ' A' ' 753' ' ' VAL . 52.1 m -95.04 105.32 17.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 32.5 m -109.16 148.86 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -120.01 114.2 21.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . 0.567 HD11 HD11 ' A' ' 743' ' ' ILE . 27.6 mt -57.81 134.2 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 61.5 p -109.12 -32.15 7.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -110.49 177.84 4.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 77.34 174.79 41.76 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.495 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 716' ' ' PRO . . . . . 0.53 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.6 Cg_endo -69.74 0.39 5.7 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.74 2.293 . . . . 0.0 112.319 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.53 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 67.4 m-85 -115.74 31.87 6.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 19.3 tttp -65.87 135.16 54.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.907 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.19 34.16 30.44 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.481 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -123.11 144.72 49.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.874 0.369 . . . . 0.0 110.952 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 25.4 mm -99.24 146.51 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.116 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -164.75 157.94 30.53 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.512 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.417 ' C ' HG13 ' A' ' 734' ' ' VAL . 22.2 t -101.19 124.71 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.883 0.373 . . . . 0.0 111.154 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 724' ' ' VAL . . . . . 0.427 HG22 HG22 ' A' ' 734' ' ' VAL . 40.7 t -61.78 112.76 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.141 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.58 -36.78 15.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -146.26 144.29 29.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.835 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -112.85 117.43 32.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 728' ' ' THR . . . . . 0.548 HG22 ' H ' ' A' ' 729' ' ' GLU . 0.6 OUTLIER -98.54 171.21 8.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.153 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 729' ' ' GLU . . . . . 0.548 ' H ' HG22 ' A' ' 728' ' ' THR . 12.6 pt-20 -62.25 -47.92 82.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.436 ' N ' ' HG3' ' A' ' 729' ' ' GLU . 69.9 m -123.92 16.26 9.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.817 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.51 173.36 14.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.177 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 732' ' ' ALA . . . . . 0.657 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -154.86 117.46 4.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.105 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 733' ' ' ARG . . . . . 0.469 ' N ' ' HD3' ' A' ' 733' ' ' ARG . 0.9 OUTLIER -81.87 98.21 8.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.84 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 734' ' ' VAL . . . . . 0.427 HG22 HG22 ' A' ' 724' ' ' VAL . 69.6 t -103.14 142.79 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.168 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -97.5 102.38 14.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 40.7 mt -52.17 157.54 1.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -88.36 -36.4 16.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 61.2 m -73.98 -72.09 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 60.0 p -62.71 -17.45 60.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.184 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 3.3 m 53.0 39.36 29.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -133.58 151.72 51.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 742' ' ' THR . . . . . 0.457 ' CG2' ' HB3' ' A' ' 733' ' ' ARG . 53.7 m -80.99 143.1 32.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.11 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 743' ' ' ILE . . . . . 0.567 HD11 HD11 ' A' ' 712' ' ' ILE . 11.6 pt -143.71 141.82 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.183 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 58.3 p -85.17 117.35 24.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.833 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 39.2 t -134.79 141.19 43.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.132 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -51.4 128.14 21.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -46.51 -27.46 1.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -81.6 -45.35 15.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -53.32 -16.99 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.657 HD11 ' HB3' ' A' ' 732' ' ' ALA . 24.7 mt -89.21 135.96 33.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 89.8 m -118.06 93.59 4.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.091 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 3.4 p -41.44 135.33 2.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 753' ' ' VAL . . . . . 0.508 HG21 HG22 ' A' ' 709' ' ' THR . 97.2 t . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.104 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.799 0.333 . . . . 0.0 110.908 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -82.0 -58.44 2.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . 0.419 HD12 ' CG ' ' A' ' 708' ' ' GLN . 51.3 tp -65.09 -11.55 40.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.925 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 706' ' ' ILE . . . . . 0.534 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -65.05 106.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.099 179.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 124.75 -17.31 7.28 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 708' ' ' GLN . . . . . 0.419 ' CG ' HD12 ' A' ' 705' ' ' LEU . 36.6 mm-40 -77.6 154.64 32.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.36 . . . . 0.0 110.931 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 709' ' ' THR . . . . . 0.5 HG22 HG21 ' A' ' 753' ' ' VAL . 68.2 m -86.4 112.95 21.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.182 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . 0.538 ' HA ' HG23 ' A' ' 753' ' ' VAL . 29.4 m -114.87 148.13 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.15 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 711' ' ' ARG . . . . . 0.448 ' HB2' HD13 ' A' ' 721' ' ' ILE . 19.3 ttt180 -122.81 113.39 19.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . 0.504 HG12 HD23 ' A' ' 750' ' ' LEU . 31.0 mt -61.1 107.82 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 3.5 m -101.46 12.3 37.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -145.82 140.59 27.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 99.9 -168.58 21.44 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.497 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 716' ' ' PRO . . . . . 0.554 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.6 Cg_endo -69.77 -23.88 30.24 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.697 2.265 . . . . 0.0 112.354 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.554 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 55.3 m-85 -94.36 32.82 1.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.939 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -66.58 112.85 4.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.869 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 100.98 27.67 7.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.478 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 720' ' ' TYR . . . . . 0.468 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 10.9 m-85 -119.23 137.28 53.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 110.915 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.448 HD13 ' HB2' ' A' ' 711' ' ' ARG . 12.4 mm -96.07 153.23 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.154 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -172.27 157.79 27.79 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.468 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 48.9 t -98.84 124.87 52.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.866 0.365 . . . . 0.0 111.12 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 43.8 t -60.54 108.63 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.133 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.12 -41.16 17.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.951 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -141.35 146.87 37.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 727' ' ' ALA . . . . . 0.418 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -111.5 120.37 41.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.11 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.9 163.02 13.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.181 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.99 -46.74 87.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 69.8 m -124.33 19.68 8.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.883 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.29 173.31 17.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.168 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 732' ' ' ALA . . . . . 0.477 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -157.28 117.59 3.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.064 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 733' ' ' ARG . . . . . 0.455 ' N ' ' HD3' ' A' ' 733' ' ' ARG . 0.9 OUTLIER -80.48 98.72 7.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 61.2 t -102.81 142.27 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -98.15 102.61 14.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 736' ' ' LEU . . . . . 0.468 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 34.9 mt -52.47 157.08 1.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.9 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -91.27 -23.22 20.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 13.8 m -83.6 -70.48 0.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 70.3 p -73.32 -2.58 22.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.155 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.2 m 40.01 45.93 1.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -132.44 151.91 51.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 742' ' ' THR . . . . . 0.443 ' CG2' ' HB3' ' A' ' 733' ' ' ARG . 54.9 m -84.66 133.95 34.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.124 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 14.7 pt -136.43 140.46 43.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.137 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 54.7 p -83.0 118.16 23.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 48.9 t -135.79 143.9 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.132 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.54 128.61 32.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 747' ' ' ARG . . . . . 0.407 ' HG2' ' HB2' ' A' ' 732' ' ' ALA . 27.5 mtm180 -46.53 -37.76 8.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -71.17 -44.33 65.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -54.86 -16.14 2.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.504 HD23 HG12 ' A' ' 712' ' ' ILE . 12.3 mt -98.14 126.37 43.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.934 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 92.1 m -103.95 102.85 12.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 10.4 p -42.63 121.16 1.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.116 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 753' ' ' VAL . . . . . 0.538 HG23 ' HA ' ' A' ' 710' ' ' VAL . 10.8 t . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.166 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 13.5 p30 . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.768 0.318 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.69 -37.62 65.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . 0.454 ' HG ' HG21 ' A' ' 724' ' ' VAL . 48.0 tp -83.85 -14.84 50.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.935 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 706' ' ' ILE . . . . . 0.538 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -63.87 108.35 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.103 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 118.18 -14.84 12.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.438 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -73.16 162.23 29.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 0.0 110.891 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 709' ' ' THR . . . . . 0.511 HG22 HG21 ' A' ' 753' ' ' VAL . 95.5 m -96.66 109.78 22.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 34.5 m -114.01 156.08 15.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.144 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 -123.98 117.43 24.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 23.4 mt -60.49 143.72 14.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.11 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 43.7 t -115.18 -34.78 4.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -113.37 179.98 3.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 78.34 177.09 47.87 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.526 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 716' ' ' PRO . . . . . 0.405 ' HG2' ' CE2' ' A' ' 717' ' ' TYR . 53.4 Cg_endo -69.78 1.79 4.13 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.726 2.284 . . . . 0.0 112.304 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.538 ' CD1' HD11 ' A' ' 736' ' ' LEU . 84.4 m-85 -120.33 35.82 4.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -67.5 139.3 57.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.883 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 71.76 32.96 63.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.466 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -119.21 158.52 25.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.843 0.354 . . . . 0.0 110.941 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 22.3 mm -107.88 147.55 12.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -163.23 162.21 34.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.491 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 37.1 t -106.35 129.72 59.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 0.0 111.157 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 724' ' ' VAL . . . . . 0.454 HG21 ' HG ' ' A' ' 705' ' ' LEU . 41.1 t -66.48 108.27 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.104 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -85.24 -41.12 15.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.921 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -143.06 151.24 40.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -111.94 116.88 31.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.65 158.85 16.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -50.0 -64.59 0.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.888 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 731' ' ' THR . 48.8 m -109.53 24.06 13.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.856 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 731' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 730' ' ' SER . 0.7 OUTLIER -160.03 173.29 16.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.17 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 732' ' ' ALA . . . . . 0.587 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -152.61 121.42 6.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 11.3 mmt85 -74.43 102.3 4.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.837 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 56.0 t -108.93 139.27 32.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.106 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -106.65 106.01 16.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 736' ' ' LEU . . . . . 0.538 HD11 ' CD1' ' A' ' 717' ' ' TYR . 30.4 mt -53.57 157.5 2.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -87.66 -37.12 17.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 14.3 m -73.64 -66.32 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.808 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 20.0 p -68.06 -15.99 63.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.131 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.7 m 49.15 42.07 20.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 741' ' ' GLN . . . . . 0.405 HE22 ' CG2' ' A' ' 743' ' ' ILE . 2.5 pp0? -129.09 148.72 51.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 4.5 m -87.66 144.29 26.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.136 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 743' ' ' ILE . . . . . 0.405 ' CG2' HE22 ' A' ' 741' ' ' GLN . 7.8 pt -151.79 144.72 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.154 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 91.3 p -87.56 118.88 27.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 65.4 t -133.47 143.13 39.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.127 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.23 129.71 21.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 24.1 mtm105 -49.58 -36.24 23.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.87 -45.03 65.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -53.86 -24.54 16.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 732' ' ' ALA . 21.3 mt -84.03 144.65 28.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 6.3 m -124.42 99.24 6.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 9.1 p -47.83 118.99 2.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.113 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 753' ' ' VAL . . . . . 0.511 HG21 HG22 ' A' ' 709' ' ' THR . 95.8 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.104 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.79 0.328 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -74.55 -55.63 5.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . 0.409 HD12 ' CG ' ' A' ' 708' ' ' GLN . 48.1 tp -64.04 -12.24 36.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.904 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 706' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' A' ' 727' ' ' ALA . 0.6 OUTLIER -65.18 108.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 122.06 -13.08 9.11 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.519 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 708' ' ' GLN . . . . . 0.409 ' CG ' HD12 ' A' ' 705' ' ' LEU . 40.4 mm-40 -77.71 160.91 28.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 0.0 110.937 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 87.1 m -93.65 107.35 19.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.12 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . 0.422 HG12 ' HA ' ' A' ' 752' ' ' THR . 34.2 m -112.05 150.96 14.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.131 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 711' ' ' ARG . . . . . 0.421 ' HB2' HD13 ' A' ' 721' ' ' ILE . 23.1 ttm-85 -122.21 115.69 22.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.845 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 25.8 mt -62.41 142.1 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.1 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 29.1 t -122.21 -22.38 5.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.791 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -110.04 177.64 4.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 67.45 -179.54 15.72 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.463 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 716' ' ' PRO . . . . . 0.575 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.1 Cg_endo -69.82 -8.24 23.11 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.694 2.262 . . . . 0.0 112.299 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.575 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 38.4 m-85 -103.56 29.89 5.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.919 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -65.22 137.43 57.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 74.26 36.12 51.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.486 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 720' ' ' TYR . . . . . 0.466 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 6.3 m-85 -123.81 145.01 49.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.889 0.376 . . . . 0.0 110.89 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.421 HD13 ' HB2' ' A' ' 711' ' ' ARG . 21.7 mm -98.58 154.04 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.144 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 722' ' ' GLY . . . . . 0.421 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -173.79 161.02 31.35 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.478 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 54.3 t -105.16 125.1 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 111.145 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.41 108.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.119 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -84.79 -40.41 17.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.928 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -140.79 149.82 42.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.827 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 727' ' ' ALA . . . . . 0.617 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -113.5 118.66 35.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.081 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.73 164.37 11.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.149 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -57.16 -52.08 66.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 5.1 m -120.16 16.44 12.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.837 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.4 173.28 14.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.136 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 732' ' ' ALA . . . . . 0.658 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -151.93 121.02 6.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.11 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -80.53 98.4 7.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.866 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 90.0 t -103.32 140.72 20.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.123 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 735' ' ' GLU . . . . . 0.402 ' O ' ' CD ' ' A' ' 735' ' ' GLU . 6.5 tm-20 -99.34 99.43 10.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.849 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 736' ' ' LEU . . . . . 0.466 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 27.6 mt -49.71 157.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.948 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -90.34 -31.86 16.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.879 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 58.8 m -75.09 -65.12 0.92 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 71.8 p -74.09 -8.53 56.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.103 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 3.3 m 44.75 43.17 6.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -132.68 155.62 48.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 20.0 m -87.95 141.26 28.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.107 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 11.8 pt -146.53 145.06 20.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.157 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 89.5 p -87.66 118.1 26.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 92.9 t -132.71 142.86 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.147 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.55 128.57 17.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -49.62 -28.4 5.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.846 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -81.36 -42.55 20.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -55.25 -19.15 7.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.823 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.658 HD11 ' HB3' ' A' ' 732' ' ' ALA . 18.0 mt -88.85 134.86 33.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 751' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 752' ' ' THR . 86.4 m -116.07 89.7 3.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.147 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . 0.422 ' HA ' HG12 ' A' ' 710' ' ' VAL . 9.4 p -36.52 118.09 0.53 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.135 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 87.7 t . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.101 179.942 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.83 0.348 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -71.85 -60.83 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 18.9 tp -62.26 -16.45 53.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.943 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 706' ' ' ILE . . . . . 0.523 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -60.84 110.41 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.083 179.838 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.86 -19.93 10.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.483 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -66.85 166.66 12.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 110.951 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 709' ' ' THR . . . . . 0.402 HG22 ' CG2' ' A' ' 753' ' ' VAL . 71.8 m -99.92 109.19 21.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.151 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . 0.48 HG12 HG22 ' A' ' 752' ' ' THR . 35.7 m -113.12 151.5 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.161 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 711' ' ' ARG . . . . . 0.479 ' HB2' HD13 ' A' ' 721' ' ' ILE . 29.6 ttt180 -123.39 114.44 20.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . 0.409 HD12 HD21 ' A' ' 736' ' ' LEU . 34.7 mt -61.72 134.73 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 4.2 t -112.79 -31.66 6.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -102.01 176.37 5.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 71.7 177.95 28.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 716' ' ' PRO . . . . . 0.569 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.5 Cg_endo -69.78 -6.93 19.79 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.706 2.27 . . . . 0.0 112.307 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.569 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 44.5 m-85 -105.89 33.24 3.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -68.87 138.11 54.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.93 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 77.17 30.92 54.15 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.483 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -120.77 144.59 48.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.79 0.329 . . . . 0.0 110.948 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 711' ' ' ARG . 38.7 mm -97.4 150.38 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.09 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -166.48 161.81 35.49 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.461 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 63.8 t -107.55 126.74 63.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.845 0.355 . . . . 0.0 111.175 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 50.2 t -63.73 104.73 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -80.58 -41.66 23.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.894 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -143.34 146.6 33.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.89 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 727' ' ' ALA . . . . . 0.447 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -106.17 115.33 30.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.121 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.18 160.65 14.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.114 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -47.03 -70.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 3.2 m -106.09 16.9 24.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.87 173.32 13.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 732' ' ' ALA . . . . . 0.601 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -150.68 120.91 7.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 54.9 mmm-85 -76.65 98.43 4.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 71.5 t -104.78 144.76 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -105.3 101.6 11.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 736' ' ' LEU . . . . . 0.409 HD21 HD12 ' A' ' 712' ' ' ILE . 52.5 mt -50.55 161.18 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.904 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -95.5 -44.98 7.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 40.5 t -67.55 -64.7 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 82.1 p -70.75 -21.85 62.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 17.2 m 55.56 43.66 28.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.838 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -127.21 145.13 50.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.936 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 17.3 m -85.2 116.83 23.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.143 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 11.5 pt -124.37 149.62 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 82.2 p -94.23 118.19 31.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.818 ' HB ' HD21 ' A' ' 750' ' ' LEU . 62.0 t -127.85 144.92 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.15 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -50.72 125.93 14.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -44.61 -24.1 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -89.31 -42.86 11.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -53.85 -18.54 3.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.818 HD21 ' HB ' ' A' ' 745' ' ' VAL . 12.6 mt -91.25 134.41 34.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 19.6 m -112.39 90.76 3.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . 0.48 HG22 HG12 ' A' ' 710' ' ' VAL . 10.2 p -41.13 118.31 0.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.099 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 753' ' ' VAL . . . . . 0.402 ' CG2' HG22 ' A' ' 709' ' ' THR . 86.0 t . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.078 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.768 0.318 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -77.08 -55.55 5.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . 0.426 HD12 ' CG ' ' A' ' 708' ' ' GLN . 45.6 tp -62.03 -14.12 32.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.894 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 706' ' ' ILE . . . . . 0.532 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -64.81 107.19 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 121.65 -16.09 9.03 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.482 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 708' ' ' GLN . . . . . 0.426 ' CG ' HD12 ' A' ' 705' ' ' LEU . 51.6 mm-40 -74.58 155.54 37.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.878 0.371 . . . . 0.0 110.907 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 55.9 m -92.34 110.43 21.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.162 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 752' ' ' THR . 35.4 m -113.3 161.97 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 711' ' ' ARG . . . . . 0.497 ' HB2' HD13 ' A' ' 721' ' ' ILE . 23.6 ttt-85 -129.85 117.89 20.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . 0.429 HD11 HD11 ' A' ' 743' ' ' ILE . 26.5 mt -62.36 111.21 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.127 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 1.1 t -107.55 18.47 21.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -153.11 130.48 11.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.933 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 109.48 -171.79 15.48 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.467 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 716' ' ' PRO . . . . . 0.553 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 54.0 Cg_endo -69.73 -19.92 35.63 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.667 2.245 . . . . 0.0 112.384 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.553 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 70.3 m-85 -99.81 31.35 3.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 19.0 tttp -64.93 133.31 51.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.904 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 719' ' ' GLY . . . . . 0.44 ' HA2' ' CZ ' ' A' ' 711' ' ' ARG . . . 84.9 23.83 47.81 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.466 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -116.15 143.68 45.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.906 0.384 . . . . 0.0 110.911 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.59 HD12 HG21 ' A' ' 753' ' ' VAL . 44.9 mm -97.82 162.46 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.162 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 722' ' ' GLY . . . . . 0.588 ' N ' HG22 ' A' ' 721' ' ' ILE . . . 178.2 153.07 10.83 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.501 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 42.7 t -97.57 129.75 47.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 111.124 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 48.1 t -64.89 108.84 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -85.42 -40.28 16.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -141.86 146.01 35.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.844 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 727' ' ' ALA . . . . . 0.445 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -106.6 119.0 38.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.073 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.86 156.61 18.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.148 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -42.31 -74.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 58.6 m -103.53 19.68 19.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.16 173.34 14.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.122 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 732' ' ' ALA . . . . . 0.687 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -152.2 122.5 7.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.072 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 6.1 mmt85 -77.84 98.66 5.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.49 142.38 18.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.131 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -104.24 105.38 15.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 66.7 mt -49.76 157.66 0.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -88.74 -57.99 2.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.808 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 8.9 t -59.0 -70.8 0.14 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.849 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 69.6 p -58.39 -34.46 70.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.125 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 3.9 t 66.57 47.36 1.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -130.73 147.89 52.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 22.9 m -89.65 129.11 36.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.126 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 743' ' ' ILE . . . . . 0.429 HD11 HD11 ' A' ' 712' ' ' ILE . 9.2 pt -137.32 150.75 26.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.161 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 78.6 p -95.25 121.65 37.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.587 HG12 ' HB2' ' A' ' 749' ' ' ARG . 19.0 t -134.54 143.87 36.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.119 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -49.51 126.18 12.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.921 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 -43.96 -29.55 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -81.12 -43.08 19.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 749' ' ' ARG . . . . . 0.587 ' HB2' HG12 ' A' ' 745' ' ' VAL . 76.5 mtt180 -53.4 -16.4 1.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.687 HD11 ' HB3' ' A' ' 732' ' ' ALA . 14.6 mt -92.17 145.38 24.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 90.5 m -125.86 95.68 4.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . 0.454 ' HA ' HG12 ' A' ' 710' ' ' VAL . 3.3 p -38.39 118.46 0.72 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 753' ' ' VAL . . . . . 0.59 HG21 HD12 ' A' ' 721' ' ' ILE . 93.6 t . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.105 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 2.4 m120 . . . . . 0 C--O 1.23 0.05 0 CA-C-O 120.831 0.348 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -76.61 -62.49 1.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . 0.482 HD12 ' CG ' ' A' ' 708' ' ' GLN . 33.9 tp -60.59 -10.91 5.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 706' ' ' ILE . . . . . 0.517 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -63.41 110.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 118.3 -21.28 10.1 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 708' ' ' GLN . . . . . 0.482 ' CG ' HD12 ' A' ' 705' ' ' LEU . 38.5 mm-40 -70.6 158.65 35.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.908 0.385 . . . . 0.0 110.945 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 709' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 753' ' ' VAL . 87.6 m -91.28 109.47 20.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.127 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . 0.535 HG21 HG21 ' A' ' 734' ' ' VAL . 26.9 m -112.51 146.6 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 711' ' ' ARG . . . . . 0.549 ' HB2' HD13 ' A' ' 721' ' ' ILE . 52.5 ttt180 -121.53 113.63 20.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 20.8 mt -56.86 143.67 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.161 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 17.0 t -118.25 -28.02 5.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -116.39 177.14 4.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.94 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 76.64 179.01 47.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.448 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 716' ' ' PRO . . . . . 0.493 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.3 Cg_endo -69.78 -1.94 9.34 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.679 2.252 . . . . 0.0 112.317 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.493 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 75.5 m-85 -115.02 31.66 6.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.975 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -65.95 131.41 46.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.904 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.79 29.06 44.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.447 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 720' ' ' TYR . . . . . 0.42 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 8.0 m-85 -116.16 142.58 46.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.832 0.349 . . . . 0.0 110.951 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . 0.549 HD13 ' HB2' ' A' ' 711' ' ' ARG . 30.9 mm -98.52 152.53 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.156 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 722' ' ' GLY . . . . . 0.41 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -169.93 164.14 37.55 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.52 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . 0.474 ' C ' HG13 ' A' ' 734' ' ' VAL . 55.1 t -106.34 123.17 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.84 0.352 . . . . 0.0 111.137 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 724' ' ' VAL . . . . . 0.824 ' HA ' HG22 ' A' ' 734' ' ' VAL . 45.8 t -63.49 112.18 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -91.05 -37.06 13.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -142.69 144.21 32.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 727' ' ' ALA . . . . . 0.429 ' N ' HD11 ' A' ' 706' ' ' ILE . . . -113.49 113.77 25.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.142 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 728' ' ' THR . . . . . 0.545 HG22 ' H ' ' A' ' 729' ' ' GLU . 1.2 m -96.21 170.29 9.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.168 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 729' ' ' GLU . . . . . 0.545 ' H ' HG22 ' A' ' 728' ' ' THR . 14.4 pt-20 -63.15 -49.08 75.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.458 ' N ' ' HG3' ' A' ' 729' ' ' GLU . 60.4 m -120.68 14.2 11.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.89 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.6 173.27 14.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.127 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 732' ' ' ALA . . . . . 0.562 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -155.32 117.54 4.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.086 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 733' ' ' ARG . . . . . 0.454 ' HB3' ' CG2' ' A' ' 742' ' ' THR . 0.9 OUTLIER -81.36 102.99 10.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 734' ' ' VAL . . . . . 0.824 HG22 ' HA ' ' A' ' 724' ' ' VAL . 53.4 t -111.7 137.55 43.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -90.11 101.61 14.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 736' ' ' LEU . . . . . 0.42 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 23.5 mt -50.89 156.37 1.0 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.896 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -85.12 -40.35 16.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 54.7 m -70.44 -70.55 0.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 43.5 p -61.74 -24.61 66.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.0 m 59.33 38.43 23.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -134.9 155.36 50.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.928 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 742' ' ' THR . . . . . 0.454 ' CG2' ' HB3' ' A' ' 733' ' ' ARG . 54.9 m -81.7 138.95 35.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.138 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 8.4 pt -141.18 143.25 28.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 84.2 p -85.13 112.33 20.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . 0.546 ' HB ' HD21 ' A' ' 750' ' ' LEU . 47.9 t -127.29 147.22 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.097 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -58.04 127.64 33.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.905 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -48.16 -25.68 1.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -84.72 -43.54 14.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -58.5 -11.63 3.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.562 HD11 ' HB3' ' A' ' 732' ' ' ALA . 18.5 mt -96.1 127.4 42.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 20.4 m -104.47 103.58 13.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.117 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 2.3 p -47.88 121.3 4.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 753' ' ' VAL . . . . . 0.528 HG23 ' HA ' ' A' ' 710' ' ' VAL . 6.3 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 2.2 m120 . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.758 0.313 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -82.2 -49.19 10.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.915 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 37.7 tp -65.2 -10.44 31.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 706' ' ' ILE . . . . . 0.608 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.5 OUTLIER -70.04 108.69 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 179.86 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 120.4 -15.76 9.91 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.449 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -74.62 158.63 33.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.39 . . . . 0.0 110.918 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 709' ' ' THR . . . . . 0.473 HG22 HG21 ' A' ' 753' ' ' VAL . 98.6 m -94.76 107.33 19.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 31.6 m -111.02 160.68 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 711' ' ' ARG . . . . . 0.405 ' HB2' HG22 ' A' ' 753' ' ' VAL . 26.9 ttt180 -130.43 108.74 10.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.84 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 712' ' ' ILE . . . . . 0.466 HG12 HD23 ' A' ' 750' ' ' LEU . 72.0 mt -55.78 102.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.144 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 5.3 m -97.61 23.23 7.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 714' ' ' GLN . . . . . 0.402 ' CB ' ' HG2' ' A' ' 749' ' ' ARG . 12.2 mp0 -149.59 -179.23 6.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 59.82 -167.56 8.7 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.478 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 716' ' ' PRO . . . . . 0.576 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.2 Cg_endo -69.79 -33.38 16.59 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.679 2.252 . . . . 0.0 112.328 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 717' ' ' TYR . . . . . 0.576 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 50.1 m-85 -85.11 44.9 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -73.42 131.21 41.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.854 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.66 37.42 20.03 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.469 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -124.35 139.6 53.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.866 0.365 . . . . 0.0 110.901 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 39.1 mm -95.95 145.41 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.158 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -165.02 160.1 33.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 41.6 t -104.61 128.34 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 111.111 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.51 111.03 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.087 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.37 -34.54 15.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -146.44 146.98 30.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 727' ' ' ALA . . . . . 0.431 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -108.12 115.55 30.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.11 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.64 159.06 15.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.173 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -47.68 -67.24 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.482 ' O ' HG23 ' A' ' 731' ' ' THR . 75.3 m -109.5 25.55 11.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.84 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 731' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -160.04 173.22 16.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.155 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 732' ' ' ALA . . . . . 0.518 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -150.8 120.02 6.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.102 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -73.79 96.52 2.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 95.9 t -103.61 140.19 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.135 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -100.69 100.82 11.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 51.5 mt -50.6 160.68 0.4 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -96.81 -37.51 10.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 35.4 t -70.51 -59.13 3.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 68.5 p -78.38 -23.27 46.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.149 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 5.0 m 60.42 40.42 17.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -125.34 150.17 47.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 26.9 m -91.03 111.61 23.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 6.9 pt -119.64 150.2 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.085 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 82.9 p -90.84 124.1 34.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 74.5 t -136.66 143.04 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.092 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -49.03 129.84 17.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 12.1 mtm105 -50.07 -29.44 8.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -79.32 -44.76 20.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 749' ' ' ARG . . . . . 0.402 ' HG2' ' CB ' ' A' ' 714' ' ' GLN . 37.5 mtm180 -54.87 -15.57 2.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 750' ' ' LEU . . . . . 0.518 HD11 ' HB3' ' A' ' 732' ' ' ALA . 23.8 mt -92.93 128.64 38.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 85.7 m -112.06 103.09 11.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 16.7 p -43.94 116.66 1.03 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 753' ' ' VAL . . . . . 0.473 HG21 HG22 ' A' ' 709' ' ' THR . 96.6 t . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.332 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 32.2 t -87.51 83.39 7.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.873 0.368 . . . . 0.0 110.823 -179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 1.5 t -120.1 149.97 41.35 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.872 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -154.7 174.55 33.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.464 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 1.3 t -81.8 125.04 30.19 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.882 0.372 . . . . 0.0 110.894 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 23.0 t -40.33 -48.13 2.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . -101.83 140.4 14.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.48 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 4.1 mpp? -104.21 41.27 1.33 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.814 0.34 . . . . 0.0 110.885 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 82.5 p -118.16 125.26 49.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.866 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -103.04 -55.75 2.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.857 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -130.55 148.1 18.55 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.512 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 8.5 mtt85 -72.97 -62.08 1.59 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.804 0.335 . . . . 0.0 110.875 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -96.93 -127.93 5.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.506 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -107.52 103.4 12.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.83 0.348 . . . . 0.0 110.869 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 38.0 mtp85 -55.58 144.33 26.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.849 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -10.85 58.32 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.855 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -96.94 21.07 10.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.897 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -72.87 -52.97 12.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.922 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 38.9 tp -65.45 -12.73 55.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.941 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 706' ' ' ILE . . . . . 0.527 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -65.78 108.22 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.195 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 122.95 -17.67 8.08 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.493 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -77.81 155.27 31.19 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.875 0.369 . . . . 0.0 110.868 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 709' ' ' THR . . . . . 0.436 HG22 HG21 ' A' ' 753' ' ' VAL . 64.6 m -85.6 112.33 20.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . 0.449 HG21 HG21 ' A' ' 734' ' ' VAL . 33.7 m -112.84 145.7 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.135 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 22.0 ttp85 -119.71 112.23 19.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.912 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 20.9 mt -57.81 138.13 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.148 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 12.4 t -114.43 -28.39 7.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.833 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -113.99 177.13 4.75 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 75.42 179.56 44.59 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.456 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 716' ' ' PRO . . . . . 0.513 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.4 Cg_endo -69.86 -4.7 14.63 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.682 2.255 . . . . 0.0 112.315 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.513 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 56.1 m-85 -109.47 29.74 7.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.923 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -64.84 124.41 21.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.922 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 89.14 19.59 49.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.501 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 720' ' ' TYR . . . . . 0.463 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 18.4 m-85 -108.47 143.07 37.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.861 0.362 . . . . 0.0 110.921 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.426 HG22 ' N ' ' A' ' 722' ' ' GLY . 27.9 mm -98.13 153.85 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.129 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 722' ' ' GLY . . . . . 0.426 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -173.43 158.54 28.0 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.508 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 40.8 t -101.67 125.26 55.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.916 0.388 . . . . 0.0 111.136 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 27.0 t -61.47 111.12 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -90.46 -37.18 14.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.938 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -142.12 148.8 38.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.826 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 727' ' ' ALA . . . . . 0.444 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -114.71 118.62 34.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.161 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 728' ' ' THR . . . . . 0.452 HG22 ' H ' ' A' ' 729' ' ' GLU . 0.7 OUTLIER -102.84 167.9 9.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.145 -179.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 729' ' ' GLU . . . . . 0.452 ' H ' HG22 ' A' ' 728' ' ' THR . 13.6 pt-20 -65.35 -42.7 92.56 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 731' ' ' THR . 73.6 m -125.25 19.36 8.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.853 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 731' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -160.05 173.19 16.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.182 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 732' ' ' ALA . . . . . 0.605 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -150.86 118.2 6.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.088 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 733' ' ' ARG . . . . . 0.438 ' HD3' ' CB ' ' A' ' 744' ' ' SER . 25.2 mmt180 -75.98 101.53 5.26 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.858 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 734' ' ' VAL . . . . . 0.449 HG21 HG21 ' A' ' 710' ' ' VAL . 82.2 t -108.21 141.62 23.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.156 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -102.95 104.2 14.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.86 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 736' ' ' LEU . . . . . 0.463 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 47.8 mt -51.79 159.3 0.84 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -91.1 -43.77 9.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.838 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 57.0 m -73.05 -69.15 0.43 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.875 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 43.0 p -65.7 -7.47 15.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.151 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 29.6 p 40.28 47.28 2.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 20.2 mt-30 -125.01 148.85 48.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 23.2 m -94.32 104.94 16.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.153 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 6.9 pt -115.12 146.9 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.137 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . 0.438 ' CB ' ' HD3' ' A' ' 733' ' ' ARG . 2.5 t -94.87 132.13 40.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.849 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 40.2 t -142.73 147.35 20.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.1 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . 0.462 ' HB3' ' CG ' ' A' ' 749' ' ' ARG . 10.7 t0 -46.78 127.73 10.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.868 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 747' ' ' ARG . . . . . 0.453 ' HG2' ' HB2' ' A' ' 732' ' ' ALA . 26.9 mtm180 -48.86 -37.01 18.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -74.72 -44.13 51.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.944 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 749' ' ' ARG . . . . . 0.462 ' CG ' ' HB3' ' A' ' 746' ' ' ASP . 84.0 mtt180 -55.11 -14.45 1.61 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.605 HD11 ' HB3' ' A' ' 732' ' ' ALA . 28.3 mt -92.84 129.21 38.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.879 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 22.2 m -101.6 95.66 6.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 2.8 p -43.46 118.82 1.45 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.162 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 753' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 754' ' ' GLY . 11.2 t -81.22 165.03 2.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.178 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . 0.543 ' N ' HG12 ' A' ' 753' ' ' VAL . . . -179.63 101.89 0.16 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.486 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . 0.417 ' C ' ' O ' ' A' ' 754' ' ' GLY . 59.5 p -35.46 131.74 0.46 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.902 0.382 . . . . 0.0 110.842 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -133.35 -177.31 4.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.852 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.869 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 48.3 t -102.45 143.0 32.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.856 0.36 . . . . 0.0 110.831 -179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 4.3 t -165.69 111.06 0.87 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.852 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -128.93 163.36 22.32 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.478 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 96.1 p -87.65 113.47 23.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.874 0.369 . . . . 0.0 110.835 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 45.9 p -110.25 -50.43 2.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.852 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 138.07 -172.62 22.82 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.479 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 19.0 mtt -136.1 149.22 48.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.794 0.33 . . . . 0.0 110.878 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 2.3 m -129.52 166.81 18.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.872 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 20.3 mtt180 -74.95 168.9 19.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.873 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -96.17 107.47 3.52 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.463 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 698' ' ' ARG . . . . . 0.427 ' HD2' ' N ' ' A' ' 699' ' ' GLY . 6.1 ppt_? -100.03 -33.24 10.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.821 0.344 . . . . 0.0 110.87 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . 0.427 ' N ' ' HD2' ' A' ' 698' ' ' ARG . . . -72.5 -177.54 31.12 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.496 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.93 130.29 42.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.343 . . . . 0.0 110.872 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -48.74 106.73 0.11 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.872 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -76.93 98.97 5.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.847 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -117.44 27.97 8.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.56 -61.46 1.78 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.868 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . 0.466 HD12 ' HB2' ' A' ' 708' ' ' GLN . 21.4 tp -61.6 -15.59 40.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.967 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 706' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 727' ' ' ALA . 0.6 OUTLIER -63.67 105.41 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.189 179.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 119.64 -12.09 11.05 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.493 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 708' ' ' GLN . . . . . 0.466 ' HB2' HD12 ' A' ' 705' ' ' LEU . 50.4 mm-40 -75.68 160.89 29.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.927 0.394 . . . . 0.0 110.881 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 87.2 m -94.67 106.5 18.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.123 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 29.4 m -111.03 155.44 12.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.13 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -125.19 113.57 17.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . 0.533 HG12 HD23 ' A' ' 750' ' ' LEU . 64.3 mt -63.24 104.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.085 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 3.2 m -104.07 28.25 6.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.877 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -161.14 142.07 11.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.897 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 97.04 -166.08 23.26 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.525 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 716' ' ' PRO . . . . . 0.569 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.6 Cg_endo -69.75 -27.94 25.93 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.679 2.253 . . . . 0.0 112.342 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.569 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 53.7 m-85 -96.88 44.38 1.06 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.964 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 62.1 tttt -71.97 136.0 46.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.897 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 73.6 40.07 47.62 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.474 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 720' ' ' TYR . . . . . 0.467 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 17.7 m-85 -127.09 140.57 52.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.828 0.346 . . . . 0.0 110.966 -179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.422 HG22 ' N ' ' A' ' 722' ' ' GLY . 36.2 mm -96.53 153.62 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.145 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 722' ' ' GLY . . . . . 0.422 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -170.24 164.21 37.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.437 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 53.2 t -108.68 123.05 64.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 111.08 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 724' ' ' VAL . . . . . 0.707 HG22 HG22 ' A' ' 734' ' ' VAL . 46.7 t -65.17 111.68 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.131 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -93.09 -30.01 15.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.926 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -143.84 144.41 31.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.841 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 727' ' ' ALA . . . . . 0.608 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -108.61 114.89 29.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.07 157.24 17.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.099 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 729' ' ' GLU . . . . . 0.47 ' O ' ' NE ' ' A' ' 747' ' ' ARG . 27.6 tt0 -44.23 -73.8 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 43.5 m -103.35 20.78 17.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -153.74 173.26 16.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.119 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 732' ' ' ALA . . . . . 0.459 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -152.72 122.81 7.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.083 179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 34.8 mmm-85 -75.0 96.62 3.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.888 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 734' ' ' VAL . . . . . 0.707 HG22 HG22 ' A' ' 724' ' ' VAL . 73.7 t -100.76 145.7 10.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.145 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -106.95 101.86 11.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.929 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 736' ' ' LEU . . . . . 0.467 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 53.5 mt -49.71 158.4 0.47 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.925 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 14.4 m170 -87.69 -48.62 7.73 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.859 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 68.5 m -61.67 -74.77 0.08 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 81.5 p -58.59 -28.9 66.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.135 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.8 m 61.81 49.3 4.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.86 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -137.57 152.07 49.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.892 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 18.9 m -84.98 137.69 32.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.139 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 13.1 pt -143.39 142.93 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.155 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 94.6 p -86.68 112.16 21.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.834 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.512 ' HB ' HD21 ' A' ' 750' ' ' LEU . 72.6 t -127.07 148.06 31.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.16 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -54.94 131.98 45.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.869 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 747' ' ' ARG . . . . . 0.47 ' NE ' ' O ' ' A' ' 729' ' ' GLU . 48.8 mtm180 -52.73 -28.82 23.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.875 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -77.55 -44.65 27.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.94 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 85.5 mtt180 -58.29 -14.41 7.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.533 HD23 HG12 ' A' ' 712' ' ' ILE . 14.4 mt -99.07 128.25 45.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.907 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 29.0 m -113.51 102.94 10.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.085 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 18.4 p -45.17 119.42 2.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.151 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 85.0 t -63.47 -43.18 98.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.16 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -78.0 123.11 6.22 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.487 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 5.2 m -134.52 174.9 10.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.876 0.37 . . . . 0.0 110.852 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -117.94 162.57 17.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.913 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 5.9 ptp85 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.871 -179.898 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 31.7 p -143.41 154.32 43.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.9 0.381 . . . . 0.0 110.846 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 62.6 m -123.3 149.49 44.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 -179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 107.43 72.96 0.81 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.506 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 12.1 t -94.93 112.68 24.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.373 . . . . 0.0 110.855 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 39.3 t -44.42 119.99 2.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.899 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 179.35 87.4 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.488 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 3.5 ptt? -83.26 -37.91 22.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.764 0.316 . . . . 0.0 110.865 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 2.5 t -139.5 117.86 12.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.856 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 6.7 ptp85 -111.26 140.89 45.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -138.4 125.6 3.23 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.5 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 5.2 tpt85 -120.97 152.48 38.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.829 0.347 . . . . 0.0 110.892 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -66.4 -124.04 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.496 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 48.3 mtt180 -106.83 43.09 1.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.789 0.328 . . . . 0.0 110.84 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -74.79 83.5 2.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -115.9 103.29 10.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.884 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -132.48 40.95 3.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.91 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -78.88 -66.31 0.88 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . 0.514 HD12 ' HB2' ' A' ' 708' ' ' GLN . 27.2 tp -59.62 -14.1 12.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.914 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 706' ' ' ILE . . . . . 0.548 HD11 ' HB2' ' A' ' 727' ' ' ALA . 0.6 OUTLIER -62.83 104.25 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.128 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 125.21 -16.03 7.22 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.472 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 708' ' ' GLN . . . . . 0.514 ' HB2' HD12 ' A' ' 705' ' ' LEU . 48.7 mm-40 -77.32 158.78 29.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.0 110.875 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 709' ' ' THR . . . . . 0.53 ' O ' HG23 ' A' ' 753' ' ' VAL . 62.3 m -90.71 110.23 21.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.152 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . 0.544 ' HA ' HG23 ' A' ' 753' ' ' VAL . 29.4 m -112.54 144.98 19.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.097 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 711' ' ' ARG . . . . . 0.474 ' CZ ' ' HA2' ' A' ' 719' ' ' GLY . 29.1 ttt85 -116.99 110.89 18.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.837 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . 0.421 HG12 HD23 ' A' ' 750' ' ' LEU . 51.2 mt -59.62 114.3 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.113 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 42.4 p -108.4 18.05 21.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.884 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 8.5 mm-40 -147.98 137.44 22.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 99.99 -173.67 25.74 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.525 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 716' ' ' PRO . . . . . 0.57 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.4 Cg_endo -69.7 -16.75 37.96 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.764 2.309 . . . . 0.0 112.315 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.57 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 35.2 m-85 -98.2 23.22 8.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -58.36 135.61 57.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.855 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 719' ' ' GLY . . . . . 0.474 ' HA2' ' CZ ' ' A' ' 711' ' ' ARG . . . 79.15 28.62 53.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.475 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -116.6 142.68 46.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.905 0.384 . . . . 0.0 110.917 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.424 HD13 ' HB2' ' A' ' 711' ' ' ARG . 12.5 mm -101.94 148.96 6.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.132 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -167.26 160.67 34.4 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.487 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 54.8 t -101.56 123.19 54.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.899 0.38 . . . . 0.0 111.156 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 59.2 t -60.43 105.56 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.187 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -83.56 -37.4 23.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -143.11 148.96 37.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.868 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 727' ' ' ALA . . . . . 0.548 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -115.4 116.43 28.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.151 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 728' ' ' THR . . . . . 0.453 HG22 ' H ' ' A' ' 729' ' ' GLU . 0.4 OUTLIER -100.68 168.2 9.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.111 -179.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 729' ' ' GLU . . . . . 0.453 ' H ' HG22 ' A' ' 728' ' ' THR . 18.8 pt-20 -64.54 -45.72 85.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.483 ' O ' HG23 ' A' ' 731' ' ' THR . 72.6 m -122.97 19.4 10.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 731' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -159.87 173.32 16.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.119 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 732' ' ' ALA . . . . . 0.559 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -151.64 121.2 6.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.138 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -79.73 97.16 6.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.883 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 66.5 t -101.3 147.81 7.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -107.25 100.6 10.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.931 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 67.0 mt -50.76 159.43 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.907 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 21.4 m170 -95.6 -31.19 13.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 3.6 t -76.1 -62.43 1.61 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.876 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 81.0 p -75.89 -16.62 60.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.165 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 6.0 m 54.5 42.05 31.58 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.879 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 58.9 mm-40 -128.55 156.76 42.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.931 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 26.5 m -95.81 120.43 36.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.156 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 8.1 pt -125.84 145.52 33.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 96.3 p -86.53 121.76 29.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.869 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.499 ' HB ' HD21 ' A' ' 750' ' ' LEU . 60.5 t -134.36 147.52 30.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.128 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.57 129.11 37.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.878 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 -48.95 -32.05 8.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -77.68 -41.04 39.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.898 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -60.77 -9.54 4.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.559 HD11 ' HB3' ' A' ' 732' ' ' ALA . 13.4 mt -101.56 122.18 43.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.903 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 97.5 m -98.8 101.33 12.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.142 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 3.1 p -44.68 118.24 1.53 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.157 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 753' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 754' ' ' GLY . 4.1 t -80.54 168.6 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.135 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . 0.567 ' H ' HG12 ' A' ' 753' ' ' VAL . . . -74.96 145.46 33.69 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.523 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 49.7 m -105.78 143.95 33.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.858 0.361 . . . . 0.0 110.844 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 19.9 tpp85 -88.7 121.0 30.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.886 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 3.2 ttt85 . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.833 -179.865 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 78.9 p -143.71 132.59 22.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.876 0.369 . . . . 0.0 110.897 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 4.8 m -104.21 124.42 49.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 -179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -46.49 158.4 0.39 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.53 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 29.9 p -144.54 123.72 12.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.853 0.359 . . . . 0.0 110.905 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 65.8 m -120.29 158.48 26.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.839 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 151.25 -111.56 0.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.468 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 24.5 mtm -41.49 132.06 2.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.808 0.337 . . . . 0.0 110.833 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 30.8 t -132.0 127.91 37.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.869 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 3.0 tpt85 -40.69 -60.92 1.03 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.907 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -48.89 124.97 13.5 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.472 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 10.6 mmt85 -38.87 137.53 0.64 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.837 0.351 . . . . 0.0 110.877 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -116.78 112.81 2.62 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.465 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 22.1 ptt180 -43.47 148.79 0.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.771 0.32 . . . . 0.0 110.891 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -95.05 142.29 27.69 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.885 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -123.78 77.98 1.57 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.825 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -107.42 32.59 4.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.917 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 28.9 tp10 -73.7 -54.1 8.86 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.887 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . 0.401 HD12 ' CG ' ' A' ' 708' ' ' GLN . 48.6 tp -66.12 -14.44 61.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 706' ' ' ILE . . . . . 0.523 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -64.11 107.2 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.105 179.866 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 120.91 -14.72 9.64 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.505 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 708' ' ' GLN . . . . . 0.401 ' CG ' HD12 ' A' ' 705' ' ' LEU . 65.0 mm-40 -73.72 158.78 34.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.841 0.353 . . . . 0.0 110.939 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 82.1 m -95.28 107.65 19.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.153 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 24.4 m -112.0 157.1 12.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.136 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 15.7 ttp180 -125.12 110.66 14.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.871 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . 0.525 HG12 HD23 ' A' ' 750' ' ' LEU . 34.9 mt -60.45 108.32 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.173 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 3.4 m -109.33 31.53 5.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.898 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 714' ' ' GLN . . . . . 0.441 ' CB ' ' HG2' ' A' ' 749' ' ' ARG . 33.9 mt-30 -160.03 131.04 5.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 102.64 -163.86 16.4 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.482 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 716' ' ' PRO . . . . . 0.547 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 54.3 Cg_endo -69.71 -34.89 13.85 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.707 2.271 . . . . 0.0 112.339 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.547 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 48.3 m-85 -88.31 38.64 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.949 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -71.4 132.86 45.42 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.915 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.36 33.57 31.49 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.481 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 720' ' ' TYR . . . . . 0.484 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 13.2 m-85 -122.41 141.06 52.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.936 -179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 14.1 mm -98.03 148.88 5.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.133 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -167.28 161.58 35.4 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.556 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.446 HG23 ' NE2' ' A' ' 737' ' ' HIS . 46.6 t -104.74 127.55 59.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.83 0.347 . . . . 0.0 111.139 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 724' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 707' ' ' GLY . 60.7 t -64.01 109.66 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.161 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -89.84 -35.81 15.44 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.857 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -143.25 149.2 37.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 727' ' ' ALA . . . . . 0.509 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -110.18 115.78 30.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.131 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 1.1 m -103.53 154.97 18.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.162 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -41.07 -75.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.848 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.414 ' O ' HG23 ' A' ' 731' ' ' THR . 61.8 m -104.31 25.37 10.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 731' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -157.85 173.17 17.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.152 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 732' ' ' ALA . . . . . 0.502 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -151.87 122.11 7.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.076 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 53.6 mmm-85 -76.56 99.19 4.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.89 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 87.6 t -105.16 142.89 17.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.107 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 43.6 tt0 -103.22 105.62 15.95 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 736' ' ' LEU . . . . . 0.484 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 39.4 mt -50.22 160.14 0.39 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 737' ' ' HIS . . . . . 0.446 ' NE2' HG23 ' A' ' 723' ' ' VAL . 9.8 m170 -95.15 -24.07 17.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 13.4 m -83.98 -71.24 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 31.3 p -67.94 -16.88 64.26 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.153 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 8.8 m 55.71 41.9 29.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.836 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 42.9 mm-40 -125.9 148.82 49.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.93 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 29.1 m -89.29 129.22 35.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.156 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 7.0 pt -135.4 145.77 31.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.122 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 88.6 p -87.57 117.49 26.41 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 81.2 t -131.05 143.06 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.089 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -48.94 132.82 18.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 46.0 mtm180 -52.31 -32.97 40.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -75.84 -42.44 49.56 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.942 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 749' ' ' ARG . . . . . 0.441 ' HG2' ' CB ' ' A' ' 714' ' ' GLN . 90.6 mtt180 -58.06 -11.86 2.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.879 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.525 HD23 HG12 ' A' ' 712' ' ' ILE . 14.4 mt -101.07 127.2 47.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.94 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 60.6 m -112.16 103.51 11.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.132 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 14.5 p -42.63 116.78 0.91 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.148 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 87.4 t -62.23 -50.15 81.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.148 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 101.0 -157.98 19.1 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.491 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 34.1 m -97.94 148.91 22.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.842 0.353 . . . . 0.0 110.844 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 12.8 tpp85 -74.51 121.26 21.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.863 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.888 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.539 -0.225 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 92.3 p -113.9 109.88 19.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.909 0.385 . . . . 0.0 110.887 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 94.1 p -172.7 166.12 5.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.8 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -155.6 95.91 0.15 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.51 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 3.0 m -152.71 151.94 31.12 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.913 0.387 . . . . 0.0 110.865 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 99.3 p -113.22 86.07 2.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.875 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 84.89 119.83 0.9 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.521 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 1.8 ppp? -79.55 -39.93 30.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.812 0.339 . . . . 0.0 110.909 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 79.4 p -88.41 111.7 22.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.805 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 11.7 mtm-85 -94.66 108.04 20.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.883 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -41.8 135.84 3.15 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.457 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 21.4 ptt180 -111.61 81.08 1.39 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.795 0.331 . . . . 0.0 110.893 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 700' ' ' ARG . . . -100.87 -142.89 13.31 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.522 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 700' ' ' ARG . . . . . 0.434 ' C ' ' O ' ' A' ' 699' ' ' GLY . 0.0 OUTLIER -34.98 149.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.825 0.345 . . . . 0.0 110.838 -179.858 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 52.6 mmm-85 -126.57 100.05 6.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.848 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -97.32 79.86 2.84 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.875 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 20.9 p30 -88.45 34.51 0.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 27.8 tp10 -85.38 -55.99 3.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . 0.437 ' HG ' HG21 ' A' ' 724' ' ' VAL . 48.9 tp -60.87 -13.64 16.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.929 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 706' ' ' ILE . . . . . 0.587 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -66.31 109.83 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.141 179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.18 -12.66 12.71 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.489 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -76.94 164.05 26.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.923 0.392 . . . . 0.0 110.877 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 53.4 m -99.23 110.04 22.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.159 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 21.1 m -113.34 152.87 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.109 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 16.3 ttt85 -123.5 114.01 19.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.827 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 714' ' ' GLN . 20.1 mt -56.64 133.04 21.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.166 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 12.8 t -107.97 -29.4 9.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 714' ' ' GLN . . . . . 0.415 ' O ' ' CG2' ' A' ' 712' ' ' ILE . 26.7 mm-40 -112.85 -179.64 3.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.9 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 76.42 -179.03 49.15 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.541 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 716' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.76 -10.95 29.83 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.641 2.227 . . . . 0.0 112.383 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -107.67 35.03 3.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.949 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 18.5 ttpp -65.95 107.16 1.77 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.856 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 107.19 30.42 4.17 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.463 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -117.92 147.87 42.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 0.0 110.899 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 30.5 mm -98.8 147.12 7.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.171 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -165.17 161.49 34.86 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.501 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 48.9 t -106.06 129.47 59.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.903 0.382 . . . . 0.0 111.125 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 724' ' ' VAL . . . . . 0.437 HG21 ' HG ' ' A' ' 705' ' ' LEU . 39.3 t -64.68 109.19 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.101 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.4 mmpt? -86.19 -38.49 17.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -143.86 149.77 37.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.894 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -113.06 118.19 34.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.82 164.31 11.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.174 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -56.08 -54.88 39.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.893 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 59.5 m -118.13 17.16 14.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.878 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.69 173.25 14.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.143 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 732' ' ' ALA . . . . . 0.722 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -150.98 120.46 6.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.076 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 18.3 mmt180 -79.02 97.38 6.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.837 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 99.3 t -102.28 144.32 13.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.167 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -104.84 101.99 11.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.866 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 31.3 mt -50.78 158.68 0.63 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.954 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 15.5 m170 -87.6 -55.4 3.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.88 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 22.2 t -61.31 -68.61 0.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.903 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 61.7 p -59.96 -30.26 68.97 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.101 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 12.0 t 59.54 48.36 9.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.901 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -133.7 149.28 51.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.901 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 17.0 m -88.53 110.86 21.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.17 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 7.5 pt -118.69 147.75 22.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.145 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 95.5 p -89.97 126.25 35.68 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.857 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.6 ' HB ' HD21 ' A' ' 750' ' ' LEU . 57.6 t -138.21 141.87 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.138 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . 0.453 ' HB2' ' CG ' ' A' ' 749' ' ' ARG . 0.7 OUTLIER -48.54 127.58 13.54 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.908 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 26.2 mtm180 -45.36 -36.47 4.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.869 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -77.26 -44.42 29.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.958 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 749' ' ' ARG . . . . . 0.453 ' CG ' ' HB2' ' A' ' 746' ' ' ASP . 56.0 mtt180 -49.35 -28.18 4.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.722 HD11 ' HB3' ' A' ' 732' ' ' ALA . 13.6 mt -79.88 139.56 37.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.896 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 50.7 m -116.6 91.95 3.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.165 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 11.9 p -42.57 117.97 1.12 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.125 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 78.6 t -65.53 -51.34 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -57.91 169.21 4.63 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.475 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 2.2 t -109.0 132.02 54.51 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.899 0.38 . . . . 0.0 110.866 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 14.5 tpp85 -91.22 85.95 6.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.855 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.347 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 27.3 m -58.64 -47.08 85.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.897 0.38 . . . . 0.0 110.85 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 99.2 p -124.71 122.65 38.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.875 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -115.91 83.46 0.34 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.504 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 4.0 t -105.48 -59.33 1.78 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.875 0.369 . . . . 0.0 110.902 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 20.4 t 46.84 42.09 11.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.851 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 70.67 131.44 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.512 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 2.3 ttt -134.2 -49.99 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.738 0.304 . . . . 0.0 110.84 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 6.9 t -71.1 118.28 13.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.907 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 22.2 mmm180 -110.85 112.76 24.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.824 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -128.84 157.2 21.45 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.491 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -83.39 141.45 31.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.827 0.346 . . . . 0.0 110.936 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -122.36 137.45 11.39 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.468 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 46.1 mtm180 -53.6 -46.92 70.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.809 0.338 . . . . 0.0 110.867 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 701' ' ' ARG . . . . . 0.431 ' NH1' ' HB2' ' A' ' 701' ' ' ARG . 7.6 mtp-105 -56.07 141.66 39.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.868 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -87.5 97.43 10.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.881 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -112.29 34.71 4.14 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.9 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 36.6 tp10 -85.94 -56.83 3.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . 0.51 ' HG ' HG21 ' A' ' 724' ' ' VAL . 47.6 tp -59.99 -13.25 10.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.901 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 706' ' ' ILE . . . . . 0.523 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -62.88 108.95 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 117.04 -13.82 14.03 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.49 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 708' ' ' GLN . . . . . 0.488 ' CG ' HD12 ' A' ' 705' ' ' LEU . 55.7 mm-40 -73.77 161.15 30.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.902 0.382 . . . . 0.0 110.895 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 709' ' ' THR . . . . . 0.674 HG22 HG21 ' A' ' 753' ' ' VAL . 97.2 m -97.64 106.85 19.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.167 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 27.1 m -112.69 156.64 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.151 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 711' ' ' ARG . . . . . 0.556 ' HB2' HD13 ' A' ' 721' ' ' ILE . 23.2 ttp180 -127.27 115.13 18.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 44.6 mt -60.27 128.85 21.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.123 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 4.5 t -126.4 11.99 7.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.811 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 714' ' ' GLN . . . . . 0.45 ' CB ' ' HG2' ' A' ' 749' ' ' ARG . 24.5 mt-30 -138.72 128.08 24.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.948 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 105.85 -162.38 14.14 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.474 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 716' ' ' PRO . . . . . 0.558 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.5 Cg_endo -69.82 -32.88 17.47 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.735 2.29 . . . . 0.0 112.327 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.558 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 50.4 m-85 -91.82 42.72 1.11 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.957 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 39.5 tttm -78.24 97.4 5.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.87 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 120.96 34.67 0.88 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.505 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 720' ' ' TYR . . . . . 0.442 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 14.4 m-85 -127.51 147.57 50.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.857 0.36 . . . . 0.0 110.919 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.556 HD13 ' HB2' ' A' ' 711' ' ' ARG . 28.7 mm -98.22 154.11 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.093 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 722' ' ' GLY . . . . . 0.429 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -172.44 151.43 14.44 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.461 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 41.2 t -94.89 129.29 45.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 0.0 111.134 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 724' ' ' VAL . . . . . 0.51 HG21 ' HG ' ' A' ' 705' ' ' LEU . 38.4 t -63.79 109.08 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.143 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.0 mmpt? -85.37 -40.76 16.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -143.14 149.47 38.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.824 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 727' ' ' ALA . . . . . 0.464 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -110.97 119.79 40.23 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.109 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.47 160.95 14.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.155 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -52.13 -62.17 1.81 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.428 ' O ' HG23 ' A' ' 731' ' ' THR . 38.3 m -111.57 22.43 15.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.829 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 731' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -158.17 173.23 17.03 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.146 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 732' ' ' ALA . . . . . 0.629 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -151.41 119.44 6.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -75.96 102.03 5.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.841 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 93.9 t -107.46 145.98 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.113 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 11.8 tt0 -108.47 104.55 13.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.917 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 736' ' ' LEU . . . . . 0.442 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 38.0 mt -50.88 161.36 0.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.925 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -95.41 -27.89 15.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.888 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 3.9 m -82.39 -74.07 0.36 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.884 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 28.2 p -62.43 -19.2 63.25 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.152 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.2 m 57.09 41.63 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -123.78 146.72 48.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.906 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 18.4 m -90.78 108.2 19.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.118 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 9.5 pt -111.76 154.1 13.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.186 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 84.6 p -97.41 124.8 41.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.845 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.68 ' HB ' HD21 ' A' ' 750' ' ' LEU . 62.0 t -136.88 145.32 30.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.094 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -53.07 128.29 27.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.85 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 10.0 mtm105 -45.57 -34.77 3.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.886 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -77.05 -40.06 47.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.87 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 749' ' ' ARG . . . . . 0.45 ' HG2' ' CB ' ' A' ' 714' ' ' GLN . 63.9 mtt180 -56.8 -21.96 32.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.856 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.68 HD21 ' HB ' ' A' ' 745' ' ' VAL . 10.6 mt -88.83 139.22 30.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 88.8 m -119.46 96.03 5.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.167 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 7.3 p -39.81 118.25 0.84 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.165 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 753' ' ' VAL . . . . . 0.674 HG21 HG22 ' A' ' 709' ' ' THR . 98.6 t -56.74 -44.3 81.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.124 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 171.66 73.7 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.511 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 58.2 m -83.82 84.93 7.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.877 0.37 . . . . 0.0 110.863 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -108.28 15.11 24.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.883 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.871 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 70.7 m -114.34 94.34 4.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.837 0.351 . . . . 0.0 110.808 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 3.0 m -140.98 137.86 33.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.814 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 145.06 117.65 1.14 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.477 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 56.0 p -169.04 167.34 10.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.854 0.359 . . . . 0.0 110.86 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 3.0 t -117.82 100.73 7.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.838 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . -132.79 -109.16 1.14 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.489 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 19.8 mmt -44.55 128.56 6.54 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.739 0.304 . . . . 0.0 110.888 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 4.0 m -128.84 92.14 3.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.861 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 28.1 ttt85 -57.28 104.2 0.16 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.889 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -43.92 -63.29 2.32 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.474 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -93.49 90.38 6.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.862 0.363 . . . . 0.0 110.882 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -77.82 148.7 33.77 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.43 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -76.57 158.81 30.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.811 0.338 . . . . 0.0 110.877 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 701' ' ' ARG . . . . . 0.454 ' HD2' ' N ' ' A' ' 701' ' ' ARG . 1.7 mpt_? -72.39 104.01 3.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.852 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -120.36 48.4 1.59 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.873 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -86.92 34.52 0.67 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -75.45 -58.68 3.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 45.4 tp -60.08 -14.31 16.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.87 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 706' ' ' ILE . . . . . 0.587 HD11 ' HB2' ' A' ' 727' ' ' ALA . 0.7 OUTLIER -64.17 108.55 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.134 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.62 -12.91 12.0 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -74.72 166.43 23.6 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.86 0.362 . . . . 0.0 110.937 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 709' ' ' THR . . . . . 0.609 HG22 HG21 ' A' ' 753' ' ' VAL . 62.7 m -100.39 110.19 22.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.182 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . 0.423 HG12 HG22 ' A' ' 752' ' ' THR . 26.3 m -114.25 158.48 14.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.169 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 711' ' ' ARG . . . . . 0.503 ' HB2' HD13 ' A' ' 721' ' ' ILE . 23.4 ttm-85 -131.76 112.46 12.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 15.7 mt -57.22 133.34 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.131 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 15.9 t -109.21 -29.79 8.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.857 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -112.12 178.72 4.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.932 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 76.09 178.05 43.91 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.513 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 716' ' ' PRO . . . . . 0.52 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.9 Cg_endo -69.71 -11.06 30.12 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.652 2.234 . . . . 0.0 112.326 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.52 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 52.9 m-85 -103.9 29.12 6.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.927 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -62.04 135.29 57.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.901 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 77.33 37.39 31.82 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.48 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 720' ' ' TYR . . . . . 0.473 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 24.6 m-85 -124.1 140.22 53.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.845 0.355 . . . . 0.0 110.981 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.503 HD13 ' HB2' ' A' ' 711' ' ' ARG . 11.5 mm -98.81 148.76 5.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.134 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -167.98 169.66 41.49 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.449 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 53.3 t -112.13 126.87 69.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.88 0.371 . . . . 0.0 111.104 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 724' ' ' VAL . . . . . 0.46 HG22 HG22 ' A' ' 734' ' ' VAL . 99.1 t -62.66 108.01 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.147 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 8.1 mmpt? -84.18 -40.21 18.43 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.875 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -142.63 150.28 40.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 727' ' ' ALA . . . . . 0.587 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -108.57 118.52 36.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.066 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -105.11 156.97 17.58 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.142 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 729' ' ' GLU . . . . . 0.442 ' O ' ' NE ' ' A' ' 747' ' ' ARG . 6.3 tp10 -42.89 -75.02 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.898 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 25.1 m -103.0 18.92 20.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.84 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.72 173.36 14.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.178 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 732' ' ' ALA . . . . . 0.497 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -151.0 120.43 6.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.09 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 49.1 mmm-85 -75.53 101.46 4.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.83 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 734' ' ' VAL . . . . . 0.46 HG22 HG22 ' A' ' 724' ' ' VAL . 87.1 t -107.47 144.23 16.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.159 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -104.32 104.18 14.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 736' ' ' LEU . . . . . 0.473 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 40.4 mt -52.69 161.43 0.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.949 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 18.2 m170 -90.66 -48.7 6.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.853 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 3.6 m -61.0 -72.75 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.881 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 77.4 p -61.2 -27.0 68.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.145 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 13.8 t 59.91 49.41 7.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.902 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -138.52 151.55 47.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 21.1 m -83.37 137.43 33.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.153 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 13.2 pt -142.79 148.52 19.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 81.0 p -92.12 119.39 31.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.846 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.495 ' HB ' HD21 ' A' ' 750' ' ' LEU . 32.4 t -133.72 142.42 41.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.127 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -49.7 132.01 21.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 747' ' ' ARG . . . . . 0.442 ' NE ' ' O ' ' A' ' 729' ' ' GLU . 36.7 mtm180 -54.04 -20.44 6.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -87.89 -44.05 11.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.887 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 53.0 mtm180 -56.88 -17.23 8.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.871 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 732' ' ' ALA . 19.3 mt -89.83 134.32 34.26 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.978 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 21.6 m -115.02 90.85 3.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.097 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . 0.423 HG22 HG12 ' A' ' 710' ' ' VAL . 16.2 p -41.84 118.56 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.097 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 753' ' ' VAL . . . . . 0.609 HG21 HG22 ' A' ' 709' ' ' THR . 98.3 t -59.14 -55.96 20.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.189 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . 0.405 ' O ' ' C ' ' A' ' 755' ' ' SER . . . -62.27 -148.81 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.52 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . 0.405 ' C ' ' O ' ' A' ' 754' ' ' GLY . 72.4 m -37.88 142.57 0.15 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.819 0.342 . . . . 0.0 110.872 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -105.49 125.45 51.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.89 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 15.8 mmt180 . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.859 -179.885 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 24.5 p -72.02 122.84 21.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.879 0.371 . . . . 0.0 110.881 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 14.4 t -59.2 135.18 57.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.84 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 171.37 102.64 0.16 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.509 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 70.1 m -124.01 150.51 44.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.889 0.376 . . . . 0.0 110.861 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 9.2 m -76.12 133.15 40.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.914 -179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . -83.5 161.89 39.29 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.522 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.67 173.04 7.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.807 0.337 . . . . 0.0 110.889 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 70.0 m -75.58 147.61 39.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.837 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.02 -3.64 8.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.862 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -112.58 -152.98 11.61 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.449 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -101.91 43.54 1.06 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.859 0.361 . . . . 0.0 110.84 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -93.11 88.13 1.25 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.511 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -114.71 140.87 48.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.765 0.317 . . . . 0.0 110.887 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 701' ' ' ARG . . . . . 0.421 ' NH1' ' HB2' ' A' ' 701' ' ' ARG . 20.4 mtm105 -125.44 165.7 17.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -110.87 -27.36 8.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.859 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 703' ' ' ASN . . . . . 0.404 ' HA ' HD13 ' A' ' 706' ' ' ILE . 11.0 p-10 -62.49 -13.61 32.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.922 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -53.41 -16.32 1.37 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 30.4 tp -101.8 -17.07 16.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.917 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 706' ' ' ILE . . . . . 0.504 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -67.46 103.12 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 123.21 -7.02 9.26 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.517 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -78.58 168.24 20.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.857 0.36 . . . . 0.0 110.921 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 52.8 m -102.91 105.45 15.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.115 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . 0.539 HG12 ' HA ' ' A' ' 752' ' ' THR . 35.8 m -109.86 158.47 9.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.114 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 711' ' ' ARG . . . . . 0.54 ' HB2' HD13 ' A' ' 721' ' ' ILE . 14.4 ttm-85 -128.54 115.9 18.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.863 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 49.1 mt -59.26 142.64 14.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.151 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 18.0 t -118.84 -30.57 5.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 36.8 mm-40 -112.09 172.12 7.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.87 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 80.87 179.57 53.06 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.493 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 716' ' ' PRO . . . . . 0.481 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.7 Cg_endo -69.7 -8.39 23.47 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.755 2.303 . . . . 0.0 112.321 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.481 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 63.6 m-85 -106.94 27.43 8.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -60.89 130.94 48.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.883 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.26 37.8 20.21 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.473 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 720' ' ' TYR . . . . . 0.4 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 10.5 m-85 -125.65 142.77 51.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.868 0.366 . . . . 0.0 110.906 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.54 HD13 ' HB2' ' A' ' 711' ' ' ARG . 26.4 mm -96.43 146.65 7.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.095 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -163.49 165.0 36.54 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.483 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.513 HG23 ' NE2' ' A' ' 737' ' ' HIS . 29.3 t -110.28 128.01 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.849 0.357 . . . . 0.0 111.171 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 33.9 t -64.8 108.93 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.103 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -85.28 -38.34 18.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.881 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -145.12 149.48 35.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.842 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 727' ' ' ALA . . . . . 0.477 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -108.32 117.67 34.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.158 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.03 155.75 18.69 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.151 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 729' ' ' GLU . . . . . 0.482 ' O ' ' NE ' ' A' ' 747' ' ' ARG . 24.7 tt0 -43.09 -74.59 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.914 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.42 ' O ' HG23 ' A' ' 731' ' ' THR . 58.5 m -103.24 24.6 10.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.879 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 731' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -158.05 173.2 17.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.161 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 732' ' ' ALA . . . . . 0.558 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -151.09 121.58 7.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.12 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 16.2 mmt85 -76.75 98.75 4.89 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.885 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 57.4 t -103.95 150.85 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.151 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 52.4 tt0 -111.7 102.67 10.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.828 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 736' ' ' LEU . . . . . 0.4 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 31.9 mt -50.88 157.39 0.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 737' ' ' HIS . . . . . 0.513 ' NE2' HG23 ' A' ' 723' ' ' VAL . 18.6 m170 -95.34 -23.12 17.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.841 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 3.7 t -82.26 -68.68 0.68 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.873 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 34.4 p -70.97 -17.41 62.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.159 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 55.6 m 58.28 40.58 24.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.864 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -125.3 153.91 42.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.929 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 26.2 m -96.88 121.19 38.47 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.14 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 7.9 pt -126.36 155.46 36.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.131 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 92.0 p -97.44 121.13 38.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.889 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.67 HG12 ' HB2' ' A' ' 749' ' ' ARG . 21.7 t -134.43 144.62 34.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.152 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -48.98 131.16 18.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.877 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 747' ' ' ARG . . . . . 0.482 ' NE ' ' O ' ' A' ' 729' ' ' GLU . 36.9 mtm180 -50.74 -17.83 0.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -90.53 -37.42 13.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.936 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 749' ' ' ARG . . . . . 0.67 ' HB2' HG12 ' A' ' 745' ' ' VAL . 31.4 mtm180 -61.96 -8.58 5.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.901 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.558 HD11 ' HB3' ' A' ' 732' ' ' ALA . 14.6 mt -100.77 135.6 41.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.968 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 33.1 m -118.7 93.63 4.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.168 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . 0.539 ' HA ' HG12 ' A' ' 710' ' ' VAL . 6.4 p -39.9 121.23 1.26 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.098 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 753' ' ' VAL . . . . . 0.429 HG21 HD12 ' A' ' 721' ' ' ILE . 96.4 t -67.42 -55.4 17.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.152 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -57.79 131.98 52.32 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.454 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 44.5 m -79.99 122.23 26.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.875 0.369 . . . . 0.0 110.908 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 5.7 ptt180 -89.63 8.21 32.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.844 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.943 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 71.3 p -65.17 164.82 12.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.87 0.367 . . . . 0.0 110.85 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 89.6 p -107.73 117.97 35.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.901 -179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 61.78 62.53 5.64 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.473 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 67.1 p -83.37 138.02 33.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.896 0.379 . . . . 0.0 110.823 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 40.9 p -157.78 166.79 31.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.848 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 167.42 167.82 28.67 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.471 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -76.36 173.67 11.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.783 0.325 . . . . 0.0 110.895 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . 0.409 ' O ' ' C ' ' A' ' 696' ' ' ARG . 40.4 t -72.9 -54.42 8.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.85 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . 0.409 ' C ' ' O ' ' A' ' 695' ' ' SER . 17.9 ttm-85 -36.16 -67.4 0.17 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.86 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -45.21 -48.2 10.55 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.539 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 17.6 tpt180 -62.97 130.38 44.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.359 . . . . 0.0 110.857 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -86.24 104.93 2.93 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.487 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 2.9 ptp85 -44.19 135.5 4.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.745 0.307 . . . . 0.0 110.877 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 15.1 mmt85 -113.41 126.46 55.37 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.875 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.34 46.21 2.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -91.82 24.45 3.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -76.03 -55.21 5.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.876 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . 0.501 ' HG ' HG21 ' A' ' 724' ' ' VAL . 52.0 tp -62.45 -16.07 53.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.959 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 706' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 727' ' ' ALA . 0.7 OUTLIER -61.59 109.52 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.114 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 120.84 -20.69 8.6 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.486 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -73.0 157.45 37.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.897 0.38 . . . . 0.0 110.895 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 709' ' ' THR . . . . . 0.507 ' O ' HG23 ' A' ' 753' ' ' VAL . 55.1 m -90.61 110.28 21.43 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.178 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . 0.491 ' HA ' HG23 ' A' ' 753' ' ' VAL . 33.1 m -111.65 146.94 15.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.129 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 711' ' ' ARG . . . . . 0.495 ' HB2' HD13 ' A' ' 721' ' ' ILE . 12.8 ttp-105 -117.44 113.14 21.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.853 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . 0.439 ' CG2' ' O ' ' A' ' 714' ' ' GLN . 35.6 mt -58.73 127.35 17.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 26.2 t -105.66 -26.51 11.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.844 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 714' ' ' GLN . . . . . 0.439 ' O ' ' CG2' ' A' ' 712' ' ' ILE . 9.8 mm-40 -113.95 175.53 5.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.882 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 77.41 177.27 46.11 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.516 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 716' ' ' PRO . . . . . 0.573 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 54.5 Cg_endo -69.69 -0.06 6.3 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.684 2.256 . . . . 0.0 112.398 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.573 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 58.0 m-85 -115.34 33.89 5.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.962 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -66.39 137.11 56.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.894 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 77.66 28.48 57.12 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.513 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -117.92 141.38 48.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 0.0 110.926 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.495 HD13 ' HB2' ' A' ' 711' ' ' ARG . 27.2 mm -96.67 155.01 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.147 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 722' ' ' GLY . . . . . 0.451 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -173.81 157.78 26.29 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.489 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 44.1 t -100.95 129.91 51.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-O 120.881 0.372 . . . . 0.0 111.158 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 724' ' ' VAL . . . . . 0.501 HG21 ' HG ' ' A' ' 705' ' ' LEU . 23.1 t -65.14 113.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.123 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -91.49 -39.6 11.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.901 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -141.9 149.65 40.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 727' ' ' ALA . . . . . 0.629 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -110.57 115.88 30.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.44 157.51 16.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.157 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -45.96 -70.39 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.913 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.41 ' O ' HG23 ' A' ' 731' ' ' THR . 2.7 m -106.19 23.68 13.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.854 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 731' ' ' THR . . . . . 0.41 HG23 ' O ' ' A' ' 730' ' ' SER . 0.7 OUTLIER -157.71 173.27 17.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.155 -179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 732' ' ' ALA . . . . . 0.482 ' HB3' ' CD1' ' A' ' 750' ' ' LEU . . . -151.36 119.6 6.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.111 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 25.1 mmt-85 -75.37 97.07 3.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.9 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 734' ' ' VAL . . . . . 0.454 HG21 HG21 ' A' ' 710' ' ' VAL . 69.6 t -103.89 145.23 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.16 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -104.24 101.36 11.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 32.5 mt -49.82 160.8 0.28 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.928 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -89.46 -62.8 1.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.828 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 2.1 t -53.85 -70.27 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.832 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 71.0 p -58.61 -35.09 71.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.142 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 6.6 t 65.77 41.31 3.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -128.7 145.79 51.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 20.7 m -85.1 133.3 34.23 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.144 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 7.6 pt -141.61 149.46 20.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.189 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 97.5 p -91.5 117.93 30.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.89 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 21.5 t -130.46 142.77 42.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.152 179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . 0.477 ' HB3' ' CG ' ' A' ' 749' ' ' ARG . 7.9 t0 -46.96 126.42 8.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.823 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -48.87 -35.09 13.95 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -76.96 -41.82 41.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 749' ' ' ARG . . . . . 0.477 ' CG ' ' HB3' ' A' ' 746' ' ' ASP . 79.2 mtt180 -57.21 -18.51 16.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.482 ' CD1' ' HB3' ' A' ' 732' ' ' ALA . 21.3 mt -89.07 127.67 35.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.956 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 18.3 m -101.11 97.99 8.47 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.132 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 4.6 p -43.36 118.69 1.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.11 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 753' ' ' VAL . . . . . 0.542 HG12 ' N ' ' A' ' 754' ' ' GLY . 5.8 t -81.08 167.45 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . 0.542 ' N ' HG12 ' A' ' 753' ' ' VAL . . . 130.87 129.05 3.03 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.521 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 6.4 t -85.72 122.16 29.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.818 0.342 . . . . 0.0 110.884 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.0 132.0 49.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.884 -179.932 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.319 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 14.1 m -125.06 87.36 2.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.853 0.359 . . . . 0.0 110.866 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 13.6 m -94.64 94.31 8.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -76.95 -175.55 42.12 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.516 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 49.7 m -111.97 139.97 47.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.898 0.38 . . . . 0.0 110.85 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 9.1 t -98.93 174.69 6.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.883 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . -164.49 106.46 0.27 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.493 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 59.0 mtp -56.91 106.75 0.33 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.778 0.323 . . . . 0.0 110.873 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 16.6 m -109.47 119.37 39.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.883 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 10.9 mmm180 -114.38 42.51 2.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.86 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -134.24 -166.93 11.38 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.466 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 10.0 mmt85 -105.92 43.13 1.16 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.856 0.36 . . . . 0.0 110.861 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -71.04 -39.31 63.35 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.474 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -91.02 155.1 18.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.752 0.311 . . . . 0.0 110.924 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 43.3 mtt85 -108.91 155.32 20.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.876 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -63.11 95.32 0.08 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.856 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -116.35 20.74 14.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.892 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -73.49 -54.13 8.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.0 -12.48 18.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.899 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 706' ' ' ILE . . . . . 0.586 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -66.8 111.41 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.149 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.6 -17.39 11.14 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.473 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -73.62 154.12 39.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.857 0.361 . . . . 0.0 110.884 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 63.9 m -90.67 111.12 22.33 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.16 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . 0.437 HG12 ' HA ' ' A' ' 752' ' ' THR . 31.6 m -115.29 156.88 16.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.15 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 17.1 ttm180 -125.72 115.97 20.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . 0.675 HD11 HD11 ' A' ' 743' ' ' ILE . 26.2 mt -56.33 142.98 10.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . 0.55 ' C ' ' NE2' ' A' ' 714' ' ' GLN . 41.8 t -116.76 -36.77 3.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.871 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 714' ' ' GLN . . . . . 0.55 ' NE2' ' C ' ' A' ' 713' ' ' SER . 0.4 OUTLIER -105.37 -175.71 2.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.916 -179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 69.48 175.05 12.67 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.513 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 716' ' ' PRO . . . . . 0.576 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.2 Cg_endo -69.81 -4.38 13.95 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.677 2.252 . . . . 0.0 112.323 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.576 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 45.4 m-85 -108.2 29.42 7.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 6.2 ttpm? -64.06 136.74 57.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.933 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 77.53 32.12 47.95 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.497 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -118.59 145.91 45.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.81 0.338 . . . . 0.0 110.955 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 48.7 mm -97.0 147.8 6.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.149 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -170.47 148.72 11.78 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.467 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.498 ' C ' HG13 ' A' ' 734' ' ' VAL . 55.1 t -97.3 126.26 50.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.872 0.367 . . . . 0.0 111.159 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 724' ' ' VAL . . . . . 0.808 ' HA ' HG22 ' A' ' 734' ' ' VAL . 41.8 t -59.97 113.27 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.15 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -90.47 -39.08 12.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -142.51 144.89 33.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.847 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -106.11 118.03 35.56 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.091 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.38 155.35 20.1 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.128 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 729' ' ' GLU . . . . . 0.402 ' O ' ' NE ' ' A' ' 747' ' ' ARG . 15.6 tp10 -45.07 -71.7 0.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.882 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 73.5 m -106.91 26.29 10.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.826 -179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -157.44 173.37 17.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.16 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 732' ' ' ALA . . . . . 0.669 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -155.73 119.96 4.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.065 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 733' ' ' ARG . . . . . 0.457 ' HB3' ' CG2' ' A' ' 742' ' ' THR . 1.5 mpt_? -84.82 98.36 10.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 734' ' ' VAL . . . . . 0.808 HG22 ' HA ' ' A' ' 724' ' ' VAL . 55.8 t -103.62 146.05 11.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.113 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -100.8 102.13 13.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.877 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 31.3 mt -49.84 157.61 0.58 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 5.7 m170 -85.47 -43.8 13.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.92 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 48.1 m -71.78 -72.95 0.2 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.869 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 67.9 p -58.64 -18.13 27.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.177 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 9.2 t 48.97 47.95 21.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.899 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 4.8 pt20 -138.66 155.18 48.49 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 742' ' ' THR . . . . . 0.457 ' CG2' ' HB3' ' A' ' 733' ' ' ARG . 66.4 m -84.67 133.09 34.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.15 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 743' ' ' ILE . . . . . 0.675 HD11 HD11 ' A' ' 712' ' ' ILE . 7.3 pt -135.62 138.3 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.159 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 45.8 p -80.84 120.94 25.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.896 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.46 HG13 ' CZ ' ' A' ' 749' ' ' ARG . 98.2 t -138.89 144.15 30.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.143 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -54.36 127.93 29.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 747' ' ' ARG . . . . . 0.402 ' NE ' ' O ' ' A' ' 729' ' ' GLU . 30.0 mtm180 -45.39 -40.14 7.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.915 -179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 64.2 mm-40 -71.7 -46.01 60.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.902 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 749' ' ' ARG . . . . . 0.46 ' CZ ' HG13 ' A' ' 745' ' ' VAL . 39.1 mtp180 -49.84 -26.49 4.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.9 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.669 HD11 ' HB3' ' A' ' 732' ' ' ALA . 16.5 mt -82.65 129.39 34.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.932 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 20.1 m -111.0 98.73 7.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.157 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . 0.437 ' HA ' HG12 ' A' ' 710' ' ' VAL . 20.6 p -42.11 117.68 1.02 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.166 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 83.7 t -65.38 -45.25 93.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.137 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -40.54 117.97 1.06 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 70.5 m -92.56 177.82 6.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.89 0.376 . . . . 0.0 110.835 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 10.3 mmm180 -134.73 177.11 8.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.829 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 -179.852 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 5.1 m 47.23 46.87 16.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.878 0.37 . . . . 0.0 110.859 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 12.4 m -102.91 41.08 1.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.875 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -167.47 -106.7 0.19 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.447 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 7.4 t -70.11 152.11 44.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.877 0.37 . . . . 0.0 110.862 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 3.6 m -164.19 176.18 9.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.882 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . -123.73 144.57 15.59 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.487 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 7.8 ttt -126.35 86.47 2.52 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.754 0.312 . . . . 0.0 110.891 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 46.6 p -80.53 175.73 10.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.852 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 35.4 mtp85 -81.68 40.57 0.6 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.892 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -101.81 113.49 4.65 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.477 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 62.9 mtt-85 -80.69 80.64 7.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.855 0.36 . . . . 0.0 110.869 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -131.27 -111.47 1.39 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.438 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 700' ' ' ARG . . . . . 0.429 ' NH1' ' HB2' ' A' ' 700' ' ' ARG . 8.8 ttm105 -59.22 134.94 57.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.798 0.332 . . . . 0.0 110.881 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 701' ' ' ARG . . . . . 0.657 ' H ' ' NE ' ' A' ' 701' ' ' ARG . 0.0 OUTLIER -116.27 -179.76 3.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -74.5 98.53 3.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.84 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 15.1 p30 -109.33 24.3 13.28 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.867 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -73.91 -61.01 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.909 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 46.9 tp -62.44 -11.97 19.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.882 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 706' ' ' ILE . . . . . 0.535 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -65.5 108.65 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.115 179.872 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 119.69 -15.52 10.5 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.472 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 38.8 mm-40 -76.72 156.28 32.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.914 0.388 . . . . 0.0 110.934 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 709' ' ' THR . . . . . 0.439 HG22 ' HB ' ' A' ' 753' ' ' VAL . 53.9 m -89.3 113.95 25.28 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . 0.449 ' HA ' HG23 ' A' ' 753' ' ' VAL . 33.9 m -117.83 154.12 19.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.094 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 711' ' ' ARG . . . . . 0.626 ' CZ ' HD11 ' A' ' 721' ' ' ILE . 31.2 ttm-85 -126.02 113.89 17.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . 0.53 HG12 HD23 ' A' ' 750' ' ' LEU . 40.8 mt -64.02 110.36 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.147 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 5.8 t -107.95 20.79 18.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.818 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -149.18 134.37 18.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.941 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 101.3 -164.77 18.09 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.51 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 716' ' ' PRO . . . . . 0.557 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 54.0 Cg_endo -69.76 -30.56 22.1 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.665 2.244 . . . . 0.0 112.359 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.557 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 44.7 m-85 -91.21 38.82 0.98 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 17.4 tttm -73.0 126.35 29.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.902 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 87.62 35.38 9.37 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.486 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -128.06 144.31 51.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 110.956 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.626 HD11 ' CZ ' ' A' ' 711' ' ' ARG . 39.1 mm -97.98 156.82 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.16 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 722' ' ' GLY . . . . . 0.478 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -174.1 155.18 21.11 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.518 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.464 HG23 ' NE2' ' A' ' 737' ' ' HIS . 38.3 t -98.4 129.18 49.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.862 0.363 . . . . 0.0 111.174 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 724' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 707' ' ' GLY . 21.8 t -67.31 112.28 2.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.151 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.49 -39.97 10.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -137.63 146.55 44.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.856 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 727' ' ' ALA . . . . . 0.431 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -115.73 116.42 28.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.147 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 728' ' ' THR . . . . . 0.491 HG22 ' H ' ' A' ' 729' ' ' GLU . 0.4 OUTLIER -100.48 169.43 9.08 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.094 -179.88 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 729' ' ' GLU . . . . . 0.491 ' H ' HG22 ' A' ' 728' ' ' THR . 15.6 pt-20 -66.65 -42.44 86.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.482 ' O ' HG23 ' A' ' 731' ' ' THR . 60.5 m -125.32 18.31 8.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.879 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 731' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -159.9 173.59 15.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.178 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 732' ' ' ALA . . . . . 0.546 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -153.52 122.31 6.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.102 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 733' ' ' ARG . . . . . 0.492 ' HD3' ' CB ' ' A' ' 744' ' ' SER . 11.1 mmt85 -79.11 98.33 6.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 58.9 t -103.99 138.81 27.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.165 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -98.01 101.92 13.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 57.9 mt -50.9 160.55 0.45 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.962 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 737' ' ' HIS . . . . . 0.464 ' NE2' HG23 ' A' ' 723' ' ' VAL . 15.0 m170 -100.09 -38.47 8.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.862 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 4.6 m -66.68 -52.72 41.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.837 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 74.1 p -87.32 -23.58 24.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.137 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.7 m 63.77 41.78 6.66 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.865 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 39.0 mm-40 -126.95 154.21 44.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.939 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 21.3 m -92.23 122.13 34.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.153 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 6.8 pt -133.84 142.13 42.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.107 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . 0.492 ' CB ' ' HD3' ' A' ' 733' ' ' ARG . 3.1 t -87.51 132.62 33.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.615 ' HB ' HD21 ' A' ' 750' ' ' LEU . 81.9 t -143.26 148.58 19.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.101 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . 0.408 ' HB2' ' CG ' ' A' ' 749' ' ' ARG . 20.1 m-20 -50.28 119.8 4.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.866 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 40.0 mtm180 -38.73 -44.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.843 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -65.92 -47.84 73.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.905 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 749' ' ' ARG . . . . . 0.408 ' CG ' ' HB2' ' A' ' 746' ' ' ASP . 91.4 mtt180 -49.53 -20.53 0.76 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.904 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.615 HD21 ' HB ' ' A' ' 745' ' ' VAL . 12.9 mt -92.34 122.7 35.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.937 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 39.4 m -103.17 107.19 17.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.187 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 1.6 p -44.63 121.08 2.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.14 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 753' ' ' VAL . . . . . 0.653 HG12 ' O ' ' A' ' 753' ' ' VAL . 22.0 t -82.45 19.74 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.133 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 165.18 74.38 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 89.8 p -93.47 169.34 10.42 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.863 0.363 . . . . 0.0 110.862 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 1.6 ptt-85 -49.56 162.5 0.16 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.841 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.258 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 46.8 p -169.53 177.62 4.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.836 0.351 . . . . 0.0 110.849 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 4.8 m -145.9 174.96 10.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.86 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -151.42 151.45 23.4 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.494 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 5.7 t -153.2 132.37 12.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.872 0.367 . . . . 0.0 110.846 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 84.3 p -132.33 -47.28 0.91 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.848 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 93.65 143.47 13.47 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.467 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -139.75 135.49 33.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.765 0.317 . . . . 0.0 110.863 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 18.1 m -90.01 93.4 9.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.843 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 60.2 ttp180 -132.98 134.77 44.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.923 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -60.35 -97.62 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.473 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 15.1 ptt180 -59.37 166.25 2.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.865 0.364 . . . . 0.0 110.905 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -129.19 -162.73 11.01 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.446 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -97.2 172.92 7.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 0.0 110.891 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 47.1 ttt180 -64.19 119.63 10.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -118.1 91.97 3.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -113.19 27.98 9.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.911 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -79.67 -58.05 3.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.877 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . 0.457 HD12 ' CG ' ' A' ' 708' ' ' GLN . 45.5 tp -59.99 -15.31 21.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.904 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 706' ' ' ILE . . . . . 0.529 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -62.08 108.84 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 179.838 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 120.13 -16.25 10.05 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.501 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 708' ' ' GLN . . . . . 0.457 ' CG ' HD12 ' A' ' 705' ' ' LEU . 46.6 mm-40 -73.82 163.58 27.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.878 0.37 . . . . 0.0 110.922 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 709' ' ' THR . . . . . 0.423 HG22 ' CG2' ' A' ' 753' ' ' VAL . 44.9 m -99.49 110.2 22.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.158 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.48 157.38 14.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.102 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -127.01 110.43 12.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.869 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . 0.534 HG12 HD23 ' A' ' 750' ' ' LEU . 40.7 mt -60.63 105.5 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 55.2 m -103.4 24.39 11.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.865 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 714' ' ' GLN . . . . . 0.404 ' CB ' ' HG2' ' A' ' 749' ' ' ARG . 14.4 mp0 -152.75 147.29 25.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.884 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 90.44 -166.69 32.0 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.502 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 716' ' ' PRO . . . . . 0.554 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.9 Cg_endo -69.77 -29.95 23.0 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.697 2.265 . . . . 0.0 112.362 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.554 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 55.0 m-85 -93.15 45.46 1.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.942 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -75.02 135.79 41.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 75.95 39.65 32.51 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.458 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 720' ' ' TYR . . . . . 0.401 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 16.7 m-85 -125.98 140.68 52.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.854 0.359 . . . . 0.0 110.935 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 31.3 mm -96.63 149.2 4.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.119 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -169.05 158.71 31.44 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.5 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 48.5 t -101.88 130.96 50.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.89 0.376 . . . . 0.0 111.131 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 42.8 t -67.32 107.63 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.083 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . 0.426 ' HA ' ' NZ ' ' A' ' 725' ' ' LYS . 0.0 OUTLIER -84.53 -38.9 19.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 179.914 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -147.05 145.61 29.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -104.86 121.45 43.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.064 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -106.51 158.96 16.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.146 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -45.35 -71.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.917 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 74.3 m -106.23 18.71 21.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.58 173.32 14.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 732' ' ' ALA . . . . . 0.494 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -150.19 120.32 7.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 11.7 mmt85 -75.69 97.66 3.88 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.849 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 93.3 t -105.36 145.33 13.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.157 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 16.3 tt0 -107.21 101.58 10.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.875 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 736' ' ' LEU . . . . . 0.401 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 45.8 mt -49.64 158.69 0.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.912 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -89.32 -54.27 4.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 1.5 t -62.32 -67.94 0.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 81.8 p -61.72 -25.34 67.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.124 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 11.7 t 55.1 51.65 13.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.873 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -136.16 145.55 45.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.931 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 19.7 m -89.04 112.68 23.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.141 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 6.8 pt -121.48 155.67 25.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.157 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 90.9 p -97.39 124.2 41.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.433 HG12 ' HB2' ' A' ' 749' ' ' ARG . 50.1 t -134.52 149.9 30.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.17 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -54.98 126.58 25.14 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.88 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 34.5 mtm180 -45.06 -31.5 1.38 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.848 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 4.3 mm-40 -79.39 -42.38 25.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.891 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 749' ' ' ARG . . . . . 0.433 ' HB2' HG12 ' A' ' 745' ' ' VAL . 76.7 mtt180 -55.55 -13.8 1.75 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.93 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.534 HD23 HG12 ' A' ' 712' ' ' ILE . 17.8 mt -98.66 125.94 44.11 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 29.2 m -107.77 97.46 7.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.105 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 16.4 p -40.75 119.04 1.05 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.119 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 753' ' ' VAL . . . . . 0.423 ' CG2' HG22 ' A' ' 709' ' ' THR . 91.0 t -64.9 -60.44 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.094 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -52.62 156.25 4.67 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.538 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 46.4 p -119.43 164.7 15.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.807 0.337 . . . . 0.0 110.884 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -107.42 120.41 42.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.883 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 28.9 ttm180 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.906 -179.931 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.454 -0.259 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 30.8 t -168.46 105.17 0.45 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.875 0.369 . . . . 0.0 110.828 -179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 65.3 m -113.59 132.52 55.7 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.843 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -64.03 179.11 7.12 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.451 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 3.0 m -144.59 174.68 10.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.875 0.369 . . . . 0.0 110.873 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 52.4 p -146.3 118.53 8.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.844 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . -133.71 69.46 0.53 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.507 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 8.8 mtm -104.58 149.81 25.18 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.769 0.319 . . . . 0.0 110.845 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 2.1 m -122.16 139.53 53.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.828 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 12.9 tpp180 -64.25 -51.9 61.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.86 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -105.18 69.91 0.24 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.486 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -55.99 -49.22 74.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.822 0.344 . . . . 0.0 110.86 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -61.23 135.33 48.32 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.457 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 71.8 mtt-85 -83.07 130.35 35.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 110.854 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -106.62 46.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.875 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -123.64 40.87 3.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -104.18 28.93 6.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.862 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -70.32 -47.24 62.0 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.906 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . 0.447 HD12 ' HB2' ' A' ' 708' ' ' GLN . 17.5 tp -70.49 -15.47 62.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.94 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 706' ' ' ILE . . . . . 0.52 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -63.34 104.47 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.156 179.796 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 122.86 -13.42 8.59 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.491 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 708' ' ' GLN . . . . . 0.447 ' HB2' HD12 ' A' ' 705' ' ' LEU . 49.6 mm-40 -75.99 161.65 28.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.89 0.376 . . . . 0.0 110.914 -179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 709' ' ' THR . . . . . 0.508 HG22 HG21 ' A' ' 753' ' ' VAL . 52.1 m -95.04 105.32 17.23 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 32.5 m -109.16 148.86 12.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.111 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 15.8 ttm180 -120.01 114.2 21.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.84 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . 0.567 HD11 HD11 ' A' ' 743' ' ' ILE . 27.6 mt -57.81 134.2 22.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.123 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 61.5 p -109.12 -32.15 7.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.825 -179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 63.6 mm-40 -110.49 177.84 4.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 77.34 174.79 41.76 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.495 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 716' ' ' PRO . . . . . 0.53 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.6 Cg_endo -69.74 0.39 5.7 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.74 2.293 . . . . 0.0 112.319 -179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.53 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 67.4 m-85 -115.74 31.87 6.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.891 -179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 19.3 tttp -65.87 135.16 54.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.907 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.19 34.16 30.44 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.481 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -123.11 144.72 49.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.874 0.369 . . . . 0.0 110.952 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 25.4 mm -99.24 146.51 8.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.116 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -164.75 157.94 30.53 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.512 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.417 ' C ' HG13 ' A' ' 734' ' ' VAL . 22.2 t -101.19 124.71 55.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.883 0.373 . . . . 0.0 111.154 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 724' ' ' VAL . . . . . 0.427 HG22 HG22 ' A' ' 734' ' ' VAL . 40.7 t -61.78 112.76 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.141 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.58 -36.78 15.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -146.26 144.29 29.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.835 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -112.85 117.43 32.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 728' ' ' THR . . . . . 0.548 HG22 ' H ' ' A' ' 729' ' ' GLU . 0.6 OUTLIER -98.54 171.21 8.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.153 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 729' ' ' GLU . . . . . 0.548 ' H ' HG22 ' A' ' 728' ' ' THR . 12.6 pt-20 -62.25 -47.92 82.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.865 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.436 ' N ' ' HG3' ' A' ' 729' ' ' GLU . 69.9 m -123.92 16.26 9.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.817 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.51 173.36 14.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.177 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 732' ' ' ALA . . . . . 0.657 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -154.86 117.46 4.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.105 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 733' ' ' ARG . . . . . 0.469 ' N ' ' HD3' ' A' ' 733' ' ' ARG . 0.9 OUTLIER -81.87 98.21 8.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.84 -179.868 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 734' ' ' VAL . . . . . 0.427 HG22 HG22 ' A' ' 724' ' ' VAL . 69.6 t -103.14 142.79 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.168 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -97.5 102.38 14.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 40.7 mt -52.17 157.54 1.34 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.904 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 16.8 m170 -88.36 -36.4 16.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.865 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 61.2 m -73.98 -72.09 0.29 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.913 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 60.0 p -62.71 -17.45 60.76 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.184 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 3.3 m 53.0 39.36 29.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.863 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -133.58 151.72 51.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 742' ' ' THR . . . . . 0.457 ' CG2' ' HB3' ' A' ' 733' ' ' ARG . 53.7 m -80.99 143.1 32.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.11 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 743' ' ' ILE . . . . . 0.567 HD11 HD11 ' A' ' 712' ' ' ILE . 11.6 pt -143.71 141.82 25.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.183 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 58.3 p -85.17 117.35 24.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.833 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 39.2 t -134.79 141.19 43.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.132 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -51.4 128.14 21.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.876 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -46.51 -27.46 1.11 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.904 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -81.6 -45.35 15.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.934 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -53.32 -16.99 1.53 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.88 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.657 HD11 ' HB3' ' A' ' 732' ' ' ALA . 24.7 mt -89.21 135.96 33.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.892 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 89.8 m -118.06 93.59 4.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.091 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 3.4 p -41.44 135.33 2.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 753' ' ' VAL . . . . . 0.508 HG21 HG22 ' A' ' 709' ' ' THR . 97.2 t -80.1 -54.29 11.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.104 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -73.16 75.53 0.95 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.487 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 10.6 m -47.03 -49.58 20.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.845 0.355 . . . . 0.0 110.828 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -66.38 177.1 1.59 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.808 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 . . . . . 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.851 -179.886 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 N-CA-C 112.445 -0.262 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 26.8 m 48.67 41.91 18.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.846 0.355 . . . . 0.0 110.841 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 3.0 t -78.59 -48.81 14.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.857 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 79.41 -45.1 2.79 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.506 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 27.7 t -80.57 161.77 24.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.884 0.373 . . . . 0.0 110.873 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 49.8 m -130.42 -56.07 1.09 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.857 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 161.33 132.68 1.37 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.478 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 50.8 mtp -85.33 116.7 23.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.81 0.338 . . . . 0.0 110.849 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 2.6 m -123.31 122.04 37.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.96 9.4 14.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.884 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -108.73 64.9 0.25 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.502 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 46.4 ttp85 -104.96 101.18 10.76 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.896 0.379 . . . . 0.0 110.865 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -119.51 39.84 2.39 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.525 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 2.4 tpm_? -138.42 143.11 39.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.816 0.341 . . . . 0.0 110.854 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -109.0 118.03 35.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.86 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -97.8 117.86 33.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.834 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -127.04 33.89 4.84 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.908 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -82.0 -58.44 2.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.914 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . 0.419 HD12 ' CG ' ' A' ' 708' ' ' GLN . 51.3 tp -65.09 -11.55 40.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.925 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 706' ' ' ILE . . . . . 0.534 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -65.05 106.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.099 179.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 124.75 -17.31 7.28 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.49 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 708' ' ' GLN . . . . . 0.419 ' CG ' HD12 ' A' ' 705' ' ' LEU . 36.6 mm-40 -77.6 154.64 32.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.36 . . . . 0.0 110.931 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 709' ' ' THR . . . . . 0.5 HG22 HG21 ' A' ' 753' ' ' VAL . 68.2 m -86.4 112.95 21.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.182 -179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . 0.538 ' HA ' HG23 ' A' ' 753' ' ' VAL . 29.4 m -114.87 148.13 17.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.15 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 711' ' ' ARG . . . . . 0.448 ' HB2' HD13 ' A' ' 721' ' ' ILE . 19.3 ttt180 -122.81 113.39 19.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . 0.504 HG12 HD23 ' A' ' 750' ' ' LEU . 31.0 mt -61.1 107.82 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.145 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 3.5 m -101.46 12.3 37.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 11.7 mm100 -145.82 140.59 27.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.898 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 99.9 -168.58 21.44 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.497 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 716' ' ' PRO . . . . . 0.554 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.6 Cg_endo -69.77 -23.88 30.24 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.697 2.265 . . . . 0.0 112.354 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.554 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 55.3 m-85 -94.36 32.82 1.48 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.939 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -66.58 112.85 4.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.869 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 100.98 27.67 7.29 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.478 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 720' ' ' TYR . . . . . 0.468 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 10.9 m-85 -119.23 137.28 53.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.83 0.348 . . . . 0.0 110.915 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.448 HD13 ' HB2' ' A' ' 711' ' ' ARG . 12.4 mm -96.07 153.23 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.154 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -172.27 157.79 27.79 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.468 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 48.9 t -98.84 124.87 52.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.866 0.365 . . . . 0.0 111.12 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 43.8 t -60.54 108.63 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.133 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.12 -41.16 17.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.951 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -141.35 146.87 37.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.836 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 727' ' ' ALA . . . . . 0.418 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -111.5 120.37 41.89 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.11 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.9 163.02 13.3 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.181 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -58.99 -46.74 87.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 69.8 m -124.33 19.68 8.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.883 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.29 173.31 17.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.168 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 732' ' ' ALA . . . . . 0.477 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -157.28 117.59 3.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.064 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 733' ' ' ARG . . . . . 0.455 ' HD3' ' N ' ' A' ' 733' ' ' ARG . 0.9 OUTLIER -80.48 98.72 7.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 -179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 61.2 t -102.81 142.27 17.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -98.15 102.61 14.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.887 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 736' ' ' LEU . . . . . 0.468 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 34.9 mt -52.47 157.08 1.59 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.9 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 17.2 m170 -91.27 -23.22 20.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.862 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 13.8 m -83.6 -70.48 0.56 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 70.3 p -73.32 -2.58 22.65 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.155 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.2 m 40.01 45.93 1.7 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -132.44 151.91 51.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.948 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 742' ' ' THR . . . . . 0.443 ' CG2' ' HB3' ' A' ' 733' ' ' ARG . 54.9 m -84.66 133.95 34.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.124 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 14.7 pt -136.43 140.46 43.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.137 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 54.7 p -83.0 118.16 23.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.877 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 48.9 t -135.79 143.9 35.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.132 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.54 128.61 32.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 747' ' ' ARG . . . . . 0.407 ' HG2' ' HB2' ' A' ' 732' ' ' ALA . 27.5 mtm180 -46.53 -37.76 8.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -71.17 -44.33 65.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.915 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 62.3 mtt180 -54.86 -16.14 2.45 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.888 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.504 HD23 HG12 ' A' ' 712' ' ' ILE . 12.3 mt -98.14 126.37 43.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.934 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 92.1 m -103.95 102.85 12.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.141 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 10.4 p -42.63 121.16 1.91 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.116 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 753' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 754' ' ' GLY . 10.8 t -81.03 168.67 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.166 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . 0.595 ' N ' HG12 ' A' ' 753' ' ' VAL . . . -80.22 157.33 40.68 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.504 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 95.6 p -122.71 100.91 7.16 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.828 0.347 . . . . 0.0 110.856 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 5.9 ppt_? -121.82 148.33 44.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.878 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 27.3 p -105.74 175.66 5.42 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.852 0.358 . . . . 0.0 110.902 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 68.2 p -166.66 176.14 7.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.881 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 112.68 76.08 0.76 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.487 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 79.0 p -71.28 -49.8 39.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.89 0.376 . . . . 0.0 110.832 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 88.1 p -55.86 140.72 41.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.859 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . -112.02 -105.17 2.78 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.534 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.77 159.61 35.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.799 0.333 . . . . 0.0 110.864 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 6.2 m -131.73 161.77 32.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.868 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . 0.423 ' N ' ' HD3' ' A' ' 696' ' ' ARG . 0.0 OUTLIER -117.81 137.49 52.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.87 -179.915 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -130.7 -167.57 12.03 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.522 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -130.68 89.25 2.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.877 0.37 . . . . 0.0 110.85 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -130.62 169.64 21.33 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.457 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 24.0 ttp180 -73.11 152.43 41.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.766 0.317 . . . . 0.0 110.878 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 16.7 mtm-85 -69.31 115.15 8.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -109.17 108.97 19.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.92 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -117.42 28.8 8.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.69 -37.62 65.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.833 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . 0.454 ' HG ' HG21 ' A' ' 724' ' ' VAL . 48.0 tp -83.85 -14.84 50.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.935 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 706' ' ' ILE . . . . . 0.538 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -63.87 108.35 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.103 179.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 118.18 -14.84 12.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.438 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 49.5 mm-40 -73.16 162.23 29.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.844 0.354 . . . . 0.0 110.891 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 709' ' ' THR . . . . . 0.511 HG22 HG21 ' A' ' 753' ' ' VAL . 95.5 m -96.66 109.78 22.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 34.5 m -114.01 156.08 15.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.144 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 711' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 -123.98 117.43 24.74 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 23.4 mt -60.49 143.72 14.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.11 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 43.7 t -115.18 -34.78 4.9 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.836 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 37.0 mm-40 -113.37 179.98 3.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 78.34 177.09 47.87 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.526 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 716' ' ' PRO . . . . . 0.405 ' HG2' ' CE2' ' A' ' 717' ' ' TYR . 53.4 Cg_endo -69.78 1.79 4.13 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.726 2.284 . . . . 0.0 112.304 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.538 ' CD1' HD11 ' A' ' 736' ' ' LEU . 84.4 m-85 -120.33 35.82 4.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 57.0 tttt -67.5 139.3 57.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.883 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 71.76 32.96 63.54 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.466 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -119.21 158.52 25.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.843 0.354 . . . . 0.0 110.941 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 22.3 mm -107.88 147.55 12.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.128 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -163.23 162.21 34.62 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.491 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 37.1 t -106.35 129.72 59.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.877 0.37 . . . . 0.0 111.157 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 724' ' ' VAL . . . . . 0.454 HG21 ' HG ' ' A' ' 705' ' ' LEU . 41.1 t -66.48 108.27 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.104 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -85.24 -41.12 15.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.921 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -143.06 151.24 40.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.903 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 727' ' ' ALA . . . . . . . . . . . . . . . -111.94 116.88 31.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -103.65 158.85 16.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.14 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -50.0 -64.59 0.76 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.888 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 731' ' ' THR . 48.8 m -109.53 24.06 13.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.856 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 731' ' ' THR . . . . . 0.48 HG23 ' O ' ' A' ' 730' ' ' SER . 0.7 OUTLIER -160.03 173.29 16.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.17 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 732' ' ' ALA . . . . . 0.587 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -152.61 121.42 6.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.116 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 11.3 mmt85 -74.43 102.3 4.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.837 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 56.0 t -108.93 139.27 32.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.106 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -106.65 106.01 16.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 736' ' ' LEU . . . . . 0.538 HD11 ' CD1' ' A' ' 717' ' ' TYR . 30.4 mt -53.57 157.5 2.15 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.879 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 15.4 m170 -87.66 -37.12 17.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.888 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 14.3 m -73.64 -66.32 0.71 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.808 -179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 20.0 p -68.06 -15.99 63.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.131 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.7 m 49.15 42.07 20.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.866 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 741' ' ' GLN . . . . . 0.405 HE22 ' CG2' ' A' ' 743' ' ' ILE . 2.5 pp0? -129.09 148.72 51.06 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.917 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 4.5 m -87.66 144.29 26.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.136 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 743' ' ' ILE . . . . . 0.405 ' CG2' HE22 ' A' ' 741' ' ' GLN . 7.8 pt -151.79 144.72 16.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.154 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 91.3 p -87.56 118.88 27.34 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.859 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 65.4 t -133.47 143.13 39.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.127 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.23 129.71 21.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.846 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 24.1 mtm105 -49.58 -36.24 23.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -70.87 -45.03 65.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.926 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -53.86 -24.54 16.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.86 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 732' ' ' ALA . 21.3 mt -84.03 144.65 28.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 6.3 m -124.42 99.24 6.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.145 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 9.1 p -47.83 118.99 2.56 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.113 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 753' ' ' VAL . . . . . 0.511 HG21 HG22 ' A' ' 709' ' ' THR . 95.8 t -62.14 -44.56 99.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.104 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 154.8 -116.52 0.73 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.489 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 87.3 p -135.1 126.76 29.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.827 0.346 . . . . 0.0 110.899 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.31 166.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.828 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 15.9 mtt180 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.861 -179.914 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.275 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 1.7 t -101.11 41.83 1.16 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.878 0.37 . . . . 0.0 110.829 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 1.5 t -163.07 140.64 7.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -72.81 93.04 0.64 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.5 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 78.6 p -137.23 117.96 14.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.906 0.384 . . . . 0.0 110.828 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 39.9 t -144.16 159.64 42.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.874 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 49.81 44.4 39.65 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.465 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 7.5 ttt -131.05 115.7 16.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.783 0.325 . . . . 0.0 110.872 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 3.0 t -46.98 105.73 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.81 137.1 57.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.89 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -100.03 82.31 0.53 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.477 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 24.1 mmm-85 -85.71 101.48 12.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 110.843 -179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -102.33 -81.78 1.59 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.507 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 48.5 mtt180 -102.07 123.64 46.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.859 0.361 . . . . 0.0 110.866 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 701' ' ' ARG . . . . . 0.409 ' C ' ' HD2' ' A' ' 701' ' ' ARG . 0.5 OUTLIER -55.75 147.48 18.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.844 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.66 41.75 3.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.826 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -100.68 25.83 7.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.894 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 38.1 tp10 -74.55 -55.63 5.72 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . 0.409 HD12 ' CG ' ' A' ' 708' ' ' GLN . 48.1 tp -64.04 -12.24 36.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.904 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 706' ' ' ILE . . . . . 0.617 HD11 ' HB2' ' A' ' 727' ' ' ALA . 0.6 OUTLIER -65.18 108.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.125 179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 122.06 -13.08 9.11 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.519 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 708' ' ' GLN . . . . . 0.409 ' CG ' HD12 ' A' ' 705' ' ' LEU . 40.4 mm-40 -77.71 160.91 28.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.837 0.351 . . . . 0.0 110.937 -179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 87.1 m -93.65 107.35 19.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.12 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . 0.422 HG12 ' HA ' ' A' ' 752' ' ' THR . 34.2 m -112.05 150.96 14.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.131 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 711' ' ' ARG . . . . . 0.421 ' HB2' HD13 ' A' ' 721' ' ' ILE . 23.1 ttm-85 -122.21 115.69 22.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.845 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 25.8 mt -62.41 142.1 17.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.1 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 29.1 t -122.21 -22.38 5.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.791 -179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -110.04 177.64 4.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.905 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 67.45 -179.54 15.72 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.463 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 716' ' ' PRO . . . . . 0.575 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.1 Cg_endo -69.82 -8.24 23.11 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.694 2.262 . . . . 0.0 112.299 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.575 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 38.4 m-85 -103.56 29.89 5.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.919 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 40.9 tttm -65.22 137.43 57.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.899 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 74.26 36.12 51.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.486 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 720' ' ' TYR . . . . . 0.466 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 6.3 m-85 -123.81 145.01 49.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.889 0.376 . . . . 0.0 110.89 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.421 HD13 ' HB2' ' A' ' 711' ' ' ARG . 21.7 mm -98.58 154.04 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.144 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 722' ' ' GLY . . . . . 0.421 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -173.79 161.02 31.35 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.478 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 54.3 t -105.16 125.1 60.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.879 0.371 . . . . 0.0 111.145 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 48.5 t -60.41 108.4 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.119 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.7 mmpt? -84.79 -40.41 17.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.928 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -140.79 149.82 42.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.827 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 727' ' ' ALA . . . . . 0.617 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -113.5 118.66 35.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.081 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.73 164.37 11.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.149 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -57.16 -52.08 66.73 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 5.1 m -120.16 16.44 12.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.837 -179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -151.4 173.28 14.73 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.136 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 732' ' ' ALA . . . . . 0.658 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -151.93 121.02 6.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.11 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 22.7 mmt180 -80.53 98.4 7.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.866 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 90.0 t -103.32 140.72 20.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.123 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 735' ' ' GLU . . . . . 0.402 ' O ' ' CD ' ' A' ' 735' ' ' GLU . 6.5 tm-20 -99.34 99.43 10.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.849 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 736' ' ' LEU . . . . . 0.466 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 27.6 mt -49.71 157.05 0.61 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.948 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -90.34 -31.86 16.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.879 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 58.8 m -75.09 -65.12 0.92 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.837 -179.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 71.8 p -74.09 -8.53 56.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.103 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 3.3 m 44.75 43.17 6.59 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.876 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -132.68 155.62 48.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.881 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 20.0 m -87.95 141.26 28.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.107 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 11.8 pt -146.53 145.06 20.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.157 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 89.5 p -87.66 118.1 26.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 92.9 t -132.71 142.86 41.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.147 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.55 128.57 17.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.873 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 23.4 mtm180 -49.62 -28.4 5.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.846 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 40.3 mm-40 -81.36 -42.55 20.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.893 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -55.25 -19.15 7.5 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.823 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.658 HD11 ' HB3' ' A' ' 732' ' ' ALA . 18.0 mt -88.85 134.86 33.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.9 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 751' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 752' ' ' THR . 86.4 m -116.07 89.7 3.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.147 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . 0.422 ' HA ' HG12 ' A' ' 710' ' ' VAL . 9.4 p -36.52 118.09 0.53 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.135 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 753' ' ' VAL . . . . . . . . . . . . . 87.7 t -66.37 -65.11 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.101 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -64.29 122.33 25.02 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.486 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 86.5 p -126.18 113.92 17.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.859 0.362 . . . . 0.0 110.825 -179.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 756' ' ' ARG . . . . . 0.414 ' HB2' ' NH1' ' A' ' 756' ' ' ARG . 0.2 OUTLIER -91.2 127.6 36.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.891 -179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.921 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 25.4 m 60.69 42.18 14.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.877 0.37 . . . . 0.0 110.877 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 28.7 p -148.65 163.4 37.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.849 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . -175.12 167.43 39.52 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 39.2 t -78.62 100.68 7.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.87 0.367 . . . . 0.0 110.884 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 69.6 p -83.53 -45.68 13.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.827 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 94.72 101.15 1.74 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.487 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 12.8 mmm -89.94 -59.64 2.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.809 0.338 . . . . 0.0 110.884 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 3.2 t -114.57 109.05 17.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.817 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 31.6 mmt180 -93.13 115.41 28.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.838 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -133.22 130.29 5.69 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.467 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -60.1 -44.93 94.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.861 0.362 . . . . 0.0 110.872 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -41.65 140.84 1.48 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.506 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -56.37 178.08 0.06 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.866 0.365 . . . . 0.0 110.879 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 31.4 ttm180 -100.76 49.37 0.89 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.918 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -95.9 41.61 1.1 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.884 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -95.84 28.81 2.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -71.85 -60.83 2.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 18.9 tp -62.26 -16.45 53.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.943 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 706' ' ' ILE . . . . . 0.523 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.7 OUTLIER -60.84 110.41 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.083 179.838 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 118.86 -19.93 10.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.483 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 53.9 mm-40 -66.85 166.66 12.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 110.951 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 709' ' ' THR . . . . . 0.402 HG22 ' CG2' ' A' ' 753' ' ' VAL . 71.8 m -99.92 109.19 21.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.151 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . 0.48 HG12 HG22 ' A' ' 752' ' ' THR . 35.7 m -113.12 151.5 15.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.161 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 711' ' ' ARG . . . . . 0.479 ' HB2' HD13 ' A' ' 721' ' ' ILE . 29.6 ttt180 -123.39 114.44 20.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.89 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . 0.409 HD12 HD21 ' A' ' 736' ' ' LEU . 34.7 mt -61.72 134.73 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 4.2 t -112.79 -31.66 6.66 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -102.01 176.37 5.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 71.7 177.95 28.96 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.484 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 716' ' ' PRO . . . . . 0.569 ' HG2' ' CE1' ' A' ' 717' ' ' TYR . 53.5 Cg_endo -69.78 -6.93 19.79 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.706 2.27 . . . . 0.0 112.307 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.569 ' CE1' ' HG2' ' A' ' 716' ' ' PRO . 44.5 m-85 -105.89 33.24 3.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.918 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -68.87 138.11 54.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.93 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 77.17 30.92 54.15 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.483 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -120.77 144.59 48.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.79 0.329 . . . . 0.0 110.948 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.479 HD13 ' HB2' ' A' ' 711' ' ' ARG . 38.7 mm -97.4 150.38 4.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.09 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -166.48 161.81 35.49 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.461 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 63.8 t -107.55 126.74 63.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.845 0.355 . . . . 0.0 111.175 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 50.2 t -63.73 104.73 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.132 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -80.58 -41.66 23.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.894 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -143.34 146.6 33.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.89 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 727' ' ' ALA . . . . . 0.447 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -106.17 115.33 30.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.121 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.18 160.65 14.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.114 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 33.3 tp10 -47.03 -70.72 0.09 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.88 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 3.2 m -106.09 16.9 24.35 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.845 -179.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -148.87 173.32 13.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 732' ' ' ALA . . . . . 0.601 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -150.68 120.91 7.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.123 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 54.9 mmm-85 -76.65 98.43 4.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 71.5 t -104.78 144.76 14.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.106 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 19.7 tt0 -105.3 101.6 11.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.877 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 736' ' ' LEU . . . . . 0.409 HD21 HD12 ' A' ' 712' ' ' ILE . 52.5 mt -50.55 161.18 0.34 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.904 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 16.3 m170 -95.5 -44.98 7.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.841 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 40.5 t -67.55 -64.7 0.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.876 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 82.1 p -70.75 -21.85 62.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.101 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 17.2 m 55.56 43.66 28.0 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.838 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 67.8 mm-40 -127.21 145.13 50.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.936 -179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 17.3 m -85.2 116.83 23.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.143 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 11.5 pt -124.37 149.62 28.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 82.2 p -94.23 118.19 31.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.843 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.818 ' HB ' HD21 ' A' ' 750' ' ' LEU . 62.0 t -127.85 144.92 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.15 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -50.72 125.93 14.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.839 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 30.2 mtm180 -44.61 -24.1 0.17 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.88 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -89.31 -42.86 11.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.922 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -53.85 -18.54 3.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.899 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.818 HD21 ' HB ' ' A' ' 745' ' ' VAL . 12.6 mt -91.25 134.41 34.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.893 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 19.6 m -112.39 90.76 3.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . 0.48 HG22 HG12 ' A' ' 710' ' ' VAL . 10.2 p -41.13 118.31 0.99 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.099 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 753' ' ' VAL . . . . . 0.402 ' CG2' HG22 ' A' ' 709' ' ' THR . 86.0 t -61.29 -45.47 98.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.078 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . 90.8 -167.37 32.02 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.489 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 19.7 m -100.72 147.53 25.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.917 0.389 . . . . 0.0 110.82 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 16.5 ptt85 -123.96 -1.48 8.32 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.911 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.823 -179.868 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 19.3 m -81.38 107.07 13.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.871 0.367 . . . . 0.0 110.889 -179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 4.4 t -91.63 -61.46 1.64 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.856 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 134.64 -167.83 23.78 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.518 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 58.2 m -81.57 89.86 6.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 0.0 110.831 -179.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 8.1 t -59.96 -57.94 10.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.835 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . -132.98 74.22 0.44 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.487 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 9.3 tmm? -58.14 -61.14 2.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.796 0.332 . . . . 0.0 110.861 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 6.0 t -75.73 102.44 5.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -179.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 26.0 mmt-85 -118.41 88.81 3.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.841 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -62.15 -47.64 88.4 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.522 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 8.2 mmp_? -125.33 156.83 38.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.828 0.347 . . . . 0.0 110.903 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -123.89 166.82 16.29 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.508 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.02 -13.13 14.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.859 0.362 . . . . 0.0 110.912 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 2.2 tpp85 -136.56 146.74 46.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.889 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -76.76 98.28 4.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.893 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -105.99 26.12 10.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -77.08 -55.55 5.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.916 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . 0.426 HD12 ' CG ' ' A' ' 708' ' ' GLN . 45.6 tp -62.03 -14.12 32.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.894 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 706' ' ' ILE . . . . . 0.532 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -64.81 107.19 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.143 179.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 121.65 -16.09 9.03 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.482 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 708' ' ' GLN . . . . . 0.426 ' CG ' HD12 ' A' ' 705' ' ' LEU . 51.6 mm-40 -74.58 155.54 37.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.878 0.371 . . . . 0.0 110.907 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 709' ' ' THR . . . . . . . . . . . . . 55.9 m -92.34 110.43 21.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.162 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . 0.454 HG12 ' HA ' ' A' ' 752' ' ' THR . 35.4 m -113.3 161.97 11.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.1 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 711' ' ' ARG . . . . . 0.497 ' HB2' HD13 ' A' ' 721' ' ' ILE . 23.6 ttt-85 -129.85 117.89 20.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . 0.429 HD11 HD11 ' A' ' 743' ' ' ILE . 26.5 mt -62.36 111.21 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.127 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 1.1 t -107.55 18.47 21.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -153.11 130.48 11.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.933 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 109.48 -171.79 15.48 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.467 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 716' ' ' PRO . . . . . 0.553 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 54.0 Cg_endo -69.73 -19.92 35.63 Favored 'Trans proline' 0 C--O 1.231 0.173 0 C-N-CA 122.667 2.245 . . . . 0.0 112.384 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.553 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 70.3 m-85 -99.81 31.35 3.28 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.917 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 19.0 tttp -64.93 133.31 51.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.904 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 719' ' ' GLY . . . . . 0.44 ' HA2' ' CZ ' ' A' ' 711' ' ' ARG . . . 84.9 23.83 47.81 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.466 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -116.15 143.68 45.17 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.906 0.384 . . . . 0.0 110.911 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.59 HD12 HG21 ' A' ' 753' ' ' VAL . 44.9 mm -97.82 162.46 2.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.162 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 722' ' ' GLY . . . . . 0.588 ' N ' HG22 ' A' ' 721' ' ' ILE . . . 178.2 153.07 10.83 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.501 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 42.7 t -97.57 129.75 47.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.861 0.362 . . . . 0.0 111.124 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 48.1 t -64.89 108.84 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.123 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 9.5 mmpt? -85.42 -40.28 16.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.904 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -141.86 146.01 35.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.844 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 727' ' ' ALA . . . . . 0.445 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -106.6 119.0 38.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.073 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.86 156.61 18.17 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.148 -179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -42.31 -74.92 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.896 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 58.6 m -103.53 19.68 19.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.895 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -151.16 173.34 14.52 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.122 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 732' ' ' ALA . . . . . 0.687 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -152.2 122.5 7.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.072 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 6.1 mmt85 -77.84 98.66 5.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.906 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.49 142.38 18.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.131 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -104.24 105.38 15.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.896 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 66.7 mt -49.76 157.66 0.55 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 13.2 m170 -88.74 -57.99 2.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.808 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 8.9 t -59.0 -70.8 0.14 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.849 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 69.6 p -58.39 -34.46 70.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.125 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 3.9 t 66.57 47.36 1.65 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.886 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -130.73 147.89 52.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 22.9 m -89.65 129.11 36.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.126 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 743' ' ' ILE . . . . . 0.429 HD11 HD11 ' A' ' 712' ' ' ILE . 9.2 pt -137.32 150.75 26.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.161 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 78.6 p -95.25 121.65 37.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.587 HG12 ' HB2' ' A' ' 749' ' ' ARG . 19.0 t -134.54 143.87 36.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.119 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -49.51 126.18 12.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.921 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 35.6 mtm180 -43.96 -29.55 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -81.12 -43.08 19.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.913 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 749' ' ' ARG . . . . . 0.587 ' HB2' HG12 ' A' ' 745' ' ' VAL . 76.5 mtt180 -53.4 -16.4 1.39 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.909 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.687 HD11 ' HB3' ' A' ' 732' ' ' ALA . 14.6 mt -92.17 145.38 24.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 90.5 m -125.86 95.68 4.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.095 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . 0.454 ' HA ' HG12 ' A' ' 710' ' ' VAL . 3.3 p -38.39 118.46 0.72 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 753' ' ' VAL . . . . . 0.59 HG21 HD12 ' A' ' 721' ' ' ILE . 93.6 t -71.24 -42.31 74.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.105 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -43.58 -48.47 7.24 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.5 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 29.8 t -93.06 -73.69 0.55 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.84 0.352 . . . . 0.0 110.857 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 28.9 mtp85 -73.62 165.01 25.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.83 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 757' ' ' ARG . . . . . 0.416 ' C ' ' HD3' ' A' ' 757' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.841 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 69.8 m -104.52 127.52 52.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.914 0.388 . . . . 0.0 110.849 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 19.1 t -100.97 -55.13 2.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.856 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 136.68 -61.77 0.6 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.469 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 67.3 p 40.36 42.21 1.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.882 0.372 . . . . 0.0 110.858 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 20.4 m -71.51 175.4 5.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.841 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 158.95 97.33 0.12 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.532 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -126.09 150.64 48.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.737 0.303 . . . . 0.0 110.912 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 20.7 m -102.33 151.23 22.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.841 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 6.2 tpm_? -113.0 -52.34 2.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.85 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -67.61 98.02 0.44 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.499 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 698' ' ' ARG . . . . . . . . . . . . . 8.7 tpm_? -75.05 89.68 2.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.85 0.357 . . . . 0.0 110.875 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -137.82 -154.53 6.59 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.515 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -104.58 142.86 33.91 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.798 0.332 . . . . 0.0 110.859 -179.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 19.8 ttp180 -115.09 107.57 15.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.862 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -105.97 48.55 0.83 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.862 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -99.58 43.93 1.04 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.885 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -76.61 -62.49 1.61 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.882 179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . 0.482 HD12 ' CG ' ' A' ' 708' ' ' GLN . 33.9 tp -60.59 -10.91 5.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.927 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 706' ' ' ILE . . . . . 0.517 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.6 OUTLIER -63.41 110.98 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.117 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 724' ' ' VAL . . . 118.3 -21.28 10.1 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.495 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 708' ' ' GLN . . . . . 0.482 ' CG ' HD12 ' A' ' 705' ' ' LEU . 38.5 mm-40 -70.6 158.65 35.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.908 0.385 . . . . 0.0 110.945 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 709' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 753' ' ' VAL . 87.6 m -91.28 109.47 20.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.127 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . 0.535 HG21 HG21 ' A' ' 734' ' ' VAL . 26.9 m -112.51 146.6 17.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.145 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 711' ' ' ARG . . . . . 0.549 ' HB2' HD13 ' A' ' 721' ' ' ILE . 52.5 ttt180 -121.53 113.63 20.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . . . . . . . . . 20.8 mt -56.86 143.67 10.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.161 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 17.0 t -118.25 -28.02 5.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 714' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -116.39 177.14 4.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.94 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 76.64 179.01 47.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.448 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 716' ' ' PRO . . . . . 0.493 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.3 Cg_endo -69.78 -1.94 9.34 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.679 2.252 . . . . 0.0 112.317 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.493 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 75.5 m-85 -115.02 31.66 6.55 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.975 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 13.7 tttp -65.95 131.41 46.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.904 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.79 29.06 44.15 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.447 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 720' ' ' TYR . . . . . 0.42 ' HB3' ' CD2' ' A' ' 736' ' ' LEU . 8.0 m-85 -116.16 142.58 46.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.832 0.349 . . . . 0.0 110.951 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . 0.549 HD13 ' HB2' ' A' ' 711' ' ' ARG . 30.9 mm -98.52 152.53 4.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.156 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 722' ' ' GLY . . . . . 0.41 ' N ' HG22 ' A' ' 721' ' ' ILE . . . -169.93 164.14 37.55 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.52 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . 0.474 ' C ' HG13 ' A' ' 734' ' ' VAL . 55.1 t -106.34 123.17 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.84 0.352 . . . . 0.0 111.137 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 724' ' ' VAL . . . . . 0.824 ' HA ' HG22 ' A' ' 734' ' ' VAL . 45.8 t -63.49 112.18 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.13 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 7.2 mmmm -91.05 -37.06 13.67 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.872 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -142.69 144.21 32.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 727' ' ' ALA . . . . . 0.429 ' N ' HD11 ' A' ' 706' ' ' ILE . . . -113.49 113.77 25.61 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.142 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 728' ' ' THR . . . . . 0.545 HG22 ' H ' ' A' ' 729' ' ' GLU . 1.2 m -96.21 170.29 9.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.168 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 729' ' ' GLU . . . . . 0.545 ' H ' HG22 ' A' ' 728' ' ' THR . 14.4 pt-20 -63.15 -49.08 75.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.868 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.458 ' N ' ' HG3' ' A' ' 729' ' ' GLU . 60.4 m -120.68 14.2 11.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.89 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 731' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.6 173.27 14.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.127 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 732' ' ' ALA . . . . . 0.562 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -155.32 117.54 4.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.086 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 733' ' ' ARG . . . . . 0.454 ' HB3' ' CG2' ' A' ' 742' ' ' THR . 0.9 OUTLIER -81.36 102.99 10.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.911 -179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 734' ' ' VAL . . . . . 0.824 HG22 ' HA ' ' A' ' 724' ' ' VAL . 53.4 t -111.7 137.55 43.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -90.11 101.61 14.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 736' ' ' LEU . . . . . 0.42 ' CD2' ' HB3' ' A' ' 720' ' ' TYR . 23.5 mt -50.89 156.37 1.0 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.896 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 18.5 m170 -85.12 -40.35 16.86 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 54.7 m -70.44 -70.55 0.29 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 43.5 p -61.74 -24.61 66.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.142 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 2.0 m 59.33 38.43 23.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.886 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -134.9 155.36 50.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.928 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 742' ' ' THR . . . . . 0.454 ' CG2' ' HB3' ' A' ' 733' ' ' ARG . 54.9 m -81.7 138.95 35.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.138 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 8.4 pt -141.18 143.25 28.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 84.2 p -85.13 112.33 20.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . 0.546 ' HB ' HD21 ' A' ' 750' ' ' LEU . 47.9 t -127.29 147.22 32.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.097 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -58.04 127.64 33.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.905 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 18.6 mtm180 -48.16 -25.68 1.58 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.819 -179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -84.72 -43.54 14.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.929 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 749' ' ' ARG . . . . . . . . . . . . . 48.2 mtm180 -58.5 -11.63 3.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.562 HD11 ' HB3' ' A' ' 732' ' ' ALA . 18.5 mt -96.1 127.4 42.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 20.4 m -104.47 103.58 13.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.117 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 2.3 p -47.88 121.3 4.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.134 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 753' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 754' ' ' GLY . 6.3 t -83.06 168.81 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . 0.572 ' N ' HG12 ' A' ' 753' ' ' VAL . . . -126.37 157.64 20.26 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.499 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 57.5 p -61.05 -63.64 1.23 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.881 0.372 . . . . 0.0 110.847 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 756' ' ' ARG . . . . . 0.448 ' O ' ' C ' ' A' ' 757' ' ' ARG . 14.4 ptm180 -62.19 169.79 2.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.868 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 757' ' ' ARG . . . . . 0.448 ' C ' ' O ' ' A' ' 756' ' ' ARG . 11.3 mtp85 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.915 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 687' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 N-CA-C 112.432 -0.267 . . . . 0.0 112.432 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 688' ' ' SER . . . . . . . . . . . . . 61.6 p -99.6 119.07 37.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.925 0.393 . . . . 0.0 110.866 -179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 81.4 p -96.68 176.96 5.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.845 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 690' ' ' GLY . . . . . . . . . . . . . . . 175.64 154.06 11.02 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.515 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 691' ' ' SER . . . . . . . . . . . . . 15.0 m -73.25 142.12 47.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.916 0.389 . . . . 0.0 110.789 -179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 692' ' ' SER . . . . . . . . . . . . . 14.8 t -145.38 174.86 10.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.837 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 693' ' ' GLY . . . . . . . . . . . . . . . 154.19 93.87 0.1 Allowed Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.472 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 694' ' ' MET . . . . . . . . . . . . . 2.9 mmm -96.18 -43.56 7.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.774 0.321 . . . . 0.0 110.917 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 695' ' ' SER . . . . . . . . . . . . . 16.6 m -48.16 136.71 11.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.835 -179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 696' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.81 164.97 12.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.843 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 697' ' ' GLY . . . . . . . . . . . . . . . -131.2 -142.71 5.1 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.491 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 698' ' ' ARG . . . . . 0.488 ' H ' ' NE ' ' A' ' 698' ' ' ARG . 0.0 OUTLIER -84.24 26.62 0.74 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.843 0.354 . . . . 0.0 110.844 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 699' ' ' GLY . . . . . . . . . . . . . . . -80.8 85.8 1.36 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.487 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 700' ' ' ARG . . . . . . . . . . . . . 53.4 ttp180 -80.75 -43.64 19.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.846 0.355 . . . . 0.0 110.904 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 701' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 -136.48 112.23 9.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.854 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 702' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -111.01 48.17 0.94 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 703' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -84.49 35.2 0.54 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.842 -179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 704' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -82.2 -49.19 10.4 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.915 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 705' ' ' LEU . . . . . . . . . . . . . 37.7 tp -65.2 -10.44 31.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 706' ' ' ILE . . . . . 0.608 ' N ' ' CD1' ' A' ' 706' ' ' ILE . 0.5 OUTLIER -70.04 108.69 2.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.097 179.86 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 707' ' ' GLY . . . . . . . . . . . . . . . 120.4 -15.76 9.91 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.449 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 708' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -74.62 158.63 33.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.918 0.39 . . . . 0.0 110.918 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 709' ' ' THR . . . . . 0.473 HG22 HG21 ' A' ' 753' ' ' VAL . 98.6 m -94.76 107.33 19.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.116 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 710' ' ' VAL . . . . . . . . . . . . . 31.6 m -111.02 160.68 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 711' ' ' ARG . . . . . 0.405 ' HB2' HG22 ' A' ' 753' ' ' VAL . 26.9 ttt180 -130.43 108.74 10.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.84 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 712' ' ' ILE . . . . . 0.466 HG12 HD23 ' A' ' 750' ' ' LEU . 72.0 mt -55.78 102.92 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.144 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 713' ' ' SER . . . . . . . . . . . . . 5.3 m -97.61 23.23 7.98 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.832 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 714' ' ' GLN . . . . . 0.402 ' CB ' ' HG2' ' A' ' 749' ' ' ARG . 12.2 mp0 -149.59 -179.23 6.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 715' ' ' GLY . . . . . . . . . . . . . . . 59.82 -167.56 8.7 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.478 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 716' ' ' PRO . . . . . 0.576 ' HG2' ' CD1' ' A' ' 717' ' ' TYR . 53.2 Cg_endo -69.79 -33.38 16.59 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.679 2.252 . . . . 0.0 112.328 -179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 717' ' ' TYR . . . . . 0.576 ' CD1' ' HG2' ' A' ' 716' ' ' PRO . 50.1 m-85 -85.11 44.9 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.926 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 718' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -73.42 131.21 41.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.854 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 719' ' ' GLY . . . . . . . . . . . . . . . 80.66 37.42 20.03 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.469 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 720' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -124.35 139.6 53.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.866 0.365 . . . . 0.0 110.901 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 721' ' ' ILE . . . . . . . . . . . . . 39.1 mm -95.95 145.41 8.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.158 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 722' ' ' GLY . . . . . . . . . . . . . . . -165.02 160.1 33.33 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 723' ' ' VAL . . . . . . . . . . . . . 41.6 t -104.61 128.34 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.891 0.377 . . . . 0.0 111.111 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 724' ' ' VAL . . . . . . . . . . . . . 57.4 t -65.51 111.03 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.087 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 725' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.37 -34.54 15.63 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.915 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 726' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -146.44 146.98 30.77 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.833 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 727' ' ' ALA . . . . . 0.431 ' HB2' HD11 ' A' ' 706' ' ' ILE . . . -108.12 115.55 30.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.11 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 728' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.64 159.06 15.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.173 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 729' ' ' GLU . . . . . . . . . . . . . 16.8 tt0 -47.68 -67.24 0.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.862 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.482 ' O ' HG23 ' A' ' 731' ' ' THR . 75.3 m -109.5 25.55 11.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.84 -179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 731' ' ' THR . . . . . 0.482 HG23 ' O ' ' A' ' 730' ' ' SER . 0.8 OUTLIER -160.04 173.22 16.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.155 -179.925 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 732' ' ' ALA . . . . . 0.518 ' HB3' HD11 ' A' ' 750' ' ' LEU . . . -150.8 120.02 6.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.102 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 733' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -73.79 96.52 2.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.847 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 734' ' ' VAL . . . . . . . . . . . . . 95.9 t -103.61 140.19 22.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.135 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 735' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -100.69 100.82 11.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 736' ' ' LEU . . . . . . . . . . . . . 51.5 mt -50.6 160.68 0.4 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 737' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -96.81 -37.51 10.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 738' ' ' SER . . . . . . . . . . . . . 35.4 t -70.51 -59.13 3.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.894 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 68.5 p -78.38 -23.27 46.9 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.149 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 740' ' ' CYS . . . . . . . . . . . . . 5.0 m 60.42 40.42 17.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.867 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 741' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -125.34 150.17 47.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 742' ' ' THR . . . . . . . . . . . . . 26.9 m -91.03 111.61 23.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.206 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 743' ' ' ILE . . . . . . . . . . . . . 6.9 pt -119.64 150.2 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.085 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 744' ' ' SER . . . . . . . . . . . . . 82.9 p -90.84 124.1 34.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.898 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 74.5 t -136.66 143.04 36.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.092 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 746' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -49.03 129.84 17.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.887 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 747' ' ' ARG . . . . . . . . . . . . . 12.1 mtm105 -50.07 -29.44 8.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.883 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 748' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -79.32 -44.76 20.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.93 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 749' ' ' ARG . . . . . 0.402 ' HG2' ' CB ' ' A' ' 714' ' ' GLN . 37.5 mtm180 -54.87 -15.57 2.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.883 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 750' ' ' LEU . . . . . 0.518 HD11 ' HB3' ' A' ' 732' ' ' ALA . 23.8 mt -92.93 128.64 38.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.883 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 751' ' ' THR . . . . . . . . . . . . . 85.7 m -112.06 103.09 11.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.115 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 752' ' ' THR . . . . . . . . . . . . . 16.7 p -43.94 116.66 1.03 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.123 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 753' ' ' VAL . . . . . 0.473 HG21 HG22 ' A' ' 709' ' ' THR . 96.6 t -63.26 -45.72 97.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.129 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 754' ' ' GLY . . . . . . . . . . . . . . . -39.96 141.3 0.76 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.482 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 755' ' ' SER . . . . . . . . . . . . . 11.0 t -120.4 -52.01 2.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.892 0.377 . . . . 0.0 110.852 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 756' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -129.34 -3.39 4.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 757' ' ' ARG . . . . . . . . . . . . . 18.5 ptt180 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.9 180.0 . . . . . . . . 0 0 . 1 stop_ save_